
<html lang="en"     class="pb-page"  data-request-id="5b461d3b-e594-48cd-8d24-71303ebc689f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-8;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b01457"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials" /></meta><meta name="dc.Creator" content="Mario  Fiore" /></meta><meta name="dc.Creator" content="Stefano  Forli" /></meta><meta name="dc.Creator" content="Fabrizio  Manetti" /></meta><meta name="dc.Description" content="The p38/MAPK-activated kinase 2 (MK2) pathway is involved in a series of pathological conditions (inflammation diseases and metastasis) and in the resistance mechanism to antitumor agents. None of ..." /></meta><meta name="Description" content="The p38/MAPK-activated kinase 2 (MK2) pathway is involved in a series of pathological conditions (inflammation diseases and metastasis) and in the resistance mechanism to antitumor agents. None of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 9, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01457" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01457" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01457" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01457" /></link>
        
    
    

<title>Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01457" /></meta><meta property="og:title" content="Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0039.jpeg" /></meta><meta property="og:description" content="The p38/MAPK-activated kinase 2 (MK2) pathway is involved in a series of pathological conditions (inflammation diseases and metastasis) and in the resistance mechanism to antitumor agents. None of the p38 inhibitors entered advanced clinical trials because of their unwanted systemic side effects. For this reason, MK2 was identified as an alternative target to block the pathway but avoiding the side effects of p38 inhibition. However, ATP-competitive MK2 inhibitors suffered from low solubility, poor cell permeability, and scarce kinase selectivity. Fortunately, non-ATP-competitive inhibitors of MK2 have been already discovered that allowed circumventing the selectivity issue. These compounds showed the additional advantage to be effective at lower concentrations in comparison to the ATP-competitive inhibitors. Therefore, although the significant difficulties encountered during the development of these inhibitors, MK2 is still considered as an attractive target to treat inflammation and related diseases to prevent tumor metastasis and to increase tumor sensitivity to chemotherapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01457"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01457">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01457&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01457&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01457&amp;href=/doi/10.1021/acs.jmedchem.5b01457" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3609-3634</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01273" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01718" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Fiore">Mario Fiore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Forli">Stefano Forli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Manetti">Fabrizio Manetti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, via A. Moro 2, I-53100 Siena, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +39 0577 234330. Fax: +39 0577 234254. E-mail: <a href="/cdn-cgi/l/email-protection#80e6e1e2f2e9fae9efaeede1eee5f4f4e9c0f5eee9f3e9aee9f4"><span class="__cf_email__" data-cfemail="4c2a2d2e3e2536252362212d22293838250c3922253f25622538">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01457&amp;href=/doi/10.1021%2Facs.jmedchem.5b01457" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3609–3634</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 26, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 September 2015</li><li><span class="item_label"><b>Published</b> online</span>9 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01457" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01457</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3609%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMario%2BFiore%252C%2BStefano%2BForli%252C%2BFabrizio%2BManetti%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D8%26contentID%3Dacs.jmedchem.5b01457%26title%3DTargeting%2BMitogen-Activated%2BProtein%2BKinase-Activated%2BProtein%2BKinase%2B2%2B%2528MAPKAPK2%252C%2BMK2%2529%253A%2BMedicinal%2BChemistry%2BEfforts%2BTo%2BLead%2BSmall%2BMolecule%2BInhibitors%2Bto%2BClinical%2BTrials%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3634%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01457"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3100</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01457" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Forli&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Manetti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3609-3634&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01457&quot;},&quot;abstract&quot;:&quot;The p38/MAPK-activated kinase 2 (MK2) pathway is involved in a series of pathological conditions (inflammation diseases and metastasis) and in the resistance mechanism to antitumor agents. None of the p38 inhibitors entered advanced clinical trials because of their unwanted systemic side effects. For this reason, MK2 was identified as an alternative target to block the pathway but avoiding the side effects of p38 inhibition. However, ATP-competitive MK2 inhibitors suffered from low solubility, poor cell permeability, and scarce kinase selectivity. Fortunately, non-ATP-competitive inhibitors of MK2 have been already discovered that allowed circumventing the selectivity issue. These compounds showed the additional advantage to be effective at lower concentrations in comparison to the ATP-competitive inhibitors. Therefore, although the significant difficulties encountered during the development of these inhibitors, MK2 is still considered as an attractive target to treat inflammation and related diseases to prev&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01457" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01457&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01457" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01457&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01457" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01457&amp;href=/doi/10.1021/acs.jmedchem.5b01457" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01457" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01457" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01457%26sid%3Dliteratum%253Aachs%26pmid%3D26502061%26genre%3Darticle%26aulast%3DFiore%26date%3D2016%26atitle%3DTargeting%2BMitogen-Activated%2BProtein%2BKinase-Activated%2BProtein%2BKinase%2B2%2B%2528MAPKAPK2%252C%2BMK2%2529%253A%2BMedicinal%2BChemistry%2BEfforts%2BTo%2BLead%2BSmall%2BMolecule%2BInhibitors%2Bto%2BClinical%2BTrials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D8%26spage%3D3609%26epage%3D3634%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/jmcmar.2016.59.issue-8/20160428/jmcmar.2016.59.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The p38/MAPK-activated kinase 2 (MK2) pathway is involved in a series of pathological conditions (inflammation diseases and metastasis) and in the resistance mechanism to antitumor agents. None of the p38 inhibitors entered advanced clinical trials because of their unwanted systemic side effects. For this reason, MK2 was identified as an alternative target to block the pathway but avoiding the side effects of p38 inhibition. However, ATP-competitive MK2 inhibitors suffered from low solubility, poor cell permeability, and scarce kinase selectivity. Fortunately, non-ATP-competitive inhibitors of MK2 have been already discovered that allowed circumventing the selectivity issue. These compounds showed the additional advantage to be effective at lower concentrations in comparison to the ATP-competitive inhibitors. Therefore, although the significant difficulties encountered during the development of these inhibitors, MK2 is still considered as an attractive target to treat inflammation and related diseases to prevent tumor metastasis and to increase tumor sensitivity to chemotherapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmacological treatment of inflammatory diseases, including rheumatoid arthritis, was based for many years on prostaglandin synthesis inhibitors and NSAIDs such as COX-2 inhibitors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(7)</a> A very important step forward in the treatment of these diseases was allowed by the disease-modifying antirheumatic drugs (DMARD)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(4)</a> that interfere with molecular and cellular steps crucial for the propagation of inflammatory disease. An example is represented by the anticytokine drugs, such as the monoclonal antibody adalimumab or the genetically engineered fusion protein etanercept, constituted by two recombinant human TNF-receptor p75 monomers fused with the Fc domain of human immunoglobulin G1. On the other hand, the p38 MAPK/MAPK-activated kinase 2 (MK2) signaling pathway has been studied for many years for its involvement in inflammation, cell migration, and cell cycle regulation.<a onclick="showRef(event, 'ref3 ref4 ref5 ref2'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref2">(1-4)</a> Experimental evidence clearly showed that production of pro-inflammatory cytokines (such as TNFα and interleukins), induction of enzymes such as COX-2, and emergence of related inflammatory diseases mainly depended on activation of the p38α MAPK/MK2 signaling pathway. On this basis, many small molecules have been described as p38α inhibitors, several of them entered clinical trials, but none progressed to phase III<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(5)</a> mainly because of their systemic side effects (hepatotoxicity, cardiac toxicity, central nervous system disorders). Another reason why p38 inhibitors are not suitable drugs for chronic anti-inflammatory diseases derives from the original observation that C-reactive protein levels (a biomarker of inflammation) undergo an initial reduction just after administration of the p38 inhibitors to return to baseline values after few week treatments.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(90)</a> This phenomenon was initially attributed to a physiological escape that involved other inflammatory pathways. Further studies demonstrated that inhibition of p38 activity also suppressed a feedback control by which p38 blocked upstream kinases such as the transforming growth factor-β activated kinase 1 (TAK1) [via TAK-binding protein 1 (TAB1) phosphorylation)].<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(91)</a> Consequent activation of TAK1 in turn induced downstream kinases (such as the c-Jun <i>N</i>-terminal kinase, JNK, involved in inflammatory signals and liver dysfunctions) to hyperactivation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(92)</a> An additional consequence of p38 inhibition is the loss of mixed-lineage kinase (MLK) activation that is responsible for the production of anti-inflammatory agents such as IL-10 and the dual specificity phosphatase 1 (DUSP1).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(93)</a> These results suggested that inhibition of p38 kinase activity was not the optimal approach for treating chronic inflammatory diseases such as rheumatoid arthritis. However, additional experimental results showed that a dual inhibitor able to block both the p38 kinase activity and its activation in cells did not lead to resistance mechanisms occurred after administration of classical p38 kinase inhibitor.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(94)</a> Although this compound entered phase II clinical trials for the treatment of rheumatoid arthritis in combination with methotrexate, it suffered from a solubility/exposure issue.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(95)</a></div><div class="NLM_p">Moreover, the fact that p38 is involved in the regulation of more than 60 substrates with various physiological roles<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(6)</a> may contribute to account for the problems consequent to administration of p38 inhibitors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(92)</a></div><div class="NLM_p">The current exception to the disappointing clinical results obtained for the treatment of inflammatory diseases with p38 inhibitors is represented by the chronic obstructive pulmonary disease, for which the imminent results of the phase II studies with RV-568 (structure not disclosed) could be of pivotal importance to understand if p38 inhibition is as effective as phosphodiesterase-4 inhibition and corticosteroid inhalation in the treatment of the disease.<a onclick="showRef(event, 'ref6 ref14'); return false;" href="javascript:void(0);" class="ref ref6 ref14">(5, 100)</a></div><div class="NLM_p">In the last years, the significant unwanted side effects caused by direct inhibitors of p38 MAPK and their failure in clinical trials prompted the researchers to point toward downstream targets of the signaling pathway such as MK2. Following this approach, the feedback control of p38 on the TAB1–TAK1 system is maintained as well as the activation of downstream anti-inflammatory targets (MLK).</div><div class="NLM_p">MK2 is the first substrate of p38 which was identified. It is involved in regulation of TNFα and interleukin-6 (IL-6) production by increasing the stability and translation of the corresponding mRNA. In particular, MK2 phosphorylates tristetraprolin (TTP) inhibits TTP destabilizing activity toward TNF mRNA,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(96, 97)</a> thus permitting its translation.</div><div class="NLM_p">MK2 is currently considered as a novel DMARD ligand and a possible alternative to p38 for the treatment of inflammatory diseases. In fact, differently from p38α knockout mice that suffer from embryonic lethality and compromised fertility, health of MK2-null mice is not affected. Moreover, MK2 knockout mice show levels of cytokines significantly reduced in the serum and in the brain, as well as fewer or no symptoms in arthritis or lung sensitization models. In addition, neuroprotective effects (also in the case of ischemic injury) found after MK2 depletion suggest that chronic neuroinflammation associated with neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis could be in part modulated by MK2 activity.</div><div class="NLM_p">MK2 is also involved in the process of actin regulation. Among various actin-modulating proteins that are targets of MK2 [examples are represented by the Lin-11 Isl-1 Mec-3 kinase (LIMK), filamentous actin capping protein Z-interacting protein (CAP-zip), p16 subunit of the seven-member actin-related protein-2/3 complex (p16-Arc)], Hsp27 plays a pivotal role in actin remodeling and cell migration. Hsp27 in its unphosphorylated form is able to act as an actin filament cap-binding protein, thus inhibiting polymerization of globular actin into filamentous actin (F-actin). MK2-mediated Hsp27 phosphorylation<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(3)</a> blocks capping activity, thus promoting actin polymerization and remodeling.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(8)</a> In addition, phosphorylated Hsp27 is unable to undergo to multimeric self-aggregation, with the consequent loss of its chaperoning activity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(99)</a> Involvement of the MK2/Hsp27 system in actin remodeling and cell migration is also of pivotal importance for cancer cell invasion and metastasis. Finally, the p38 MAPK/MK2 pathway also activates the checkpoint signaling to G<sub>2</sub>/M arrest and cell survival after DNA damage caused by chemotherapy, thus leading to resistance to therapeutical protocols.</div><div class="NLM_p">Very recent evidence demonstrated that MK2 is also involved in cardiac hypertrophy and fibrosis. In fact, MK2 inhibitors are able to alleviate cardiac fibrosis in myocardial infarction.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(9)</a> MK2 inactivation significantly reduced cardiomyocyte hypertrophy in mice by reducing COX-2 protein synthesis but not affecting mRNA levels and protein stability.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(10)</a> Contrasting results have been obtained in the case of pulmonary fibrosis in mice, where disruption of MK2 prevented myofibroblast formation and might contribute to fibrosis instead of preventing or reducing it.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(11)</a> On the contrary, a peptide inhibitor of MK2 decreased the fibrotic responses in idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(12)</a></div><div class="NLM_p">These findings clearly suggest that targeting MK2 to block downstream events could be equivalent to a direct inhibition of p38α, with the advantage of lacking p38-dependent side effects. Therefore, although the significant difficulties encountered during the development of these inhibitors, MK2 is still considered as an attractive target because the inhibitors of the MK2 activity could serve as therapeutic agents for the treatment of diseases associated with inflammation and neuroinflammation. They may be also used to reduce migration of cancer cells and metastasis formation. Moreover, given the ability of MK2 to activate a cell cycle checkpoint, MK2 inhibitors are also considered as effective tools to bypass DNA reparation induced by chemotherapy and thus to increase tumor cell sensitivity to chemotherapy. Finally, MK2 inhibitors may represent an alternative and innovative approach to the treatment of fibrosis-related diseases.</div><div class="NLM_p">Almost all of disclosed MK2 inhibitors belong to the type I class of inhibitors that bind to the ATP binding site of the kinase and thus compete with intracellular ATP to inhibit phosphorylation and activation of the substrates. After discovering a plethora of compounds with minimal to modest in vitro activity toward MK2,<a onclick="showRef(event, 'ref2 ref23'); return false;" href="javascript:void(0);" class="ref ref2 ref23">(4, 13)</a> significant improvements in efficacy and safety have been made in comparison to previous generation compounds. In fact, compounds with in vivo efficacy have been already reported.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(15)</a> However, one of the major limitations of the MK2 inhibitors discovered so far is their low biochemical efficiency (BE), expressed as the ratio between <i>K</i><sub>i</sub> (the binding affinity to the kinase) and EC<sub>50</sub> (cellular activity). In fact, ability to bind MK2 is usually 10–100-fold higher than functional response (i.e., drug concentration that inhibits TNFα production in cells), resulting in BE values in the range between 0.1 and 0.01. Among all of the MK2 inhibitors disclosed, only very few exceptions showed optimal BE values (see compounds <b>61</b> and <b>81</b>, with BE of about 0.5 and 1, respectively). Studies on the biochemical mechanisms of drug action demonstrate that two-thirds of marketed drugs show BE values higher than 0.4,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(14)</a> thus suggesting that MK2 inhibitors are unlikely to become a drug. In fact, whether high concentrations of compounds are required to have a cellular efficacy, their cytotoxicity and off-target effects could be exacerbated, thus increasing attrition probability. On the contrary, compounds that do not compete with ATP could be active at lower concentrations and have higher probability to be optimized to become a drug. Unfortunately, the currently available non-ATP competitive and uncompetitive MK2 inhibitors do not give any experimental support to this hypothesis, being their BE far from the optimal values (see below).</div><div class="NLM_p">The high affinity of the inactive MK2 to ATP has been proposed as the major determinant of low BE values for MK2 inhibitors. In fact, many other kinases have low ATP affinity in their inactive form and high ATP affinity in their active form. As a consequence, their known inhibitors have been selected among compounds that bind the inactive form of the kinase, do not compete with the high intracellular ATP concentration, and, consequently, are required at low concentrations to give cellular effects. Differently, given the high affinity of the inactive MK2 to ATP, putative ligands of the ATP binding site of either the active or inactive form of MK2 are required to compete with the high levels of ATP. For this purpose, higher concentrations of ATP-competitive inhibitors are required for cellular activity, thus decreasing BE values. On the basis of these considerations and taking into account the importance of MK2 in modulating inflammation, cell cycle, and cell motility, non-ATP-competitive and allosteric inhibitors of MK2 are under investigation as modulators of the p38 MAPK/MK2 signaling pathway.</div><div class="NLM_p last">In recent years, excellent surveys of the studies on the biology of p38/MK2 pathway have been reported,<a onclick="showRef(event, 'ref3 ref4 ref5 ref2'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref2">(1-4)</a> also describing the efforts made to find new and effective MK2 inhibitors.<a onclick="showRef(event, 'ref4 ref2 ref23'); return false;" href="javascript:void(0);" class="ref ref4 ref2 ref23">(2, 4, 13)</a> In this review, the most important classes of small molecules able to inhibit MK2 by an ATP-competitive and a non-ATP-competitive mechanism are reviewed. In particular, the rational design planned by medicinal chemists is described, as well as the structure-affinity and structure–activity relationships that could be elaborated by comparison of molecular structures and affinity/activity data of the disclosed compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Structural and Functional Features of MK2</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human MK2 is a Ser/Thr protein kinase with a primary sequence comprised of 400 amino acids (UniProt entry P49137, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(16)</a> divided into a proline-rich <i>N</i>-terminal region (the sequence 10–40, a unique feature among MAP kinases, mainly arranged in β-strands), a protein kinase catalytic domain (residues 64–325), and a regulatory domain at the <i>C</i>-terminal portion, the latter consisting of α-helices. In particular, the region ranging from positions 328 and 364 is constituted by an autoinhibitory α-helix that is arranged in such a way to block the access to the catalytic machinery. Deletion of the regulatory domain unveils the active site, allows substrate to access, and causes an increase of the catalytic activity. In a similar way, phosphorylation of Thr222 and Ser272 of the catalytic domain, as well as Thr334 by p38α (also reported as MAPK14, which is one of the four p38 MAP kinases, UniProt entry Q16539) leads to a conformational rearrangement of the autoinhibitory α-helix with a consequent kinase activation. Ser9, Thr25, and Ser328 are additional phosphorylation sites, with the latter processed by autocatalysis. Moreover, the <i>C</i>-terminal region 366–390 represents the p38 MAPK-binding site, also referred to as the docking region. A a bipartite nuclear localization signal (NLS, 371–374 and 385–389, respectively) and a nuclear export signal (NES, a motif with the sequence 356–365) are of crucial importance for interaction with p38 and its migration to the cytoplasm.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MK2 structure. A Pro-rich <i>N</i>-terminal region is connected to the kinase catalytic domain that contains two major phosphorylation sites (Thr222 and Ser272). A third phosphorylation site (Thr334) precedes the nuclear export signal (NES, responsible for MK2 translocation from the nucleus to the cytoplasm) and a bipartite nuclear localization signal (NLS, responsible for accumulation of the p38/MK2 complex within the nucleus of resting cells). A <i>C</i>-terminal domain (p38 binding site) guarantees for direct interactions between MK2 and p38.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In resting cells, the constitutively active NLS maintains the p38/MK2 complex within the nucleus. Early studies<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(17)</a> based on fluorescence resonance energy transfer (FRET) allowed the identification of an inactive closed conformation of MK2 with part of the autoinhibitory domain (the amino acid sequence 339–353 of the <i>C</i>-terminal region)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(18)</a> masking the binding site. Upon cellular stress-based activation of p38, a p38-dependent phosphorylation of MK2 Thr334 induces a conformational rearrangement of the autoinhibitory domain of MK2 to an open form. The catalytic domain is unmasked and the NLS is revealed, with consequent kinase activation and translocation of the MK2-p38 complex from the nucleus to the cytoplasm. In a similar way, phosphomimetic mutations, such as T334D or T334E, increase the levels of MK2 within the cytoplasm. On the other hand, phosphorylation of Thr222 is responsible for activation of downstream targets involved in cell motility, cell cycle, and apoptosis as well as in mRNA stabilization.</div><div class="NLM_p">Early kinetic and thermodynamic studies on the catalysis and function of the MK2-p38 complex showed direct interactions between the <i>C</i>-terminal sequence 370–400 of MK2 and p38 to form a tight complex (<i>K</i><sub>d</sub> = 20 nM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(19)</a> The importance of this sequence was also suggested by the fact that its deletion was able alone to abrogate p38-dependent MK2 phosphorylation and activation. A 2.7 Å resolution crystal structure of the heterodimeric complex between unphosphorylated MK2 and unphosphorylated p38α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2oza">2oza</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(20)</a> showed a direct contact between the <i>N</i>-terminal portions of both proteins as well as additional interactions between their <i>C</i>-termini. The Gly-rich portion of the phosphate binding loop (P loop, constituted by the 71–76 GXGXXG sequence belonging to the ATP binding site) was in a β-sheet conformation, as already found in constitutively active MK2 enzymes (see below). Among the five major interface regions of the complex, the <i>C</i>-terminal docking region of MK2 was crucial for the MK2-p38 interactions. Additional crystal structures of the p38−MK2 heterodimeric complex were solved at 3.0 and 4.0 Å (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4tyh">4tyh</a><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2onl">2onl</a>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(21)</a> respectively ), the latter representing the first example of full length kinase crystallized in a complex.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures of the MK2 Kinase and Its Complexes Stored in the PDB</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0008.gif" alt="" id="GRAPHIC-d930e375-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">When more than one MK2 chain has been crystallized, the solved sequence and protein construct are referred to the first chain listed in the previous column. Solved sequence: the amino acid sequence listed in the PDB structure. Protein construct: the MK2 protein construct used in the study.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">All the structures have been obtained by X-ray diffraction.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Graphical representations of the binding mode of MK2 inhibitors have been elaborated with Discovery Studio 3.0 Visualizer software (Accelrys Software, Inc.) by the corresponding PDB files. The coordinates of the complex between MK2 and AMP-PNP have been taken from the patent text (<a href="https://www.google.com.ar/patents/EP1578687A2?cl=en" class="extLink">https://www.google.com.ar/patents/EP1578687A2?cl=en</a>, accessed August 7, 2015), edited to correct typos probably due to a previous scanning from original patent documents, and then converted to a PDB file by means of an in-house script.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Bipyramidal crystals, by soaking.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Orthorhombic crystals, by cocrystallization.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">T222E mutant.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Scheich, C.; Smith, M. A.; Barker, J. D.; Kahmann, J.; Hesterkamp, T.; Schade, M. Unpublished results.</p></div></div><div></div></div><div class="NLM_p">A series of point mutations were found to differently affect MK2 activity. In particular, K93R and D207A are defective mutations that abrogate kinase activity, T222A and S272A strongly decrease kinase activity, T334A slightly decreases kinase activity, T222D or S272D are mimic of phosphorylated states and result in a slight increase of basal kinase activity, T334D or T334E are mimic of phosphorylated states and result in a significant increase of basal kinase activity, T222E associated with T334E are mimic of phosphorylated states and lead to constitutive protein kinase activity, and K353R abrogates MK2 SUMOylation (that is a post-translational reversible modification affecting MK2 activity), thus leading to an increase of its protein kinase activity. A summary of mutagenesis data and the corresponding literature references can be found at the UniProt Web site.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(22)</a></div><div class="NLM_p last">A shorter splicing variant of MK2 (the isoform 2) does also exist, bearing the alternative GCLHDKNSDQATWLTRL sequence instead of the canonical 354–400 amino acid sequence, thus lacking the NES, NLS, and p38 docking domain.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3 Crystallization Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Crystallization of the kinase domain of MK2 is a difficult task to be performed, and the structures of MK2 alone or in complex with small molecule ligands and inhibitors have been solved only to low/medium resolution. A survey of the three-dimensional structures of MK2 alone or in complex with small molecules is reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Despite the low/medium resolution gained for most of the MK2 crystal structures, MK2 can be efficiently expressed by <i>Escherichia coli</i>, thus allowing for high-throughput design and production of protein constructs. X-ray crystallography studies reveal that MK2 can be arranged in trimer structures that are however unable to give interactions with p38. Seven different crystal forms of MK2 (referred to as rods, plates, cubes, bipyramids, hexagonal bullets, hexagonal bullets collapsed from the latter form, and sharp blocks) have been identified and described by different research groups.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(23)</a> An analysis of the MK2 crystal structures deposited within the PDB<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(24)</a> reveals that the construct 41–364 (a constitutively active form of the enzyme) has been most often used to obtain complexes between the protein and various small molecule inhibitors (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Moreover, a construct design strategy based on a rational mutagenesis approach was set up to optimize crystallization conditions and to define the construct(s) to be most efficiently expressed. Truncations at both the <i>C</i>- and <i>N</i>-terminus, mutations of solvent-exposed charged amino acids to Ala, deletion of the activation loop, as well as changes at the phosphorylation sites were the structural variations applied to the MK2 sequence. The 47–366 MK2 construct bearing the T222E activating mutation was the sole structure that diffracted well and was solved to 2.9 Å as a bipyramidal crystal structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ka0">3ka0</a>). The pH range and the precipitating reagents were crucial keys for a more effective crystallization. Deletion of the activation loop was not tolerated, while the overall crystallization process was more sensitive to <i>N</i>-truncation in comparison to <i>C</i>-truncation.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(23)</a> Another study showed that deletion of the 1–40 sequence of the Pro-rich domain resulted in higher expression level and enhanced solubility of MK2, while best crystals were built upon removing part of the <i>C</i>-terminal domain (namely, the sequence 365–400).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(25)</a> The constitutively active form 41–364 of MK2 was thus crystallized with both ADP and the broad-spectrum kinase inhibitor staurosporine <b>152</b> (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ny3">1ny3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1nxk">1nxk</a>, solved at 3.2 and 2.7 Å, respectively, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The complex with ADP allowed the identification of the pockets that accommodated the molecular portions of ATP and ADP (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In particular, the “phosphate binding region” (a cavity delimited by Lys93, Asn191, Asp207, and capped by Ile74) was filled by the diphosphate moiety of ADP. Glu145, Glu190, Leu70, Gly71, and Leu72 constituted the “sugar pocket” and surrounded the ribose moiety of ADP. The adenine residue was accommodated within the hinge region, delimited by Glu139, Cys140, Leu141, and Asp142. Finally, a rather small hydrophobic area between the adenine binding region and the solvent, not occupied by ADP, constituted the “front pocket”. On the other hand, the complex with <b>152</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) showed a binding mode of the inhibitor within the ATP binding site very similar to that found in the complexes with CDK2, Src, Lck, and, in particular, with PKA. The ATP binding site was characterized by a narrow and deep groove, resulting from a closed conformation. As a Met was the gatekeeper amino acid (Met138), the ATP binding pocket had a reduced size and a narrow shape in comparison to other kinases. As a consequence, planar compounds were preferably accommodated within the pocket and their structure was difficult to be decorated to improve affinity and kinase selectivity. This finding anticipated that identification of selective kinase inhibitors could result a challenging exercise, given the high similarity of the kinase binding sites.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereographical representation of the major interactions between ADP and the ATP binding site of MK2, as taken from the PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ny3">1ny3</a>. The adenine ring is involved in two hydrogen bonds (represented as black dotted lines) with Glu139 and Leu141. An additional hydrogen bond is found between the pyrophosphate moiety and the charged terminal group of Lys93. Amino acids of the phosphate binding region, the sugar pocket, and the hinge region are shown as well as the gatekeeper Met138.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The unbound MK2 (the apo form, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kwp">1kwp</a>, 2.8 Å resolution) was the first crystallized structure, characterized by an inactive kinase conformation with the Gly-rich loop in an α-helical form, the substrate binding site locked by the autoinhibitory domain (even if the ATP binding pocket was in an open form) and the Lys93-Glu104 salt bridge disrupted.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(26)</a> Differently, the complex between MK2 and <b>153</b> (AMP-PNP, a nonhydrolyzable ATP analogue, namely the γ-imino-ATP, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) showed a different inactive conformation with the Gly-rich loop in a β-sheet form and the Lys93-Glu104 salt bridge disrupted.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(27)</a> All the remaining complexes between MK2 and small molecules (including ADP) were in an active conformation with the Gly-rich loop in a β-sheet form, and the Lys93-Glu104 salt bridge present. Exceptionally, the complex with the pyrazolo[1,5-<i>a</i>]pyrimidine <b>87</b> (TEI-I01800, <a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>) was the first structure in the active form, with the Lys93-Glu104 salt bridge but with the Gly-rich loop in an α-helical form (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3a2c">3a2c</a>, 2.9 Å resolution).<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(28, 29)</a> It was hypothesized that the conformational shift of MK2 from β-sheet to α-helical was induced by the presence of the large <i>p</i>-ethoxyanilino side chain at the position 7 that forced the structure of the inhibitor to a nonplanar conformation to avoid intramolecular clashes with the methyl group at position 6. To support this hypothesis, an analogue compound was designed without the aryl moiety at position 7 and with a pyrroline ring bridging the positions 6 and 7 of the pyrazolo-pyrimidine scaffold, thus leading to a pyrazolo[1,5-<i>a</i>]pyrrolo[3,2-<i>e</i>]pyrimidine compound. The new tricyclic compound <b>91</b> (also referred to as TEI-L03090, <a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>) showed micromolar inhibitory activity toward both MK2 and CDK2 (4700 and 630 nM, respectively), without appreciable selectivity. It was cocrystallized with MK2 that showed a Gly-rich loop in an β-sheet form (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3wi6">3wi6</a>, 2.99 Å resolution).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(30)</a> The N1 and 8-NH of the inhibitor showed two hydrogen bonds with both the NH and carbonyl groups of Leu141. Moreover, the piperidino basic nitrogen was involved in an additional hydrogen bonds with the backbone carbonyl group of Glu190. Similar interactions were also found in the complex with <b>87</b>, although they showed better geometrical parameters (distance and angles) in comparison to the complex with <b>91</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(28)</a> The inhibitor was able to be accommodated within the ATP binding site of MK2 in its β form.</div><div class="NLM_p">In the attempt to rationalize the kinase selectivity profile of <b>87</b>, analysis of its complex with CDK2 showed a strained conformation of the inhibitor that led to the lack of interactions between its substituent at the position 7 and the ATP binding site of CDK2, that assumed a β-sheet form. This unprofitable interaction pattern may be responsible for the lower affinity of <b>87</b> toward CDK2 in comparison to MK2 and consequently for its 177-fold kinase selectivity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(31)</a></div><div class="NLM_p last">Another study demonstrated that, similarly to the complex between MK2 and <b>87</b>,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(28)</a> 2,4-diaminopyrimidine <b>80</b> induced the Gly-rich loop to assume an α-helical conformation (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ka0">3ka0</a>),<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(32)</a> even if the Lys93-Glu104 salt bridge was maintained. On the contrary, the 2,4-diaminopyrimidine analogue <b>78</b> was cocrystallized with MK2 in the β-form (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kc3">3kc3</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(32)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4 ATP-Competitive MK2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The need to discover new therapeutics for inflammatory diseases led to hypothesize the downstream MK2 as a druggable target. High throughput screening (HTS) campaigns and the release of the three-dimensional structure of MK2 in its apo-form and in complex with ADP or with various small molecule inhibitors gave impetus to the discovery of many ATP-competitive MK2 inhibitors. However, the classical approach to block this kinase by competing with ATP for its binding site generated two challenging issues to be solved in the case of MK2 inhibitors. First, the ATP binding site of MK2 is structurally similar to that of other kinases (MK3, MK5, PKA, CDK2, etc.), thus strongly affecting selectivity. Second, either the high cellular levels of ATP or the high affinity of ATP for its binding site on MK2 caused very low BE for small molecule ATP-competitive inhibitors. Finally, solubility and permeability profiles appropriate for in vivo administration were a very difficult task to be addressed.</div><div class="NLM_p">Routine hit-to-lead and lead optimization studies led to the identification of compounds with subnanomolar affinity toward MK2. Disappointingly, the corresponding activity in cell-based assays was significantly lower in most cases. On the other hand, selected compounds showed oral anti-inflammatory efficacy in models of inflammation, but none have entered clinical trials yet.</div><div class="NLM_p">The large number of small molecule ATP-competitive MK2 inhibitors identified and disclosed in the recent years belong to different chemical classes but share common pharmacophoric portions. An analysis of the complexes between MK2 and its inhibitors deposited within the PDB showed a conserved hydrogen bond acceptor motif able to interact with the backbone NH group of Leu141. Moreover, a hydrogen acceptor group (often represented by a carbonyl oxygen atom) was an additional anchor point that interacted with the terminal ammonium group of Lys93 of the phosphate binding region. Hydrophobic contacts also contributed to the stabilization of the complexes, together with hydrogen bond interactions specific for each inhibitor. The ability of a few compounds to induce a conformational rearrangement of the Phe90 side chain and to open up an additional binding pocket could be a very important step in the process to discover MK2 selective compounds.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(61)</a></div><div class="NLM_p">In the next sections, a survey of the most important ATP-competitive MK2 inhibitors is reported, together with biological data from in vitro and in vivo assays as well as structure–activity relationship considerations.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">4.1 Compounds from Pfizer Global Research and Development</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">4.1.1 Benzopyranopyridines</h4><div class="NLM_p">Benzopyranopyridine derivatives were identified by HTS as moderate inhibitors of MK2 with an ATP-competitive mechanism.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(33)</a> The prototypical compound <b>1</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which showed an IC<sub>50</sub> value of about 2 μM (expressed as the inhibition of MK2 ability to phosphorylate a peptide susbtrate), was modified by deleting the malononitrile group and by decoration of the condensed phenyl ring. Resulting derivatives showed that different substituents and substitution patterns were tolerated, increasing MK2 inhibition to submicromolar values. The same compounds were also able to reduce TNFα expression in U937 cells treated with LPS but with a different trend in comparison to the results of the enzymatic assay. The best compound <b>2</b> (IC<sub>50</sub> = 130 nM) also affected TNFα production in an acute rat model of inflammation (EC<sub>50</sub> = 920 nM) after LPS administration. Given its MK2 inhibitory activity, the ability of <b>2</b> to inhibit Hsp27 phosphorylation consequent to the p38/MK2 pathway activation was also assayed in Werner syndrome (WS) cells.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(34)</a> In fact, this pathway could be involved in F-actin stress fiber formation in WS cells, leading them to resemble aged cells. Thus, inhibition of MK2 activity was expected to reactivate the Hsp27 capping activity on actin, resulting in reduced actin polymerization. However, although <b>2</b> blocked Hsp27 phosphorylation in WS cells at 25 μM, higher amounts of stress fibers were found with respect to control. This result led to the suggestion that F-actin stress fiber production may derive from off-target effects possibly caused by LIMK activation and consequent inactivation of cofilin, a protein with depolymerizing activity toward actin.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(8)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Benzopyranopyridine derivatives from Pfizer Global Research and Development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">4.1.2 Pyrrolopyridinones</h4><div class="NLM_p">A new class of MK2 inhibitors was obtained by hit optimization of a pyrrolopyridinone compound identified by HTS.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> Preliminary SAR considerations were obtained by decoration of the pyridine appendage (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Inhibition of MK2 activity in a cell-free assay significantly increased from unsubstituted pyridine (<b>3</b>, IC<sub>50</sub> = 171 nM) to the corresponding quinoline-substituted analogue (<b>7</b>, 8.5 nM). The presence of an aromatic substituent was profitable for activity (compare <b>3</b> and <b>4</b>), and the nitrogen atom of the quinoline seemed to have a crucial role in defining the inhibitory activity toward MK2 (compare <b>7</b> and <b>6</b>). Moreover, activity was maintained in the low micromolar range by a variety of substituents at the phenyl ring of <b>4</b>, even if meta and para substituents were preferred in comparison to groups at the ortho positions. This suggested that a planar or quasiplanar conformation of the arylpyridine side chain could be important for activity. The new compounds showed an ATP-competitive mechanism of action and were selective toward a large panel of kinases, apart MK3 and MK5, which shared a high degree of sequence identity with MK2 and possessed a larger hinge region and front pocket that could accommodate the arylpyridine substituent. X-ray crystallography on the complex between MK2 and <b>5</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2p3g">2p3g</a>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) confirmed the expected binding mode of the inhibitor, with the arylpyridine moiety pointing toward the protein surface and partially exposed to the solvent. The pyridine nitrogen and the lactam moiety were responsible for the hydrogen bond interactions with protein residues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pyrrolopyridinone Derivatives from Pfizer</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">171</td><td class="colsep0 rowsep0" align="char" char=".">19000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">1400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">2-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">126</td><td class="colsep0 rowsep0" align="char" char=".">4800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3-naphthyl</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">4200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">3-quinoline</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">4400</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Expressed as the inhibition of MK2 ability to phosphorylate the KKKALSRQLSVAA peptide.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Expressed as the ability to inhibit TNFα production in LPS-stimulated U937 cells.</p></div></div></div><div class="NLM_p last">Improvement of MK2 inhibition in cell-free assays (with IC<sub>50</sub> spanning from micromolar to nanomolar concentrations) did not correlate with increased potency in the cell-based assays. In fact, reduction of cellular production of TNFα, resulting from MK2 inhibition, was obtained with micromolar concentrations of the inhibitors (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The weak efficacy of the new compounds in U937 cell-based assay could be attributed to poor physicochemical properties. However, even if efforts have been made to improve solubility and enhance oral bioavailability of these compounds,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(36)</a> the sole solubility can not explain the gap found between activity in cell-free and cell-based assays. As an example, <b>5</b> showed a 160 μM solubility, significantly higher than that of the quinoline analogue <b>7</b> (<0.4 μM). These compounds had comparable activity in U937 cell assay (EC<sub>50</sub> of about 4–5 μM), while the inhibitory activity of the less soluble compound in the cell-free assay was 15-fold better than that of <b>5</b>. However, one of the most reliable explanation for the lack of correlation between the two sets of data could be based on the ATP competitive mechanism of action of these compounds. In fact, their interaction with the MK2 target was disfavored by either the high cellular concentration of ATP (1–5 mM) or its affinity value for MK2 (<i>K</i><sub>m</sub> = 30 μM). The mechanism of action of these compounds were confirmed in U937 cells stimulated with LPS, where <b>5</b> inhibited both phosphorylation of Hsp27 at Ser78 and TNFα production. Moreover, the inability of <b>5</b> to inhibit kinases involved in the production of TNFα, as well as to block p38 pathway components that were upstream of MK2, strongly suggested that this compound acted on U937 cells by interfering with MK2. TNFα production was also strongly reduced (>80%, when <b>5</b> was administered 2 h prior to LPS stimulation) by oral administration in a rat model of acute inflammation. In this case, compound concentration in the plasma samples was about 3 μg/mL. The same compound also improved cell viability in a nephrotic syndrome-related podocyte injury model by inhibition of MK2 activity and consequent reduction of COX-2 mRNA expression and Hsp27 phosphorylation.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(37)</a> On the other hand, <b>7</b> was used as MK2 inhibitor to study how senescence underwent an acceleration in fibroblasts from human WS, without reaching conclusive and unambiguous results.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(38)</a></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">4.1.3 Carbolines from Pfizer Global Research and Development</h4><div class="NLM_p">A commercially available β-carboline (<b>8</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was also identified as a weak ATP competitive inhibitor of MK2 (2500 nM in the enzymatic assay).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(39)</a> Attempts to improve its biological profile have been made by changes at the methoxy substituents. Replacement with a hydroxy (<b>9</b>) and a carboxymethyl group (<b>10</b>) retained a single-digit micromolar activity (4500 and 6600 nM, respectively), while deletion (unsubstitution of the phenyl ring), replacement with different substituents, and variation of the substitution pattern caused a significant loss in activity. Moreover, aromatization of the piperidine ring was not tolerated, as well as replacement of the nitrogen atom with an oxygen (pyrane analogue) or a methylene group (cyclohexyl analogue), thus suggesting that basicity and nonplanar arrangement of the condensed ring played an important role for activity. The pendant carboxylic group appeared to be as a mandatory substituent for activity. While <i>N</i>-alkylation of the basic nitrogen was tolerated only for small groups such as Me (<b>11</b>) and Et (<b>12</b>), alkylation of the pyrrole nitrogen was detrimental for activity. SAR analysis at the positions 3 and 4 of the piperidine ring showed that a Me and Et group at position 4 as in <b>13</b> and <b>14</b> maintained a micromolar activity (2200 nM), similarly to hydrogen bond acceptor/donor groups (such as the hydroxymethyl and aminomethyl substituents of <b>15</b> and <b>16</b>, respectively) at position 3 (3000 and 5900 nM, respectively). Considering that small alkyl groups were tolerated at both the positions 2 (corresponding to the nitrogen atom) and 4 of the condensed piperidine ring, two- and three-carbon bridges between N2 and C4 have been built. While <b>18</b> maintained a micromolar activity (5100 nM), its homologue <b>17</b> had a better profile, with a 18-fold increased activity toward MK2 (290 nM) and selectivity against a panel of structurally related kinases, including MK3 and MK5. In a cell-based assay on U937 cells, <b>17</b> showed a dramatic loss of activity (81 μM) that was attributed to weak cellular permeability. Disruption of the zwitterionic form by esterification of the carboxy group led to a decreased activity in cell-free assay and a significant enhancement in activity in cell-based assay. The most active compounds was the isopropyl derivative <b>19</b> that showed a two-log unit improvement in activity toward U937 cells (0.83 μM), probably consequent to an intracellular conversion of the ester prodrug into the corresponding free acidic and biologically active form. When <b>19</b> was administered in rats 1 h before LPS stimulation, it was able to inhibit TNFα production by more than 84%.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. β-Carboline Derivatives from Pfizer</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">2500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">6-OH</td><td class="colsep0 rowsep0" align="left">1-COOH</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">4500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">6-COOMe</td><td class="colsep0 rowsep0" align="left">1-COOH</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">6600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH</td><td class="colsep0 rowsep0" align="left">NMe</td><td class="colsep0 rowsep0" align="char" char=".">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH</td><td class="colsep0 rowsep0" align="left">NEt</td><td class="colsep0 rowsep0" align="char" char=".">5800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH, 4-Me</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">2200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH, 4-Et</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">2200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH, 3-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">1-COOH, 3-CH<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">5900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Expressed as the inhibition of MK2 ability to phosphorylate the KKKALSRQLSVAA peptide.</p></div></div></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">4.1.4 Polycondensed Benzothiophene Derivatives</h4><div class="NLM_p">A benzothiophene condensed with a seven-membered lactam ring constituted the scaffold of a new series of MK2 inhibitors (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(40)</a> These compounds however showed structural features common to known MK2 inhibitors: a methoxy substituent that interacted with the hinge region and a lactam moiety condensed to a five-membered heterocyclic ring that was at hydrogen bond distance from conserved catalytic residues of the MK2 active site. In the attempt to find compounds with significant inhibitory activity toward MK2 and selectivity against similar kinases, changes to the original scaffold (<b>20</b>) suggested that the nitrogen at position 5 was crucial for activity (its replacement with sulfur or a methylene spacer was detrimental), although it was unable to make hydrogen bond interactions with MK2, as evidenced in the cocrystallized complex structure between MK2 and the amino derivative of <b>20</b> (<b>24</b>, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyk">3fyk</a>). The importance of this nitrogen atom could reside in its electronic properties as electron-donating group and in its ability to induce a different conformation and shape of the seven-membered ring in comparison to S and to a CH<sub>2</sub> group. Moreover, configuration of the stereogenic center at position 3 affected activity. In fact, <b>21</b> had significantly better inhibitory activity in cell-free and cell-based assay (40 and 700 nM, respectively) in comparison to its enantiomer <b>22</b> (300 and 3800 nM, respectively). Unfortunately, <b>21</b> was not selective (less than 10-fold selectivity) toward 18 out of a panel of 90 kinases. Transformation of the C3 methyl group of <b>21</b> into the corresponding primary alcohol (<b>23</b>) and amine (<b>24</b>) susbtituents led to an enhancement of the activity in the enzymatic assay (14 and 5 nM, respectively), while the results from a cell-based assay on U937 cells were not encouraging in particular for <b>24</b> (2600 nM), probably because the protonatable amine nitrogen affected cell permeability. Introduction of bulkier linear and cyclic amino groups at C3, as well as replacement of the C7 methoxy group with various alkoxy and aryloxy substituents afforded compounds with weaker activity in both assays.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Polycondensed Benzothiophene Derivatives from Pfizer</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0011.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0012.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 ability to phosphorylate the KKKALSRQLSVAA peptide.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in LPS-stimulated U937 cells.</p></div></div><div></div></div><div class="NLM_p">Previous SAR analysis suggested that pyrrolopyridinone compounds, bearing a conformationally constrained (rigid) moiety (such as the arylpyridine group found in <b>3</b> and its congeners, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) able to occupy the hinge region of MK2, could gain good selectivity toward a panel of kinases, also similar to MK2.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> On this basis, with the aim of enhancing kinase selectivity of the benzothiophene derivatives, their molecular portion bearing the methoxy substituent was rigidified with an additional condensed ring.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(41)</a> A furan (<b>25</b>) and a pyridine ring (<b>26</b>) caused an increase in activity (16 and 1 nM in the enzymatic assay, 90 and 50 nM in the cell-based assay, respectively), without selectivity toward CDK2 and other 26 kinases out of a panel of 109 kinases (<b>26</b> showed a 0.8 nM activity toward CDK2). In the next step, the position adjacent to the heteroatom was decorated by an aryl moiety reminiscent of the aromatic ring found in pyrrolopyridinone derivatives such as <b>4</b>–<b>7</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The 3-Cl (<b>27</b>), 3-Ph (<b>28</b>), 3-pyrid-3-yl (<b>29</b>), and 3-(4-methylpyrid-3-yl) (<b>30</b>) derivatives of <b>26</b> retained a single-digit nanomolar activity in the enzymatic assay (2, 9, 5, and 5 nM, respectively) with a slight reduction of cellular potency (130, 180, 220, and 150 nM, respectively). They however showed a selectivity for MK2 versus CDK2 ranging from 10 to >1000-fold. The most active compounds <b>29</b> and <b>30</b> (also referred to as PF-3644022 or PF022) were demonstrated to reduce TNFα production by a mechanism of action that selectively inhibited MK2. In fact, only 4 out of 50 kinases assayed were inhibited by more than 70% by <b>30</b> at a 1 μM concentration. The crystallographic structure of the complex between MK2 and <b>30</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyj">3fyj</a>) clearly described the interactions between the inhibitor and the MK2 catalytic site. Although the lactam moiety was reported to interact with the conserved Lys93 and Asp207, dihedral angles of the crystallographic structure assumed suboptimal values. The sole hydrogen bond contact involved the selectivity element (the bipyridyl moiety) that was in part accommodated within the hinge region and pointed toward the solvent. In particular, the nitrogen atom of the condensed pyridine ring made a hydrogen bond with the NH backbone group of Leu141, as the methoxy oxygen atom of <b>24</b> did.</div><div class="NLM_p">An in deep biological profiling of <b>30</b> confirmed an ATP-competitive mechanism of action and a good selectivity toward a panel of 200 human kinases,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(15)</a> interestingly, only 16 of these kinase were inhibited by more than 50% and 11 of them belonged to Ca<sup>2+</sup>/calmodulin-dependent kinase group that also comprised MK2. Expectedly, inhibitory activity of <b>30</b> toward MK2 and MK5 was similar, while a 10-fold selectivity was found for MK3. In functional assays, TNFα production stimulated by LPS administration was inhibited at submicromolar concentrations (150 nM) in U937 cells, and a comparable IC<sub>50</sub> value (201 nM) accounted for the inhibition of MK2 ability to phosphorylate Hsp27. Taken together, these data strongly supported the hypothesis that a decrease of TNFα production was consequent to selective inhibition of MK2. In addition, pharmacokinetic parameters of <b>30</b> were considered appropriate for proceeding to in vivo evaluation. In fact, this compound showed rapid absorption (<i>T</i><sub>max</sub> of about 10 min in a 3 mg/kg suspension), oral bioavailability, good half-life (about 9 h), and low clearance. Oral administration showed efficacy of <b>30</b> in the rat model of acute inflammation, with a dose-dependent response for inhibition of TNFα production (inhibition was higher than 90%). Encouraging results were also obtained in the rat model of chronic inflammation, where arthritis was induced by administration of peptidoglycan–polysaccharide complexes from group A streptococcal cell wall (an animal models of systemic inflammation induced by bacterial endotoxins). A significant reduction of chronic paw swelling was found (about 80%), even if lower than that induced by p38 inhibitors (90–95%).</div><div class="NLM_p">Unfortunately, <b>30</b> showed acute hepatotoxicity in beagle dogs and monkeys. An impressive increase (up to 25000%) of bile salts and bilirubin total amount was found that caused reversible liver injury.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(42)</a> To understand the mechanism leading to increased levels of the serum biomarkers of hepatotoxicity, hepatic metabolism of benzothiophene derivatives was studied. In addition to various hydroxylated metabolites, <b>30</b> was transformed in a pair of diastereomeric glutathione conjugates at position 11.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(43)</a> Moreover, an additional glutathione metabolite was generated by metabolic attack to the pendant pyridine ring. Incorporation of a polyether side chain as a metabolism shunt led to <b>31</b> (PF318), where the <i>O</i>-dealkylation occurred as the principal biotransformation way, while the diazepinone conjugate disappeared. This compounds also retained a 25 nM inhibitory activity toward MK2, although its cellular potency was significantly reduced to 255 nM. Surprisingly, enhanced exposure and plasma concentrations upon oral administration caused hepatic tissue damage of increased severity in comparison to that found for <b>30</b>. Considering that the level of bilirubin and bile salts are affected by hepatobiliary transporters (the multidrug resistance-associated protein 2, MRP2, and the bile salt export pump, BSEP, respectively), MK2 inhibitors were evaluated for their activity toward these transporters. Both MRP2 and BSEP, as well as P-gp, were strongly inhibited by <b>30</b> and its derivative <b>31</b>, with IC<sub>50</sub> values ranging from 7 to 38 μM, thus suggesting off-target effects toward these transporters. Previous SAR considerations showing that the cationic form of basic compounds negatively affected their affinity for MRP2, prompted the researcher to introduce a piperazine ring instead of the polyether chain. The resulting compound <b>32</b> (PF029) did not inhibit the activity of MRP2, BSEP, and P-gp at the maximum test dose (70–80 μM) and, consequently, did not induce liver toxicity in dogs (5–300 mg/kg oral dose).</div><div class="NLM_p last">In a very recent work, <b>30</b> has been used as a probe to confirm the link between both p38/MK2 and Sonic Hedgehog (Shh) pathways in breast cancer cells. In particular, experimental evidence demonstrated that Shh served as activator of p38 and MK2 by inducing their phosphorylation. Phospho-p38 and phospho-MK2 in turn acted as activators of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), thus resulting in enhanced glycolytic activity and cell proliferation in MCF-7 and MDA-MB-231 cells. Significantly decreased levels of phospho-PFKFB3 have been found upon treatment with the MK2 inhibitor <b>30</b>, thus demonstrating a direct involvement of MK2 in the phosphorylation and activation of PFKFB3.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(44)</a> This very intriguing result suggested that the combined administration of MK2 inhibitors and small molecules able to block the Hh pathway<a onclick="showRef(event, 'ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59">(45-48)</a> could be a useful strategy for the treatment of specific tumors, such as the breast cancer.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.2 Compounds from Boehringer-Ingelheim Pharmaceuticals</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">4.2.1 Carbolines</h4><div class="NLM_p">A dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) was used to evaluate the ability of small molecules to inhibit MK2 catalysis.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(50)</a> As a result, a new class of carboline derivatives with micromolar activity was discovered (one of the prototypical entries of this class was the tetrahydro-β-carbolinone <b>33</b> with an IC<sub>50</sub> of 5400 nM, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Improved potency was obtained by substitution of the amide group with aromatic and heteroaromatic amide moieties. While substituted phenyl ring resulted in slightly enhanced activity, a significant improvement was gained with pyridine (<b>34</b>, 520 nM) and thiazole (<b>35</b>, 820 nM) rings. Further decoration of the thiazole with a 4-amide (<b>36</b>) or 4-methylamide (<b>37</b>) substituents ameliorated the activity by about one log unit (89 and 72 nM, respectively). Lengthening the amide chain by polar group (as in <b>38</b>) led to compounds with IC<sub>50</sub> in the range between 20 and 35 nM. The three-dimensional structure of the complex between MK2 and <b>38</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pzy">2pzy</a>) showed the ligand accommodated within the ATP binding site and interacting with the hinge region. The two amide moieties made hydrogen bonds with the NH of Leu141 and the carbonyl group of Leu70. The terminal amine substituent, as well as the lactam moiety that seemed to affect activity, were not involved in hydrogen bonds with MK2.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Carboline Analogues from Boehringer-Ingelheim Pharmaceuticals</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0013.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0014.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 in a DELFI assay.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in LPS-stimulated THP-1 cells.</p></div></div><div></div></div><div class="NLM_p">Evaluation of TNFα production in THP-1 cells stimulated by LPS showed that the new compounds were inactive (IC<sub>50</sub> > 10 μM), with the sole exception of <b>39</b> (44 nM in the cell-free assay, 1600 nM in the cell-based assay) that lacked a terminal polar group. This result suggested that polar groups could affect membrane permeability and result in the lack of cellular activity.</div><div class="NLM_p">Transformation of the indolopyridinone scaffold into the corresponding dihydropyrazino[1,2-<i>a</i>]indolone<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(51)</a> resulted in a slight improvement in cell-free assay, although cellular potency was maintained at micromolar concentrations (compare activity data for <b>39</b> and <b>41</b>, as well as and <b>40</b> and <b>42</b>). However, the basic nitrogen atom of the piperidine analogues led to better solubility (about 100 mg/L for <b>42</b> at pH = 7.4, in comparison to cyclohexyl compounds, such as <b>39</b> and <b>41</b>, that showed a solubility lower than 1.5 mg/L). In the attempt to combine the positive effect of the piperazine ring on cell-free assay with an improvement of cellular activity, basicity of the nitrogen atom was attenuated by the synthesis of less polar derivatives. Exploration of the <i>N</i>-alkyl series led to compounds that maintained both a nanomolar activity in cell-free assay and a solubility of about 30 mg/L, while showing a measurable submicromolar activity in the cell-based assay (<b>43</b>–<b>45</b>). The <i>neo</i>-pentyl group at the piperidine ring of <b>45</b> was the most profitable substituent for activity and was kept fixed when a SAR analysis was attempted at the opposite pyrazinone ring. The <i>gem</i>-dimethyl (<b>46</b>) and the spiro cyclobutyl analogue <b>47</b> showed a further increase in cellular potency (430 and 300 nM, respectively), with a significant kinase selectivity. Evaluation of the effects of <b>47</b> on the phosphorylation of upstream (p38) and downstream (Hsp27) components led to the suggestion that cellular activity of such a compound is mediated by MK2 inhibition. However, <b>47</b> did not affect TNFα production in the LPS assay, probably because of its high binding to plasma proteins.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(51)</a></div><div class="NLM_p last">Introduction of polar groups (hydroxymethyl and aminomethyl) at the position adjacent to the lactam moiety of both the carboline and pyrazinoindolone derivatives led to compounds with weak activity in the cell-free assay (the best values were in the two-digit nanomolar concentrations) and with cellular potency higher than 10000 nM.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(52)</a></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.3 Compounds from Merck Research Laboratories</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">4.3.1 Spiropiperidines</h4><div class="NLM_p">Compounds bearing a common quinolinylpyridine system (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) were used in a hybridization approach to find new entries able to block MK2 activity via an ATP-competitive mechanism of action. The three-dimensional coordinates of the complexes between MK2 and <b>7</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jbo">2jbo</a> and 2jbp,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(53)</a> as well as <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r2y">3r2y</a>)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(54)</a> or <b>48</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r30">3r30</a>),<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(54)</a> two ATP-competitive MK2 inhibitors previously described by Pfizer,<a onclick="showRef(event, 'ref46 ref65'); return false;" href="javascript:void(0);" class="ref ref46 ref65">(35, 55)</a> showed that the common cycles of the two ligands were accommodated with the same orientation and conformation within the binding site of MK2. The quinoline ring pointed toward the solvent and occupied the front pocket of the ATP binding site without any specific interaction with the protein. The pyridine nitrogen made a hydrogen bond with the NH group of the Leu141 backbone. Moreover, the carbonyl group of both ligands interacted by hydrogen bond with the ammonium terminal group of Lys93. The distinctive molecular portions of the inhibitors also showed contacts with MK2. In particular, the NH lactam group of <b>7</b> interacted by a hydrogen bond with the carboxyl terminus of Asp207, while the terminal amino group of <b>48</b> made a bifurcated hydrogen bond with both the carbonyl groups of Glu190 backbone and Asn191 side chain. In the attempt to maintain the interactions with MK2 found for the common molecular portions and to gain the specific interactions of the NH lactam of <b>7</b> and the amine group of <b>48</b>, a molecular hybridization approach has been performed to synthesize new hybrid putative MK2 inhibitors. The first hybrid inhibitor <b>49</b> was designed by changing the pyrrolopyridinone system into a pyrazolopiperazine nucleus on the basis of the easier synthetic feasibility of the pyrazole scaffold in comparison to the pyrrole analogue. Moreover, a methyleneamino side chain was added, reminiscent of compound <b>48</b>. Unfortunately, affinity of <b>49</b> toward MK2 was significantly decreased in a cell-free immobilized metal ion affinity-based fluorescence polarization (IMAP) assay (151 nM) in comparison to both parent compounds (49 and 28 nM, respectively).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(54)</a> Details on the binding mode of <b>49</b> into the MK2 ATP binding site were obtained by the X-ray crystallographic structure (not disclosed) that showed a suboptimal arrangement of the amino group that was unable to make hydrogen bonds with Asn191. Given the initial failure of this approach, a small library of additional compounds was designed to explore the chemical space around the overall molecular structure and in particular to restore the interactions with amino acid residues of the ribose pocket. To have a good affinity and cellular activity profile, the most challenging issue to be solved for a compound was to set up the right balance between solubility and membrane permeability. Satisfactory results were obtained by combination of the pyrrolopyridinone scaffold with a piperidine ring in aza-spiro compounds, such as <b>50</b> and <b>51</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). They showed nanomolar affinity toward MK2 (6.3 and 4.3 nM, respectively) and micromolar inhibitory activity (4800 and 910 nM, respectively) for the production of TNFα in THP-1 cells. Compound <b>51</b> also affected Hsp27 phosphorylation (620 nM) and was selective toward a large panel of kinases. Moreover, the presence of the spiropiperidine basic moiety improved several pharmacokinetic parameters, such as lipophilicity and solubility, as well as plasma protein binding and microsomial stability. Unexpectedly, absorption was very poor following oral administration (rat AUC 0.016 μM·h at a 10 μmol/kg dose), while a moderate bioavailability was detected upon intravenous and subcutaneous administration (rat AUC of 1.26 and 2.71 μM·h at a 4 μmol/kg and 10 μmol/kg dose, respectively). Bioavailability consequent to subcutaneous adminstration led <b>51</b> to be efficacious in the in vivo inhibition of LPS-induced acute TNFα production in rats. On the basis of these results, <b>51</b> was considered as a good starting point for a lead optimization process focused on the enhancement of oral bioavailability. Replacement of the methylenedioxophenyl moiety of <b>51</b> with aryl (variously substituted phenyl moieties) and heteroaryl (naphthyl, quinolyl, pyridyl, and pyrimidyl) substituents was tolerated and resulted in compounds with nanomolar affinity.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(56)</a> This suggested that the aromatic portion accommodated within the front region of the ATP binding site was not of crucial importance in determining affinity toward MK2. Cellular activity of these compounds was in the micromolar range in most cases and seemed to be correlated with lipophilicity values higher than 1 (expressed as calculated logP). However, an increased lipophilicity did not result in enhanced membrane permeability and oral bioavailability. The basicity of the unsubstituted 4-piperidine, which was introduced to ameliorate the solubility profile of these compounds, was suspected to be in part responsible of the lack of permeability and oral bioavailability.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(56)</a> The most simple attempt made to reduce p<i>K</i><sub>a</sub> values of these compounds was to change the substitution pattern of the piperazine ring by moving the basic nitrogen toward the electron-deficient pyrrole ring, resulting in a net electron-withdrawing balance. Accordingly with this hypothesis, 4- and 3-piperidyl analogues showed a difference of more than 0.4 log unit in their clogP. As an example, the 3-piperidyl analogue of <b>51</b> (<b>52</b>) showed an experimental p<i>K</i><sub>a</sub> = 8.3, one log unit lower than that found for <b>51</b> (9.3). Moreover, pharmacokinetic parameters were in general improved: Caco-2 permeability was 34 nm/s, AUC in rats after oral administration was 3.2 μM·h, with reduced microsomial stability both in human and rat (>60 and 48 min half-life, respectively). The oral exposure (bioavailability after oral administration) significantly improved in comparison to 4-piperidine analogues was in part counterbalanced by a 6-fold reduced affinity toward MK2 (28 nM) with respect to <b>51</b> (4.3 nM). Similar results in terms of affinity and pharmacokinetic parameters were found for compounds bearing an alkyloxy-substituted pyridine nucleus instead of the methylenedioxophenyl moiety, even if the oral bioavailability decreased to lower values (0.88 μM·h). Given the enhanced pharmacokinetic profile of 3-piperidyl spiro analogues, they were synthesized as enantiomerically pure compounds (ee >99%). As a general trend, the (<i>S</i>)-enantiomer showed affinity and cellular activity higher than that of the (<i>R</i>)-stereoisomer. As an example, (<i>S</i>)-<b>52</b> showed an affinity 4- and 12-fold better in comparison to the racemic compound and the (<i>R</i>)-stereoisomer, respectively. A similar trend was found for inhibitory activity in cell-based assay that occurred at submicromolar concentrations. Oral availability of (<i>S</i>)-<b>52</b> was not improved with respect to the racemic mixture (<i>F</i> = 48%, AUC = 3.5 μM·h).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hybridization approach to design pyrazolo-pyperazines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Spiro-piperidines from Merck Research Laboratories</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0015.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0016.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 in a IMAP assay.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production and Hsp27 phosphorylation in LPS-stimulated THP-1 cells, as well as to inhibit TNFα production in hPBMC cells, respectively.</p></div></div><div></div></div><div class="NLM_p">The lack of any specific interaction between the terminal aryl moiety (i.e., the methylenedioxophenyl system of <b>51</b>) and the front pocket of the ATP binding site prompted the researchers to introduce an amide spacer able in principle to make hydrogen bond contacts.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(57)</a> Replacement of the original moiety with a benzamido and naphthylamido terminal group, in combination with a pyridine instead of the central pyrimidine ring, gave very active compounds. Better activity found for pyridine-containing compounds was attributed to a conformational preference caused by electrostatic favorable interactions between the pyridine N and the amide NH as well as between the amide CO and a pyridine CH moiety.</div><div class="NLM_p last">A few compounds taken as representative examples of three subseries of 4-piperidine, 3-piperidine, and 3-pyrrolidine derivatives showed impressive enhancement of both MK2 affinity (with values up to subnanomolar concentrations) and cellular activity (up to two-digit nanomolar concentrations).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(57)</a> A SAR analysis of biological data allowed to rule out several considerations: (i) Unsubstituted piperidine derivatives had better affinity in comparison to the corresponding alkylated analogues (compare <b>53</b> and <b>54</b>). (ii) Values of MK2 affinity and cellular activity in the Hsp27 and TNFα assays showed a similar trend (compound with better affinity were also more active in cells). (iii) Unexpectedly, biological data for the assay on human peripheral blood mononuclear cells (hPBMC) showed very high potency, but their trend was opposite in comparison to that of affinity and other cell-based assay: among congeneric compounds, those with lower affinity and lower cellular activity in the TNFα and Hsp27 assays had very high activity in the hPBMC assay (compare <b>54</b> and <b>53</b>, <b>55</b> and (<i>S</i>)-<b>55</b>), probably due to off-target effects. (iv) Among 3-piperidine derivatives <b>52</b>, <b>55</b>, and <b>56</b>, the (<i>S</i>)-enantiomers were confirmed to be more active than the corresponding (<i>R</i>)-enantiomers and racemic mixtures. (v) Although log <i>P</i> and p<i>K</i><sub>a</sub> values for these compounds could suggest acceptable membrane permeability, PAMPA values were in general very low (around 0 nm/s), apart for several fluorinated derivatives, such as <b>56</b>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">4.3.2 Aminopyrazinylthiourea Derivatives</h4><div class="NLM_p">A HTS led to the identification of a micromolar inhibitor of MK2 (<b>57</b>, IC<sub>50</sub> = 2.0 μM, EC<sub>50</sub> = 7.9 μM in reducing LPS-stimulated TNFα production in THP-1 cells) with an aminopyrazinylthiourea scaffold (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(58)</a> An intensive SAR study showed that the thiourea spacer can not be replaced by a urea system, the aminopyrazine moiety was a mandatory feature, while replacement of the chlorine with small alkyl groups was tolerated. In particular, the corresponding methyl, ethyl, propyl, and cyclopropyl analogues showed IC<sub>50</sub> values of 4.0, 1.5, 2.3, and 0.47 μM, respectively, in the MK2 enzyme assay. In alternative, decoration of the phenyl ring led to identify a series of carbamates with improved activity. As examples, methyl, ethyl, <i>n</i>-butyl, <i>i</i>-butyl, <i>t</i>-butyl, and benzyl carbamate side chains at position 4 of the parent compound showed IC<sub>50</sub> values of 0.94, 0.31, 0.23, 0.15, 0.19, and 0.46 μM, respectively. A cyclic carbamate was also found to have a 0.21 μM inhibition of MK2. The best chemical features found for the right part (small alkyl groups such as <i>n</i>-Pr and <i>c</i>-Pr) and for the left part (<i>t</i>-Bu and cyclic carbamates) of the molecular scaffold were combined and led to compounds with a two-digit nanomolar inhibition of MK2 (from 15 to 45 nM) and micromolar activity (from 0.75 to 3.0 μM) in cells. Because they were also effective in reducing TNFα production in an acute inflammation mouse model, further modifications were attempted. Although thiourea was found to be a fundamental structural feature for activity, it was replaced with other groups in the attempt to avoid its potential cytotoxicity. However, compounds bearing an amide, sulfonamide, and guanidine moiety, as well as a five- or six-membered heterocycle instead of the thiourea group showed a weak activity (in the micromolar range) in the enzyme and cell-based assays.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(98)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aminopyrazinylthiourea from Merck Research Laboratories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.3.3 Imidazo[1,2-<i>a</i>]pyrazines</h4><div class="NLM_p">In addition to play a critical role in the signal transduction pathways that regulate the production of pro-inflammatory cytokines, MK2 was recently identified as a cell cycle checkpoint kinase acting at the cytoplasm during the late G<sub>2</sub>/M phase. In a similar way, also CHK1 is a serine/threonine protein kinase that is the effector of the G<sub>2</sub> phase checkpoint. As a consequence, both MK2 and CHK1 inhibitors are considered as possible anticancer agents able to block cell cycle checkpoints, cell cycle arrest, and DNA repair induced by chemotherapeutics. In this context, a HTS campaign for the identification of new ATP-competitive CHK1 inhibitors led to the discovery of an imidazo[1,2-<i>a</i>]pyrazine (<b>58</b>, <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>) with submicromolar in vitro potency (IC<sub>50</sub> = 650 nM) toward MK2.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(59)</a> Attempts to improve the potency and selectivity of this compound led to diaminocyclohexyl derivatives that showed a significantly better profile. As an example, <b>59</b> had a IC<sub>50</sub> = 60 nM and a 18-fold selectivity toward CHK1. Its mechanism of action at the molecular level was not investigated, although a similar compound was cocrystallized within the ATP binding site of CHK1. Any further change to the structural features of <b>59</b> led to loss in MK2 potency.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Imidazopyrazines Merck Research Laboratories</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0017.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0018.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 ability to phosphorylate a peptide substrate.</p></div></div><div></div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.4 Compounds from Novartis Institutes for BioMedical Research</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.4.1 Pyrrolopyrimidinones and Pyrazoles</h4><div class="NLM_p">Another class of MK2 inhibitors<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(60)</a> was derived directly by the pyrrolopyridinones previously reported.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> The new pyrrolopyrimidinones were obtained by transformation of the pyridone moiety into a pyrimidinone ring (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>), keeping fixed the pyridino substituent at the position 2 of the pyrrole. The two hydrogen bond donors (NH) groups at both the pyrrole and lactam moiety appeared as crucial keys for activity, while a <i>p</i>-F styryl chain at the position 2 of the pyridine led to <b>60</b>, with submicromolar activity (200 and 350 nM, respectively) in both the cell-free and hPBMC cellular assay. In an attempt to ameliorate the poor solubility of <b>60</b> (3 mg/L), the fluorine was replaced with larger polar groups. Although the most active compound <b>61</b> showed a solubility enhanced to 41 mg/L, its activity (51 and 110 nM) was significantly lower than that of the pyrrolopyridinones described by Pfizer (single-digit nanomolar inhibitory activity in cell-free assay and a single-digit micromolar activity in U937 cells).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> It also showed a modest selectivity toward a panel of about 30 kinases, with a 24 nM activity toward the closely related MK5. MK2 was identified as the target of this compound, although targeting of kinases upstream of p38 can not be excluded.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pyrrolopyrimidinones and Pyrazoles from Novartis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0019.gif" alt="" id="fx12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0020.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div><div class="footnote" id="t8fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in hPBMC cells stimulated with both LPS and IFNγ, and to inhibit Hsp27 phosphorylation in anisomycin-stimulated THP-1 cells (in parentheses).</p></div><div class="footnote" id="t8fn3"><sup>Table c</sup><p class="last">R group is in meta position.</p></div></div><div></div></div><div class="NLM_p last">Following a scaffold-hopping strategy, the pyrrolopyrimidinone core was simplified to give a benzamide scaffold bearing a five-membered heterocycle at the para position instead of the pyridine substituent (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(61)</a> A 3-aminopyrazole was identified as the heterocycle the most profitable for activity. As an example, <b>62</b> showed a micromolar activity (2000 nM) in a cell-free assay. Not surprisingly, further analysis of the benzamide portion revealed that rigidification into the corresponding lactam moiety (as in <b>63</b>) resulted in a significant improvement in affinity (84 nM) but without cellular activity even if this compound showed appreciable permeability. Moreover, in the search for better substituents than the methoxy group, a benzimidazole (<b>64</b>) and an indole nucleus (<b>65</b>) maintained a 82 and 61 nM activity, respectively, and gained, at the same time, a single-digit micromolar activity in both cellular assays (inhibition of TNFα production in hPBMC stimulated by LPS, and inhibition of Hsp27 phosphorylation in THP-1 cells stimulated by anisomycin). X-ray crystallographic studies on the complex between MK2 and <b>65</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kga">3kga</a>) showed that the aminopyrazole moiety was accommodated within the hinge region (as the arylpyridine group of the parent compounds) and made hydrogen bonds with both Glu139 and Leu141. On the other hand, the lactam carbonyl gave the usual hydrogen bonds with the conserved residues Lys93 and Asp207. Very interestingly, the indole portion of the inhibitors forced the structure of MK2 to an induced fit of Phe90. As a result, a hydrophobic pocket was opened behind the hinge region that was probably responsible for the high kinase selectivity found for <b>65</b>. A 68% inhibition of the TNFα production in LPS-treated mice was found at a 100 mg/kg oral dosage, while no inhibition was measured at a 30 mg/kg oral dose. This was probably due to the low solubility of <b>65</b> (<2 mg/L) that, at the 30 mg/kg dose, only guaranteed a 1700 nM blood concentration, lower than that required to exert an effect in cells (in fact, in hPBMC, TNFα production was inhibited with an EC<sub>50</sub> = 2500 nM).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.4.2 Pyrrolo-isoquinolines and Tetracyclic Derivatives</h4><div class="NLM_p">A HTS campaign led to the identification of a micromolar inhibitor of MK2 (3800 nM) bearing a pyrrolo[2,3-<i>f</i>]isoquinoline amide scaffold <b>66</b> (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(62)</a> reminiscent of the pyrrolopyridine compounds previously reported by others.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> A combination of the structural features of both classes of compounds resulted in tetracyclic derivatives with five-, six-, and seven-membered lactam rings. SAR analysis of the MK2 inhibitory properties showed that the six-membered lactam ring was better for activity, as already found for pyrazinoindolone derivatives previously described.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(52)</a> Moreover, the NH lactam group was important for hydrogen bond interactions and thus did not tolerate alkyl substituents. One of the most active compounds of this series was <b>67</b>, bearing a styryl chain already found as a profitable substituent for pyrrolopyrimidinones,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(60)</a> had a 1 and 9 nM activity in cell-free assay and as inhibition of TNFα production in hPBMC, respectively. A very interesting selectivity (about 200-fold) was also found toward c-Jun N-terminal kinase 2 (JNK2), whose inhibition may affect TNFα production in cells. Unfortunately, the overall selectivity toward a panel of 26 kinases was significantly low (13 kinases were inhibited by <b>67</b> with IC<sub>50</sub> < 1000 nM). The corresponding 3-F,4-OMe-phenyl derivative <b>68</b>, although underwent a reduction in activity (15 and 97 nM in the cell-free and in the hPBMC assay, respectively), also inhibited Hsp27 phosphorylation at 500 nM concentration and was very selective toward kinases (JNK2 was inhibited with a 1420 nM IC<sub>50</sub>, while none of the remaining 25 kinases was affected). A similar activity/selectivity profile was found for <b>69</b>. These findings suggested that phenyl and pyridyl substituents conferred kinase selectivity, while styryl groups broadened activity toward a wide range of kinases. None of the tetracyclic compounds showed activity after oral administration in LPS-treated mice, with the sole exception of the ketone derivative <b>70</b> that reduced TNFα release by 73% (13 μM plasma level after 2 h).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Tricyclic and Tetracyclic Pyrrole Derivatives from Novartis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0021.gif" alt="" id="fx14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0022.gif" alt="" id="fx15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div><div class="footnote" id="t9fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in hPBMC cells stimulated with both LPS and IFNγ, and to inhibit Hsp27 phosphorylation in anisomycin-stimulated THP-1 cells (in parentheses).</p></div></div><div></div></div><div class="NLM_p">Lack of solubility and oral bioavailability were the major limitation of the tetracyclic compounds described above. To address this issue, a systematic approach to modify each of the four rings was applied (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). In particular, dearomatization of the central phenyl ring of <b>69</b> into a cyclohexadiene moiety (<b>71</b>) maintained an activity comparable to that of the parent compound, while ring expansion or contraction led to significantly less active compounds.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(63)</a> Next, three- and four-membered spiroalkanes were attached to the lactam moiety with different substitution patterns. In particular, spirocyclopropanes <b>72</b> and <b>73</b> showed an appreciable activity profile as MK2 inhibitors and in cell assays, even if they still suffered from low solubility (9 and <4 μM, respectively, in comparison to 8 μM found for <b>71</b>). A dramatic enhancement of MK2 inhibitory activity was found with spiroazetidines at the lactam moiety. The unsubstituted derivative <b>74</b> had a 17 nM activity toward MK2 and submicromolar ability to inhibit TNFα production and Hsp27 phosphorylation in cell-based assays (100 nM). Its solubility was considerably improved to 337 μM. The corresponding <i>N</i>-methyl and <i>N</i>-ethyl analogues (<b>75</b> and <b>76</b>, respectively) retained submicromolar cellular activity, while their MK2 inhibition occurred at concentrations lower than 3 nM. In the case of the <i>N</i>-methyl azetidine derivatives (such as <b>75</b>), inhibition of MK2 occurred at the same concentration, irrespective of the aryl substituent at the pyridine ring. Importantly, the sole derivatives bearing a <i>o</i>-F phenyl substituent at the pyridine ring showed solubility values from 337 (<b>74</b>) to >1000 μM (<b>77</b>), probably consequent to an out-of-plane rotation of the pendant phenyl ring in comparison to the tetracyclic core. Finally, changing the pyridine into a pyrimidine, as well as the central pyrrole into a <i>N</i>-methyl pyrrole or furan, led to compounds with lower activity and solubility. Compounds <b>73</b> and <b>75</b> were further tested for their ability to inhibit LPS-induced TNFα production in vivo in mice models. A good oral activity was found after a 100 mg/kg administration: TNFα release was inhibited by 96 and 90%, respectively, at 30 and 6 μM plasma concentration. Encouraging pharmacokinetic parameters for <b>72</b> in rats at 1 mg/kg po (in terms of maximal plasma concentration, clearance, and half-life time) allowed its evaluation in the chronic models of rheumatoid arthritis. A significant reduction in swelling was observed without body weight reduction. However, considering that 1 μM <b>72</b> showed <i>a</i> > 95% inhibition of 14 out of 262 human kinases, as well as its high plasma concentration in rats and mice, the overall effects observed in chronic model may in part derive from off-target activity toward kinases different from MK2. Differently from the spirocyclopropanes as <b>72</b>, which showed appreciable absorption and acceptable clearance in vivo, the spiroazetidines as <b>75</b> had the best activity toward MK2 and in cell-based assays. Details of the binding mode of <b>75</b> into the ATP-binding pocket of MK2 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3m2w">3m2w</a>) revealed the important role of the nitrogen atom of the azetidine ring that made a water-bridged hydrogen bond interaction with the carboxy terminus of Glu145, in addition to the usual hydrogen bond between the nitrogen atom of the condensed pyridine and Lys141.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Tetracyclic Pyrrole Derivatives from Novartis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0023.gif" alt="" id="fx16" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0024.gif" alt="" id="fx17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div><div class="footnote" id="t10fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in hPBMC cells stimulated with both LPS and IFNγ, and to inhibit Hsp27 phosphorylation in anisomycin-stimulated THP-1 cells (in parentheses).</p></div></div><div></div></div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.5 Compounds from Abbott Laboratories</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.5.1 Aminopyrimidines</h4><div class="NLM_p">The X-ray three-dimensional structure of the complex between MK2 and 2,4-diaminopyrimidine derivatives <b>78</b> and <b>80</b> (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kc3">3kc3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ka0">3ka0</a>) showed an unexpected binding mode of the inhibitors within the ATP binding site.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(32)</a> In fact, the diaminopyrimidine system was known to interact with the hinge region of various kinases and expected to form hydrogen bonds with Glu139 and Leu141 of the MK2 hinge region. On the contrary, the indazolepyrimidine <b>78</b> and the phenolpyrimidine <b>80</b> (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>) showed their aminopyrimidine moiety at hydrogen bond distance from the catalytic Lys93 and Thr206 near the DFG region, while the opposite benzofuran and benzothiophene ring were accommodated within the hinge region and pointed to the solvent. Given this binding mode, four different molecular portions were modified to optimize potency and selectivity of the small molecule inhibitors:<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(64)</a> (i) to better interact with the extended hinge region, the 2-benzofuran ring of <b>78</b> was replaced with the 2-benzothiophene found in <b>80</b>, thus resulting in <b>79</b> that maintained a MK2 inhibitory activity of 160 nM. The phenol moiety (see <b>80</b>) was not further considered because of its metabolic liability; (ii) an aromatic and aliphatic amide introduced in place of the primary amine group led to inactive compounds; (iii) a significant enhancement in activity to 56 nM was gained by rigidification of the NH bridge into a bicyclic pyrrolo[2,3-<i>d</i>]pyrimidine moiety as in <b>81</b>; (iv) in turn, the NH group of the newly generated pyrrole nucleus was substituted with various polar groups to gain interactions with the Glu145 and Glu190 residues of the ribose pocket by hydrogen bonds and salt bridges. The most active compounds (<b>82</b> and <b>83</b>) had better MK2 inhibitory activity (19 and 35 nM, respectively) in comparison to <b>81</b> (56 nM). These compounds also showed a submicromolar inhibition of TNFα production in LPS-stimulated peripheral human monocytes, but their oral bioavailability at a 10 mg/kg dose was negligible. Given the weak enzymatic and cellular activity of the compounds, as well as a very low oral exposure, further development of the series was abandoned.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Aminopyrimidine Derivatives from Abbott Laboratories</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0025.gif" alt="" id="fx18" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0026.gif" alt="" id="fx19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate by using a homogeneous time-resolved fluorescence method.</p></div><div class="footnote" id="t11fn2"><sup>Table b</sup><p class="last">Expressed as the ability to inhibit TNFα production in LPS-stimulated peripheral human monocytes (PHM).</p></div></div><div></div></div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">4.6 Compounds from Teijin Pharma and BioFocus</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.6.1 Pyrazolo[1,5-<i>a</i>]pyrimidines</h4><div class="NLM_p">A HTS campaign on a focused kinase library comprised of 5075 compounds led to the identification of a micromolar MK2 inhibitor belonging to the class of pyrazolo[1,5-<i>a</i>]pyrimidine derivatives (<b>84</b>, <a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(65)</a> This compound acted as an ATP-competitive MK2 inhibitor and showed an IC<sub>50</sub> = 1300 nM in a cell-free assay as well as a significantly better affinity toward CDK2 (55 nM). In the attempt to improve MK2 affinity and to enhance selectivity, a large series of derivatives was designed and synthesized. Among them, C2-substituted analogues of <b>84</b> were inactive, while insertion of a halogen substituent at the position C3 led to compounds that retained a single-digit micromolar activity while gaining a single-digit nanomolar activity toward CDK2. As a consequence, both the positions C2 and C3 were left unsubstituted in the next derivatives. A 3-fold better cell-free activity (400 nM) was found when the diaminocyclohexyl side chain at C5 was replaced by a racemic 3-piperidylamino moiety, as in <b>86</b>. A similar trend was observed by introduction of small alkyl groups (Me and Et) at the position C6. As an example, <b>85</b> showed a 400 nM activity and improved selectivity toward CDK2. Interesting results were also obtained by changing the C7 side chain to a <i>p</i>-ethoxyaniline moiety, as in <b>87</b>. In particular, the (<i>S</i>)-enantiomer of <b>87</b> had a 130 nM activity, about a log unit better than that of the corresponding (<i>R</i>)-enantiomer (1200 nM), and a 177-fold selectivity. Although several structural features of the complex between MK2 and the pyrazolo[1,5-<i>a</i>]pyrimidine (and pyridine) derivatives was predicted by docking simulations,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(66)</a> the availability of the three-dimensional coordinates of the complex between <b>87</b> and MK2 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3a2c">3a2c</a>)<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(28, 29)</a> shed light into their direct interactions. In particular, a nonplanar conformation that minimized steric clashes between the C6 and C7 substituents of the inhibitor was found. Moreover, the pendant aryl moiety was accommodated within a pocket originated by a β-sheet-to-α-helix conformational rearrangement occurred at the Gly-rich loop of MK2. The analysis of the complex suggested further variations at the position C7. While larger alkoxy groups instead of the <i>p</i>-methoxy substituent of <b>87</b> led to compounds that retained similar activity (ranging from 130 to 160 nM) and gained some CDK2 selectivity, biaryl groups and bicyclic heteroaryl moieties increased activity by about 20-fold (as in <b>88</b>–<b>90</b>). Both <b>87</b> and <b>90</b> were able to reduce TNFα production in LPS-stimulated THP-1 cells (EC<sub>50</sub> of 7.2 and 7.6 μM, respectively) and in a murine model of endotoxin shock (C57BL/6 mice treated with a 100 mg/kg oral dose showed 14% of serum TNFα). Pharmacokinetic parameters (bioavailability, total clearance, and half-life time) were also satisfactory.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Pyrazolopyrimidine Derivatives from Teijin Pharma and BioFocus</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0027.gif" alt="" id="fx20" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0028.gif" alt="" id="fx21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div><div class="footnote" id="t12fn2"><sup>Table b</sup><p class="last">Compounds <b>87</b>–<b>90</b> were in their (<i>S</i>)-configuration.</p></div></div><div></div></div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35">4.7 Compounds from Wyeth Research</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.7.1 Squarate Derivatives</h4><div class="NLM_p">A squarate derivative (<b>92</b>, <a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>) was identified by means of a HTS campaign and cocrystallyzed with the 41–364 truncated form of MK2 at 3.3 Å resolution (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fpm">3fpm</a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(67)</a> Hydrogen bonds between the terminal ammonium group of Lys93 and one of the carbonyl oxygen atoms of <b>92</b>, as well as between the pyridine nitrogen and the NH group of Leu141 (hinge region), were the major interactions found in the crystal structure. The micromolar MK2 inhibitory activity of <b>92</b> in a cell-free assay (8.9 μM), its poor kinase selectivity, and the ability to significantly inhibit members of the CYP450 family (in the micromolar and submicromolar range) suggested the need to improve both potency and selectivity. Changes at the benzylamino portion showed that the presence of a methyl group with the appropriate configuration was a crucial key for activity. In fact, the (<i>S</i>)-enantiomer (<b>93</b>) and the unsubstituted derivative (<b>94</b>) underwent a deep decrease of activity. Moreover, decoration of the phenyl ring led to the identification of various hydrogen donor groups at the meta position as profitable substituents, with the 3-hydroxyl group of <b>95</b> and <b>96</b> being the most effective (0.38 and 0.39 μM, respectively). They both gained a 20-fold higher activity in comparison to the parent compound <b>92</b>, and <b>96</b> also showed an inhibition of CYP450 isozymes higher than 10 μM. On the other hand, variations at the pyridine ring resulted in micromolar inhibition of MK2, with the sole exception of <b>97</b>, which showed an IC<sub>50</sub> = 0.67 μM. The most active compounds were also evaluated for their ability to inhibit the production of TNFα in THP-1 cells pretreated with LPS. The increased polarity of <b>95</b> and <b>96</b> seemed to be related to a lower activity in the cell-based assay in comparison to <b>92</b> (34 and >40 vs 11 μM found for <b>92</b>). On the contrary, <b>97</b>, obtained by keeping fixed the core structure of <b>92</b>, showed a 0.67 and a 1.1 μM activity in cell-free and cell-based assays even if off-target effects have not been investigated. Kinase selectivity was also ameliorated.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Squarate Derivatives from Wyeth Research</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0029.gif" alt="" id="fx22" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0030.gif" alt="" id="fx23" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>Table a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div></div><div></div></div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">4.8 MK2 Inhibitors from Marine Sponges</h3><div class="NLM_p">Crude extracts of marine sponges were evaluated for their ability to inhibit MK2 activity. Two meroterpenoids were found in the metanolic portion obtained from <i>Acanthodendrilla</i> sp.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(68)</a> that was collected in 1996 on reefs near Makassar (Indonesia). Repeated extractions and fractionations, followed by reverse-phase HPLC, yielded (+)-makassaric acid <b>98</b> and the structurally related (+)-subersic acid <b>99</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Their MK2 inhibition, evaluated by means of an ELISA-based assay on the 41–353 human recombinant MK2, was in the micromolar range (9.6 and 20 μM, respectively). Later, a short and very versatile synthesis of <b>98</b> was proposed as a tool to obtain small libraries of analogue compounds in the attempt to figure out SAR considerations and finally to improve MK2 inhibitory activity.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(69)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MK2 inhibitors extracted from marine sponges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39">4.9 MK2 Inhibitors Designed by Computer-Aided Drug Discovery Approaches</h3><div class="NLM_p">In the attempt to find new inhibitors of MK2, a series of theoretical studies based on both structure- and ligand-based drug design approaches have been performed starting from the structure of MK2 and already known MK2 inhibitors. 3D QSAR,<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(70-72)</a> pharmacophoric models,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(73)</a> and docking studies<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(71)</a> were generated for pyrrolopyridinones disclosed by Anderson,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> for carbolines described by Wu,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(50)</a> and for thiourea derivatives described by Lin.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(58)</a> Disappointingly, although all of these models were described as useful tools for designing novel MK2 inhibitors, none of them was effectively used for this purpose. A more elaborated computational protocol based on compounds reported by Novartis,<a onclick="showRef(event, 'ref71 ref43 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref43 ref72">(60-62)</a> comprised also of database search within commercially available collections of compounds, led to hypothesize several original scaffolds as putative MK2 inhibitors that, however, have not been tested.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(74)</a></div><div class="NLM_p last">Recently, a computational protocol for the study of tautomerization and ionization of the previously described pyrrolopyridinone<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(35)</a> and benzothiophene derivatives<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(40, 41)</a> showed that inclusion of all tautomers and isomers was a mandatory condition to obtain reliable and robust models to be used in the hit-to-lead and lead optimization steps of the ligand design process.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(49)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">4.10 Peptides as Inhibitors of MK2 Activity</h3><div class="NLM_p">A 23-mer cell-permeant peptide able to inhibit MK2 activity was built by linking a modified analogue of the selective, not cell permeant, peptidic inhibitor of MK2 (KKKALNRQLGVAA) with a cell-penetrating peptide (CPP).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(75)</a> The resulting sequence <b>100</b> (WLRRIKAWLRRIKALNRQLGVAA) was evaluated for its ability to reduce MK2-dependent Hsp27 phosphorylation. A 80% decrease of Hsp27 phosphorylation was obtained with 200 μM <b>100</b> in an in vitro kinase assay that evaluated recombinant human Hsp27 phosphorylation by purified MK2. As a comparison, the original nonpenetrating peptide reduced Hsp27 phosphorylation by only 64%. Hsp27 phosphorylation was also reduced in keloid fibroblasts treated with the inhibitor peptide (10 μM). At the same concentration, expression of connective tissue growth factor and collagen was also decreased by 68 and 76%, respectively. A reduced concentration of the inhibitor (5 μM) did not affect these parameters. Unfortunately, the new peptidic inhibitor showed a kinase selectivity lower than that found for the original MK2 inhibitor. In the attempt to design more specific kinase inhibitors with a peptidic scaffold, additional CPP were added to the MK2 inhibitor peptide KALNRQLGVAA.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(76)</a> As a result, although the peptide <b>101</b> bearing a YARAAARQARA CPP (YARAAARQARAKALNRQLGVAA) showed a significant decrease of MK2 inhibitory activity in comparison to <b>100</b> (5.8 versus 0.74 μM), its selectivity toward a panel of 43 kinases was ameliorated. The most relevant examples were represented by p38α, interleukin-1 receptor-associated kinase 4, myosin light chain kinase, PKBβ, PKCδ, and rho-associated coiled-coil-containing kinase 1, whose percent kinase activity were 61, 12, 4, 18, 11, and 0 after treatment with 30 μM <b>100</b>, in comparison to 100, 68, 66, 96, 105, and 95 after treatment with 300 μM <b>101</b>. Moreover, while <b>100</b> induced cell death at 40 μM, the YARAAARQARA-containing peptide <b>101</b> could be used at concentrations up to 3000 μM without toxicity toward pleural mesothelial cells. As expected, these peptides were also able to reduce pro-inflammatory cytokine (TNFα and IL-6) production in LPS-induced THP-1 monocytes as well as to decrease Hsp27 phosphorylation in the same cells.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(77)</a> Further studies on <b>101</b> led to the identification of the analogue <b>102</b> (YARAAARQARAKALARQLGVAA, also referred to as MMI-0100, bearing a Asn to Ala substitution at the position 15) that showed kinase selectivity and a MK2 inhibitory activity corresponding to IC<sub>50</sub> = 22 μM.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(76)</a> This peptide was used in various in vivo animal models. As examples, its anti-inflammatory activity was used to reduce formation of scars and adhesions without affecting intestinal healing in cases of abdominal surgery.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(78)</a> Moreover, treatment with <b>102</b> resulted in a significant reduction of intimal hyperplasia in ex vivo and in vivo mouse vein graft models,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(79)</a> as also previously found for <b>100</b> in a human saphenous vein model.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(80)</a> It also inhibited cardiac fibrosis in myocardial infarction<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(9)</a> and affected MK2-induced inflammatory and fibrotic responses in idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(12)</a></div><div class="NLM_p last">Recent studies on the role of matrix stiffness on the uptake of MK2 inhibitory peptides shed light on an unusual effect found upon treatment with <b>102</b> that was required in millimolar concentrations for efficacy in cells while it was active in the range between 10 and 100 μM in animal models. This evidence resulted from the fact that matrix stiffness (of polystyrene used for tissue culture) and cell density affected uptake.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(81)</a> These results suggested that studies on possible changes of drug uptake consequent to diseases-induced tissue rigidity should be included in the drug discovery processes and, in principle, also in the personalized therapies.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">5 Non-ATP-competitive MK2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although the significant number of small molecules able to inhibit MK2 by an ATP-competitive mechanism of action, they in general showed poor BE, expressed as the ratio between binding affinity (<i>K</i><sub>i</sub> toward MK2) and cellular activity (EC<sub>50</sub>). This is mainly due to the high binding affinity of ATP toward MK2 (2 μM) and the high cellular concentration of ATP (about 2–5 mM). As a consequence, a mechanism of action different from ATP-competitive could enhance BE of MK2 inhibitors. In fact, a non-ATP-competitive inhibitor is expected to achieve inhibitory efficacy easier than compounds that do compete with the high concentration of cellular ATP and its high affinity for MK2. Moreover, non-ATP-competitive inhibitors should guarantee higher selectivity profiles as a consequence of the fact that they do not bind the ATP binding site that is similar among kinases.</div><div class="NLM_p">Several attempts have been made to identify and optimize small molecules acting as non-ATP-competitive and uncompetitive inhibitors of MK2. As an example, Merck researchers applied a particular HTS to find allosteric, non-ATP-competitive MK2 inhibitors by application of the automated ligand identification system (ALIS) technique. ALIS is an integrated affinity selection–mass spectrometry protocol comprised of sequential rapid size-exclusion chromatography, reverse-phase chromatography, and electrospray ionization mass spectrometry, efficiently used for rapid and direct identification of noncovalent small molecule ligands from combinatorial libraries and mixtures. Three steps are included in the overall process: the soluble target biomolecule is exposed to a mass-encoded small molecule library to allow the formation of any suitable ligand–protein complex (affinity-based ligand selection); the resulting complexes are separated from nonbinding protein and ligands by size-exclusion chromatography during a rapid and low temperature step that also allows identification of complex with weak affinity ligands; finally, a reverse-phase chromatography column induces complex dissociation, while the eluted ligand is analyzed by a high-resolution mass spectrometer and identified on the basis of its molecular weight. Further details on the ALIS method and its advantages in comparison to other affinity selection–mass spectrometry techniques are reported in the original literature.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(82)</a></div><div class="NLM_p">ALIS was included in a HTS procedure with recombinant purified MK2 consisting of the minimal kinase domain, spanning from residue 41 to 338. Truncation of both the amino and carboxy termini was mainly chosen to reduce termal stability of the kinase domain. In fact, an α-helical motif (sequence 334–364) of the carboxy terminus, folded on the kinase domain surface, interacts with the substrate binding cavity, thus stabilizing the kinase domain and limiting its accessibility by ligands. Its removal could increase the probability of the ALIS screening to find small molecules that are able to bind both the classical and allosteric sites on MK2.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">5.1 Compounds from Merck Research Laboratories</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">5.1.1 Furan-2-carboxamide Derivatives</h4><div class="NLM_p">Application of ALIS protocol to Merck mixture-based combinatorial libraries led to the identification of a diaryl 2-furyl amide <b>103</b> (<a class="ref internalNav" href="#tbl14" aria-label="Table 14">Table 14</a>) that showed a novel binding mode in comparison to the classical ATP-competitive small molecules.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(83)</a> Different NMR studies and biochemical (enzymatic analysis of MK2 inhibition) experiments were set up to demonstrate that <b>103</b> bound MK2 without competing with ATP (non-ATP-competitive inhibition) and that its binding was site-specific. This compound showed a single-digit micromolar activity in a DELFIA immunoassay (5500 nM) and toward SW1353 chondrosarcoma cells (about 2000 nM) without appreciable cytotoxicity as well as a significant kinase selectivity in an in-house profiling panel assay. Interestingly, its activity was not affected by variations of ATP concentration.</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Furan-2-carboxamides from Merck Research Laboratories</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0031.gif" alt="" id="fx24" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0032.gif" alt="" id="fx25" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>Table a</sup><p class="last">Cell-free activity was determined in a DELFIA immunoassay.</p></div><div class="footnote" id="t14fn2"><sup>Table b</sup><p class="last">Cellular activity is expressed as inhibition of Hsp27 phosphorylation in SW1353 chondrosarcoma cells (103–105) or TNFα production in THP-1 cells (106–122). Both values are reported for 105.</p></div><div class="footnote" id="t14fn3"><sup>Table c</sup><p class="last">Substituents R and R<sup>1</sup> were not specified for these compounds.</p></div></div><div></div></div><div class="NLM_p">A classical medicinal chemistry approach was planned in the attempt to improve biochemical (in a cell DELFIA immunoassay) and cell-based activity (inhibition of phosphorylation of the Hsp27 natural substrate in SW1353 cells) as well as ADME-Tox parameters. Changes at the <i>p</i>-Cl phenyl ring in terms of substitution pattern and substituents (Me, OMe, CF<sub>3</sub>) did not result in better compounds. Similarly, small variations at the piperazinephenyl moiety and replacement of the central furan core with five- and six-membered heterocycles resulted in compounds with activity comparable to or lower than that of the parent compound. A significant improvement in activity resulted from <i>N</i>-substitution of the carboxamide group, probably due to a conformational rearrangement of the amide bond to a <i>cis</i>-isomer that was reported as more stable by about 3 kcal/mol. Tertiary amides bearing homologous alkyl chains showed submicromolar activity in both assays, without cytotoxicity. The ethyl chain led to the best compound (<b>104</b>), with IC<sub>50</sub> and EC<sub>50</sub> values of 130 and 800 nM, respectively. Even better results were obtained with heterocyclic substituents. Among them, the 2-pyridyl derivative <b>105</b>, with IC<sub>50</sub> and EC<sub>50</sub> values of 110 and 350 μM, was further profiled: apart from a > 50% inhibition toward CK1γ3, it did not affect activity of a panel of 150 kinases; no inhibition was found toward a panel of CYP450 enzymes. Its pharmacokinetic properties showed appreciable oral bioavailability in rat, with inhibition of pro-inflammatory cytokine secretion in human THP-1 acute monocytic leukemia cells consequent to MK2 inhibition. LPS-stimulated THP-1 cells treated with <b>105</b> suffered from inhibition of TNFα and IL-6 production. MMP13 secretion was inhibited in both SW1353 chondrosarcoma and human primary chondrocyte cells. Although the promising biological profile shown by <b>105</b>, its inhibitory activity of TNFα production in THP-1 was about 5 μM, thus suggesting a significant difference between binding in cell-free assay and cellular activity.</div><div class="NLM_p">As previously found, changes at the <i>p</i>-Cl phenyl moiety did not result in more active compounds, with the sole exception of the <i>p</i>-CN analogue <b>106</b> that retained the same affinity found for <b>105</b> (about 110 nM).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(84)</a> Moreover, the corresponding methylated analogue <b>107</b> showed a further improvement of affinity (79 nM).</div><div class="NLM_p last">Given that the para-substitution was the best substitution pattern for the central phenyl ring C, diverse nitrogenated heterocyclic rings were attached instead of the terminal piperazine portion. Although the 3- and 4-piperidine, as well as the 1,4-diazepane analogues, only had a submicromolar affinity, the azetidine (<b>108</b>), pyrrolidine (<b>109</b>), and 2-piperidine (<b>110</b>) derivatives showed an affinity significantly enhanced (10, 10, and 5.4 nM, respectively) in comparison to the piperazine analogue <b>105</b>. Unexpectedly, compounds bearing these cycloalkylamino side chain were not further studied and discussed, while the piperazine ring was considered the best group to be kept within the structure of these MK2 inhibitors.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(84)</a> Finally, replacement of the pyridine ring with a biaryl system as in <b>111</b> suggested that only the <i>ortho</i>-substitution pattern of the central aromatic ring D was optimal to give active compounds. In fact, <i>ortho</i>-biphenyl derivatives bearing one polar substituent at the terminal phenyl ring E (<b>112</b>–<b>115</b>) showed IC<sub>50</sub> ranging from 8 to 20 nM and EC<sub>50</sub> (expressed as inhibition of TNFα production in THP-1 cells) about 3 orders of magnitude higher (from 1590 to 3460 nM). Substituents and substitution pattern on the terminal phenyl ring did not show a significant influence in determining affinity and cellular activity. Similar activity values were found for compounds bearing a biaryl system that contains a vicinal or distal pyridine ring (<b>116</b>–<b>121</b>) as well as a terminal pyrimidyl group (<b>122</b>).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">5.1.2 Dihydrooxadiazoles and Imidazoles</h4><div class="NLM_p">In a next step, the amide bond of the furan-2-carboxamide derivatives was rigidified by replacement with a five- and six-membered heterocyclic ring (<a class="ref internalNav" href="#tbl15" aria-label="Table 15">Table 15</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(85)</a> Only a dihydrooxadiazole core (<b>123</b>) was appropriate for affinity (50 nM, measured in a IMAP assay), although cellular activity was more than 2 orders of magnitude higher (6700 nM, measured as inhibition of Hsp27 phosphorylation in THP-1 cells). Affinity and activity were tolerant to the transformation of the 5-phenyl ring into pyridine (<b>124</b>–<b>127</b>), pyrimidine (<b>128</b>–<b>129</b>), and imidazole (<b>130</b>) analogues. Also a pyrimidylphenyl system as in <b>131</b> was profitable for both affinity and cellular activity (40 and 730 nM, respectively). Modification of <b>131</b> gave some SAR suggestions. In particular, para position for Cl is optimal for activity and affinity: in fact, <i>m</i>-Cl or <i>m</i>,<i>p</i>-dihalo derivatives showed a more than 5-fold reduction in affinity. On the other hand, replacement of Cl with a F as in <b>132</b> maintained the same biological profile (50 and 760 nM for affinity and cellular activity, respectively), while a <i>p</i>-CN group resulted in a 8 nM affinity (<b>133</b>). The two enantiomers of <b>133</b> were resolved (although their absolute configuration was not determined): only one of them retained a 6 nM enzymatic activity and a 170 nM inhibitory activity toward phosphorylation of Ser78 of the natural substrate Hsp27. The mechanism of action of this compound was confirmed to be as non-ATP-competitive, as already found for its analogue and parent compounds. Unfortunately, a significant gap between cell-free enzymatic data and cellular activity was maintained, probably due to low solubility and high plasma protein binding (about 97% in both rat and human). Moreover, moderate absorption and rat hepatocyte clearance were also found for <b>133</b>, thus resulting in a poor pharmacokinetic profile.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Rigidification of the <i>cis</i>-Amide into Five-Membered Heterocyclic Rings</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0033.gif" alt="" id="fx26" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0034.gif" alt="" id="fx27" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t15fn1"><div class="footnote" id="t15fn1"><sup>Table a</sup><p class="last">Measured in a IMAP assay.</p></div><div class="footnote" id="t15fn2"><sup>Table b</sup><p class="last">Cellular activity is expressed as inhibition of LPS-induced Hsp27 Ser78 phosphorylation in THP-1 cells.</p></div></div><div></div></div><div class="NLM_p last">In addition, keeping fixed the <i>p</i>-Cl or <i>p</i>-CN phenyl moiety and a 1,2-disubstitution pattern on the central five-membered core ring, it was changed to triazole and tetrazole moiety as isosteric groups of the <i>cis</i>-amide moiety. The new compounds showed an affinity decrease to two-digit nanomolar concentrations.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(86)</a> Better results were obtained with the imidazole ring that allowed restoration of a single-digit nanomolar affinity, as in <b>134</b> (7.7 nM). Further attempts to modify the piperazine ring to mitigate the oxidative metabolism on the attached phenyl ring and to fine-tune p<i>K</i><sub>a</sub> values were unsuccessful and resulted in less active compounds.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">5.1.3 Tricyclic Azepinone Derivatives</h4><div class="NLM_p">Following the rigidification approach to block the anilide system into the conformationally preferred <i>E</i>-conformer, a methylene bridge was inserted between the furan ring and the central phenyl ring of linear amide compounds (such as <b>103</b>) to yield conformationally constrained azepinone derivatives.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(87)</a> The most simple derivatives of this series (namely, the unsubstituted lactam <b>135</b> and its methyl derivative <b>136</b>, <a class="ref internalNav" href="#tbl16" aria-label="Table 16">Table 16</a>) showed a comparable weak affinity (96 and 79 nM, respectively), although significantly improved in comparison to <b>103</b> (5500 nM). This finding further supported the hypothesis that a conformational change from <i>Z</i>- to <i>E</i>-conformation occurred in <i>N</i>-alkylated tertiary anilides (such as <b>104</b>) in comparison to secondary amides (<b>103</b>) could be responsible for the 5–40-fold improvement in affinity. On the basis of previous suggestions showing that a biaryl moiety at the amide nitrogen atom was optimal for both affinity and cellular activity, pyridinylphenyl, and pyrimidinylphenyl moieties with an <i>ortho</i>-substitution pattern were added to the nitrogen atom of the lactam moiety. Among pyridinyl derivatives, only methoxy-substituted compounds <b>137</b>–<b>139</b> with a different substitution pattern showed a single-digit nanomolar affinity (4.9, 8.4, and 6.8 nM, respectively). Unsubstituted pyridinyl derivatives and their monofluoro analogues underwent a 2–5-fold drop in affinity. Differently, pyrimidinyl compounds <b>140</b>–<b>141</b> showed a 5.7 and 1.9 nM affinity, respectively. The cellular activity of the best compound <b>141</b> in inhibiting Hsp27 phosphorylation corresponded to an EC<sub>50</sub> of 138 nM, while inhibition of TNFα secretion from THP-1 cells was 150 nM. Unfortunately, tricyclic lactams showed not negligible cytotoxicity toward SW1353 cells, with CC<sub>50</sub> values in the range of two-digit micromolar concentrations. Finally, <b>141</b> was confirmed to have a non-ATP-competitive mechanism of action, and retained a high selectivity toward a panel of 21 kinases.</div><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. Further Rigidification to Azepinones (Merck Research Laboratories)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0035.gif" alt="" id="fx28" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0036.gif" alt="" id="fx29" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t16fn1"><div class="footnote" id="t16fn1"><sup>Table a</sup><p class="last">Measured in a IMAP assay.</p></div></div><div></div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">5.1.4 Tetracyclic Compounds</h4><div class="NLM_p">Further restriction of conformational flexibility of the azepinone derivatives by condensation of a fourth five-membered heterocyclic ring resulted in compounds with single-digit nanomolar affinity and cellular activity in the range between 260 and 2500 nM (<a class="ref internalNav" href="#tbl17" aria-label="Table 17">Table 17</a>).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(88)</a> Among chloro analogues, an imidazole, a methyl-imidazole, and a triazole moiety (as found in <b>142</b>, <b>146</b>, and <b>144</b>) resulted in comparable affinity (7.0, 9.2, and 9.3 nM, respectively) and activity (ranging from 1500 and 2500 nM). On the other hand, the corresponding ciano derivatives <b>143</b> and <b>145</b> had similar affinity (2.9 and 3.8 nM, respectively), but 6–8-fold better activity (260 nM) in comparison to their corresponding chloro analogues. Importantly, solubility of ciano compounds was slightly lower than that of chloro derivatives, thus suggesting that cellular activity may depend on different molecular parameters, in addition to solubility. Finally, transformation of <b>142</b> into the azocine analogue <b>147</b> resulted in a drop of affinity (18 nM), although a 2-fold enhanced solubility.</div><div class="NLM_table-wrap" id="tbl17"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 17. Condensation of a Fourth Condensed Ring to Azepinones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0037.gif" alt="" id="fx30" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t17fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub><a class="ref internalNav" href="#t17fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>142</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>143</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>144</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">2100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>145</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>146</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">2500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>147</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t17fn1"><div class="footnote" id="t17fn1"><sup>a</sup><p class="last">Measured in a IMAP assay.</p></div><div class="footnote" id="t17fn2"><sup>b</sup><p class="last">Cellular activity is expressed as inhibition of LPS-induced Hsp27 Ser78 phosphorylation in THP-1 cells.</p></div></div></div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">6 Uncompetitive MK2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52">6.1 Compounds from AstraZeneca</h3><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">6.1.1 Anilinoquinolines with an Uncompetitive Mechanism of Action</h4><div class="NLM_p">Screening the AstraZeneca core compound collection by HTS led to the discovery of the 4-anilino-6-phenyl-quinoline <b>148</b> (<a class="ref internalNav" href="#tbl18" aria-label="Table 18">Table 18</a>) as micromolar inhibitors of MK2 activity (IC<sub>50</sub> = 5200 nM in a cell-free assay).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(89)</a> Attempts to rule out SAR considerations suggested the position 6 of the quinoline ring as the most profitable to be changed. In particular, a series of <i>p</i>-substituted halo-derivatives (<b>149</b>–<b>151</b>) showed enhanced activity up to 400 nM (<b>149</b>). Unfortunately, due to very low permeability (evaluated in human Caco-2 cells), these compounds had only a micromolar ability to inhibit TNFα production in LPS-treated THP-1 cells. As an example, <b>151</b> showed an EC<sub>50</sub> = 4300 nM. Kinetic studies of reaction velocity (MK2 activity) in the presence of various ATP concentrations and 2 μM inhibitor strongly suggested an uncompetitive mechanism of action, further supported by the fact that inhibition of MK2 occurred better at higher ATP concentrations. Given the low stability in human microsomes, compound cytotoxicity, and low permeability, these compounds were not further studied.</div><div class="NLM_table-wrap" id="tbl18"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 18. ATP Uncompetitive Quinoline Derivatives from AstraZeneca</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0038.gif" alt="" id="fx31" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t18fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>148</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">5200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>149</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>150</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>151</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">700</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t18fn1"><div class="footnote" id="t18fn1"><sup>a</sup><p class="last">Expressed as the inhibition of MK2 activity toward a peptide substrate.</p></div></div></div></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">7 Conclusions and Future Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The p38 MAPK/MK2 signaling pathway is involved in a series of pathological conditions such as inflammation diseases and metastasis as well as in the resistance mechanism to antitumor agents. Inhibition of this pathway by blocking p38 was unsuccessful, and none of the p38 inhibitors was able to enter phase III clinical trials because of the unwanted and important systemic side effects. For this reason, in recent years, MK2 was selected as a druggable target in alternative to p38 in the attempt to reduce or abrogate the systemic side effects emerged by treatment with p38 inhibitors. In the field of anti-inflammatory therapy, MK2 showed the very promising profile of a disease-modifying antirheumatic drug target. In fact, differently from COX-2 inhibitors and other compounds classified as palliative drugs (i.e., NSAIDs), MK2 is able to interfere with key steps in the propagation of inflammation. As a consequence, compounds able to modulate MK2 activity are expected to be more efficacious and safe in comparison to NSAIDs and p38 inhibitors, respectively. Early studies led to discover ATP-competitive inhibitors. Unexpectedly, their optimization to lead-like and drug-like compounds suffered from major limitations in terms of scarce solubility, cell permeation, as well as kinase selectivity. A suboptimal cellular permeability led to disappointing results in both cell-based assays and in vivo models. As a consequence, enhancement of this pharmacokinetic parameter still remains a challenging issue to be addressed.</div><div class="NLM_p">In the last years, promising MK2 inhibitors were identified among compounds able to block MK2 activity by a non-ATP-competitive or ATP-uncompetitive mechanism of action. These compounds have the peculiarity of interacting with a binding site different from that of ATP, thus avoiding selectivity issues among kinases. They also show the additional advantage to be effective at lower concentrations in comparison to the ATP-competitive inhibitors. In fact, non-ATP-competitive inhibitors, by definition, are not required to compete with the high ATP concentrations found within the cells and with the high affinity of ATP for the inactive and active forms of MK2. Lower but effective concentrations of MK2 inhibitors should guarantee less pronounced side effects.</div><div class="NLM_p">Although the difficulties encountered in the process of developing drug-like MK2 inhibitors, a renewed interest derives from the important results on the pathological roles of this kinase in several diseases. The role of p38/MK2 as activators of a cell cycle checkpoint also suggested that MK2 could be a target for compounds acting as chemotherapeutic enhancers able to improve the effectiveness of already known chemotherapeutic drugs. Moreover, this enzyme is also involved in tumor metastasis and other dysfunctions linked to actin remodeling. Recent studies hypothesized that MK2 inhibitors could be effective in reducing or inhibiting cardiac fibrosis in myocardial infarction in humans and in decreasing inflammatory and fibrotic responses in idiopathic pulmonary fibrosis.</div><div class="NLM_p last">Given the pivotal importance of the p38-MK2 signaling pathway in inflammation, cell cycle, actin remodeling, and metastasis, MK2 still remains a very promising target and the identification of drug-like MK2 inhibitors with appropriate pharmacokinetics and pharmacodynamics is an appealing challenge for medicinal chemists. Efforts to be made in the very near future should be focused on the identification of new compounds with a profile of significant kinase selectivity, appropriate solubility, and cell permeability to be submitted to clinical trials. To this aim, non-ATP-competitive or ATP-uncompetitive inhibitors of MK2 appear to be the most promising compounds to be studied and optimized.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01457" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Manetti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Biotecnologie, Chimica e Farmacia, Università
di Siena, via A. Moro
2, I-53100 Siena, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ef898e8d9d86958680c1828e818a9b9b86af9a81869c86c1869b"><span class="__cf_email__" data-cfemail="9cfafdfeeef5e6f5f3b2f1fdf2f9e8e8f5dce9f2f5eff5b2f5e8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Fiore</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Biotecnologie, Chimica e Farmacia, Università
di Siena, via A. Moro
2, I-53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Forli</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road,  La Jolla, California 92037, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Mario Fiore</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=BIO-d930e3357-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mario Fiore</b> graduated in 2012 in Pharmacy at the University of Siena (Italy) working on small molecule inhibitors of MK2. In 2014, he was awarded a Master’s degree in Nutrition at Funiber (Fondazione Universitaria Iberoamericana) and in 2015 a Master’s degree in Cosmetic Techniques and Chemistry at the University of Siena. Currently, he has a collaboration with Inuvance.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Stefano Forli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=BIO-d930e3362-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stefano Forli</b> obtained his Ph.D. from the Università di Siena in 2006 in molecular modeling applied to medicinal chemistry. He is currently Staff Scientist at the Molecular Graphics Laboratory, Department of Integrative Structural and Computational Biology, at The Scripps Research Institute. He has been involved in numerous drug design projects, including the study of compounds that interfere with the polymerization cascade of α/β tubulin and actin, dual inhibitors of c-Src/Abl kinases, and COX-1/2 selective inhibitors. He is currently involved in the study of inhibitors of several HIV-1 therapeutic targets and in the development of software for drug design, notably AutoDock docking software.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Fabrizio Manetti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=BIO-d930e3367-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fabrizio Manetti</b> received a Ph.D. in Pharmaceutical Sciences at the Department of Pharmaceutical and Applied Chemistry at the University of Siena in 1996. Since 2002, he is a researcher in Medicinal Chemistry at the Department of Biotechnology, Chemistry and Pharmacy of the same University. His research activity of the past few years was focused on small molecule inhibitors of COX-2 and on modulators of kinases involved in cytoskeleton reorganization, actin remodeling, and cancer (i.e., 14-3-3, LIMK, and ERK-8). Additional research projects are based on ligand-based drug design approaches to find new modulators of the Hedgehog signaling pathway. He is cofounder of Lead Discovery Siena, a spinoff operating in the field of drug design and lead optimization.</p></figure></div><div class="ack" id="ACK-d930e3372-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partially supported by grant R01 GM069832 from the National Institutes of Health to S.F.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> Abbreviations Used</h2><tr><td class="NLM_term">MAPKAPK2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase-activated protein kinase 2</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">DMARD</td><td class="NLM_def"><p class="first last">disease-modifying antirheumatic drugs</p></td></tr><tr><td class="NLM_term">BE</td><td class="NLM_def"><p class="first last">biochemical efficiency</p></td></tr><tr><td class="NLM_term">TAK1</td><td class="NLM_def"><p class="first last">transforming growth factor-β activated kinase 1</p></td></tr><tr><td class="NLM_term">TAB1</td><td class="NLM_def"><p class="first last">TAK-binding protein 1</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun <i>N</i>-terminal kinase</p></td></tr><tr><td class="NLM_term">MLK</td><td class="NLM_def"><p class="first last">mixed-lineage kinases</p></td></tr><tr><td class="NLM_term">DUSP1</td><td class="NLM_def"><p class="first last">dual specificity phosphatase 1</p></td></tr><tr><td class="NLM_term">TTP</td><td class="NLM_def"><p class="first last">tristetraprolin</p></td></tr><tr><td class="NLM_term">CAP-zip</td><td class="NLM_def"><p class="first last">filamentous actin capping protein Z-interacting protein</p></td></tr><tr><td class="NLM_term">p16-Arc</td><td class="NLM_def"><p class="first last">p16 subunit of the seven-member actin-related protein-2/3 complex</p></td></tr><tr><td class="NLM_term">NLS</td><td class="NLM_def"><p class="first last">nuclear localization signal</p></td></tr><tr><td class="NLM_term">NES</td><td class="NLM_def"><p class="first last">nuclear export signal</p></td></tr><tr><td class="NLM_term">WS</td><td class="NLM_def"><p class="first last">Werner syndrome</p></td></tr><tr><td class="NLM_term">MRP2</td><td class="NLM_def"><p class="first last">multidrug resistance-associated protein 2</p></td></tr><tr><td class="NLM_term">BSEP</td><td class="NLM_def"><p class="first last">bile salt export pump</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescent immunoassay</p></td></tr><tr><td class="NLM_term">ALIS</td><td class="NLM_def"><p class="first last">automated ligand identification system</p></td></tr><tr><td class="NLM_term">IMAP</td><td class="NLM_def"><p class="first last">immobilized metal ion affinity-based fluorescence polarization</p></td></tr><tr><td class="NLM_term">F-actin</td><td class="NLM_def"><p class="first last">filamentous actin</p></td></tr><tr><td class="NLM_term">LIMK</td><td class="NLM_def"><p class="first last">Lin-11 Isl-1 Mec-3 kinase</p></td></tr><tr><td class="NLM_term">hPBMC</td><td class="NLM_def"><p class="first last">human peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">JNK2</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 2</p></td></tr><tr><td class="NLM_term">CPP</td><td class="NLM_def"><p class="first last">cell-penetrating peptide</p></td></tr><tr><td class="NLM_term">PFKFB3</td><td class="NLM_def"><p class="first last">6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3</p></td></tr><tr><td class="NLM_term">Shh</td><td class="NLM_def"><p class="first last">Sonic Hedgehog</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 101 other publications.
        </p><ol id="references" class="useLabel"><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Moens, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveinbjørnsson, B.</span><span> </span><span class="NLM_article-title">The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation</span> <span class="citation_source-journal">Genes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.3390/genes4020101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.3390%2Fgenes4020101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24705157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=101-133&author=U.+Moensauthor=S.+Kostenkoauthor=B.+Sveinbj%C3%B8rnsson&title=The+role+of+mitogen-activated+protein+kinase-activated+protein+kinases+%28MAPKAPKs%29+in+inflammation&doi=10.3390%2Fgenes4020101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation</span></div><div class="casAuthors">Moens, Ugo; Kostenko, Sergiy; Sveinbjoernsson, Baldur</div><div class="citationInfo"><span class="NLM_cas:title">Genes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-133, 33 pp.</span>CODEN:
                <span class="NLM_cas:coden">GENEG9</span>;
        ISSN:<span class="NLM_cas:issn">2073-4425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase (MAPK) pathways are implicated in several cellular processes including proliferation, differentiation, apoptosis, cell survival, cell motility, metab., stress response and inflammation.  MAPK pathways transmit and convert a plethora of extracellular signals by three consecutive phosphorylation events involving a MAPK kinase kinase, a MAPK kinase and a MAPK.  In turn MAPKs phosphorylate substrates, including other protein kinases referred to as MAPK-activated protein kinases (MAPKAPKs).  Eleven mammalian MAPKAPKs have been identified: ribosomal-S6-kinases (RSK1-4), mitogen- and stress-activated kinases (MSK1-2), MAPK-interacting kinases (MNK1-2), MAPKAPK-2 (MK2), MAPKAPK-3 (MK3) and MAPKAPK-5 (MK5).  The role of these MAPKAPKs in inflammation will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDcxWGp62ckbVg90H21EOLACvtfcHk0lg7kPMG8lF37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlGrt7s%253D&md5=3166c5885677dcb50f40bcfa4c37fd3b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fgenes4020101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fgenes4020101%26sid%3Dliteratum%253Aachs%26aulast%3DMoens%26aufirst%3DU.%26aulast%3DKostenko%26aufirst%3DS.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinases%2520%2528MAPKAPKs%2529%2520in%2520inflammation%26jtitle%3DGenes%26date%3D2013%26volume%3D4%26spage%3D101%26epage%3D133%26doi%3D10.3390%2Fgenes4020101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span><span class="refDoi"> DOI: 10.1515/hsz-2013-0197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1515%2Fhsz-2013-0197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23832958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2013&pages=1301-1315&author=M.+Gaestel&title=What+goes+up+must+come+down%3A+molecular+basis+of+MAPKAP+kinase+2%2F3-dependent+regulation+of+the+inflammatory+response+and+its+inhibition&doi=10.1515%2Fhsz-2013-0197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition</span></div><div class="casAuthors">Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1301-1315</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Inflammation is normally a fast and transient response to microbial invaders or sterile damage and has to be stringently controlled.  The closely-related mitogen-activated protein kinase-activated protein kinases MK2 and MK3 are involved in both up- and down-regulation of inflammation in mammals and govern the inflammatory response at different regulatory levels of gene expression and with different kinetics.  In conjunction with their activator MAP kinase p38, MK2 and MK3 stimulate the transcription of immediate-early genes including that of the mRNA-binding protein tristetraprolin (TTP).  TTP competes with the constitutively expressed protein human antigen R in binding to the mRNA destabilizing adenylate-uridylate -rich element.  MK2 and MK3 also regulate the activity of TTP by direct phosphorylation, det. stability and stimulate the translation of cytokine mRNAs.  In addn., TTP controls its own re-synthesis via stability and translation of its mRNA in a phosphorylation-dependent manner.  This results in a complex scenario of gene expression and guarantees fast up-regulation and intrinsic feedback control of the inflammatory response of macrophages.  Inhibition of MK2/3 by small-mol. pharmaceutical inhibitors is an emerging strategy to manipulate the inflammatory response as a therapeutic option.  This strategy could display advantages over the direct inhibition of MAP kinase p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkhC-3wPlU7Vg90H21EOLACvtfcHk0lg7kPMG8lF37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFent7s%253D&md5=76b71ea718a39f3d007aba58e38ce106</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0197%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DWhat%2520goes%2520up%2520must%2520come%2520down%253A%2520molecular%2520basis%2520of%2520MAPKAP%2520kinase%25202%252F3-dependent%2520regulation%2520of%2520the%2520inflammatory%2520response%2520and%2520its%2520inhibition%26jtitle%3DBiol.%2520Chem.%26date%3D2013%26volume%3D394%26spage%3D1301%26epage%3D1315%26doi%3D10.1515%2Fhsz-2013-0197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gurgis, F. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziaziaris, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1124/mol.113.090365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.113.090365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=345-356&author=F.+M.+S.+Gurgisauthor=W.+Ziaziarisauthor=L.+Munoz&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+in+neuroinflammation%2C+heat+shock+protein+27+phosphorylation%2C+and+cell+cycle%3A+role+and+targeting&doi=10.1124%2Fmol.113.090365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.090365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.090365%26sid%3Dliteratum%253Aachs%26aulast%3DGurgis%26aufirst%3DF.%2BM.%2BS.%26aulast%3DZiaziaris%26aufirst%3DW.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520neuroinflammation%252C%2520heat%2520shock%2520protein%252027%2520phosphorylation%252C%2520and%2520cell%2520cycle%253A%2520role%2520and%2520targeting%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D345%26epage%3D356%26doi%3D10.1124%2Fmol.113.090365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Edmunds, J. J.; Talanian, R. V.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 as a target for anti-inflammatory drug discovery</span>. In  <span class="citation_source-book">Anti-Inflammatory Drug Discovery</span>; <span class="NLM_series">RSC Drug Discovery Series No. 26</span>; <span class="NLM_contrib-group">Levi, J. I.; Laufer, S.</span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Chapter 6, pp  <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1039%2F9781849735346-00158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=158-180&author=J.+J.+Edmunds&author=R.+V.+Talanianauthor=J.+I.+Levi&author=S.+Laufer&title=Anti-Inflammatory+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2F9781849735346-00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849735346-00158%26sid%3Dliteratum%253Aachs%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DMAPKAP%2520kinase%25202%2520as%2520a%2520target%2520for%2520anti-inflammatory%2520drug%2520discovery%26btitle%3DAnti-Inflammatory%2520Drug%2520Discovery%26aulast%3DLevi%26aufirst%3DJ.%2BI.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2012%26spage%3D158%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1006358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1517%2F13543784.2015.1006358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=25599809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVKrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=383-392&author=P.+Norman&title=Investigational+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1517%2F13543784.2015.1006358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-392</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: The p38 protein kinases, in particular p38α and p38β, regulate the prodn. of multiple inflammatory mediators.  Consequentially, considerable effort has been focused on trying to develop p38 inhibitors for the treatment of inflammatory diseases.  Some 20 p38 inhibitors have progressed to clin. development, mostly for the treatment of rheumatoid arthritis, but with little success.  Increasingly, interest has turned to their use in other indications and notably chronic obstructive pulmonary disease (COPD).  Areas covered: In this review, the author discusses the eight p38 inhibitors that have been clin. evaluated.  Acumapimod is the only one of four orally delivered inhibitors that remains in active development while Phase II results of PH-797804 and losmapimod are compared.  The activity of two inhibitors designed for inhaled delivery, RV-568 and PF-03715455, is compared but little is known about AZD-7624 or the discontinued GSK-610677.  Expert opinion: Results from animal models provide a clear rationale for developing p38 inhibitors for COPD, and appear to be (partially) validated by the efficacy seen with PH-797804 and losmapimod.  Inhaled delivery provides the opportunity to enhance p38 inhibition in the lung while reducing unwanted systemic effects of p38 inhibition.  Validation of this hypothesis should come from the results of the recently completed Phase II study with RV-568.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKUbGhXQAMzrVg90H21EOLACvtfcHk0likzHepeK40Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVKrtLk%253D&md5=97485678de1e2d15bf1ace5139cba51e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1006358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1006358%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DInvestigational%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D383%26epage%3D392%26doi%3D10.1517%2F13543784.2015.1006358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Trempolec, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave-Coll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">SnapShot: p38 MAPK substrates</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.cell.2013.01.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=924&author=N.+Trempolecauthor=N.+Dave-Collauthor=A.+R.+Nebreda&title=SnapShot%3A+p38+MAPK+substrates&doi=10.1016%2Fj.cell.2013.01.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DTrempolec%26aufirst%3DN.%26aulast%3DDave-Coll%26aufirst%3DN.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DSnapShot%253A%2520p38%2520MAPK%2520substrates%26jtitle%3DCell%26date%3D2013%26volume%3D152%26spage%3D924%26doi%3D10.1016%2Fj.cell.2013.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautebin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzellotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span> </span><span class="NLM_article-title">Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1540</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span><span class="refDoi"> DOI: 10.2174/092986711795328364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F092986711795328364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=21428878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1540-1554&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=C.+Battilocchioauthor=M.+Bottaauthor=F.+Manettiauthor=M.+Roviniauthor=A.+Cappelliauthor=L.+Sautebinauthor=A.+Rossiauthor=C.+Pergolaauthor=C.+Ghelardiniauthor=N.+Galeottiauthor=F.+Makovecauthor=A.+Giordaniauthor=P.+Anzellottiauthor=S.+Tacconelliauthor=P.+Patrignaniauthor=M.+Anzini&title=Enlarging+the+NSAIDs+family%3A+ether%2C+ester+and+acid+derivatives+of+the+1%2C5-diarylpyrrole+scaffold+as+novel+anti-inflammatory+and+analgesic+agents&doi=10.2174%2F092986711795328364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Enlarging the NSAIDs family: ether, esther and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents</span></div><div class="casAuthors">Biava, M.; Porretta, G. C.; Poce, G.; Battilocchio, C.; Botta, M.; Manetti, F.; Rovini, M.; Cappelli, A.; Sautebin, L.; Rossi, A.; Pergola, C.; Ghelardini, C.; Galeotti, N.; Makovec, F.; Giordani, A.; Anzellotti, P.; Tacconelli, S.; Patrignani, P.; Anzini, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1540-1554</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of the coxib family has represented a stimulating approach in the treatment of inflammatory disorders, such as arthritis, and for the management of acute pains, in relation to the well-known traditional Non-Steroidal Anti-inflammatory Drugs (t- NSAIDs).  Prompted by the pursuit for new cyclooxygenase-2 (COX-2) inhibitors, endowed with fine tuned selectivity and high potency, in the past years we have identified novel classes of ether, ester and acid mols. characterized by the 1,5-diarylpyrrole scaffold as potentially powerful anti-inflammatory mols. (12-66).  All compds. proved to exert an in vitro inhibition profile as good as that shown by ref. compds.  Compds. bearing a p-methylsulfonylphenyl substituent at C5 displayed the best issues.  In particular, ester derivs. proved to perform the best in vitro profile in terms of selectivity and activity toward COX-2.  The cell-based assay data showed that an increase of hindrance at the C3 side chain of compds. could translate to activity enhancement.  The human whole blood (HWB) test let to highlight that submitted compds. displayed 5-10 fold higher selectivity for COX-2 vs COX-1 which should translate clin. to an acceptable gastrointestinal safety and mitigate the cardiovascular effects highlighted by highly selective COX-2 inhibitors.  Finally, to assess in vivo anti-inflammatory and analgesic activity three different tests (rat paw pressure, rat paw edema and abdominal constriction) were performed.  Results showed good in vivo anti-inflammatory and analgesic activities.  The issues gained with these classes of compds. represent, nowadays, a potent stimulus for a further enlargement of the NSAIDs family.  In this review we describe the results obtained by our research group on this topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JrB-zrA5MrVg90H21EOLACvtfcHk0ljbYA3LAVlhzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOitLs%253D&md5=6ecdeecc428187ed473c8ce520b19d36</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986711795328364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795328364%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DRovini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGaleotti%26aufirst%3DN.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DGiordani%26aufirst%3DA.%26aulast%3DAnzellotti%26aufirst%3DP.%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DPatrignani%26aufirst%3DP.%26aulast%3DAnzini%26aufirst%3DM.%26atitle%3DEnlarging%2520the%2520NSAIDs%2520family%253A%2520ether%252C%2520ester%2520and%2520acid%2520derivatives%2520of%2520the%25201%252C5-diarylpyrrole%2520scaffold%2520as%2520novel%2520anti-inflammatory%2520and%2520analgesic%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1540%26epage%3D1554%26doi%3D10.2174%2F092986711795328364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Manetti, F.</span><span> </span><span class="NLM_article-title">LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1002/med.20230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fmed.20230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22886629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKls7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=968-998&author=F.+Manetti&title=LIM+kinases+are+attractive+targets+with+many+macromolecular+partners+and+only+a+few+small+molecule+regulators&doi=10.1002%2Fmed.20230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators</span></div><div class="casAuthors">Manetti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-998</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The LIM kinases 1 and 2 (LIMK1 and LIMK2) are dual specificity (serine/threonine and tyrosine) kinases.  Although they show significant structural similarity, LIMK1 and LIMK2 show different expression, subcellular localization, and functions.  They are involved in many cellular functions, such as migration, cycle, and neuronal differentiation and also have a role in pathol. processes, such as cancer cell invasion and metastatis, as well as in neurodevelopmental disorders (namely, the William's syndrome).  LIM kinases have a relevant no. of known partners that are able to induce or limit the ability of LIMK1 and LIMK2 to phosphorylate and inactivate their major substrate, cofilin.  On the contrary, only a limited no. of small mols. that interact with the two proteins to modulate their kinase activity have been identified.  In this review, the most important partners of LIM kinases and their modulating activity toward LIMKs are described.  The small compds. identified as LIMK1 and LIMK2 modulators are also reported, as well as their role as possible therapeutic agents for LIMK-induced diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zsLWz4v2uLVg90H21EOLACvtfcHk0ljbYA3LAVlhzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKls7vK&md5=1be7588c75c7ec4cc77e35d9d7b08817</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.20230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20230%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26atitle%3DLIM%2520kinases%2520are%2520attractive%2520targets%2520with%2520many%2520macromolecular%2520partners%2520and%2520only%2520a%2520few%2520small%2520molecule%2520regulators%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D968%26epage%3D998%26doi%3D10.1002%2Fmed.20230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevilacqua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, M.</span><span> </span><span class="NLM_article-title">MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2014.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.yjmcc.2014.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=25257914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KlsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=86-101&author=L.+Xuauthor=C.+C.+Yatesauthor=P.+Lockyerauthor=L.+Xieauthor=A.+Bevilacquaauthor=J.+Heauthor=C.+Landerauthor=C.+Pattersonauthor=M.+Willis&title=MMI-0100+inhibits+cardiac+fibrosis+in+myocardial+infarction+by+direct+actions+on+cardiomyocytes+and+fibroblasts+via+MK2+inhibition&doi=10.1016%2Fj.yjmcc.2014.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition</span></div><div class="casAuthors">Xu, Lei; Yates, Cecelia C.; Lockyer, Pamela; Xie, Liang; Bevilacqua, Ariana; He, Jun; Lander, Cynthia; Patterson, Cam; Willis, Monte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86-101</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cell-permeant peptide inhibitor of MAPKAP kinase 2 (MK2), MMI-0100, inhibits MK2 and downstream fibrosis and inflammation.  Recent studies have demonstrated that MMI-0100 reduces intimal hyperplasia in a mouse vein graft model, pulmonary fibrosis in a murine bleomycin-induced model and development of adhesions in conjunction with abdominal surgery.  MK2 is crit. to the pathogenesis of ischemic heart injury as MK2-/- mice are resistant to ischemic remodeling.  Therefore, we tested the hypothesis that inhibiting MK2 with MMI-0100 would protect the heart after acute myocardial infarction (AMI) in vivo.  AMI was induced by placing a permanent LAD coronary ligation.  When MMI-0100 peptide was given 30 min after permanent LAD coronary artery ligation, the resulting fibrosis was reduced/prevented ∼ 50% at a 2 wk time point, with a corresponding improvement in cardiac function and decrease in left ventricular dilation.  In cultured cardiomyocytes and fibroblasts, MMI-0100 inhibited MK2 to reduce cardiomyocyte caspase 3/7 activity, while enhancing primary cardiac fibroblast caspase 3/7 activity, which may explain MMI-0100's salvage of cardiac function and anti-fibrotic effects in vivo.  These findings suggest that therapeutic inhibition of MK2 after acute MI, using rationally-designed cell-permeant peptides, inhibits cardiac fibrosis and maintains cardiac function by mechanisms that involve inhibiting cardiomyocyte apoptosis, while enhancing primary cardiac fibroblast cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplIBsAA5QPoLVg90H21EOLACvtfcHk0lh0Wh4l06V-6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KlsLjE&md5=a8d93f4d3cc4382fc5d3a62c757dde96</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2014.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2014.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYates%26aufirst%3DC.%2BC.%26aulast%3DLockyer%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBevilacqua%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DLander%26aufirst%3DC.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DWillis%26aufirst%3DM.%26atitle%3DMMI-0100%2520inhibits%2520cardiac%2520fibrosis%2520in%2520myocardial%2520infarction%2520by%2520direct%2520actions%2520on%2520cardiomyocytes%2520and%2520fibroblasts%2520via%2520MK2%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2014%26volume%3D77%26spage%3D86%26epage%3D101%26doi%3D10.1016%2Fj.yjmcc.2014.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Streicher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1443</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.109.213199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1161%2FCIRCRESAHA.109.213199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=1434-1443&author=J.+M.+Streicherauthor=S.+Renauthor=H.+Herschmanauthor=Y.+Wang&title=MAPK-activated+protein+kinase-2+in+cardiac+hypertrophy+and+cyclooxygenase-2+regulation+in+heart&doi=10.1161%2FCIRCRESAHA.109.213199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.109.213199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.109.213199%26sid%3Dliteratum%253Aachs%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DHerschman%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMAPK-activated%2520protein%2520kinase-2%2520in%2520cardiac%2520hypertrophy%2520and%2520cyclooxygenase-2%2520regulation%2520in%2520heart%26jtitle%3DCirc.%2520Res.%26date%3D2010%26volume%3D106%26spage%3D1434%26epage%3D1443%26doi%3D10.1161%2FCIRCRESAHA.109.213199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanburg, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayyali, U. S.</span><span> </span><span class="NLM_article-title">Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1165/rcmb.2007-0077OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1165%2Frcmb.2007-0077OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=17600313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=507-517&author=T.+Liuauthor=R.+R.+Warburtonauthor=O.+E.+Guevaraauthor=N.+S.+Hillauthor=B.+L.+Fanburgauthor=M.+Gaestelauthor=U.+S.+Kayyali&title=Lack+of+MK2+inhibits+myofibroblast+formation+and+exacerbates+pulmonary+fibrosis&doi=10.1165%2Frcmb.2007-0077OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis</span></div><div class="casAuthors">Liu, Tiegang; Warburton, Rod R.; Guevara, Oscar E.; Hill, Nicholas S.; Fenburg, Barry L.; Gaestel, Matthias; Kayyali, Usamah S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-517</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Fibroblasts play a major role in tissue repair and remodeling.  Their differentiation into myofibroblasts, marked by increased expression of smooth muscle-specific α-actin (α-SMA), is believed to be important in wound healing and fibrosis.  The authors have recently described a role for MK2 in this phenotypic differentiation in culture.  In this article, the authors demonstrate that MK2 also regulates myofibroblasts in vivo.  Disruption of MK2 in mice prevented myofibroblast formation in a model of pulmonary fibrosis.  However, MK2 disruption and consequent lack of myofibroblast formation exacerbated fibrosis rather than ameliorated it as previously postulated.  When mice lacking MK2 (MK2-/-) were exposed to bleomycin, more collagen accumulated and more fibroblasts populated fibrotic regions in their lungs than in similarly treated wild-type mice.  While there were many vimentin-pos. cells in the bleomycin-treated MK2-/- mouse lungs, few α-SMA-pos. cells were obsd. in these lungs compared with wild-type mouse lungs.  SiRNA against MK2 reduced α-SMA expression in wild-type mouse embryonic fibroblasts (MEF), consistent with its suppression in MK2-/- MEF.  On the other hand expressing constitutively active MK2 in MK2-/- MEF significantly increased α-SMA expression.  MK2-/- MEF proliferated at a faster rate and produced more collagen; however, they migrated at a slower rate than wild-type MEF.  Overexpressing phosphomimicking HSP27, a target of MK2, did not reverse the effect of MK2 disruption on fibroblast migration.  MK2 disruption did not affect Smad2 activation by transforming growth factor-β.  Thus, MK2 appears to mediate myofibroblast differentiation, and inhibiting that differentiation might contribute to fibrosis rather than protect against it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQYAgJQiTEU7Vg90H21EOLACvtfcHk0lh0Wh4l06V-6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWhsrzN&md5=54a77f1e77e39afdda766e51d771d641</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0077OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0077OC%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWarburton%26aufirst%3DR.%2BR.%26aulast%3DGuevara%26aufirst%3DO.%2BE.%26aulast%3DHill%26aufirst%3DN.%2BS.%26aulast%3DFanburg%26aufirst%3DB.%2BL.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKayyali%26aufirst%3DU.%2BS.%26atitle%3DLack%2520of%2520MK2%2520inhibits%2520myofibroblast%2520formation%2520and%2520exacerbates%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2007%26volume%3D37%26spage%3D507%26epage%3D517%26doi%3D10.1165%2Frcmb.2007-0077OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Vittal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandusky, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, D. S.</span><span> </span><span class="NLM_article-title">Peptide-mediated inhibition of MK2 ameliorates bleomycin-induced pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1165/rcmb.2012-0389OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1165%2Frcmb.2012-0389OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23470623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFajs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=47-57&author=R.+Vittalauthor=A.+Fisherauthor=H.+Guauthor=E.+A.+Micklerauthor=A.+Panitchauthor=C.+Landerauthor=O.+W.+Cummingsauthor=G.+E.+Sanduskyauthor=D.+S.+Wilkes&title=Peptide-mediated+inhibition+of+MK2+ameliorates+bleomycin-induced+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0389OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis</span></div><div class="casAuthors">Vittal, Ragini; Fisher, Amanda; Gu, Hongmei; Mickler, Elizabeth A.; Panitch, Alyssa; Lander, Cynthia; Cummings, Oscar W.; Sandusky, George E.; Wilkes, David S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-57</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase-2 (MAPKAPK2, or MK2), a serine/threonine kinase downstream of p38 mitogen-activated protein kinase, has been implicated in inflammation and fibrosis.  Compared with pathol. normal lung tissue, significantly higher concns. of activated MK2 are evident in lung biopsies of patients with idiopathic pulmonary fibrosis (IPF).  Expression is localized to fibroblasts and epithelial cells.  In the murine bleomycin model of pulmonary fibrosis, we obsd. robust, activated MK2 expression on Day 7 (prefibrotic stage) and Day 14 (postfibrotic stage).  To det. the effects of MK2 inhibition during the postinflammatory/prefibrotic and postfibrotic stages, C57BL/6 mice received intratracheal bleomycin instillation (0.025 U; Day 0), followed by PBS or the MK2 inhibitor (MK2i; 37.5 μg/kg), administered via either local (nebulized) or systemic (i.p.) routes.  MK2i or PBS was dosed daily for 14 days subsequent to bleomycin injury, beginning on either Day 7 or Day 14.  Regardless of mode of administration or stage of intervention, MK2i significantly abrogated collagen deposition, myofibroblast differentiation and activated MK2 expression.  MK2i also decreased circulating TNF-α and IL-6 concns., and modulated the local mRNA expression of profibrotic cytokine il-1β, matrix-related genes col1a2, col3a1, and lox, and transforming growth factor-β family members, including smad3, serpine1 (pai1), and smad6/7.  In vitro, MK2i dose-dependently attenuated total MK2, myofibroblast differentiation, the secretion of collagen Type I, fibronectin, and the activation of focal adhesion kinase, whereas activated MK2 was attenuated at optimal doses.  The peptide-mediated inhibition of MK2 affects both inflammatory and fibrotic responses, and thus may offer a promising therapeutic target for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLiS_pENkO7Vg90H21EOLACvtfcHk0lj7AhcJbiPmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFajs73N&md5=3f6b84ceb5c9bca1216f6160060c196d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0389OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0389OC%26sid%3Dliteratum%253Aachs%26aulast%3DVittal%26aufirst%3DR.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DMickler%26aufirst%3DE.%2BA.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DLander%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DO.%2BW.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DWilkes%26aufirst%3DD.%2BS.%26atitle%3DPeptide-mediated%2520inhibition%2520of%2520MK2%2520ameliorates%2520bleomycin-induced%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2013%26volume%3D49%26spage%3D47%26epage%3D57%26doi%3D10.1165%2Frcmb.2012-0389OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span><span class="refDoi"> DOI: 10.4155/fmc.09.98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.4155%2Ffmc.09.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=21426101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1243-1257&author=A.+Schlapbachauthor=C.+Huppertz&title=Low-molecular-weight+MK2+inhibitors%3A+a+tough+nut+to+crack%21&doi=10.4155%2Ffmc.09.98"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span></div><div class="casAuthors">Schlapbach, Achim; Huppertz, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1243-1257</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 pathway was at the center of interest for anti-inflammatory drug discovery for many years as it is crucial for the biosynthesis of TNF-α, IL-1β, and other mediators.  Most of the anti-inflammatory effects of p38 inhibition are mediated through MAPK-activated protein kinase-2 (MK2), a direct downstream target of p38, which makes MK2 a very interesting drug target.  Within the last 5 years, several classes of low-mol.-wt. MK2 inhibitors were disclosed in the patent and primary literature.  Advanced compds. could be optimized to nanomolar potencies and inhibit TNF-α release, as well as the phosphorylation of the MK2 substrate heat-shock protein 27 in cellular assays.  This article will review the recent progress in this field and will highlight and discuss the most promising compd. series disclosed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4u3apT9vA-rVg90H21EOLACvtfcHk0lj7AhcJbiPmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K&md5=0b950af46215982d171a6c8b6de98fd0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.98%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DLow-molecular-weight%2520MK2%2520inhibitors%253A%2520a%2520tough%2520nut%2520to%2520crack%2521%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1243%26epage%3D1257%26doi%3D10.4155%2Ffmc.09.98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of drug action: what does it take for success?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1038/nrd1500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1038%2Fnrd1500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=15340390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=801-808&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+drug+action%3A+what+does+it+take+for+success%3F&doi=10.1038%2Fnrd1500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Biochemical mechanisms of drug action: what does it take for success?</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">801-808</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Drug discovery is extremely difficult.  There are many unanticipated scientific, medical and business challenges to every drug discovery program.  It is important to increase our understanding of the fundamental properties of effective drugs so that we can anticipate potential problems in developing new agents.  This article addresses potential drug discovery and development risks assocd. with the biochem. mechanism of drug action, and proposes simple rules to minimize these risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhyDgozFUdrVg90H21EOLACvtfcHk0liP8Qbe2W1Nrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCnsL4%253D&md5=b06bdc6ace3168dcb011679b43b72aed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1500%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520drug%2520action%253A%2520what%2520does%2520it%2520take%2520for%2520success%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D801%26epage%3D808%26doi%3D10.1038%2Fnrd1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustkern, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span> </span><span class="NLM_article-title">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1124/jpet.110.166173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fjpet.110.166173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=20237073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=797-807&author=R.+J.+Moureyauthor=B.+L.+Burnetteauthor=S.+J.+Brustkernauthor=J.+S.+Danielsauthor=J.+L.+Hirschauthor=W.+F.+Hoodauthor=M.+J.+Meyersauthor=S.+J.+Mnichauthor=B.+S.+Pierceauthor=M.+J.+Saabyeauthor=J.+F.+Schindlerauthor=S.+A.+Southauthor=E.+G.+Webbauthor=J.+Zhangauthor=D.+R.+Anderson&title=A+benzothiophene+inhibitor+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+inhibits+tumor+necrosis+factor+%CE%B1+production+and+has+oral+anti-inflammatory+efficacy+in+acute+and+chronic+models+of+inflammation&doi=10.1124%2Fjpet.110.166173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span></div><div class="casAuthors">Mourey, Robert J.; Burnette, Barry L.; Brustkern, Sarah J.; Daniels, J. Scott; Hirsch, Jeffrey L.; Hood, William F.; Meyers, Marvin J.; Mnich, Stephen J.; Pierce, Betsy S.; Saabye, Matthew J.; Schindler, John F.; South, Sarah A.; Webb, Elizabeth G.; Zhang, Jian; Anderson, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Activation of the p38 kinase pathway in immune cells leads to the transcriptional and translational regulation of proinflammatory cytokines.  Mitogen-activated protein kinase-activated protein kinase 2 (MK2), a direct downstream substrate of p38 kinase, regulates lipopolysaccharide (LPS)-stimulated tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) prodn. through modulating the stability and translation of these mRNAs.  Developing small-mol. inhibitors of MK2 may yield anti-inflammatory efficacy with a different safety profile relative to p38 kinase inhibitors.  This article describes the pharmacol. properties of a benzothiophene MK2 inhibitor, PF-3644022 [(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one].  PF-3644022 is a potent freely reversible ATP-competitive compd. that inhibits MK2 activity (Ki = 3 nM) with good selectivity when profiled against 200 human kinases.  In the human U937 monocytic cell line or peripheral blood mononuclear cells, PF-3644022 potently inhibits TNFα prodn. with similar activity (IC50 = 160 nM).  PF-3644022 blocks TNFα and IL-6 prodn. in LPS-stimulated human whole blood with IC50 values of 1.6 and 10.3 μM, resp.  Inhibition of TNFα in U937 cells and blood correlates closely with inhibition of phospho-heat shock protein 27, a target biomarker of MK2 activity.  PF-3644022 displays good pharmacokinetic parameters in rats and is orally efficacious in both the rat acute LPS-induced TNFα model and the chronic streptococcal cell wall-induced arthritis model.  Dose-dependent inhibition of TNFα prodn. in the acute model and inhibition of paw swelling in the chronic model is obsd. with ED50 values of 6.9 and 20 mg/kg, resp.  PF-3644022 efficacy in the chronic inflammation model is strongly correlated with maintaining a Cmin higher than the EC50 measured in the rat LPS-induced TNFα model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrKp-1XQ0NyLVg90H21EOLACvtfcHk0liP8Qbe2W1Nrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D&md5=312670776fbb3fd39fc2247eba48eb6e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166173%26sid%3Dliteratum%253Aachs%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBurnette%26aufirst%3DB.%2BL.%26aulast%3DBrustkern%26aufirst%3DS.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DHood%26aufirst%3DW.%2BF.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSaabye%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26atitle%3DA%2520benzothiophene%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520inhibits%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520production%2520and%2520has%2520oral%2520anti-inflammatory%2520efficacy%2520in%2520acute%2520and%2520chronic%2520models%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D797%26epage%3D807%26doi%3D10.1124%2Fjpet.110.166173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit26"><span>The Universal Protein Resource (UniProt); <a href="http://www.uniprot.org/uniprot/P49137" class="extLink">http://www.uniprot.org/uniprot/P49137</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Universal+Protein+Resource+%28UniProt%29%3B+http%3A%2F%2Fwww.uniprot.org%2Funiprot%2FP49137+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielemann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">FRET-based detection of different conformations of MK2</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1093/embo-reports/kve157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Fembo-reports%2Fkve157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=703-708&author=A.+Neiningerauthor=H.+Thielemannauthor=M.+Gaestel&title=FRET-based+detection+of+different+conformations+of+MK2&doi=10.1093%2Fembo-reports%2Fkve157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkve157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkve157%26sid%3Dliteratum%253Aachs%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DThielemann%26aufirst%3DH.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DFRET-based%2520detection%2520of%2520different%2520conformations%2520of%2520MK2%26jtitle%3DEMBO%2520Rep.%26date%3D2001%26volume%3D2%26spage%3D703%26epage%3D708%26doi%3D10.1093%2Fembo-reports%2Fkve157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zu, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-K.</span><span> </span><span class="NLM_article-title">Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1074/jbc.270.1.202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.270.1.202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=202-206&author=Y.-L.+Zuauthor=T.+Aiauthor=C.-K.+Huang&title=Characterization+of+an+autoinhibitory+domain+in+human+mitogen-activated+protein+kinase-activated+protein+kinase+2&doi=10.1074%2Fjbc.270.1.202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.1.202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.1.202%26sid%3Dliteratum%253Aachs%26aulast%3DZu%26aufirst%3DY.-L.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.-K.%26atitle%3DCharacterization%2520of%2520an%2520autoinhibitory%2520domain%2520in%2520human%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D202%26epage%3D206%26doi%3D10.1074%2Fjbc.270.1.202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lukas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildeson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frego, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingraham, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B. G.</span><span> </span><span class="NLM_article-title">Catalysis and function of the p38α•MK2a signaling complex</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">9950</span><span class="NLM_x">–</span> <span class="NLM_lpage">9960</span><span class="refDoi"> DOI: 10.1021/bi049508v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049508v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9950-9960&author=S.+M.+Lukasauthor=R.+R.+Kroeauthor=J.+Wildesonauthor=G.+W.+Peetauthor=L.+Fregoauthor=W.+Davidsonauthor=R.+H.+Ingrahamauthor=C.+A.+Pargellisauthor=M.+E.+Labadiaauthor=B.+G.+Werneburg&title=Catalysis+and+function+of+the+p38%CE%B1%E2%80%A2MK2a+signaling+complex&doi=10.1021%2Fbi049508v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi049508v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049508v%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DS.%2BM.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DWildeson%26aufirst%3DJ.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DFrego%26aufirst%3DL.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DIngraham%26aufirst%3DR.%2BH.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DWerneburg%26aufirst%3DB.%2BG.%26atitle%3DCatalysis%2520and%2520function%2520of%2520the%2520p38%25CE%25B1%25E2%2580%25A2MK2a%2520signaling%2520complex%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9950%26epage%3D9960%26doi%3D10.1021%2Fbi049508v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B. T.,  II.</span><span> </span><span class="NLM_article-title">Molecular basis of MAPK-activated protein kinase 2:p38 assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6353</span><span class="NLM_x">–</span> <span class="NLM_lpage">6358</span><span class="refDoi"> DOI: 10.1073/pnas.0701679104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1073%2Fpnas.0701679104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=17395714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1aqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6353-6358&author=A.+Whiteauthor=C.+A.+Pargellisauthor=J.+M.+Studtsauthor=B.+G.+Werneburgauthor=B.+T.+Farmer&title=Molecular+basis+of+MAPK-activated+protein+kinase+2%3Ap38+assembly&doi=10.1073%2Fpnas.0701679104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of MAPK-activated protein kinase 2:p38 assembly</span></div><div class="casAuthors">White, Andre; Pargellis, Christopher A.; Studts, Joey M.; Werneburg, Brian G.; Farmer, Bennett T., II</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6353-6358</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">P38 MAPK and MAPK-activated protein kinase 2 (MK2) are key components of signaling pathways leading to many cellular responses, notably the proinflammatory cytokine prodn.  The phys. assocn. of p38a isoform and MK2 is believed to be physiol. important for this signaling.  We report the 2.7-Å resoln. crystal structure of the unphosphorylated complex between p38a and MK2.  These protein kinases bind "head-to-head," present their resp. active sites on approx. the same side of the heterodimer, and form extensive intermol. interactions.  Among these interactions, the MK2 Ile-366-Ala-390, which includes the bipartite nuclear localization signal, binds to the p38a-docking region.  This binding supports the involvement of noncatalytic regions to the tight binding of the MK2:p38a binary assembly.  The MK2 residues 345-365, contg. the nuclear export signal, block access to the p38a active site.  Some regulatory phosphorylation regions of both protein kinases engage in multiple interactions with one another in this complex.  This structure gives new insights into the regulation of the protein kinases p38a and MK2, aids in the better understanding of their known cellular and biochem. studies, and provides a basis for understanding other regulatory protein-protein interactions involving signal transduction proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouWpJet7sBdrVg90H21EOLACvtfcHk0lgdhPw9GIrgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1aqsrs%253D&md5=0ccf756d535e7f10b73173f98205ba6f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701679104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701679104%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DStudts%26aufirst%3DJ.%2BM.%26aulast%3DWerneburg%26aufirst%3DB.%2BG.%26aulast%3DFarmer%26aufirst%3DB.%2BT.%26atitle%3DMolecular%2520basis%2520of%2520MAPK-activated%2520protein%2520kinase%25202%253Ap38%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D6353%26epage%3D6358%26doi%3D10.1073%2Fpnas.0701679104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabakhar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepre, C.</span><span> </span><span class="NLM_article-title">Crystal structure of the p38α-MAPKAP kinase 2 heterodimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9733</span><span class="NLM_x">–</span> <span class="NLM_lpage">9739</span><span class="refDoi"> DOI: 10.1074/jbc.M611165200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.M611165200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9733-9739&author=E.+ter+Haarauthor=P.+Prabakharauthor=X.+Liuauthor=C.+Lepre&title=Crystal+structure+of+the+p38%CE%B1-MAPKAP+kinase+2+heterodimer&doi=10.1074%2Fjbc.M611165200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611165200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611165200%26sid%3Dliteratum%253Aachs%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DPrabakhar%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLepre%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520p38%25CE%25B1-MAPKAP%2520kinase%25202%2520heterodimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9733%26epage%3D9739%26doi%3D10.1074%2Fjbc.M611165200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit32"><span>UniProtKB - P49137 (MAPK2_HUMAN); <a href="http://www.uniprot.org/uniprot/P49137#showFeatures" class="extLink">http://www.uniprot.org/uniprot/P49137#showFeatures</a> (accessed August 4, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UniProtKB+-+P49137+%28MAPK2_HUMAN%29%3B+http%3A%2F%2Fwww.uniprot.org%2Funiprot%2FP49137%23showFeatures+%28accessed+August+4%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DUniProtKB%2520-%2520P49137%2520%2528MAPK2_HUMAN%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankovich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhukhan, R.</span><span> </span><span class="NLM_article-title">Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study</span> <span class="citation_source-journal">BMC Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/1472-6807-9-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1186%2F1472-6807-9-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19296855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BD1MzisV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=16&author=M.+A.+Argiriadiauthor=S.+Sousaauthor=D.+Banachauthor=D.+Marcotteauthor=T.+Xiangauthor=M.+J.+Tomlinsonauthor=M.+Demersauthor=C.+Harrisauthor=S.+Kwakauthor=J.+Hardmanauthor=M.+Pietrasauthor=L.+Quinnauthor=J.+DiMauroauthor=B.+Niauthor=J.+Mankovichauthor=D.+W.+Borhaniauthor=R.+V.+Talanianauthor=R.+Sadhukhan&title=Rational+mutagenesis+to+support+structure-based+drug+design%3A+MAPKAP+kinase+2+as+a+case+study&doi=10.1186%2F1472-6807-9-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study</span></div><div class="casAuthors">Argiriadi Maria A; Sousa Silvino; Banach David; Marcotte Douglas; Xiang Tao; Tomlinson Medha J; Demers Megan; Harris Christopher; Kwak Silvia; Hardman Jennifer; Pietras Margaret; Quinn Lisa; DiMauro Jennifer; Ni Baofu; Mankovich John; Borhani David W; Talanian Robert V; Sadhukhan Ramkrishna</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Structure-based drug design (SBDD) can provide valuable guidance to drug discovery programs.  Robust construct design and expression, protein purification and characterization, protein crystallization, and high-resolution diffraction are all needed for rapid, iterative inhibitor design.  We describe here robust methods to support SBDD on an oral anti-cytokine drug target, human MAPKAP kinase 2 (MK2).  Our goal was to obtain useful diffraction data with a large number of chemically diverse lead compounds.  Although MK2 structures and structural methods have been reported previously, reproducibility was low and improved methods were needed.  RESULTS:  Our construct design strategy had four tactics: N- and C-terminal variations; entropy-reducing surface mutations; activation loop deletions; and pseudoactivation mutations.  Generic, high-throughput methods for cloning and expression were coupled with automated liquid dispensing for the rapid testing of crystallization conditions with minimal sample requirements.  Initial results led to development of a novel, customized robotic crystallization screen that yielded MK2/inhibitor complex crystals under many conditions in seven crystal forms.  In all, 44 MK2 constructs were generated, ~500 crystals were tested for diffraction, and ~30 structures were determined, delivering high-impact structural data to support our MK2 drug design effort.  CONCLUSION:  Key lessons included setting reasonable criteria for construct performance and prioritization, a willingness to design and use customized crystallization screens, and, crucially, initiation of high-throughput construct exploration very early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMsKCHiWtGuYNpW7w2tapOfW6udTcc2eYfjBSpRI75ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzisV2lsg%253D%253D&md5=dc6b50caa25458e3f23d349ddaf8a08c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-9-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-9-16%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DSousa%26aufirst%3DS.%26aulast%3DBanach%26aufirst%3DD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DDemers%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DPietras%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DL.%26aulast%3DDiMauro%26aufirst%3DJ.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DMankovich%26aufirst%3DJ.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26aulast%3DSadhukhan%26aufirst%3DR.%26atitle%3DRational%2520mutagenesis%2520to%2520support%2520structure-based%2520drug%2520design%253A%2520MAPKAP%2520kinase%25202%2520as%2520a%2520case%2520study%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2009%26volume%3D9%26spage%3D16%26doi%3D10.1186%2F1472-6807-9-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lhk4VorE-yT5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosyak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malakian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L-</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span> </span><span class="NLM_article-title">Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1016/S0969-2126(03)00092-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2FS0969-2126%2803%2900092-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=627-636&author=K.+W.+Underwoodauthor=K.+D.+Parrisauthor=E.+Federicoauthor=L.+Mosyakauthor=R.+M.+Czerwinskiauthor=T.+Shaneauthor=M.+Taylorauthor=K.+Svensonauthor=Y.+Liuauthor=C.-L.+Hsiaoauthor=S.+Wolfromauthor=M.+Maguireauthor=K.+Malakianauthor=J.-B.+Telliezauthor=L.-L-+Linauthor=R.+W.+Krizauthor=J.+Seehraauthor=W.+S.+Somersauthor=M.+L.+Stahl&title=Catalytically+active+MAP+KAP+kinase+2+structures+in+complex+with+staurosporine+and+ADP+reveal+differences+with+the+autoinhibited+enzyme&doi=10.1016%2FS0969-2126%2803%2900092-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2803%2900092-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252803%252900092-3%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DParris%26aufirst%3DK.%2BD.%26aulast%3DFederico%26aufirst%3DE.%26aulast%3DMosyak%26aufirst%3DL.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DShane%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHsiao%26aufirst%3DC.-L.%26aulast%3DWolfrom%26aufirst%3DS.%26aulast%3DMaguire%26aufirst%3DM.%26aulast%3DMalakian%26aufirst%3DK.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DLin%26aufirst%3DL.-L-%26aulast%3DKriz%26aufirst%3DR.%2BW.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DW.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26atitle%3DCatalytically%2520active%2520MAP%2520KAP%2520kinase%25202%2520structures%2520in%2520complex%2520with%2520staurosporine%2520and%2520ADP%2520reveal%2520differences%2520with%2520the%2520autoinhibited%2520enzyme%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D627%26epage%3D636%26doi%3D10.1016%2FS0969-2126%2803%2900092-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgibbon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulghum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span> </span><span class="NLM_article-title">Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">37401</span><span class="NLM_x">–</span> <span class="NLM_lpage">37405</span><span class="refDoi"> DOI: 10.1074/jbc.C200418200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.C200418200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=12171911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVejsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=37401-37405&author=W.+Mengauthor=L.+L.+Swensonauthor=M.+J.+Fitzgibbonauthor=K.+Hayakawaauthor=E.+ter+Haarauthor=A.+E.+Behrensauthor=J.+R.+Fulghumauthor=J.+A.+Lippke&title=Structure+of+mitogen-activated+protein+kinase-activated+protein+%28MAPKAP%29+kinase+2+suggests+a+bifunctional+switch+that+couples+kinase+activation+with+nuclear+export&doi=10.1074%2Fjbc.C200418200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export</span></div><div class="casAuthors">Meng, Wuyi; Swenson, Lora L.; Fitzgibbon, Matthew J.; Hayakawa, Koto; ter Haar, Ernst; Behrens, Anne E.; Fulghum, John R.; Lippke, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">37401-37405</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MAPK-activated protein kinase 2 (MAPKAPK2), one of several kinases directly phosphorylated and activated by p38 MAPK, plays a central role in the inflammatory response.  The activated MAPKAPK2 phosphorylates its nuclear targets CREB/ATF1, serum response factor, and E2A protein E47 and its cytoplasmic targets HSP25/27, LSP-1, 5-lipoxygenase, glycogen synthase, and tyrosine hydroxylase.  The crystal structure of unphosphorylated MAPKAPK2, detd. at 2.8 Å resoln., includes the kinase domain and the C-terminal regulatory domain.  Although the protein is inactive, the kinase domain adopts an active conformation with aspartate 366 mimicking the missing phosphorylated threonine 222 in the activation loop.  The C-terminal regulatory domain forms a helix-turn-helix plus a long strand.  Phosphorylation of threonine 334, which is located between the kinase domain and the C-terminal regulatory domain, may serve as a switch for MAPKAPK2 nuclear import and export.  Phosphorylated MAPKAPK2 masks the nuclear localization signal at its C terminus by binding to p38.  It unmasks the nuclear export signal, which is part of the second C-terminal helix packed along the surface of kinase domain C-lobe, and thereby carries p38 to the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHV1tx4qFo4bVg90H21EOLACvtfcHk0lhRFkydaAXqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVejsr0%253D&md5=d83a709efe4b2a4172161fc8bec73294</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200418200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200418200%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBehrens%26aufirst%3DA.%2BE.%26aulast%3DFulghum%26aufirst%3DJ.%2BR.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520%2528MAPKAP%2529%2520kinase%25202%2520suggests%2520a%2520bifunctional%2520switch%2520that%2520couples%2520kinase%2520activation%2520with%2520nuclear%2520export%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D37401%26epage%3D37405%26doi%3D10.1074%2Fjbc.C200418200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kurumbail, R. G.; Pawlitz, J. L.; Stegeman, R. A.; Stallings, W. C.; Shieh, H.-S.; Mourey, R. J.; Bolten, S. L.; Broadus, R. M.</span><span> </span><span class="NLM_article-title">Crystalline structure of human MPAKAP kinase-2</span>. WO2003/076333, A2, <span class="NLM_month">September</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+G.+Kurumbail&author=J.+L.+Pawlitz&author=R.+A.+Stegeman&author=W.+C.+Stallings&author=H.-S.+Shieh&author=R.+J.+Mourey&author=S.+L.+Bolten&author=R.+M.+Broadus&title=Crystalline+structure+of+human+MPAKAP+kinase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DCrystalline%2520structure%2520of%2520human%2520MPAKAP%2520kinase-2%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1107/S0907444909046411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS0907444909046411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=80-87&author=A.+Fujinoauthor=K.+Fukushimaauthor=N.+Namikiauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Structural+analysis+of+an+MK2-inhibitor+complex%3A+insight+into+the+regulation+of+the+secondary+structure+of+the+Gly-rich+loop+by+TEI-I01800&doi=10.1107%2FS0907444909046411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909046411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909046411%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DNamiki%26aufirst%3DN.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520an%2520MK2-inhibitor%2520complex%253A%2520insight%2520into%2520the%2520regulation%2520of%2520the%2520secondary%2520structure%2520of%2520the%2520Gly-rich%2520loop%2520by%2520TEI-I01800%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D80%26epage%3D87%26doi%3D10.1107%2FS0907444909046411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Fujino-Nakajima, A.</span><span> </span><span class="NLM_article-title">Structural studies of ligand–protein complex: the importance of structural change for drug design</span>. Doctoral Thesis. <span class="NLM_publisher-name">Hokkaido University</span>, <span class="NLM_month">March</span><span class="NLM_day">25</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://eprints.lib.hokudai.ac.jp/dspace/handle/2115/56257" class="extLink">http://eprints.lib.hokudai.ac.jp/dspace/handle/2115/56257</a> (accessed July 31, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Fujino-Nakajima&title=Structural+studies+of+ligand%E2%80%93protein+complex%3A+the+importance+of+structural+change+for+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino-Nakajima%26aufirst%3DA.%26atitle%3DStructural%2520studies%2520of%2520ligand%25E2%2580%2593protein%2520complex%253A%2520the%2520importance%2520of%2520structural%2520change%2520for%2520drug%2520design%26pub%3DHokkaido%2520University%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1348</span><span class="refDoi"> DOI: 10.1107/S1744309113030534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS1744309113030534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24316826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1344-1348&author=A.+Fujinoauthor=K.+Fukushimaauthor=T.+Kubotaauthor=Y.+Matsumotoauthor=M.+Takimoto-Kamimura&title=Structure+of+the+%CE%B2-form+of+human+MK2+in+complex+with+the+non-selective+kinase+inhibitor+TEI-L03090&doi=10.1107%2FS1744309113030534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090</span></div><div class="casAuthors">Fujino, Aiko; Fukushima, Kei; Kubota, Takaharu; Matsumoto, Yoshiyuki; Takimoto-Kamimura, Midori</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2), a serine/threonine kinase from the p38 mitogen-activated protein kinase signalling pathway, plays an important role in the prodn. of TNF-α and other cytokines.  In a previous report, it was shown that MK2 in complex with the selective inhibitor TEI-L01800 adopts an α-helical glycine-rich loop that is induced by the stable nonplanar conformer of TEI-L01800.  To understand the mechanism of the structural change, the structure of MK2 bound to TEI-L03090, which lacks the key substituent found in TEI-L01800, was detd.  MK2-TEI-L03090 has a β-sheet glycine-rich loop in common with other kinases, as predicted.  This result suggests that a small compd. can induce a drastic conformational change in the target protein structure and can be used to design potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6JmH2azAt7Vg90H21EOLACvtfcHk0lg_Ohq0IonCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsrbM&md5=73ddbd723d3257362baf0874956de03f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS1744309113030534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309113030534%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520%25CE%25B2-form%2520of%2520human%2520MK2%2520in%2520complex%2520with%2520the%2520non-selective%2520kinase%2520inhibitor%2520TEI-L03090%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D1344%26epage%3D1348%26doi%3D10.1107%2FS1744309113030534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TI-I01800: insight into the selectivity</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span><span class="refDoi"> DOI: 10.1107/S0909049513020736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS0909049513020736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24121337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=905-909&author=A.+Fujinoauthor=K.+Fukushimaauthor=T.+Kubotaauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Crystal+structure+of+human+cyclin-dependent+kinase-2+complex+with+MK2+inhibitor+TI-I01800%3A+insight+into+the+selectivity&doi=10.1107%2FS0909049513020736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity</span></div><div class="casAuthors">Fujino, Aiko; Fukushima, Kei; Kubota, Takaharu; Kosugi, Tomomi; Takimoto-Kamimura, Midori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases.  The crystal structure of the MK2-TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been obsd. for other Ser/Thr kinases.  TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was detd. at 2.0 Å resoln.  Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2.  In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2.  However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position.  In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favorable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFXyYybtRo3bVg90H21EOLACvtfcHk0lhMf6phqeTgHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsbrN&md5=681e5085a210ae5db2e8c685183016c8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0909049513020736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049513020736%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cyclin-dependent%2520kinase-2%2520complex%2520with%2520MK2%2520inhibitor%2520TI-I01800%253A%2520insight%2520into%2520the%2520selectivity%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2013%26volume%3D20%26spage%3D905%26epage%3D909%26doi%3D10.1107%2FS0909049513020736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericsson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banach, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankovich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhukhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine MK2 inhibitors. Part I: observation of an unexpected inhibitor binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=330-333&author=M.+A.+Argiriadiauthor=A.+M.+Ericssonauthor=C.+M.+Harrisauthor=D.+L.+Banachauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=M.+D.+Demersauthor=J.+DiMauroauthor=R.+W.+Dixonauthor=J.+Hardmanauthor=S.+Kwakauthor=B.+Liauthor=J.+A.+Mankovichauthor=D.+Marcotteauthor=K.+D.+Mullenauthor=B.+Niauthor=M.+Pietrasauthor=R.+Sadhukhanauthor=S.+Sousaauthor=M.+J.+Tomlinsonauthor=L.+Wangauthor=T.+Xiangauthor=R.+V.+Talanian&title=2%2C4-Diaminopyrimidine+MK2+inhibitors.+Part+I%3A+observation+of+an+unexpected+inhibitor+binding+mode&doi=10.1016%2Fj.bmcl.2009.10.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DEricsson%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDemers%26aufirst%3DM.%2BD.%26aulast%3DDiMauro%26aufirst%3DJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMankovich%26aufirst%3DJ.%2BA.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMullen%26aufirst%3DK.%2BD.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DPietras%26aufirst%3DM.%26aulast%3DSadhukhan%26aufirst%3DR.%26aulast%3DSousa%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26atitle%3D2%252C4-Diaminopyrimidine%2520MK2%2520inhibitors.%2520Part%2520I%253A%2520observation%2520of%2520an%2520unexpected%2520inhibitor%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D330%26epage%3D333%26doi%3D10.1016%2Fj.bmcl.2009.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masih, L.</span><span> </span><span class="NLM_article-title">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2005.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=15745802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1587-1590&author=D.+R.+Andersonauthor=S.+Hegdeauthor=E.+Reinhardauthor=L.+Gomezauthor=W.+F.+Vernierauthor=L.+Leeauthor=S.+Liuauthor=A.+Sambandamauthor=P.+A.+Sniderauthor=L.+Masih&title=Aminocyanopyridine+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2005.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span></div><div class="casAuthors">Anderson, David R.; Hegde, Shridhar; Reinhard, Emily; Gomez, Leslie; Vernier, William F.; Lee, Len; Liu, Shuang; Sambandam, Aruna; Snider, Patricia A.; Masih, Liaqat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1587-1590</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered.  These compds. have demonstrated activity against the enzyme with IC50 values as low as 130 nM and suppress the expression of TNFα in U937 cells.  These represent the first small mol. inhibitors of MK-2 to be reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LFlRxNk6lbVg90H21EOLACvtfcHk0li0ZO3O2_OKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntbw%253D&md5=a6742a967cd1dfa3d03f283a5bb76b8a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSambandam%26aufirst%3DA.%26aulast%3DSnider%26aufirst%3DP.%2BA.%26aulast%3DMasih%26aufirst%3DL.%26atitle%3DAminocyanopyridine%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1587%26epage%3D1590%26doi%3D10.1016%2Fj.bmcl.2005.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dix, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murziani, P. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokicki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zayed, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipling, D.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38α<sup>MAPK</sup> inhibitors in Werner syndrome cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6832</span><span class="NLM_x">–</span> <span class="NLM_lpage">6835</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6832-6835&author=T.+Davisauthor=M.+C.+Bagleyauthor=M.+C.+Dixauthor=P.+G.+S.+Murzianiauthor=M.+J.+Rokickiauthor=C.+S.+Widdowsonauthor=J.+M.+Zayedauthor=M.+A.+Bachlerauthor=D.+Kipling&title=Synthesis+and+in+vivo+activity+of+MK2+and+MK2+substrate-selective+p38%CE%B1MAPK+inhibitors+in+Werner+syndrome+cells&doi=10.1016%2Fj.bmcl.2007.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26aulast%3DDix%26aufirst%3DM.%2BC.%26aulast%3DMurziani%26aufirst%3DP.%2BG.%2BS.%26aulast%3DRokicki%26aufirst%3DM.%2BJ.%26aulast%3DWiddowson%26aufirst%3DC.%2BS.%26aulast%3DZayed%26aufirst%3DJ.%2BM.%26aulast%3DBachler%26aufirst%3DM.%2BA.%26aulast%3DKipling%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520activity%2520of%2520MK2%2520and%2520MK2%2520substrate-selective%2520p38%25CE%25B1MAPK%2520inhibitors%2520in%2520Werner%2520syndrome%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6832%26epage%3D6835%26doi%3D10.1016%2Fj.bmcl.2007.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span><span class="refDoi"> DOI: 10.1021/jm0611004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1021%2Fjm0611004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span></div><div class="casAuthors">Anderson, David R.; Meyers, Marvin J.; Vernier, William F.; Mahoney, Matthew W.; Kurumbail, Ravi G.; Caspers, Nicole; Poda, Gennadiy I.; Schindler, John F.; Reitz, David B.; Mourey, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2647-2654</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent kinase inhibitors selective for mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) for the treatment of rheumatoid arthritis has been prepd. and evaluated.  These inhibitors have IC50 values as low as 10 nM against the target and have good selectivity profiles against a no. of kinases including CDK2, ERK, JNK, and p38.  These MK-2 inhibitors have been shown to suppress TNFα prodn. in U937 cells and to be efficacious in an acute inflammation model.  The structure-activity relationships of this series, the selectivity for MK-2 and their activity in both in vitro and in vivo models are discussed.  The obsd. selectivity is discussed with the aid of an MK-2/inhibitor crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr54CPyUUnyw7Vg90H21EOLACvtfcHk0li0ZO3O2_OKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVWqsbY%253D&md5=f10df7433917d2833c99e966141a39da</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654%26doi%3D10.1021%2Fjm0611004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Chiang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wene, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbo, J. G.</span><span> </span><span class="NLM_article-title">Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1002/jps.21425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fjps.21425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=18449936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1WjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=248-256&author=P.-C.+Chiangauthor=S.+A.+Southauthor=J.+S.+Danielsauthor=D.+R.+Andersonauthor=S.+P.+Weneauthor=L.+A.+Albinauthor=R.+J.+Moureyauthor=J.+G.+Selbo&title=Aqueous+versus+non-aqueous+salt+delivery+strategies+to+enhance+oral+bioavailability+of+a+mitogen-activated+protein+kinase-activated+protein+kinase+%28MK-2%29+inhibitor+in+rats&doi=10.1002%2Fjps.21425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats</span></div><div class="casAuthors">Chiang, Po-Chang; South, Sarah A.; Daniels, J. Scott; Anderson, David R.; Wene, Steve P.; Albin, Lesley A.; Mourey, Robert J.; Selbo, Jon G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-256</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A potent pyridine-contg. MK2 inhibitor has recently been internally discovered.  In pre-clin. dosing, the low soly. of the neutral form limited oral bioavailability and dose escalation in toxicity studies.  A mesylate salt was developed as part of a formulation strategy to enhance both oral bioavailability and dose escalation orally in pre-clin. rat studies.  Several non-aq. systems were used to deliver the mesylate salt, which resulted in varied oral bioavailability.  It was found that administration of an aq. chaser immediately after dosing drastically increased the oral bioavailability of the salt.  This finding implies that the quantity of water present in vivo is an important consideration when evaluating salts of free bases with low aq. soly. in pre-clin. in vivo rat models where limited aq. vehicle may be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopAOIZBHEqdrVg90H21EOLACvtfcHk0lhLxLxDgxh1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1WjtA%253D%253D&md5=8e681ea0d66edf27d98fdf66036fafc7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.21425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21425%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DWene%26aufirst%3DS.%2BP.%26aulast%3DAlbin%26aufirst%3DL.%2BA.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DSelbo%26aufirst%3DJ.%2BG.%26atitle%3DAqueous%2520versus%2520non-aqueous%2520salt%2520delivery%2520strategies%2520to%2520enhance%2520oral%2520bioavailability%2520of%2520a%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%2520%2528MK-2%2529%2520inhibitor%2520in%2520rats%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D248%26epage%3D256%26doi%3D10.1002%2Fjps.21425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Pengal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guess, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benndorf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smoyer, W. E.</span><span> </span><span class="NLM_article-title">Inhibition of the protein kinase MK-2 promotes podocytes from nephrotic syndrome-related injury</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">F509</span><span class="NLM_x">–</span> <span class="NLM_lpage">F519</span><span class="refDoi"> DOI: 10.1152/ajprenal.00661.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1152%2Fajprenal.00661.2010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=F509-F519&author=R.+Pengalauthor=A.+J.+Guessauthor=S.+Agrawalauthor=J.+Manleyauthor=R.+F.+Ransomauthor=R.+J.+Moureyauthor=R.+Benndorfauthor=W.+E.+Smoyer&title=Inhibition+of+the+protein+kinase+MK-2+promotes+podocytes+from+nephrotic+syndrome-related+injury&doi=10.1152%2Fajprenal.00661.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00661.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00661.2010%26sid%3Dliteratum%253Aachs%26aulast%3DPengal%26aufirst%3DR.%26aulast%3DGuess%26aufirst%3DA.%2BJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DManley%26aufirst%3DJ.%26aulast%3DRansom%26aufirst%3DR.%2BF.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBenndorf%26aufirst%3DR.%26aulast%3DSmoyer%26aufirst%3DW.%2BE.%26atitle%3DInhibition%2520of%2520the%2520protein%2520kinase%2520MK-2%2520promotes%2520podocytes%2520from%2520nephrotic%2520syndrome-related%2520injury%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DF509%26epage%3DF519%26doi%3D10.1152%2Fajprenal.00661.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokicki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipling, D.</span><span> </span><span class="NLM_article-title">The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome</span> <span class="citation_source-journal">Chem. Cent. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="refDoi"> DOI: 10.1186/1752-153X-7-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1186%2F1752-153X-7-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23360642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=18&author=T.+Davisauthor=M.+J.+Rokickiauthor=M.+C.+Bagleyauthor=D.+Kipling&title=The+effect+of+small-molecule+inhibition+of+MAPKAPK2+on+cell+ageing+phenotypes+of+fibroblasts+from+human+Werner+syndrome&doi=10.1186%2F1752-153X-7-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome</span></div><div class="casAuthors">Davis, Terence; Rokicki, Michal J.; Bagley, Mark C.; Kipling, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Central Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18</span>CODEN:
                <span class="NLM_cas:coden">CCJHA2</span>;
        ISSN:<span class="NLM_cas:issn">1752-153X</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Fibroblasts derived from the progeroid Werner syndrome (WS) show reduced replicative lifespan and a "stressed" morphol., both phenotypes being alleviated by using the p38 MAP kinase inhibitor SB203580.  Because p38 is a major hub for the control of stress-signalling pathways we were interested in examg. the possible role for downstream kinases in order to refine our understanding of the role of p38 signalling in regulation of WS cell growth.  To this end we treated WS and normal fibroblasts with MK2 inhibitors to det. whether MK2 inhibition would affect either the growth or morphol. of WS cells.  The first inhibitor, 7,8-dihydroxy-2,4-diamino-3-cyanobenzopyranopyridine (inhibitor 2), resulted in inhibition of WS cell growth and had no effect on morphol., effects that occurred below the level needed to inhibit MK2 and thus suggestive of inhibitor toxicity.  The second inhibitor, 2-(2-quinolin-3-ylpyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo-[3,2-c]pyridin-4-one (CMPD16), resulted in a significant extension of WS fibroblast replicative capacity compared to normal cells.  In addn., CMPD16 reverted the WS cellular morphol. to that seen in normal dermal fibroblasts.  These data suggest that MK2 activity plays a substantial role in proliferation control in WS cells.  CMPD16 was not as effective in cellular lifespan extension as SB203580, however, suggesting that, although MK2 is a downstream kinase involved in cell cycle arrest, other p38 targets may play a role.  Alternatively, as CMPD16 is toxic to cell growth at levels just above those that extend lifespan, it is possible that the therapeutic window is too small.  However, as CMPD16 does show significant effects in WS fibroblasts, this acts as proof-of-principle for the efforts to design and synthesize improved MK2 inhibitors.  As MK2 is involved in inflammatory processes and inflammation plays a major role in WS phenotypes, these data suggest MK2 as a potential therapeutic target for the treatment of Werner syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplRBsO_pQJR7Vg90H21EOLACvtfcHk0lhLxLxDgxh1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVensrs%253D&md5=c16ff6dc7073ddaf226bfd2eb5c1d383</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1186%2F1752-153X-7-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1752-153X-7-18%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DRokicki%26aufirst%3DM.%2BJ.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26aulast%3DKipling%26aufirst%3DD.%26atitle%3DThe%2520effect%2520of%2520small-molecule%2520inhibition%2520of%2520MAPKAPK2%2520on%2520cell%2520ageing%2520phenotypes%2520of%2520fibroblasts%2520from%2520human%2520Werner%2520syndrome%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2013%26volume%3D7%26spage%3D18%26doi%3D10.1186%2F1752-153X-7-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchler, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.05.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4657-4663&author=J.+I.+Trujilloauthor=M.+J.+Meyersauthor=D.+R.+Andersonauthor=S.+Hegdeauthor=M.+W.+Mahoneyauthor=W.+F.+Vernierauthor=I.+P.+Buchlerauthor=K.+K.+Wuauthor=S.+Yangauthor=S.+J.+Hartmannauthor=D.+B.+Reitz&title=Novel+tetrahydro-%CE%B2-carboline-1-carboxylic+acids+as+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2007.05.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DBuchler%26aufirst%3DI.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DS.%2BJ.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520tetrahydro-%25CE%25B2-carboline-1-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4657%26epage%3D4663%26doi%3D10.1016%2Fj.bmcl.2007.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessment of selectivity and cellular potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.02.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4878-4881&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Mourey&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+structure-activity+relationships%2C+assessment+of+selectivity+and+cellular+potency&doi=10.1016%2Fj.bmcl.2009.02.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520structure-activity%2520relationships%252C%2520assessment%2520of%2520selectivity%2520and%2520cellular%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4878%26epage%3D4881%26doi%3D10.1016%2Fj.bmcl.2009.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M. D.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: improvements in kinase selectivity and cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.02.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4882-4884&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Moureyauthor=M.+D.+Parikh&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+improvements+in+kinase+selectivity+and+cell+potency&doi=10.1016%2Fj.bmcl.2009.02.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520improvements%2520in%2520kinase%2520selectivity%2520and%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4882%26epage%3D4884%26doi%3D10.1016%2Fj.bmcl.2009.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckenzie, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. W.,  II.</span><span> </span><span class="NLM_article-title">Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.2174/18723128112066660018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F18723128112066660018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24138031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFajt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=15-22&author=J.+S.+Danielsauthor=Y.+Laiauthor=S.+A.+Southauthor=P.-C.+Chiangauthor=D.+Walkerauthor=B.+Fengauthor=R.+Mirelesauthor=L.+O.+Whiteleyauthor=J.+W.+Mckenzieauthor=J.+Stevensauthor=R.+Moureyauthor=D.+Andersonauthor=J.+W.+Davis&title=Inhibition+of+hepatobiliary+transporters+by+a+novel+kinase+inhibitor+contributes+to+hepatotoxicity+in+beagle+dogs&doi=10.2174%2F18723128112066660018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs</span></div><div class="casAuthors">Daniels, John Scott; Lai, Yurong; South, Sarah; Chiang, Po-Chang; Walker, Daniel; Feng, Bo; Mireles, Rouchelle; Whiteley, Laurence O.; McKenzie, Jeremy W.; Stevens, Jeffrey; Mourey, Robert; Anderson, David; Davis, John W., II</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">PF-022 (1) is a novel polycyclic benzothiophene kinase inhibitor selective for mitogen-activated protein kinase-activated protein kinase 2 (MK2).  Compd. 1 emerged as an inhibitor bearing submicromolar potency against MK2 (IC50 5 nM) and demonstrated projected human pharmacokinetics sufficient for oral dosing.  However, following a single, oral administration of 1 to beagle dogs, animals experienced an acute liver injury characterized by increases in biomarkers assocd. with hepatotoxicity; particularly noteworthy was the reversible elevation in bile salts and total bilirubin.  Accompanying this observation was an ADME appraisal which included hepatic bioactivation of 1 in multiple species and the in vitro inhibition of P-glycoprotein (P-gp; IC50 21 μM).  Simply attenuating the bioactivation via structural modification proved ineffective in improving the in vivo tolerability of this polycyclic scaffold.  Hence, disruption of hepatobiliary transporters by the compd. series was hypothesized as the likely mechanism contributing to the acute hepatotoxicity.  Indeed, closer in vitro examn. employing transporter gene overexpressing MDCK cell lines and membrane vesicles revealed potent compd.-dependent inhibition of human multi-drug resistance-assocd. protein 2 (MRP2/ABCC2; IC50 38 μM) and bile salt export pump (BSEP/ABCB11; IC50 10 μM), two crucial hepatobiliary transport proteins accountable for bilirubin and bile salt homeostasis, resp.  Subsequent introduction of pKa-altering modifications to a second generation compd. PF029 proved successful in reducing its affinity for these key efflux transporters (MRP2 IC50 >>80 μM; BSEP IC50 > 70 μM; P-gp > 90 μM), consequently mitigating this overt organ toxicity in dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUobVwgG0UbVg90H21EOLACvtfcHk0liMqetIEZ8bsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFajt7Y%253D&md5=fc0902d34c34968575639a38bbd62172</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F18723128112066660018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18723128112066660018%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMireles%26aufirst%3DR.%26aulast%3DWhiteley%26aufirst%3DL.%2BO.%26aulast%3DMckenzie%26aufirst%3DJ.%2BW.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DMourey%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DJ.%2BW.%26atitle%3DInhibition%2520of%2520hepatobiliary%2520transporters%2520by%2520a%2520novel%2520kinase%2520inhibitor%2520contributes%2520to%2520hepatotoxicity%2520in%2520beagle%2520dogs%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2013%26volume%3D7%26spage%3D15%26epage%3D22%26doi%3D10.2174%2F18723128112066660018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">South, S. A.; Stevens, J.; Walker, G.; Parikh, M.; Walker, D.; Rock, D.; Thompson, D.; Mourey, R.; Anderson, D.; Daniels, J. S.</span><span> </span><span class="NLM_article-title">Hepatic metabolism of a novel kinase inhibitor reveals a dual mechanism of bioactivation</span>. <span class="NLM_conf-name">15th North American Regional ISSX Meeting</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">October 12–16, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=South%2C+S.+A.%3B+Stevens%2C+J.%3B+Walker%2C+G.%3B+Parikh%2C+M.%3B+Walker%2C+D.%3B+Rock%2C+D.%3B+Thompson%2C+D.%3B+Mourey%2C+R.%3B+Anderson%2C+D.%3B+Daniels%2C+J.+S.+Hepatic+metabolism+of+a+novel+kinase+inhibitor+reveals+a+dual+mechanism+of+bioactivation.+15th+North+American+Regional+ISSX+Meeting%2C+San+Diego%2C+CA%2C+October+12%E2%80%9316%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSouth%26aufirst%3DS.%2BA.%26atitle%3DHepatic%2520metabolism%2520of%2520a%2520novel%2520kinase%2520inhibitor%2520reveals%2520a%2520dual%2520mechanism%2520of%2520bioactivation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span> </span><span class="NLM_article-title">Sonic Hedgehog stimulates glycolysis and proliferation of breast cancer cells: modulation of PFKFB3 activation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bbrc.2015.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2015&pages=862-868&author=X.+Geauthor=P.+Lyuauthor=Y.+Guauthor=L.+Liauthor=J.+Liauthor=Y.+Wangauthor=L.+Zhangauthor=C.+Fuauthor=Z.+Cao&title=Sonic+Hedgehog+stimulates+glycolysis+and+proliferation+of+breast+cancer+cells%3A+modulation+of+PFKFB3+activation&doi=10.1016%2Fj.bbrc.2015.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DZ.%26atitle%3DSonic%2520Hedgehog%2520stimulates%2520glycolysis%2520and%2520proliferation%2520of%2520breast%2520cancer%2520cells%253A%2520modulation%2520of%2520PFKFB3%2520activation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D464%26spage%3D862%26epage%3D868%26doi%3D10.1016%2Fj.bbrc.2015.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petricci, E.</span><span> </span><span class="NLM_article-title">Structure-activity relationships and mechanism of action of small molecule Smoothened modulators discovered by high-throughput screening and rational design</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1007/7355_2014_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2F7355_2014_61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=43-108&author=F.+Manettiauthor=M.+Taddeiauthor=E.+Petricci&title=Structure-activity+relationships+and+mechanism+of+action+of+small+molecule+Smoothened+modulators+discovered+by+high-throughput+screening+and+rational+design&doi=10.1007%2F7355_2014_61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2F7355_2014_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2014_61%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DPetricci%26aufirst%3DE.%26atitle%3DStructure-activity%2520relationships%2520and%2520mechanism%2520of%2520action%2520of%2520small%2520molecule%2520Smoothened%2520modulators%2520discovered%2520by%2520high-throughput%2520screening%2520and%2520rational%2520design%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2015%26volume%3D16%26spage%3D43%26epage%3D108%26doi%3D10.1007%2F7355_2014_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span><span class="refDoi"> DOI: 10.1021/jm2013369</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013369" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVylsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1559-1571&author=A.+Solinasauthor=H.+Faureauthor=H.+Roudautauthor=E.+Traiffortauthor=A.+Schoenfelderauthor=A.+Mannauthor=F.+Manettiauthor=M.+Taddeiauthor=M.+Ruat&title=Acylthiourea%2C+acylurea%2C+and+acylguanidine+derivatives+with+potent+hedgehog+inhibiting+activity&doi=10.1021%2Fjm2013369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity</span></div><div class="casAuthors">Solinas, Antonio; Faure, Helene; Roudaut, Hermine; Traiffort, Elisabeth; Schoenfelder, Angele; Mann, Andre; Manetti, Fabrizio; Taddei, Maurizio; Ruat, Martial</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1559-1571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Smoothened (Smo) receptor is the major transducer of the Hedgehog (Hh) signaling pathway.  On the basis of the structure of the acylthiourea Smo antagonist (MRT-10), a no. of different series of analogous compds. were prepd. by ligand-based structural optimization.  The acylthioureas, originally identified as actives, were converted into the corresponding acylureas or acylguanidines.  In each series, similar structural trends delivered potent compds. with IC50 values in the nanomolar range with respect to the inhibition of the Hh signaling pathway in various cell-based assays and of BODIPY-cyclopamine binding to human Smo.  The similarity of their biol. activities, in spite of discrete structural differences, may reveal the existence of hydrogen-bonding interactions between the ligands and the receptor pocket.  Biol. potency of compds. I(X = S, O) and II (MRT-83) were comparable to those of the clin. candidate GDC-0449.  These findings suggest that these original mols. will help delineate Smo and Hh functions and can be developed as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOqY0lv-AC7Vg90H21EOLACvtfcHk0liqO9yytATsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVylsrw%253D&md5=65039a713bea1d973353182fbba3e528</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm2013369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013369%26sid%3Dliteratum%253Aachs%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DAcylthiourea%252C%2520acylurea%252C%2520and%2520acylguanidine%2520derivatives%2520with%2520potent%2520hedgehog%2520inhibiting%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1559%26epage%3D1571%26doi%3D10.1021%2Fjm2013369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorojankina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1124/mol.110.069708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.110.069708" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=453-460&author=H.+Roudautauthor=E.+Traiffortauthor=T.+Gorojankinaauthor=L.+Vincentauthor=H.+Faureauthor=A.+Schoenfelderauthor=A.+Mannauthor=F.+Manettiauthor=A.+Solinasauthor=M.+Taddeiauthor=M.+Ruat&title=Identification+and+mechanism+of+action+of+the+acylguanidine+MRT-83%2C+a+novel+potent+Smoothened+antagonist&doi=10.1124%2Fmol.110.069708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.069708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.069708%26sid%3Dliteratum%253Aachs%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DGorojankina%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520mechanism%2520of%2520action%2520of%2520the%2520acylguanidine%2520MRT-83%252C%2520a%2520novel%2520potent%2520Smoothened%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D453%26epage%3D460%26doi%3D10.1124%2Fmol.110.069708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorojankina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as Smoothened antagonists</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span><span class="refDoi"> DOI: 10.1124/mol.110.065102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.110.065102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=658-665&author=F.+Manettiauthor=H.+Faureauthor=H.+Roudautauthor=T.+Gorojankinaauthor=E.+Traiffortauthor=A.+Schoenfelderauthor=A.+Mannauthor=A.+Solinasauthor=M.+Taddeiauthor=M.+Ruat&title=Virtual+screening-based+discovery+and+mechanistic+characterization+of+the+acylthiourea+MRT-10+family+as+Smoothened+antagonists&doi=10.1124%2Fmol.110.065102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.065102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.065102%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DGorojankina%26aufirst%3DT.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DVirtual%2520screening-based%2520discovery%2520and%2520mechanistic%2520characterization%2520of%2520the%2520acylthiourea%2520MRT-10%2520family%2520as%2520Smoothened%2520antagonists%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D658%26epage%3D665%26doi%3D10.1124%2Fmol.110.065102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaz, S.</span><span> </span><span class="NLM_article-title">Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.1021/jm201217q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201217q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ogsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2035-2047&author=S.+Natesanauthor=R.+Subramaniamauthor=C.+Bergeronauthor=S.+Balaz&title=Binding+affinity+prediction+for+ligands+and+receptors+forming+tautomers+and+ionization+species%3A+inhibition+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK2%29&doi=10.1021%2Fjm201217q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Affinity Prediction for Ligands and Receptors Forming Tautomers and Ionization Species: Inhibition of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2)</span></div><div class="casAuthors">Natesan, Senthil; Subramaniam, Rajesh; Bergeron, Charles; Balaz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2035-2047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of ionization and tautomerism of ligands and receptors is one of the unresolved issues in structure-based prediction of binding affinities.  Our soln. utilizes the thermodn. master equation, expressing the exptl. obsd. assocn. const. as the sum of products, each valid for a specific ligand-receptor species pair, consisting of the assocn. microconstant and the fractions of the involved ligand and receptor species.  The microconstants are characterized by structure-based simulations, which are run for individual species pairs.  Here we incorporated the multispecies approach into the QM/MM linear response method and used it for structural correlation of published inhibition data on mitogen-activated protein kinase (MAPK)-activated protein kinase (MK2) by 66 benzothiophene and pyrrolopyridine analogs, forming up to five tautomers and seven ionization species under exptl. conditions.  Extensive cross-validation showed that the resulting models were stable and predictive.  Inclusion of all tautomers and ionization ligand species was essential: the explained variance increased to 90% from 66% for the single-species model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph5PM-NCtdi7Vg90H21EOLACvtfcHk0li24Q7bmofPaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ogsbg%253D&md5=346653d98cea8a45bf643cc7f985435f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm201217q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201217q%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSubramaniam%26aufirst%3DR.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DBalaz%26aufirst%3DS.%26atitle%3DBinding%2520affinity%2520prediction%2520for%2520ligands%2520and%2520receptors%2520forming%2520tautomers%2520and%2520ionization%2520species%253A%2520inhibition%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2035%26epage%3D2047%26doi%3D10.1021%2Fjm201217q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">The discovery of carboline analogs as potent MAPKAP-K2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4664</span><span class="NLM_x">–</span> <span class="NLM_lpage">4669</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.05.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4664-4669&author=J.-P.+Wuauthor=J.+Wangauthor=A.+Abeywardaneauthor=D.+Andersenauthor=M.+Emmanuelauthor=E.+Gautschiauthor=D.+R.+Goldbergauthor=M.+A.+Kashemauthor=S.+Lukasauthor=W.+Maoauthor=L.+Martinauthor=T.+Morwickauthor=N.+Mossauthor=C.+Pargellisauthor=U.+R.+Patelauthor=L.+Patnaudeauthor=G.+W.+Peetauthor=D.+Skowauthor=R.+J.+Snowauthor=Y.+Wardauthor=B.+Werneburgauthor=A.+White&title=The+discovery+of+carboline+analogs+as+potent+MAPKAP-K2+inhibitors&doi=10.1016%2Fj.bmcl.2007.05.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.101%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DD.%26aulast%3DEmmanuel%26aufirst%3DM.%26aulast%3DGautschi%26aufirst%3DE.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DU.%2BR.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520carboline%2520analogs%2520as%2520potent%2520MAPKAP-K2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4664%26epage%3D4669%26doi%3D10.1016%2Fj.bmcl.2007.05.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netherton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+DeLeonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torcelliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Wastiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2&doi=10.1016%2Fj.bmcl.2007.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0li24Q7bmofPaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeLeon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWasti%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941%26doi%3D10.1016%2Fj.bmcl.2007.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieselmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of indole-based MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2008.01.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1994-1999&author=Z.+Xiongauthor=D.+A.+Gaoauthor=D.+A.+Coganauthor=D.+R.+Goldbergauthor=M.-H.+Haoauthor=N.+Mossauthor=E.+Packauthor=C.+Pargellisauthor=D.+Skowauthor=T.+Trieselmannauthor=B.+Werneburgauthor=A.+White&title=Synthesis+and+SAR+studies+of+indole-based+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2008.01.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.119%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DHao%26aufirst%3DM.-H.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTrieselmann%26aufirst%3DT.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520indole-based%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1994%26epage%3D1999%26doi%3D10.1016%2Fj.bmcl.2008.01.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Hillig, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberspaecher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteclaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Tiemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, U.</span><span> </span><span class="NLM_article-title">Structural basis for a high affinity inhibitor bound to protein kinase MK2</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span><span class="refDoi"> DOI: 10.1016/j.jmb.2007.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jmb.2007.03.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=735-745&author=R.+C.+Hilligauthor=U.+Eberspaecherauthor=F.+Monteclaroauthor=M.+Huberauthor=D.+Nguyenauthor=A.+Mengelauthor=B.+Muller-Tiemannauthor=U.+Egner&title=Structural+basis+for+a+high+affinity+inhibitor+bound+to+protein+kinase+MK2&doi=10.1016%2Fj.jmb.2007.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DMonteclaro%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DMengel%26aufirst%3DA.%26aulast%3DMuller-Tiemann%26aufirst%3DB.%26aulast%3DEgner%26aufirst%3DU.%26atitle%3DStructural%2520basis%2520for%2520a%2520high%2520affinity%2520inhibitor%2520bound%2520to%2520protein%2520kinase%2520MK2%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D369%26spage%3D735%26epage%3D745%26doi%3D10.1016%2Fj.jmb.2007.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wilde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Someren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteegh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seegers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klop, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oubrie, A.</span><span> </span><span class="NLM_article-title">Structure-based lead identification of ATP-competitive MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3818</span><span class="NLM_x">–</span> <span class="NLM_lpage">3822</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.04.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3818-3822&author=T.+Barfauthor=A.+Kapteinauthor=S.+de+Wildeauthor=R.+van+der+Heijdenauthor=R.+van+Somerenauthor=D.+Demontauthor=C.+Schultz-Fademrechtauthor=J.+Versteeghauthor=M.+van+Zeelandauthor=N.+Seegersauthor=B.+Kazemierauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=J.+de+Roosauthor=H.+Klopauthor=R.+Smeetsauthor=C.+Hofstraauthor=J.+Hornbergauthor=A.+Oubrie&title=Structure-based+lead+identification+of+ATP-competitive+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2011.04.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3Dde%2BWilde%26aufirst%3DS.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DR.%26aulast%3Dvan%2BSomeren%26aufirst%3DR.%26aulast%3DDemont%26aufirst%3DD.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DVersteegh%26aufirst%3DJ.%26aulast%3Dvan%2BZeeland%26aufirst%3DM.%26aulast%3DSeegers%26aufirst%3DN.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DKlop%26aufirst%3DH.%26aulast%3DSmeets%26aufirst%3DR.%26aulast%3DHofstra%26aufirst%3DC.%26aulast%3DHornberg%26aufirst%3DJ.%26aulast%3DOubrie%26aufirst%3DA.%26atitle%3DStructure-based%2520lead%2520identification%2520of%2520ATP-competitive%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3818%26epage%3D3822%26doi%3D10.1016%2Fj.bmcl.2011.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Hanau, C. E.; Mershon, S. M.; Graneto, M. J.; Meyers, M. J.; Hegde, S. G.; Buchler, I. P.; Wu, K. K.; Liu, S.; Nacro, K.</span><span> </span><span class="NLM_article-title">Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2</span>. WO2004/058176 A2, <span class="NLM_month">July</span><span class="NLM_day">15</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+E.+Hanau&author=S.+M.+Mershon&author=M.+J.+Graneto&author=M.+J.+Meyers&author=S.+G.+Hegde&author=I.+P.+Buchler&author=K.+K.+Wu&author=S.+Liu&author=K.+Nacro&title=Acyclic+pyrazole+compounds+for+the+inhibition+of+mitogen+activated+protein+kinase-activated+protein+kinase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanau%26aufirst%3DC.%2BE.%26atitle%3DAcyclic%2520pyrazole%2520compounds%2520for%2520the%2520inhibition%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase-2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oubrie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zwart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenboom, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kimpe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteegh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leandro-Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span> </span><span class="NLM_article-title">Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3827</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.04.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3823-3827&author=A.+Kapteinauthor=A.+Oubrieauthor=E.+de+Zwartauthor=N.+Hoogenboomauthor=J.+de+Witauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=G.+Vogelauthor=V.+de+Kimpeauthor=C.+Schultz-Fademrechtauthor=J.+Borsboomauthor=M.+van+Zeelandauthor=J.+Versteeghauthor=B.+Kazemierauthor=J.+de+Roosauthor=F.+Wijnandsauthor=J.+Dulosauthor=M.+Jaegerauthor=P.+Leandro-Garciaauthor=T.+Barf&title=Discovery+of+selective+and+orally+available+spiro-3-piperidyl+ATP-competitive+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2011.04.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3Dde%2BZwart%26aufirst%3DE.%26aulast%3DHoogenboom%26aufirst%3DN.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3DVogel%26aufirst%3DG.%26aulast%3Dde%2BKimpe%26aufirst%3DV.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DBorsboom%26aufirst%3DJ.%26aulast%3Dvan%2BZeeland%26aufirst%3DM.%26aulast%3DVersteegh%26aufirst%3DJ.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DWijnands%26aufirst%3DF.%26aulast%3DDulos%26aufirst%3DJ.%26aulast%3DJaeger%26aufirst%3DM.%26aulast%3DLeandro-Garcia%26aufirst%3DP.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520selective%2520and%2520orally%2520available%2520spiro-3-piperidyl%2520ATP-competitive%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3823%26epage%3D3827%26doi%3D10.1016%2Fj.bmcl.2011.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Oubrie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zwart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenboom, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goorden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kimpe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span> </span><span class="NLM_article-title">Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.10.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=613-618&author=A.+Oubrieauthor=A.+Kapteinauthor=E.+de+Zwartauthor=N.+Hoogenboomauthor=R.+Goordenauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=V.+de+Kimpeauthor=R.+van+der+Heijdenauthor=J.+Borsboomauthor=B.+Kazemierauthor=J.+de+Roosauthor=M.+Scheffersauthor=J.+Lommerseauthor=C.+Schultz-Fademrechtauthor=T.+Barf&title=Novel+ATP+competitive+MK2+inhibitors+with+potent+biochemical+and+cell-based+activity+throughout+the+series&doi=10.1016%2Fj.bmcl.2011.10.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3Dde%2BZwart%26aufirst%3DE.%26aulast%3DHoogenboom%26aufirst%3DN.%26aulast%3DGoorden%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3Dde%2BKimpe%26aufirst%3DV.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DR.%26aulast%3DBorsboom%26aufirst%3DJ.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DScheffers%26aufirst%3DM.%26aulast%3DLommerse%26aufirst%3DJ.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DNovel%2520ATP%2520competitive%2520MK2%2520inhibitors%2520with%2520potent%2520biochemical%2520and%2520cell-based%2520activity%2520throughout%2520the%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D613%26epage%3D618%26doi%3D10.1016%2Fj.bmcl.2011.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span> </span><span class="NLM_article-title">Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3238</span><span class="NLM_x">–</span> <span class="NLM_lpage">3242</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.04.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3238-3242&author=S.+Linauthor=M.+Lombardoauthor=S.+Malkaniauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=S.+Luellauthor=E.+Carballo-Janeauthor=L.+Yang&title=Novel+1-%282-aminopyrazin-3-yl%29methyl-2-thioureas+as+potent+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2009.04.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.088%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DNovel%25201-%25282-aminopyrazin-3-yl%2529methyl-2-thioureas%2520as%2520potent%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3238%26epage%3D3242%26doi%3D10.1016%2Fj.bmcl.2009.04.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Meng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarri, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span> </span><span class="NLM_article-title">Potency switch between CHK1 and MK2: discovery of imidazo[1,2-<i>a</i>]pyrazine- and imidazo[1,2-<i>c</i>]pyrimidine-based kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2013.03.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2863-2867&author=Z.+Mengauthor=J.+P.+Ciavarriauthor=A.+McRinerauthor=Y.+Zhaoauthor=L.+Zhaoauthor=P.+A.+Reddyauthor=X.+Zhangauthor=T.+O.+Fischmannauthor=C.+Whitehurstauthor=M.+A.+Siddiqui&title=Potency+switch+between+CHK1+and+MK2%3A+discovery+of+imidazo%5B1%2C2-a%5Dpyrazine-+and+imidazo%5B1%2C2-c%5Dpyrimidine-based+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2013.03.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.100%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DCiavarri%26aufirst%3DJ.%2BP.%26aulast%3DMcRiner%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DReddy%26aufirst%3DP.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DWhitehurst%26aufirst%3DC.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26atitle%3DPotency%2520switch%2520between%2520CHK1%2520and%2520MK2%253A%2520discovery%2520of%2520imidazo%255B1%252C2-a%255Dpyrazine-%2520and%2520imidazo%255B1%252C2-c%255Dpyrimidine-based%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2863%26epage%3D2867%26doi%3D10.1016%2Fj.bmcl.2013.03.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelchli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6146</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2008.10.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6142-6146&author=A.+Schlapbachauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=G.+Kochauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=J.+Velcickyauthor=R.+Waelchliauthor=C.+Huppertz&title=Pyrrolo-pyrimidones%3A+a+novel+class+of+MK2+inhibitors+with+potent+cellular+activity&doi=10.1016%2Fj.bmcl.2008.10.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DWaelchli%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DPyrrolo-pyrimidones%253A%2520a%2520novel%2520class%2520of%2520MK2%2520inhibitors%2520with%2520potent%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6142%26epage%3D6146%26doi%3D10.1016%2Fj.bmcl.2008.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span> </span><span class="NLM_article-title">Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1293-1297&author=J.+Velcickyauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=C.+Huppertzauthor=G.+Kochauthor=M.+Kroemerauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=A.+Schlapbach&title=Novel+3-aminopyrazole+inhibitors+of+MK-2+discovered+by+scaffold+hopping+strategy&doi=10.1016%2Fj.bmcl.2009.10.138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.138%26sid%3Dliteratum%253Aachs%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DNovel%25203-aminopyrazole%2520inhibitors%2520of%2520MK-2%2520discovered%2520by%2520scaffold%2520hopping%2520strategy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1293%26epage%3D1297%26doi%3D10.1016%2Fj.bmcl.2009.10.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4715</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.04.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4715-4718&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=P.+Hiestandauthor=W.+Jahnkeauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+I&doi=10.1016%2Fj.bmcl.2010.04.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4715%26epage%3D4718%26doi%3D10.1016%2Fj.bmcl.2010.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood-Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4719</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.04.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4719-4723&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=J.+Dawsonauthor=R.+Feifelauthor=S.+Hawtinauthor=A.+Littlewood-Evansauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+II&doi=10.1016%2Fj.bmcl.2010.04.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4719%26epage%3D4723%26doi%3D10.1016%2Fj.bmcl.2010.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericsson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmetra, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine MK2 inhibitors. Part I: structure-based inhibitor optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=334-337&author=C.+M.+Harrisauthor=A.+M.+Ericssonauthor=M.+A.+Argiriadiauthor=C.+Barberisauthor=D.+W.+Borhaniauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=G.+A.+Cunhaauthor=R.+W.+Dixonauthor=K.+E.+Frankauthor=E.+F.+Johnsonauthor=J.+Kamensauthor=S.+Kwakauthor=B.+Liauthor=K.+D.+Mullenauthor=D.+C.+Perronauthor=L.+Wangauthor=N.+Wishartauthor=X.+Wuauthor=X.+Zhangauthor=T.+R.+Zmetraauthor=R.+V.+Talanian&title=2%2C4-Diaminopyrimidine+MK2+inhibitors.+Part+I%3A+structure-based+inhibitor+optimization&doi=10.1016%2Fj.bmcl.2009.10.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.103%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DEricsson%26aufirst%3DA.%2BM.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DKamens%26aufirst%3DJ.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMullen%26aufirst%3DK.%2BD.%26aulast%3DPerron%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZmetra%26aufirst%3DT.%2BR.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26atitle%3D2%252C4-Diaminopyrimidine%2520MK2%2520inhibitors.%2520Part%2520I%253A%2520structure-based%2520inhibitor%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D334%26epage%3D337%26doi%3D10.1016%2Fj.bmcl.2009.10.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenouchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unoki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunliffe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalloo-Hosein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-<i>a</i>]pyrimidine inhibitors using a focused library and structure-based optimization approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1021/jm300411k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300411k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6700-6715&author=T.+Kosugiauthor=D.+R.+Mitchellauthor=A.+Fujinoauthor=M.+Imaiauthor=M.+Kambeauthor=S.+Kobayashiauthor=H.+Makinoauthor=Y.+Matsuedaauthor=Y.+Oueauthor=K.+Komatsuauthor=K.+Imaizumiauthor=Y.+Sakaiauthor=S.+Sugiuraauthor=O.+Takenouchiauthor=G.+Unokiauthor=Y.+Yamakoshiauthor=V.+Cunliffeauthor=J.+Frearsonauthor=R.+Gordonauthor=C.+J.+Harrisauthor=H.+Kalloo-Hoseinauthor=J.+Leauthor=G.+Patelauthor=D.+J.+Simpsonauthor=B.+Sherborneauthor=P.+S.+Thomasauthor=N.+Suzukiauthor=M.+Takimoto-Kamimuraauthor=K.+Kataoka&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MAPKAP-K2%29+as+an+antiinflammatory+target%3A+discovery+and+in+vivo+activity+of+selective+pyrazolo%5B1%2C5-a%5Dpyrimidine+inhibitors+using+a+focused+library+and+structure-based+optimization+approach&doi=10.1021%2Fjm300411k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach</span></div><div class="casAuthors">Kosugi, Tomomi; Mitchell, Dale R.; Fujino, Aiko; Imai, Minoru; Kambe, Mika; Kobayashi, Shinji; Makino, Hiroaki; Matsueda, Yohei; Oue, Yasuhiro; Komatsu, Kanji; Imaizumi, Keiichiro; Sakai, Yuri; Sugiura, Satoshi; Takenouchi, Osami; Unoki, Gen; Yamakoshi, Yuko; Cunliffe, Vicky; Frearson, Julie; Gordon, Richard; Harris, C. John; Kalloo-Hosein, Heidi; Le, Joelle; Patel, Gita; Simpson, Donald J.; Sherborne, Brad; Thomas, Peter S.; Suzuki, Naotaka; Takimoto-Kamimura, Midori; Kataoka, Ken-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6700-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library.  A homol. model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the obsd. selectivity over CDK2.  An x-ray crystal structure of a compd. from the active series bound to cryst. MAPKAP-K2 confirmed the predicted binding mode.  This has enabled the discovery of a series of pyrazolo[1,5-a]pyrimidine derivs. showing good in vitro cellular 000 0 potency as anti-TNF-α agents and in vivo efficacy in a mouse model of endotoxin shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyvBMzPdy8KbVg90H21EOLACvtfcHk0li7Y0i9vVhXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gs7k%253D&md5=78a9e895c0f7a058407de9e344a75458</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300411k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300411k%26sid%3Dliteratum%253Aachs%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMitchell%26aufirst%3DD.%2BR.%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DMakino%26aufirst%3DH.%26aulast%3DMatsueda%26aufirst%3DY.%26aulast%3DOue%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DImaizumi%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DY.%26aulast%3DSugiura%26aufirst%3DS.%26aulast%3DTakenouchi%26aufirst%3DO.%26aulast%3DUnoki%26aufirst%3DG.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DCunliffe%26aufirst%3DV.%26aulast%3DFrearson%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DKalloo-Hosein%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DSimpson%26aufirst%3DD.%2BJ.%26aulast%3DSherborne%26aufirst%3DB.%26aulast%3DThomas%26aufirst%3DP.%2BS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DK.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MAPKAP-K2%2529%2520as%2520an%2520antiinflammatory%2520target%253A%2520discovery%2520and%2520in%2520vivo%2520activity%2520of%2520selective%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520inhibitors%2520using%2520a%2520focused%2520library%2520and%2520structure-based%2520optimization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6700%26epage%3D6715%26doi%3D10.1021%2Fjm300411k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Miglani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voleti, S. R.</span><span> </span><span class="NLM_article-title">Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ejmech.2009.09.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=98-105&author=R.+Miglaniauthor=I.+A.+Cliffeauthor=S.+R.+Voleti&title=Assessment+of+the+putative+binding+conformation+of+a+pyrazolopyridine+class+of+inhibitors+of+MAPKAPK2+using+computational+studies&doi=10.1016%2Fj.ejmech.2009.09.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMiglani%26aufirst%3DR.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DVoleti%26aufirst%3DS.%2BR.%26atitle%3DAssessment%2520of%2520the%2520putative%2520binding%2520conformation%2520of%2520a%2520pyrazolopyridine%2520class%2520of%2520inhibitors%2520of%2520MAPKAPK2%2520using%2520computational%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.ejmech.2009.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirincich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J. B.</span><span> </span><span class="NLM_article-title">Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3342</span><span class="NLM_x">–</span> <span class="NLM_lpage">3351</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmc.2009.03.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3342-3351&author=F.+Loveringauthor=S.+Kirincichauthor=W.+Wangauthor=K.+Combsauthor=L.+Resnickauthor=J.+E.+Sabalskiauthor=J.+Buteraauthor=J.+Liuauthor=K.+Parrisauthor=J.+B.+Telliez&title=Identification+and+SAR+of+squarate+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmc.2009.03.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DKirincich%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DCombs%26aufirst%3DK.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DButera%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DTelliez%26aufirst%3DJ.%2BB.%26atitle%3DIdentification%2520and%2520SAR%2520of%2520squarate%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3342%26epage%3D3351%26doi%3D10.1016%2Fj.bmc.2009.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Williams, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Soest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R. J.</span><span> </span><span class="NLM_article-title">Meroterpenoid MAPKAP (MK2) inhibitors isolated from the Indonesian marine sponge <i>Acanthodendrilla</i> sp</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2127</span><span class="NLM_x">–</span> <span class="NLM_lpage">2129</span><span class="refDoi"> DOI: 10.1021/np049808d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np049808d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2127-2129&author=D.+E.+Williamsauthor=J.-B.+Telliezauthor=J.+Liuauthor=A.+Tahirauthor=R.+van+Soestauthor=R.+J.+Andersen&title=Meroterpenoid+MAPKAP+%28MK2%29+inhibitors+isolated+from+the+Indonesian+marine+sponge+Acanthodendrilla+sp&doi=10.1021%2Fnp049808d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fnp049808d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049808d%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DA.%26aulast%3Dvan%2BSoest%26aufirst%3DR.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DMeroterpenoid%2520MAPKAP%2520%2528MK2%2529%2520inhibitors%2520isolated%2520from%2520the%2520Indonesian%2520marine%2520sponge%2520Acanthodendrilla%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D2127%26epage%3D2129%26doi%3D10.1021%2Fnp049808d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Basabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodero, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urones, J. G.</span><span> </span><span class="NLM_article-title">Synthesis of (+)-makassaric acid, a protein kinase MK2 inhibitor</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6008</span><span class="NLM_x">–</span> <span class="NLM_lpage">6012</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.tet.2010.06.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=6008-6012&author=P.+Basabeauthor=M.+Martinauthor=O.+Boderoauthor=A.+Blancoauthor=I.+S.+Marcosauthor=D.+Diezauthor=J.+G.+Urones&title=Synthesis+of+%28%2B%29-makassaric+acid%2C+a+protein+kinase+MK2+inhibitor&doi=10.1016%2Fj.tet.2010.06.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBasabe%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DBodero%26aufirst%3DO.%26aulast%3DBlanco%26aufirst%3DA.%26aulast%3DMarcos%26aufirst%3DI.%2BS.%26aulast%3DDiez%26aufirst%3DD.%26aulast%3DUrones%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520of%2520%2528%252B%2529-makassaric%2520acid%252C%2520a%2520protein%2520kinase%2520MK2%2520inhibitor%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D6008%26epage%3D6012%26doi%3D10.1016%2Fj.tet.2010.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Yang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span> </span><span class="NLM_article-title">3D QSAR analysis on pyrrolopyridine analogs as mitogen-activated protein kinase-activated protein kinase 2 (MK-2) inhibitors</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.2174/157018007782794509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F157018007782794509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=557-561&author=Z.+Q.+Yangauthor=P.+H.+Sunauthor=W.+M.+Chen&title=3D+QSAR+analysis+on+pyrrolopyridine+analogs+as+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29+inhibitors&doi=10.2174%2F157018007782794509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2174%2F157018007782794509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157018007782794509%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BQ.%26aulast%3DSun%26aufirst%3DP.%2BH.%26aulast%3DChen%26aufirst%3DW.%2BM.%26atitle%3D3D%2520QSAR%2520analysis%2520on%2520pyrrolopyridine%2520analogs%2520as%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%2520inhibitors%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2007%26volume%3D4%26spage%3D557%26epage%3D561%26doi%3D10.2174%2F157018007782794509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Nayana, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommisetty, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairy, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muttineni, R.</span><span> </span><span class="NLM_article-title">Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1021/ci800294y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800294y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=53-67&author=R.+S.+Nayanaauthor=S.+K.+Bommisettyauthor=K.+Singhauthor=S.+K.+Bairyauthor=S.+Nunnaauthor=A.+Pramodauthor=R.+Muttineni&title=Structural+analysis+of+carboline+derivatives+as+inhibitors+of+MAPKAP+K2+using+3D+QSAR+and+docking+studies&doi=10.1021%2Fci800294y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Carboline Derivatives As Inhibitors of MAPKAP K2 Using 3D QSAR and Docking Studies</span></div><div class="casAuthors">Nayana, Ravi Shashi; Bommisetty, Suneel Kumar; Singh, Kriti; Bairy, Santhosh Kumar; Nunna, Sivakumari; Pramod, Akula; Muttineni, Ravikumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-67</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MAPKAPK2 (MK2), a substrate of p38 MAPKs, plays central role in p38-mediated signal transduction, and its inhibitors are promisingly useful in the treatment of inflammatory diseases.  The computational approaches comprising both ligand-based drug design and structure-based drug design were used as virtual screening strategies for the discovery of novel MK2 inhibitors.  Two quant. pharmacophore models were generated with a training set of 27 MK2 inhibitors using HypoGen module of CATALYST.  The two models suggested that two hydrogen bond acceptors, one hydrogen bond donor, and one hydrophobic feature are essential for ligand binding.  Further, 3D QSAR model with comparative mol. field anal. (CoMFA) and comparative mol. similarity index anal. (CoMSIA) was constructed using a training set of 42 inhibitors.  The predictive CoMFA and CoMSIA models have cross-validated coeffs. (q2) of 0.804 and 0.765 and regression coeffs. (r2) of 0.984 and 0.986, resp.  The structure-based studies were carried out by docking 77 known MAPKAPK2 inhibitors into the active site of receptor using Glide and analyzing the hotspots of the active site.  Docking studies revealed that Met138, Leu141, Asp207, Lys93, Cys140, Leu70, Thr206, and Gly143 are showing interactions with highly active compds.  The structure activity relationships elucidated here for carboline derivs. combined with their binding information will provide an integrated approach to explore the chem. space further for improving the potency of MAPKAPK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSC-1xZKSw5rVg90H21EOLACvtfcHk0lh0ylcK4bYrFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlartw%253D%253D&md5=d347971b0bb0632728cd4f057f2992b1</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fci800294y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800294y%26sid%3Dliteratum%253Aachs%26aulast%3DNayana%26aufirst%3DR.%2BS.%26aulast%3DBommisetty%26aufirst%3DS.%2BK.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DBairy%26aufirst%3DS.%2BK.%26aulast%3DNunna%26aufirst%3DS.%26aulast%3DPramod%26aufirst%3DA.%26aulast%3DMuttineni%26aufirst%3DR.%26atitle%3DStructural%2520analysis%2520of%2520carboline%2520derivatives%2520as%2520inhibitors%2520of%2520MAPKAP%2520K2%2520using%25203D%2520QSAR%2520and%2520docking%2520studies%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D53%26epage%3D67%26doi%3D10.1021%2Fci800294y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Hao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span> </span><span class="NLM_article-title">A computational study on thiourea analogs as potent MK-2 inhibitors</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7057</span><span class="NLM_x">–</span> <span class="NLM_lpage">7079</span><span class="refDoi"> DOI: 10.3390/ijms13067057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.3390%2Fijms13067057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22837679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=7057-7079&author=M.+Haoauthor=H.+Renauthor=F.+Luoauthor=S.+Zhangauthor=J.+Qiuauthor=M.+Jiauthor=H.+Siauthor=G.+Li&title=A+computational+study+on+thiourea+analogs+as+potent+MK-2+inhibitors&doi=10.3390%2Fijms13067057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A computational study on thiourea analogs as potent MK-2 inhibitors</span></div><div class="casAuthors">Hao, Ming; Ren, Hong; Luo, Fang; Zhang, Shuwei; Qiu, Jieshan; Ji, Mingjuan; Si, Hongzong; Li, Guohui</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7057-7079</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK-2) has been identified as a drug target for the treatment of inflammatory diseases.  Currently, a series of thiourea analogs as potent MK-2 inhibitors were studied using comprehensive computational methods by 3D-QSAR, mol. docking and mol. dynamics simulations for a further improvement in activities.  The optimal 3D models exhibit high statistical significance of the results, esp. for the CoMFA results with r2ncv, q2 values of 0.974, 0.536 for the internal validation, and r2pred, r2m values of 0.910, 0.723 for the external validation and Roy's index, resp.  In addn., more rigorous validation criteria suggested by Tropsha were also employed to check the built models.  Graphic representation of the results, as contoured 3D coeff. plots, also provides a clue to the reasonable modification of mols.: (i) The substituent with a bulky size and electron-rich group at the C5 position of the pyrazine ring is required to enhance the potency; (ii) The H-bond acceptor group in the C3 position of the pyrazine ring is likely to be helpful to increase MK-2 inhibition; (iii) The small and electropos. substituent as a hydrogen bond donor of the C2 position in the oxazolone ring is favored; in addn., several important amino acid residues were also identified as playing an important role in MK-2 inhibition.  The agreement between 3D-QSAR, mol. docking and mol. dynamics simulations also proves the rationality of the developed models.  These results, we hope, may be helpful in designing novel and potential MK-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotV6IEuaqULVg90H21EOLACvtfcHk0lhFCLKh6d2xRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWhsLk%253D&md5=089420d060e77ef69a5fb7c94b107cfd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3390%2Fijms13067057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms13067057%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DA%2520computational%2520study%2520on%2520thiourea%2520analogs%2520as%2520potent%2520MK-2%2520inhibitors%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D7057%26epage%3D7079%26doi%3D10.3390%2Fijms13067057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Kaushik, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span> </span><span class="NLM_article-title">Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span><span class="refDoi"> DOI: 10.1007/s00044-011-9910-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2Fs00044-011-9910-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3777-3784&author=U.+Kaushikauthor=V.+Sharmaauthor=V.+Kumar&title=Computation+of+pharmacophore+models+for+the+prediction+of+mitogen-activated+protein+kinase+activated+protein+kinase-2+inhibitory+activity+of+pyrrolopyridines&doi=10.1007%2Fs00044-011-9910-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines</span></div><div class="casAuthors">Kaushik, Upasna; Sharma, Vikas; Kumar, Vipin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3777-3784</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">This article is an attempt to formulate the three-dimensional pharmacophore modeling of pyrrolopyridine derivs. inhibiting mitogen-activated protein kinase activated protein kinase-2 (MK2).  To understand the essential structural features for MK2 inhibitors, pharmacophore hypothesis were built on the basis of a set of known MK2 inhibitors selected from literature using PHASE program.  Three pharmacophore models with one hydrogen-bond acceptor (A), two hydrogen-bond donors (D), one hydrophobic group (H) and one arom. ring (R) as pharmacophoric features were developed.  Amongst them the pharmacophore hypothesis ADDHR1 yielded a statistically significant 3D-QSAR model with 0.926 as R2 value and was considered to be the best pharmacophore hypothesis.  The developed pharmacophore model was externally validated by predicting the activity of test set mols.  The squared predictive correlation coeff. of 0.882 was obsd. between exptl. and predicted activity values of test set mols.  The geometry and features of pharmacophore was expected to be useful for the design of selective MK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyUkSvcSf72rVg90H21EOLACvtfcHk0lhFCLKh6d2xRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOitL%252FF&md5=6da180db8ee951a3a07cbb478922d91b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs00044-011-9910-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-011-9910-z%26sid%3Dliteratum%253Aachs%26aulast%3DKaushik%26aufirst%3DU.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DComputation%2520of%2520pharmacophore%2520models%2520for%2520the%2520prediction%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase-2%2520inhibitory%2520activity%2520of%2520pyrrolopyridines%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2012%26volume%3D21%26spage%3D3777%26epage%3D3784%26doi%3D10.1007%2Fs00044-011-9910-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Wang, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">Applications of 3D-QSAR and structure-based pharmacophore modeling, virtual screening, ADMET, and molecular docking of putative MAPKAP-K2 (MK2) inhibitors</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4418</span><span class="NLM_x">–</span> <span class="NLM_lpage">4429</span><span class="refDoi"> DOI: 10.1007/s00044-013-0492-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2Fs00044-013-0492-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=4418-4429&author=T.-J.+Wangauthor=L.+Zhouauthor=J.+Feiauthor=Z.-C.+Liauthor=L.+He&title=Applications+of+3D-QSAR+and+structure-based+pharmacophore+modeling%2C+virtual+screening%2C+ADMET%2C+and+molecular+docking+of+putative+MAPKAP-K2+%28MK2%29+inhibitors&doi=10.1007%2Fs00044-013-0492-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00044-013-0492-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-013-0492-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-J.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DFei%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.-C.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DApplications%2520of%25203D-QSAR%2520and%2520structure-based%2520pharmacophore%2520modeling%252C%2520virtual%2520screening%252C%2520ADMET%252C%2520and%2520molecular%2520docking%2520of%2520putative%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D4418%26epage%3D4429%26doi%3D10.1007%2Fs00044-013-0492-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Lopes, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span> </span><span class="NLM_article-title">Inhibition of Hsp27 phosphorylation by a cell-permeant MAPKAP kinase 2 inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bbrc.2009.03.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2009&pages=535-539&author=L.+B.+Lopesauthor=C.+Flynnauthor=P.+Komalavilasauthor=A.+Panitchauthor=C.+M.+Brophyauthor=B.+L.+Seal&title=Inhibition+of+Hsp27+phosphorylation+by+a+cell-permeant+MAPKAP+kinase+2+inhibitor&doi=10.1016%2Fj.bbrc.2009.03.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%26aufirst%3DL.%2BB.%26aulast%3DFlynn%26aufirst%3DC.%26aulast%3DKomalavilas%26aufirst%3DP.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26atitle%3DInhibition%2520of%2520Hsp27%2520phosphorylation%2520by%2520a%2520cell-permeant%2520MAPKAP%2520kinase%25202%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D382%26spage%3D535%26epage%3D539%26doi%3D10.1016%2Fj.bbrc.2009.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Ward, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1002/psc.1168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fpsc.1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19691016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSnsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=668-674&author=B.+Wardauthor=B.+L.+Sealauthor=C.+M.+Brophyauthor=A.+Panitch&title=Design+of+a+bioactive+cell-penetrating+peptide%3A+when+a+transduction+domain+does+more+than+transduce&doi=10.1002%2Fpsc.1168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce</span></div><div class="casAuthors">Ward, Brian; Seal, Brandon L.; Brophy, Colleen M.; Panitch, Alyssa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">668-674</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The discovery of cell-penetrating peptides (CPPs) has facilitated delivery of peptides into cells to affect cellular behavior.  Previously, we were successful at developing a phosphopeptide mimetic of the small heat shock-like protein HSP20.  Building on this success we developed a cell-permeant peptide inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MK2).  It is well documented that inhibition of MK2 may be beneficial for a myriad of human diseases including those involving inflammation and fibrosis.  During the optimization of the activity and specificity of the MK2 inhibitor (MK2i) we closely examd. the effect of cell-penetrating peptide identity.  Surprisingly, the identity of the CPP dictated kinase specificity and functional activity to an extent that rivaled that of the therapeutic peptide.  The results reported herein have wide implications for delivering therapeutics with CPPs and indicate that judicious choice of CPP is crucial to the ultimate therapeutic success.  Published in 2009 by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlxXNoAiKkUbVg90H21EOLACvtfcHk0ljHfy9eSyNLgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSnsbbL&md5=3f7bbb4f6c77c45c3ae0e741f6564168</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fpsc.1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.1168%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DDesign%2520of%2520a%2520bioactive%2520cell-penetrating%2520peptide%253A%2520when%2520a%2520transduction%2520domain%2520does%2520more%2520than%2520transduce%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2009%26volume%3D15%26spage%3D668%26epage%3D674%26doi%3D10.1002%2Fpsc.1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Brugnano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2011.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jconrel.2011.05.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2011&pages=128-133&author=J.+L.+Brugnanoauthor=B.+K.+Chanauthor=B.+L.+Sealauthor=A.+Panitch&title=Cell-penetrating+peptides+can+confer+biological+function%3A+regulation+of+inflammatory+cytokines+in+human+monocytes+by+MK2+inhibitor+peptides&doi=10.1016%2Fj.jconrel.2011.05.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2011.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2011.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBrugnano%26aufirst%3DJ.%2BL.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DCell-penetrating%2520peptides%2520can%2520confer%2520biological%2520function%253A%2520regulation%2520of%2520inflammatory%2520cytokines%2520in%2520human%2520monocytes%2520by%2520MK2%2520inhibitor%2520peptides%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2011%26volume%3D155%26spage%3D128%26epage%3D133%26doi%3D10.1016%2Fj.jconrel.2011.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Ward, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavalukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugnano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions</span> <span class="citation_source-journal">J. Surg. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27</span><span class="NLM_x">–</span> <span class="NLM_lpage">e36</span><span class="refDoi"> DOI: 10.1016/j.jss.2011.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jss.2011.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2011&pages=e27-e36&author=B.+C.+Wardauthor=S.+Kavalukasauthor=J.+Brugnanoauthor=A.+Barbulauthor=A.+Panitch&title=Peptide+inhibitors+of+MK2+show+promise+for+inhibition+of+abdominal+adhesions&doi=10.1016%2Fj.jss.2011.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2011.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2011.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%2BC.%26aulast%3DKavalukas%26aufirst%3DS.%26aulast%3DBrugnano%26aufirst%3DJ.%26aulast%3DBarbul%26aufirst%3DA.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DPeptide%2520inhibitors%2520of%2520MK2%2520show%2520promise%2520for%2520inhibition%2520of%2520abdominal%2520adhesions%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D169%26spage%3De27%26epage%3De36%26doi%3D10.1016%2Fj.jss.2011.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Muto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, A.</span><span> </span><span class="NLM_article-title">Inhibitor of mitogen activated protein kinase activated protein kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/j.vph.2011.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.vph.2011.07.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=47-55&author=A.+Mutoauthor=A.+Panitchauthor=N.+Kimauthor=K.+Parkauthor=P.+Komalavilasauthor=C.+M.+Brophyauthor=A.+Dardik&title=Inhibitor+of+mitogen+activated+protein+kinase+activated+protein+kinase+II+with+MMI-0100+reduces+intimal+hyperplasia+ex+vivo+and+in+vivo&doi=10.1016%2Fj.vph.2011.07.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2011.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2011.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DMuto%26aufirst%3DA.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DKomalavilas%26aufirst%3DP.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DDardik%26aufirst%3DA.%26atitle%3DInhibitor%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%2520II%2520with%2520MMI-0100%2520reduces%2520intimal%2520hyperplasia%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2012%26volume%3D56%26spage%3D47%26epage%3D55%26doi%3D10.1016%2Fj.vph.2011.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Lopes, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smoke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span> </span><span class="NLM_article-title">A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model</span> <span class="citation_source-journal">J. Vasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span><span class="refDoi"> DOI: 10.1016/j.jvs.2010.06.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jvs.2010.06.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=20864298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FjtValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=1596-1607&author=L.+B.+Lopesauthor=C.+M.+Brophyauthor=C.+R.+Flynnauthor=z.+Yiauthor=B.+P.+Bowenauthor=C.+Smokeauthor=B.+Sealauthor=A.+Panitchauthor=P.+Komalavilas&title=A+novel+cell+permeant+peptide+inhibitor+of+MAPKAP+kinase+II+inhibits+intimal+hyperplasia+in+a+human+saphenous+vein+organ+culture+model&doi=10.1016%2Fj.jvs.2010.06.168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model</span></div><div class="casAuthors">Lopes Luciana B; Brophy Colleen M; Flynn Charles R; Yi Zhengping; Bowen Benjamin P; Smoke Christopher; Seal Brandon; Panitch Alyssa; Komalavilas Padmini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1596-607</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The present study was aimed at developing a new cell-permeant peptide inhibitor (MK2i) of the kinase that phosphorylates and activates heat-shock protein (HSP)27 (MAPKAP kinase II), and evaluating the ability of this peptide to inhibit HSP27 phosphorylation and intimal thickening.  METHODS:  The ability of MK2i to reduce HSP27 phosphorylation and cell migration was evaluated in A7R5 cells stimulated with arsenite or lysophosphatidic acid.  Stable isotopic labeling using amino acids in cell culture, in combination with liquid chromatography mass spectrometry, was used to characterize the effect of MK2i on global protein expression in fibroblasts.  The effect of MK2i on intimal thickening and connective tissue growth factor expression was evaluated in human saphenous vein (HSV) rings maintained with 30% fetal bovine serum for 14 days by light microscopy and immunoblotting.  RESULTS:  Pretreatment of cells with MK2i (10 μM) prior to arsenite or lysophosphatidic acid stimulation decreased phosphorylation of HSP27 (36% ± 9% and 33% ± 10%, respectively) compared with control (not pretreated) cells.  MK2i also inhibited A7R5 migration, and downregulated the transforming growth factor-induced expression of collagen and fibronectin in keloid cells, two major matrix proteins involved in the development of intimal hyperplasia.  Treatment of HSV segments with MK2i enhanced relaxation, reduced HSP27 phosphorylation (40% ± 17%), connective tissue growth factor expression (17% ± 5%), and intimal thickness (48.2% ± 10.5%) compared with untreated segments.  On the other hand, treatment with a recombinant fusion protein containing a cell-permeant peptide attached to the HSP27 sequence increased intimal thickness of HSV segments by 48% ± 14%.  CONCLUSION:  Our results suggest that HSP27 may play a role in the development of processes leading to intimal hyperplasia in HSV, and reduction of HSP27 phosphorylation by MK2i may be a potential strategy to inhibit the development of intimal hyperplasia in HSV to prevent the autologous vascular graft failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyHbQQNoHXoyXXDYhVZBdlfW6udTcc2eZwhIgc7VQPGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FjtValtw%253D%253D&md5=bb924717dab0bc485cddccccf42ce19c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2010.06.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2010.06.168%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%26aufirst%3DL.%2BB.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DFlynn%26aufirst%3DC.%2BR.%26aulast%3DYi%26aufirst%3Dz.%26aulast%3DBowen%26aufirst%3DB.%2BP.%26aulast%3DSmoke%26aufirst%3DC.%26aulast%3DSeal%26aufirst%3DB.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DKomalavilas%26aufirst%3DP.%26atitle%3DA%2520novel%2520cell%2520permeant%2520peptide%2520inhibitor%2520of%2520MAPKAP%2520kinase%2520II%2520inhibits%2520intimal%2520hyperplasia%2520in%2520a%2520human%2520saphenous%2520vein%2520organ%2520culture%2520model%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2010%26volume%3D52%26spage%3D1596%26epage%3D1607%26doi%3D10.1016%2Fj.jvs.2010.06.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Brugnano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Matrix stiffness affects endocytic uptake of MK2-inhibitor peptides</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84821</span><span class="refDoi"> DOI: 10.1371/journal.pone.0084821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1371%2Fjournal.pone.0084821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e84821&author=J.+L.+Brugnanoauthor=A.+Panitch&title=Matrix+stiffness+affects+endocytic+uptake+of+MK2-inhibitor+peptides&doi=10.1371%2Fjournal.pone.0084821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0084821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0084821%26sid%3Dliteratum%253Aachs%26aulast%3DBrugnano%26aufirst%3DJ.%2BL.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DMatrix%2520stiffness%2520affects%2520endocytic%2520uptake%2520of%2520MK2-inhibitor%2520peptides%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De84821%26doi%3D10.1371%2Fjournal.pone.0084821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasopoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalghatgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orminati, J.-P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, J. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaddupathy, R. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintner, E. A.</span><span> </span><span class="NLM_article-title">An affinity selection-mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries. Discovery of a novel antagonist of <i>E. coli</i> dihydrofolate reductase</span> <span class="citation_source-journal">Int. J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/j.ijms.2003.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ijms.2003.11.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=238&publication_year=2004&pages=77-83&author=D.+A.+Annisauthor=J.+Athanasopoulosauthor=P.+J.+Curranauthor=J.+S.+Felschauthor=K.+Kalghatgiauthor=W.+H.+Leeauthor=H.+M.+Nashauthor=J.-P.+A.+Orminatiauthor=K.+E.+Rosnerauthor=J.+W.+Shippsauthor=R.+R.+A.+Thaddupathyauthor=A.+N.+Tylerauthor=L.+Vilenchikauthor=C.+R.+Wagnerauthor=E.+A.+Wintner&title=An+affinity+selection-mass+spectrometry+method+for+the+identification+of+small+molecule+ligands+from+self-encoded+combinatorial+libraries.+Discovery+of+a+novel+antagonist+of+E.+coli+dihydrofolate+reductase&doi=10.1016%2Fj.ijms.2003.11.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ijms.2003.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijms.2003.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DFelsch%26aufirst%3DJ.%2BS.%26aulast%3DKalghatgi%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DOrminati%26aufirst%3DJ.-P.%2BA.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShipps%26aufirst%3DJ.%2BW.%26aulast%3DThaddupathy%26aufirst%3DR.%2BR.%2BA.%26aulast%3DTyler%26aufirst%3DA.%2BN.%26aulast%3DVilenchik%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWintner%26aufirst%3DE.%2BA.%26atitle%3DAn%2520affinity%2520selection-mass%2520spectrometry%2520method%2520for%2520the%2520identification%2520of%2520small%2520molecule%2520ligands%2520from%2520self-encoded%2520combinatorial%2520libraries.%2520Discovery%2520of%2520a%2520novel%2520antagonist%2520of%2520E.%2520coli%2520dihydrofolate%2520reductase%26jtitle%3DInt.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D238%26spage%3D77%26epage%3D83%26doi%3D10.1016%2Fj.ijms.2003.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spacciapoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C. E.</span><span> </span><span class="NLM_article-title">Discovery and hit-to-lead optimization of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1021/ml200113y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200113y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=632-637&author=X.+Huangauthor=G.+W.+Shippsauthor=C.+C.+Chengauthor=P.+Spacciapoliauthor=X.+Zhangauthor=M.+A.+McCoyauthor=D.+F.+Wyssauthor=X.+Yangauthor=A.+Achabauthor=K.+Soucyauthor=D.+K.+Montavonauthor=D.+M.+Murphyauthor=C.+E.+Whitehurst&title=Discovery+and+hit-to-lead+optimization+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1021%2Fml200113y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fml200113y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200113y%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DSpacciapoli%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMcCoy%26aufirst%3DM.%2BA.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAchab%26aufirst%3DA.%26aulast%3DSoucy%26aufirst%3DK.%26aulast%3DMontavon%26aufirst%3DD.%2BK.%26aulast%3DMurphy%26aufirst%3DD.%2BM.%26aulast%3DWhitehurst%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520hit-to-lead%2520optimization%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D632%26epage%3D637%26doi%3D10.1021%2Fml200113y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.11.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22169260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=65-70&author=X.+Huangauthor=X.+Zhuauthor=X.+Chenauthor=W.+Zhouauthor=D.+Xiaoauthor=S.+Degradoauthor=R.+Aslanianauthor=J.+Fossettaauthor=D.+Lundellauthor=F.+Tianauthor=P.+Trivediauthor=A.+Palani&title=A+three-step+protocol+for+lead+optimization%3A+quick+identification+of+key+conformational+features+and+functional+groups+in+the+SAR+studies+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.11.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span></div><div class="casAuthors">Huang, Xianhai; Zhu, Xiaohong; Chen, Xiao; Zhou, Wei; Xiao, Dong; Degrado, Sylvia; Aslanian, Robert; Fossetta, James; Lundell, Daniel; Tian, Fang; Trivedi, Prashant; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A three-step protocol for SAR development was introduced and applied to the SAR studies of the MK2 inhibitor program.  Following this protocol, key conformational features and functional groups for improving MK2 inhibitor activity were quickly identified.  Through this effort, the initial gap obsd. between in vitro binding activity and cellular activity in the lead identification stage was very much reduced.  Compd. 28 was identified with single digit binding activity (IC50 = 8 nM) and good cellular activity (EC50 = 310 nM).  This provides further evidence that non-ATP-competitive binding MK2 inhibitors are feasible by targeting the outside ATP pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrI2-Vf5BZWbVg90H21EOLACvtfcHk0ljz7SnHlI8a7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyquw%253D%253D&md5=da2ff998ada081c76f2e9e251af7e109</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.074%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DDegrado%26aufirst%3DS.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DA%2520three-step%2520protocol%2520for%2520lead%2520optimization%253A%2520quick%2520identification%2520of%2520key%2520conformational%2520features%2520and%2520functional%2520groups%2520in%2520the%2520SAR%2520studies%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D65%26epage%3D70%26doi%3D10.1016%2Fj.bmcl.2011.11.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of a potent dihydrooxadiazole series of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1021/ml200238g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200238g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=100-105&author=J.+Qinauthor=P.+Dhondiauthor=X.+Huangauthor=R.+Aslanianauthor=J.+Fossettaauthor=F.+Tianauthor=D.+Lundellauthor=A.+Palani&title=Discovery+of+a+potent+dihydrooxadiazole+series+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1021%2Fml200238g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fml200238g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200238g%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520dihydrooxadiazole%2520series%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D100%26epage%3D105%26doi%3D10.1021%2Fml200238g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofolarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of potent MK2 non-ATP competitive inhibitors usign 1,2-substituted azoles as cis-amide isosteres</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3613</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2014.05.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3609-3613&author=D.+Xiaoauthor=X.+Zhuauthor=M.+Sofolaridesauthor=S.+Degradoauthor=N.+Shaoauthor=A.+Raoauthor=X.+Chenauthor=R.+Aslanianauthor=J.+Fossettaauthor=F.+Tianauthor=P.+Trivediauthor=D.+Lundellauthor=A.+Palani&title=Discovery+of+a+novel+series+of+potent+MK2+non-ATP+competitive+inhibitors+usign+1%2C2-substituted+azoles+as+cis-amide+isosteres&doi=10.1016%2Fj.bmcl.2014.05.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSofolarides%26aufirst%3DM.%26aulast%3DDegrado%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DN.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520MK2%2520non-ATP%2520competitive%2520inhibitors%2520usign%25201%252C2-substituted%2520azoles%2520as%2520cis-amide%2520isosteres%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3609%26epage%3D3613%26doi%3D10.1016%2Fj.bmcl.2014.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofolarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spacciapoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span> </span><span class="NLM_article-title">Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3262</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2013.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3262-3266&author=D.+Xiaoauthor=A.+Palaniauthor=X.+Huangauthor=M.+Sofolaridesauthor=W.+Zhouauthor=X.+Chenauthor=R.+Aslanianauthor=Z.+Guoauthor=J.+Fossettaauthor=F.+Tianauthor=P.+Trivediauthor=P.+Spacciapoliauthor=C.+E.+Whitehurstauthor=D.+Lundell&title=Conformation+constraint+of+anilides+enabling+the+discovery+of+tricyclic+lactams+as+potent+MK2+non-ATP+competitive+inhibitors&doi=10.1016%2Fj.bmcl.2013.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DSofolarides%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DSpacciapoli%26aufirst%3DP.%26aulast%3DWhitehurst%26aufirst%3DC.%2BE.%26aulast%3DLundell%26aufirst%3DD.%26atitle%3DConformation%2520constraint%2520of%2520anilides%2520enabling%2520the%2520discovery%2520of%2520tricyclic%2520lactams%2520as%2520potent%2520MK2%2520non-ATP%2520competitive%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3262%26epage%3D3266%26doi%3D10.1016%2Fj.bmcl.2013.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Rao, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.11.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1068-1072&author=A.+U.+Raoauthor=D.+Xiaoauthor=X.+Huangauthor=W.+Zhouauthor=J.+Fossettaauthor=D.+Lundellauthor=F.+Tianauthor=P.+Trivediauthor=R.+Aslanianauthor=A.+Palani&title=Facile+synthesis+of+tetracyclic+azepine+and+oxazocine+derivatives+and+their+potential+as+MAPKAP-K2+%28MK2%29+kinase&doi=10.1016%2Fj.bmcl.2011.11.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.113%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DA.%2BU.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DFacile%2520synthesis%2520of%2520tetracyclic%2520azepine%2520and%2520oxazocine%2520derivatives%2520and%2520their%2520potential%2520as%2520MAPKAP-K2%2520%2528MK2%2529%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1068%26epage%3D1072%26doi%3D10.1016%2Fj.bmcl.2011.11.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersoy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristoffersson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span> </span><span class="NLM_article-title">4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4740</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.06.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4738-4740&author=H.+Olssonauthor=P.+Sjoauthor=O.+Ersoyauthor=A.+Kristofferssonauthor=J.+Larssonauthor=B.+Norden&title=4-Anilino-6-phenyl-quinoline+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK2%29&doi=10.1016%2Fj.bmcl.2010.06.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.107%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DSjo%26aufirst%3DP.%26aulast%3DErsoy%26aufirst%3DO.%26aulast%3DKristoffersson%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DNorden%26aufirst%3DB.%26atitle%3D4-Anilino-6-phenyl-quinoline%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4738%26epage%3D4740%26doi%3D10.1016%2Fj.bmcl.2010.06.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of p38: has the fat lady sung?</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.1002/art.24264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fart.24264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19180514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=317-320&author=M.+C.+Genovese&title=Inhibition+of+p38%3A+has+the+fat+lady+sung%3F&doi=10.1002%2Fart.24264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38: has the fat lady sung?</span></div><div class="casAuthors">Genovese Mark C</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-20</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnT0jWinaMx0PI-fCgwosgfW6udTcc2eYkUTd8s1QgE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D&md5=b8aaf19800021f9f8fb00f4220c8194a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fart.24264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24264%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520p38%253A%2520has%2520the%2520fat%2520lady%2520sung%253F%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D317%26epage%3D320%26doi%3D10.1002%2Fart.24264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cheung, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Feedback control of the protein kinase TAK1 by SAPK2a/p38α</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5793</span><span class="NLM_x">–</span> <span class="NLM_lpage">5805</span><span class="refDoi"> DOI: 10.1093/emboj/cdg552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Femboj%2Fcdg552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5793-5805&author=P.+C.+Cheungauthor=D.+G.+Campbellauthor=A.+R.+Nebredaauthor=P.+Cohen&title=Feedback+control+of+the+protein+kinase+TAK1+by+SAPK2a%2Fp38%CE%B1&doi=10.1093%2Femboj%2Fcdg552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg552%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DP.%2BC.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DFeedback%2520control%2520of%2520the%2520protein%2520kinase%2520TAK1%2520by%2520SAPK2a%252Fp38%25CE%25B1%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5793%26epage%3D5805%26doi%3D10.1093%2Femboj%2Fcdg552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of anti-inflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+anti-inflammatory+drugs&doi=10.1016%2Fj.ceb.2009.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0ljHUb0bank76Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520anti-inflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D317%26epage%3D324%26doi%3D10.1016%2Fj.ceb.2009.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span> </span><span class="NLM_article-title">Targeting innate immunity protein kinase signalling in inflammation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1038/nrd2829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1038%2Fnrd2829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=480-499&author=M.+Gaestelauthor=A.+Kotlyarovauthor=M.+Kracht&title=Targeting+innate+immunity+protein+kinase+signalling+in+inflammation&doi=10.1038%2Fnrd2829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2829%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DKracht%26aufirst%3DM.%26atitle%3DTargeting%2520innate%2520immunity%2520protein%2520kinase%2520signalling%2520in%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D480%26epage%3D499%26doi%3D10.1038%2Fnrd2829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6629</span><span class="NLM_x">–</span> <span class="NLM_lpage">6639</span><span class="refDoi"> DOI: 10.1021/jm100540x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100540x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6629-6639&author=C.+Liuauthor=J.+Linauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+Hynesauthor=H.+Wuauthor=A.+J.+Dyckmanauthor=T.+Liauthor=J.+Wityakauthor=K.+M.+Gilloolyauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+F.+Zhangauthor=K.+W.+McIntyreauthor=L.+Salter-Cidauthor=D.+J.+Shusterauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=S.+E.+Kieferauthor=K.+F.+Kishauthor=J.+A.+Newittauthor=M.+McKinnonauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+4-%285-%28cyclopropylcarbamoyl%29-2-methylphenylamino%29-5-methyl-N-propylpyrrolo%5B1%2C2-f%5D%5B1%2C2%2C4%5Dtriazine-6-carboxamide+%28BMS-582949%29%2C+a+clinical+p38%CE%B1+MAP+kinase+inhibitor+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm100540x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm100540x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100540x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25204-%25285-%2528cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methyl-N-propylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carboxamide%2520%2528BMS-582949%2529%252C%2520a%2520clinical%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6629%26epage%3D6639%26doi%3D10.1021%2Fjm100540x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrudhula, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everlof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesenberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carbonyl) (propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a clinical prodrug of p38α MAP kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7775</span><span class="NLM_x">–</span> <span class="NLM_lpage">7784</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00839</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00839" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7775-7784&author=C.+Liuauthor=J.+Linauthor=J.+Hynesauthor=H.+Wuauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=T.+G.+Dharauthor=V.+M.+Vrudhulaauthor=J.+H.+Sunauthor=S.+Chaoauthor=R.+Zhaoauthor=B.+Wangauthor=B.+C.+Chenauthor=G.+Everlofauthor=C.+Gesenbergauthor=H.+Zhangauthor=P.+H.+Maratheauthor=K.+W.+McIntyreauthor=T.+L.+Taylorauthor=K.+Gilloolyauthor=D.+J.+Shusterauthor=M.+McKinnonauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+%28%284-%285-%28Cyclopropylcarbamoyl%29-2-methylphenylamino%29-5-methylpyrrolo%5B1%2C2-f%5D%5B1%2C2%2C4%5Dtriazine-6-carbonyl%29+%28propyl%29carbamoyloxy%29methyl-2-%284-%28phosphonooxy%29phenyl%29acetate+%28BMS-751324%29%2C+a+clinical+prodrug+of+p38%CE%B1+MAP+kinase+inhibitor&doi=10.1021%2Facs.jmedchem.5b00839"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00839%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DVrudhula%26aufirst%3DV.%2BM.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DEverlof%26aufirst%3DG.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520%2528%25284-%25285-%2528Cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carbonyl%2529%2520%2528propyl%2529carbamoyloxy%2529methyl-2-%25284-%2528phosphonooxy%2529phenyl%2529acetate%2520%2528BMS-751324%2529%252C%2520a%2520clinical%2520prodrug%2520of%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7775%26epage%3D7784%26doi%3D10.1021%2Facs.jmedchem.5b00839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iakovleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deppenmeier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radzioch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackshear, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2399</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1128/MCB.26.6.2399-2407.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1128%2FMCB.26.6.2399-2407.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=16508014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2399-2407&author=E.+Hittiauthor=T.+Iakovlevaauthor=M.+Brookauthor=S.+Deppenmeierauthor=A.+D.+Gruberauthor=D.+Radziochauthor=A.+R.+Clarkauthor=P.+J.+Blackshearauthor=A.+Kotlyarovauthor=M.+Gaestel&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+regulates+tumor+necrosis+factor+mRNA+stability+and+translation+mainly+by+altering+tristetraprolin+expression%2C+stability%2C+and+binding+to+adenine%2Furidine-rich+element&doi=10.1128%2FMCB.26.6.2399-2407.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element</span></div><div class="casAuthors">Hitti, Edward; Iakovleva, Tatiana; Brook, Matthew; Deppenmeier, Stefanie; Gruber, Achim D.; Radzioch, Danuta; Clark, Andrew R.; Blackshear, Perry J.; Kotlyarov, Alexey; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2399-2407</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) p38/MAPK-activated protein kinase 2 (MK2) signaling pathway plays an important role in the posttranscriptional regulation of tumor necrosis factor (TNF), which is dependent on the adenine/uridine-rich element (ARE) in the 3' untranslated region of TNF mRNA.  After lipopolysaccharide (LPS) stimulation, MK2-deficient macrophages show a 90% redn. in TNF prodn. compared to the wild type.  Tristetraprolin (TTP), a protein induced by LPS, binds ARE and destabilizes TNF mRNA.  Accordingly, macrophages lacking TTP produce large amts. of TNF.  Here, we generated MK2/TTP double knockout mice and show that, after LPS stimulation, bone marrow-derived macrophages produce TNF mRNA and protein levels comparable to those of TTP knockout cells, indicating that in the regulation of TNF biosynthesis TTP is genetically downstream of MK2.  In addn., we show that MK2 is essential for the stabilization of TTP mRNA, and phosphorylation by MK2 leads to increased TTP protein stability but reduced ARE affinity.  These data suggest that MK2 inhibits the mRNA destabilizing activity of TTP and, in parallel, codegrdn. of TTP together, with the target mRNA resulting in increased cellular levels of TTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4feIpdvtDbVg90H21EOLACvtfcHk0ljVeohdP9aWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygurs%253D&md5=a932366c73c9851e331b017ed2cf73ee</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.6.2399-2407.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.6.2399-2407.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DIakovleva%26aufirst%3DT.%26aulast%3DBrook%26aufirst%3DM.%26aulast%3DDeppenmeier%26aufirst%3DS.%26aulast%3DGruber%26aufirst%3DA.%2BD.%26aulast%3DRadzioch%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DBlackshear%26aufirst%3DP.%2BJ.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520regulates%2520tumor%2520necrosis%2520factor%2520mRNA%2520stability%2520and%2520translation%2520mainly%2520by%2520altering%2520tristetraprolin%2520expression%252C%2520stability%252C%2520and%2520binding%2520to%2520adenine%252Furidine-rich%2520element%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2399%26epage%3D2407%26doi%3D10.1128%2FMCB.26.6.2399-2407.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ronkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedje, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bcp.2010.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1915-1920&author=N.+Ronkinaauthor=M.+B.+Menonauthor=J.+Schwermannauthor=C.+Tiedjeauthor=E.+Hittiauthor=A.+Kotlyarovauthor=M.+Gaestel&title=MAPKAP+kinases+MK2+and+MK3+in+inflammation%3A+complex+regulation+of+TNF+biosynthesis+via+expression+and+phosphorylation+of+tristetraprolin&doi=10.1016%2Fj.bcp.2010.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DRonkina%26aufirst%3DN.%26aulast%3DMenon%26aufirst%3DM.%2BB.%26aulast%3DSchwermann%26aufirst%3DJ.%26aulast%3DTiedje%26aufirst%3DC.%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinases%2520MK2%2520and%2520MK3%2520in%2520inflammation%253A%2520complex%2520regulation%2520of%2520TNF%2520biosynthesis%2520via%2520expression%2520and%2520phosphorylation%2520of%2520tristetraprolin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1915%26epage%3D1920%26doi%3D10.1016%2Fj.bcp.2010.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2015.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Linauthor=S.+Malkaniauthor=M.+Lombardoauthor=L.+Yangauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=J.+J.+Hale&title=Design%2C+synthesis%2C+and+biological+evaluation+of+aminopyrazine+derivatives+as+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2015.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520aminopyrazine%2520derivatives%2520as%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1016%2Fj.bmcl.2015.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rogalla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnsperger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preville, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducasse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieske, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor α by phosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">18947</span><span class="refDoi"> DOI: 10.1074/jbc.274.27.18947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.274.27.18947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10383393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADyaK1MXksVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18947&author=T.+Rogallaauthor=M.+Ehrnspergerauthor=X.+Previlleauthor=A.+Kotlyarovauthor=G.+Lutschauthor=C.+Ducasseauthor=C.+Paulauthor=M.+Wieskeauthor=A.-P.+Arrigoauthor=J.+Buchnerauthor=M.+Gaestel&title=Regulation+of+Hsp27+oligomerization%2C+chaperone+function%2C+and+protective+activity+against+oxidative+stress%2Ftumor+necrosis+factor+%CE%B1+by+phosphorylation&doi=10.1074%2Fjbc.274.27.18947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor α by phosphorylation</span></div><div class="casAuthors">Rogalla, Thorsten; Ehrnsperger, Monika; Preville, Xavier; Kotlyarov, Alexey; Lutsch, Gudrun; Ducasse, Cecile; Paul, Catherine; Wieske, Martin; Arrigo, Andre-Patrick; Buchner, Johannes; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18947-18956</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The small heat shock proteins (sHsps) from human (Hsp27) and mouse (Hsp25) form large oligomers which can act as mol. chaperones in vitro and protect cells from heat shock and oxidative stress when overexpressed.  In addn., mammalian sHsps are rapidly phosphorylated by MAPKAP kinase 2/3 at two or three serine residues in response to various extracellular stresses.  Here we analyze the effect of sHsp phosphorylation on its quaternary structure, chaperone function, and protection against oxidative stress.  We show that in vitro phosphorylation of recombinant sHsp as well as mol. mimicry of Hsp27 phosphorylation lead to a significant decrease of the oligomeric size.  We demonstrate that both phosphorylated sHsps and the triple mutant Hsp27-S15D,S78D,S82D show significantly decreased abilities to act as mol. chaperones suppressing thermal denaturation and facilitating refolding of citrate synthase in vitro.  In parallel, Hsp27 and its mutants were analyzed for their ability to confer resistance against oxidative stress when overexpressed in L929 and 13.S.1.24 cells.  While wild type Hsp27 confers resistance, the triple mutant S15D,S78D,S82D cannot protect against oxidative stress effectively.  These data indicate that large oligomers of sHsps are necessary for chaperone action and resistance against oxidative stress whereas phosphorylation down-regulates these activities by dissocn. of sHsp complexes to tetramers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqu7XpGFfUrVg90H21EOLACvtfcHk0ljVeohdP9aWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVWlsrY%253D&md5=482a8e582b95984ba46724882cbffc13</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.27.18947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.27.18947%26sid%3Dliteratum%253Aachs%26aulast%3DRogalla%26aufirst%3DT.%26aulast%3DEhrnsperger%26aufirst%3DM.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DLutsch%26aufirst%3DG.%26aulast%3DDucasse%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DWieske%26aufirst%3DM.%26aulast%3DArrigo%26aufirst%3DA.-P.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520Hsp27%2520oligomerization%252C%2520chaperone%2520function%252C%2520and%2520protective%2520activity%2520against%2520oxidative%2520stress%252Ftumor%2520necrosis%2520factor%2520%25CE%25B1%2520by%2520phosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18947%26doi%3D10.1074%2Fjbc.274.27.18947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit14"><span><span> </span><span class="NLM_article-title">An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease</span>. ClinicalTrials.go; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT01867762" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01867762</a> (accessed October 19, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Effectiveness+and+Safety+Study+of+Inhaled+JNJ+49095397+%28RV568%29+in+Patients+With+Moderate+to+Severe+Chronic+Obstructive+Pulmonary+Disease.+ClinicalTrials.go%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2013%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01867762+%28accessed+October+19%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Effectiveness%2520and%2520Safety%2520Study%2520of%2520Inhaled%2520JNJ%252049095397%2520%2528RV568%2529%2520in%2520Patients%2520With%2520Moderate%2520to%2520Severe%2520Chronic%2520Obstructive%2520Pulmonary%2520Disease%26jtitle%3DClinicalTrials.go%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Cumming, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edfeldt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evertsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, S. L.</span><span> </span><span class="NLM_article-title">Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1021/jm501038s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501038s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=278-293&author=J.+G.+Cummingauthor=J.+E.+Debreczeniauthor=F.+Edfeldtauthor=F.+Evertssonauthor=M.+Harrisonauthor=G.+A.+Holdgateauthor=M.+J.+Jamesauthor=S.+G.+Lamontauthor=K.+Oldhamauthor=J.+E.+Sullivanauthor=S.+L.+Wells&title=Discovery+and+characterization+of+MAPK-activated+protein+kinase-2+prevention+of+activation+inhibitors&doi=10.1021%2Fjm501038s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm501038s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501038s%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DEdfeldt%26aufirst%3DF.%26aulast%3DEvertsson%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DM.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DOldham%26aufirst%3DK.%26aulast%3DSullivan%26aufirst%3DJ.%2BE.%26aulast%3DWells%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520MAPK-activated%2520protein%2520kinase-2%2520prevention%2520of%2520activation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D278%26epage%3D293%26doi%3D10.1021%2Fjm501038s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref2':['cit2'],'ref6':['cit6'],'ref13':['cit13'],'ref1':['cit1'],'ref17':['cit17'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref25':['cit25'],'ref24':['cit24'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref85':['cit85'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref70':['cit70'],'ref71':['cit71'],'ref43':['cit43'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref15':['cit15'],'ref16':['cit16'],'ref69':['cit69'],'ref18':['cit18'],'ref14':['cit14'],'ref101':['cit101']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juraj Velcicky, Achim Schlapbach, Richard Heng, Laszlo Revesz, Daniel Pflieger, Ernst Blum, Stuart Hawtin, Christine Huppertz, Roland Feifel, <span class="NLM_string-name hlFld-ContribAuthor">Rene Hersperger</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (4)
                                     , 392-396. <a href="https://doi.org/10.1021/acsmedchemlett.8b00098" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00098%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModulating%252BADME%252BProperties%252Bby%252BFluorination%25253A%252BMK2%252BInhibitors%252Bwith%252BImproved%252BOral%252BExposure%26aulast%3DVelcicky%26aufirst%3DJuraj%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28022018%26date%3D16032018%26date%3D20032018%26volume%3D9%26issue%3D4%26spage%3D392%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lale  Ozcan</span>, <span class="hlFld-ContribAuthor ">Canan  Kasikara</span>, <span class="hlFld-ContribAuthor ">Arif  Yurdagul</span>, <span class="hlFld-ContribAuthor ">George  Kuriakose</span>, <span class="hlFld-ContribAuthor ">Brian  Hubbard</span>, <span class="hlFld-ContribAuthor ">Michael H.  Serrano-Wu</span>, <span class="hlFld-ContribAuthor ">Ira  Tabas</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , e0246600. <a href="https://doi.org/10.1371/journal.pone.0246600" title="DOI URL">https://doi.org/10.1371/journal.pone.0246600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0246600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0246600%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DAllosteric%252BMAPKAPK2%252Binhibitors%252Bimprove%252Bplaque%252Bstability%252Bin%252Badvanced%252Batherosclerosis%26aulast%3DOzcan%26aufirst%3DLale%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D5%26spage%3De0246600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ismail S.  Mohiuddin</span>, <span class="hlFld-ContribAuthor ">Sung‐Jen  Wei</span>, <span class="hlFld-ContribAuthor ">In‐Hyoung  Yang</span>, <span class="hlFld-ContribAuthor ">Gloria M.  Martinez</span>, <span class="hlFld-ContribAuthor ">Shengping  Yang</span>, <span class="hlFld-ContribAuthor ">Eun J.  Cho</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dalby</span>, <span class="hlFld-ContribAuthor ">Min H.  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of cell‐based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA‐PKcs and OCT4–MK2 interactions. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology and Bioengineering</span><span> <strong>2021,</strong> <em>118 </em>
                                    (5)
                                     , 1987-2000. <a href="https://doi.org/10.1002/bit.27712" title="DOI URL">https://doi.org/10.1002/bit.27712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bit.27712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbit.27712%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520and%2520Bioengineering%26atitle%3DDevelopment%252Bof%252Bcell%2525E2%252580%252590based%252Bhigh%252Bthroughput%252Bluminescence%252Bassay%252Bfor%252Bdrug%252Bdiscovery%252Bin%252Binhibiting%252BOCT4%25252FDNA%2525E2%252580%252590PKcs%252Band%252BOCT4%2525E2%252580%252593MK2%252Binteractions%26aulast%3DMohiuddin%26aufirst%3DIsmail%2BS.%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D5%26spage%3D1987%26epage%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samdani  Ansar</span>, <span class="hlFld-ContribAuthor ">Umashankar  Vetrivel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of small molecule and peptide inhibitors for selective targeting of ROCK1: an integrative computational approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>10 </em>, 1-19. <a href="https://doi.org/10.1080/07391102.2021.1898470" title="DOI URL">https://doi.org/10.1080/07391102.2021.1898470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1898470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1898470%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bdesign%252Bof%252Bsmall%252Bmolecule%252Band%252Bpeptide%252Binhibitors%252Bfor%252Bselective%252Btargeting%252Bof%252BROCK1%25253A%252Ban%252Bintegrative%252Bcomputational%252Bapproach%26aulast%3DAnsar%26aufirst%3DSamdani%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu  Ruiz</span>, <span class="hlFld-ContribAuthor ">Maya  Khairallah</span>, <span class="hlFld-ContribAuthor ">Dharmendra  Dingar</span>, <span class="hlFld-ContribAuthor ">George  Vaniotis</span>, <span class="hlFld-ContribAuthor ">Ramzi J.  Khairallah</span>, <span class="hlFld-ContribAuthor ">Benjamin  Lauzier</span>, <span class="hlFld-ContribAuthor ">Simon  Thibault</span>, <span class="hlFld-ContribAuthor ">Joëlle  Trépanier</span>, <span class="hlFld-ContribAuthor ">Yanfen  Shi</span>, <span class="hlFld-ContribAuthor ">Annie  Douillette</span>, <span class="hlFld-ContribAuthor ">Bahira  Hussein</span>, <span class="hlFld-ContribAuthor ">Sherin Ali  Nawaito</span>, <span class="hlFld-ContribAuthor ">Pramod  Sahadevan</span>, <span class="hlFld-ContribAuthor ">Albert  Nguyen</span>, <span class="hlFld-ContribAuthor ">Fatiha  Sahmi</span>, <span class="hlFld-ContribAuthor ">Marc‐Antoine  Gillis</span>, <span class="hlFld-ContribAuthor ">Martin G.  Sirois</span>, <span class="hlFld-ContribAuthor ">Matthias  Gaestel</span>, <span class="hlFld-ContribAuthor ">William C.  Stanley</span>, <span class="hlFld-ContribAuthor ">Céline  Fiset</span>, <span class="hlFld-ContribAuthor ">Jean‐Claude  Tardif</span>, <span class="hlFld-ContribAuthor ">Bruce G.  Allen</span>. </span><span class="cited-content_cbyCitation_article-title">MK2‐Deficient Mice Are Bradycardic and Display Delayed Hypertrophic Remodeling in Response to a Chronic Increase in Afterload. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Heart Association</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     <a href="https://doi.org/10.1161/JAHA.120.017791" title="DOI URL">https://doi.org/10.1161/JAHA.120.017791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/JAHA.120.017791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FJAHA.120.017791%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Heart%2520Association%26atitle%3DMK2%2525E2%252580%252590Deficient%252BMice%252BAre%252BBradycardic%252Band%252BDisplay%252BDelayed%252BHypertrophic%252BRemodeling%252Bin%252BResponse%252Bto%252Ba%252BChronic%252BIncrease%252Bin%252BAfterload%26aulast%3DRuiz%26aufirst%3DMatthieu%26date%3D2021%26volume%3D10%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhi  Bai</span>, <span class="hlFld-ContribAuthor ">Ting  He</span>, <span class="hlFld-ContribAuthor ">Mingchuan  Liu</span>, <span class="hlFld-ContribAuthor ">Lincheng  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Chen  Yang</span>, <span class="hlFld-ContribAuthor ">Wenbin  Jia</span>, <span class="hlFld-ContribAuthor ">Ke  Tao</span>, <span class="hlFld-ContribAuthor ">Juntao  Han</span>, <span class="hlFld-ContribAuthor ">Dahai  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Integrative Analysis of MicroRNAs and mRNAs in LPS-Induced Macrophage Inflammation Based on Adipose Tissue Stem Cell Therapy. </span><span class="cited-content_cbyCitation_journal-name">Inflammation</span><span> <strong>2021,</strong> <em>44 </em>
                                    (1)
                                     , 407-420. <a href="https://doi.org/10.1007/s10753-020-01345-3" title="DOI URL">https://doi.org/10.1007/s10753-020-01345-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10753-020-01345-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10753-020-01345-3%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammation%26atitle%3DIntegrative%252BAnalysis%252Bof%252BMicroRNAs%252Band%252BmRNAs%252Bin%252BLPS-Induced%252BMacrophage%252BInflammation%252BBased%252Bon%252BAdipose%252BTissue%252BStem%252BCell%252BTherapy%26aulast%3DBai%26aufirst%3DXiaozhi%26date%3D2021%26date%3D2020%26volume%3D44%26issue%3D1%26spage%3D407%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria C.  Rezcallah</span>, <span class="hlFld-ContribAuthor ">Trisha  Al-mazi</span>, <span class="hlFld-ContribAuthor ">Alaina J.  Ammit</span>. </span><span class="cited-content_cbyCitation_article-title">Cataloguing the phosphorylation sites of tristetraprolin (TTP): Functional implications for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2021,</strong> <em>78 </em>, 109868. <a href="https://doi.org/10.1016/j.cellsig.2020.109868" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109868%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DCataloguing%252Bthe%252Bphosphorylation%252Bsites%252Bof%252Btristetraprolin%252B%252528TTP%252529%25253A%252BFunctional%252Bimplications%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DRezcallah%26aufirst%3DMaria%2BC.%26date%3D2021%26volume%3D78%26spage%3D109868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivar S.  Stein</span>, <span class="hlFld-ContribAuthor ">Deborah K.  Park</span>, <span class="hlFld-ContribAuthor ">Nicole  Claiborne</span>, <span class="hlFld-ContribAuthor ">Karen  Zito</span>. </span><span class="cited-content_cbyCitation_article-title">Non-ionotropic NMDA receptor signaling gates bidirectional structural plasticity of dendritic spines. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2021,</strong> <em>34 </em>
                                    (4)
                                     , 108664. <a href="https://doi.org/10.1016/j.celrep.2020.108664" title="DOI URL">https://doi.org/10.1016/j.celrep.2020.108664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2020.108664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2020.108664%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DNon-ionotropic%252BNMDA%252Breceptor%252Bsignaling%252Bgates%252Bbidirectional%252Bstructural%252Bplasticity%252Bof%252Bdendritic%252Bspines%26aulast%3DStein%26aufirst%3DIvar%2BS.%26date%3D2021%26volume%3D34%26issue%3D4%26spage%3D108664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Gordon</span>, <span class="hlFld-ContribAuthor ">Edward T  Hellriegel</span>, <span class="hlFld-ContribAuthor ">Heidi Rath  Hope</span>, <span class="hlFld-ContribAuthor ">David  Burt</span>, <span class="hlFld-ContribAuthor ">Joseph B  Monahan</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology: Advances and Applications</span><span> <strong>2021,</strong> <em>Volume 13 </em>, 123-134. <a href="https://doi.org/10.2147/CPAA.S305308" title="DOI URL">https://doi.org/10.2147/CPAA.S305308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/CPAA.S305308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FCPAA.S305308%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%253A%2520Advances%2520and%2520Applications%26atitle%3DSafety%25252C%252BTolerability%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamics%252Bof%252Bthe%252BMK2%252BInhibitor%252BATI-450%252Bin%252BHealthy%252BSubjects%25253A%252BA%252BPlacebo-Controlled%25252C%252BRandomized%252BPhase%252B1%252BStudy%26aulast%3DGordon%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3DVolume%252013%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Petzelbauer</span>. </span><span class="cited-content_cbyCitation_article-title">Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8344. <a href="https://doi.org/10.3390/ijms21218344" title="DOI URL">https://doi.org/10.3390/ijms21218344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218344%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPrevention%252Bof%252BMelanoma%252BExtravasation%252Bas%252Ba%252BNew%252BTreatment%252BOption%252BExemplified%252Bby%252Bp38%25252FMK2%252BInhibition%26aulast%3DPetzelbauer%26aufirst%3DPeter%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sung-Jen  Wei</span>, <span class="hlFld-ContribAuthor ">Thinh H.  Nguyen</span>, <span class="hlFld-ContribAuthor ">In-Hyoung  Yang</span>, <span class="hlFld-ContribAuthor ">Dustin G.  Mook</span>, <span class="hlFld-ContribAuthor ">Monish Ram  Makena</span>, <span class="hlFld-ContribAuthor ">Dattesh  Verlekar</span>, <span class="hlFld-ContribAuthor ">Ashly  Hindle</span>, <span class="hlFld-ContribAuthor ">Gloria M.  Martinez</span>, <span class="hlFld-ContribAuthor ">Shengping  Yang</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Shimada</span>, <span class="hlFld-ContribAuthor ">C. Patrick  Reynolds</span>, <span class="hlFld-ContribAuthor ">Min H.  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     <a href="https://doi.org/10.1038/s41419-020-2563-4" title="DOI URL">https://doi.org/10.1038/s41419-020-2563-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-020-2563-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-020-2563-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DMYC%252Btranscription%252Bactivation%252Bmediated%252Bby%252BOCT4%252Bas%252Ba%252Bmechanism%252Bof%252Bresistance%252Bto%252B13-cisRA-mediated%252Bdifferentiation%252Bin%252Bneuroblastoma%26aulast%3DWei%26aufirst%3DSung-Jen%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenning  Li</span>, <span class="hlFld-ContribAuthor ">Fa-yu  Liu</span>, <span class="hlFld-ContribAuthor ">Keith L.  Kirkwood</span>. </span><span class="cited-content_cbyCitation_article-title">The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages. </span><span class="cited-content_cbyCitation_journal-name">Oral Oncology</span><span> <strong>2020,</strong> <em>103 </em>, 104591. <a href="https://doi.org/10.1016/j.oraloncology.2020.104591" title="DOI URL">https://doi.org/10.1016/j.oraloncology.2020.104591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.oraloncology.2020.104591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.oraloncology.2020.104591%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Oncology%26atitle%3DThe%252Bp38%25252FMKP-1%252Bsignaling%252Baxis%252Bin%252Boral%252Bcancer%25253A%252BImpact%252Bof%252Btumor-associated%252Bmacrophages%26aulast%3DLi%26aufirst%3DZhenning%26date%3D2020%26volume%3D103%26spage%3D104591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judith  Wenzina</span>, <span class="hlFld-ContribAuthor ">Silvio  Holzner</span>, <span class="hlFld-ContribAuthor ">Emmi  Puujalka</span>, <span class="hlFld-ContribAuthor ">Phil F.  Cheng</span>, <span class="hlFld-ContribAuthor ">Agnes  Forsthuber</span>, <span class="hlFld-ContribAuthor ">Karin  Neumüller</span>, <span class="hlFld-ContribAuthor ">Klaudia  Schossleitner</span>, <span class="hlFld-ContribAuthor ">Beate M.  Lichtenberger</span>, <span class="hlFld-ContribAuthor ">Mitchell P.  Levesque</span>, <span class="hlFld-ContribAuthor ">Peter  Petzelbauer</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2020,</strong> <em>140 </em>
                                    (4)
                                     , 878-890.e5. <a href="https://doi.org/10.1016/j.jid.2019.08.451" title="DOI URL">https://doi.org/10.1016/j.jid.2019.08.451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jid.2019.08.451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jid.2019.08.451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DInhibition%252Bof%252Bp38%25252FMK2%252BSignaling%252BPrevents%252BVascular%252BInvasion%252Bof%252BMelanoma%26aulast%3DWenzina%26aufirst%3DJudith%26date%3D2020%26volume%3D140%26issue%3D4%26spage%3D878%26epage%3D890.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela Carmen  Oniciu</span>. </span><span class="cited-content_cbyCitation_article-title">Eight-membered Rings With One Nitrogen. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00011-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00011-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00011-1%26sid%3Dliteratum%253Aachs%26atitle%3DEight-membered%252BRings%252BWith%252BOne%252BNitrogen%26aulast%3DOniciu%26aufirst%3DDaniela%2BCarmen%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourabh  Soni</span>, <span class="hlFld-ContribAuthor ">Prince  Anand</span>, <span class="hlFld-ContribAuthor ">Yogendra S.  Padwad</span>. </span><span class="cited-content_cbyCitation_article-title">MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1115-1" title="DOI URL">https://doi.org/10.1186/s13046-019-1115-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1115-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1115-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DMAPKAPK2%25253A%252Bthe%252Bmaster%252Bregulator%252Bof%252BRNA-binding%252Bproteins%252Bmodulates%252Btranscript%252Bstability%252Band%252Btumor%252Bprogression%26aulast%3DSoni%26aufirst%3DSourabh%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourabh  Soni</span>, <span class="hlFld-ContribAuthor ">Munish Kumar  Saroch</span>, <span class="hlFld-ContribAuthor ">Bal  Chander</span>, <span class="hlFld-ContribAuthor ">Narendra Vijay  Tirpude</span>, <span class="hlFld-ContribAuthor ">Yogendra S.  Padwad</span>. </span><span class="cited-content_cbyCitation_article-title">MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1167-2" title="DOI URL">https://doi.org/10.1186/s13046-019-1167-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1167-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1167-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DMAPKAPK2%252Bplays%252Ba%252Bcrucial%252Brole%252Bin%252Bthe%252Bprogression%252Bof%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%252Bby%252Bregulating%252Btranscript%252Bstability%26aulast%3DSoni%26aufirst%3DSourabh%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulf  Hedström</span>, <span class="hlFld-ContribAuthor ">Monica  Norberg</span>, <span class="hlFld-ContribAuthor ">Emma  Evertsson</span>, <span class="hlFld-ContribAuthor ">Sarah R.  Lever</span>, <span class="hlFld-ContribAuthor ">Magnus  Munck af Rosenschöld</span>, <span class="hlFld-ContribAuthor ">Hans  Lönn</span>, <span class="hlFld-ContribAuthor ">Peter  Bold</span>, <span class="hlFld-ContribAuthor ">Helena  Käck</span>, <span class="hlFld-ContribAuthor ">Pia  Berntsson</span>, <span class="hlFld-ContribAuthor ">Johanna  Vinblad</span>, <span class="hlFld-ContribAuthor ">Jianming  Liu</span>, <span class="hlFld-ContribAuthor ">Anette  Welinder</span>, <span class="hlFld-ContribAuthor ">Johan  Karlsson</span>, <span class="hlFld-ContribAuthor ">Arjan  Snijder</span>, <span class="hlFld-ContribAuthor ">Katerina  Pardali</span>, <span class="hlFld-ContribAuthor ">Ulf  Andersson</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Davis</span>, <span class="hlFld-ContribAuthor ">Mickael  Mogemark</span>. </span><span class="cited-content_cbyCitation_article-title">An Angle on MK2 Inhibition—Optimization and Evaluation of Prevention of Activation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (19)
                                     , 1701-1709. <a href="https://doi.org/10.1002/cmdc.201900303" title="DOI URL">https://doi.org/10.1002/cmdc.201900303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900303%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAn%252BAngle%252Bon%252BMK2%252BInhibition%2525E2%252580%252594Optimization%252Band%252BEvaluation%252Bof%252BPrevention%252Bof%252BActivation%252BInhibitors%26aulast%3DHedstr%25C3%25B6m%26aufirst%3DUlf%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D19%26spage%3D1701%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengjie  Guo</span>, <span class="hlFld-ContribAuthor ">Dongdong  Sun</span>, <span class="hlFld-ContribAuthor ">Zhimin  Fan</span>, <span class="hlFld-ContribAuthor ">Yuxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Miaomiao  Shao</span>, <span class="hlFld-ContribAuthor ">Jianhao  Hou</span>, <span class="hlFld-ContribAuthor ">Yuqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Rongfang  Wei</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjun  Qian</span>, <span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Ye  Yang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fonc.2019.00722" title="DOI URL">https://doi.org/10.3389/fonc.2019.00722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2019.00722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2019.00722%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252BMK2%252BIs%252Ba%252BNovel%252BApproach%252Bto%252BInterfere%252Bin%252BMultiple%252BMyeloma%26aulast%3DGuo%26aufirst%3DMengjie%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Duan</span>, <span class="hlFld-ContribAuthor ">Xue  Yang</span>, <span class="hlFld-ContribAuthor ">Changfeng  Li</span>, <span class="hlFld-ContribAuthor ">Lihua  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Water-Soluble Methotrexate-Polyethyleneglycol-Rhodamine Prodrug Micelle for High Tumor Inhibition Activity. </span><span class="cited-content_cbyCitation_journal-name">AAPS PharmSciTech</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     <a href="https://doi.org/10.1208/s12249-019-1462-4" title="DOI URL">https://doi.org/10.1208/s12249-019-1462-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12249-019-1462-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12249-019-1462-4%26sid%3Dliteratum%253Aachs%26jtitle%3DAAPS%2520PharmSciTech%26atitle%3DHighly%252BWater-Soluble%252BMethotrexate-Polyethyleneglycol-Rhodamine%252BProdrug%252BMicelle%252Bfor%252BHigh%252BTumor%252BInhibition%252BActivity%26aulast%3DDuan%26aufirst%3DXiao%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kateřina  Štefková</span>, <span class="hlFld-ContribAuthor ">Markéta  Hanáčková</span>, <span class="hlFld-ContribAuthor ">Jan  Kučera</span>, <span class="hlFld-ContribAuthor ">Katarzyna Anna  Radaszkiewicz</span>, <span class="hlFld-ContribAuthor ">Barbora  Ambrůžová</span>, <span class="hlFld-ContribAuthor ">Lukáš  Kubala</span>, <span class="hlFld-ContribAuthor ">Jiří  Pacherník</span>. </span><span class="cited-content_cbyCitation_article-title">MAPK p38alpha Kinase Influences Haematopoiesis in Embryonic Stem Cells. </span><span class="cited-content_cbyCitation_journal-name">Stem Cells International</span><span> <strong>2019,</strong> <em>2019 </em>, 1-16. <a href="https://doi.org/10.1155/2019/5128135" title="DOI URL">https://doi.org/10.1155/2019/5128135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/5128135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F5128135%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cells%2520International%26atitle%3DMAPK%252Bp38alpha%252BKinase%252BInfluences%252BHaematopoiesis%252Bin%252BEmbryonic%252BStem%252BCells%26aulast%3D%25C5%25A0tefkov%25C3%25A1%26aufirst%3DKate%25C5%2599ina%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rakesh Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Abul Kalam  Najmi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (4)
                                     , 367-379. <a href="https://doi.org/10.2174/1389450119666180816121323" title="DOI URL">https://doi.org/10.2174/1389450119666180816121323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450119666180816121323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450119666180816121323%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DNovel%252BTherapeutic%252BPotential%252Bof%252BMitogen-Activated%252BProtein%252BKinase%252BActivated%252BProtein%252BKinase%252B2%252B%252528MK2%252529%252Bin%252BChronic%252BAirway%252BInflammatory%252BDisorders%26aulast%3DSingh%26aufirst%3DRakesh%2BKumar%26date%3D2019%26volume%3D20%26issue%3D4%26spage%3D367%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kranthi Kumar  Konidala</span>, <span class="hlFld-ContribAuthor ">Uma Devi  Bommu</span>, <span class="hlFld-ContribAuthor ">Suneetha  Yeguvapalli</span>, <span class="hlFld-ContribAuthor ">Neeraja  Pabbaraju</span>. </span><span class="cited-content_cbyCitation_article-title">In silico insights into prediction and analysis of potential novel pyrrolopyridine analogs against human MAPKAPK-2: a new SAR-based hierarchical clustering approach. </span><span class="cited-content_cbyCitation_journal-name">3 Biotech</span><span> <strong>2018,</strong> <em>8 </em>
                                    (9)
                                     <a href="https://doi.org/10.1007/s13205-018-1405-x" title="DOI URL">https://doi.org/10.1007/s13205-018-1405-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13205-018-1405-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13205-018-1405-x%26sid%3Dliteratum%253Aachs%26jtitle%3D3%2520Biotech%26atitle%3DIn%252Bsilico%252Binsights%252Binto%252Bprediction%252Band%2525C2%2525A0analysis%252Bof%252Bpotential%2525C2%2525A0novel%252Bpyrrolopyridine%252Banalogs%252Bagainst%252Bhuman%252BMAPKAPK-2%25253A%252Ba%252Bnew%252BSAR-based%252Bhierarchical%252Bclustering%252Bapproach%26aulast%3DKonidala%26aufirst%3DKranthi%2BKumar%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaxian  Wu</span>, <span class="hlFld-ContribAuthor ">Huiqiong  He</span>, <span class="hlFld-ContribAuthor ">Yunhe  Ding</span>, <span class="hlFld-ContribAuthor ">Sirui  Liu</span>, <span class="hlFld-ContribAuthor ">Depeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Hongchao  Jiang</span>, <span class="hlFld-ContribAuthor ">Dan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lei  Sun</span>, <span class="hlFld-ContribAuthor ">Richard D.  Ye</span>, <span class="hlFld-ContribAuthor ">Feng  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">MK2 mediates macrophage activation and acute lung injury by regulating
              let-7e
              miRNA. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Lung Cellular and Molecular Physiology</span><span> <strong>2018,</strong> <em>315 </em>
                                    (3)
                                     , L371-L381. <a href="https://doi.org/10.1152/ajplung.00019.2018" title="DOI URL">https://doi.org/10.1152/ajplung.00019.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajplung.00019.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajplung.00019.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Lung%2520Cellular%2520and%2520Molecular%2520Physiology%26atitle%3DMK2%252Bmediates%252Bmacrophage%252Bactivation%252Band%252Bacute%252Blung%252Binjury%252Bby%252Bregulating%252Blet-7e%252BmiRNA%26aulast%3DWu%26aufirst%3DYaxian%26date%3D2018%26volume%3D315%26issue%3D3%26spage%3DL371%26epage%3DL381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yizhu  Li</span>, <span class="hlFld-ContribAuthor ">Frederik  Köpper</span>, <span class="hlFld-ContribAuthor ">Matthias  Dobbelstein</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2018,</strong> <em>428 </em>, 45-54. <a href="https://doi.org/10.1016/j.canlet.2018.04.030" title="DOI URL">https://doi.org/10.1016/j.canlet.2018.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2018.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2018.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DInhibition%252Bof%252BMAPKAPK2%25252FMK2%252Bfacilitates%252BDNA%252Breplication%252Bupon%252Bcancer%252Bcell%252Btreatment%252Bwith%252Bgemcitabine%252Bbut%252Bnot%252Bcisplatin%26aulast%3DLi%26aufirst%3DYizhu%26date%3D2018%26volume%3D428%26spage%3D45%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Depeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaozong  Li</span>, <span class="hlFld-ContribAuthor ">Yudong  Hu</span>, <span class="hlFld-ContribAuthor ">Hongchao  Jiang</span>, <span class="hlFld-ContribAuthor ">Yaxian  Wu</span>, <span class="hlFld-ContribAuthor ">Yunhe  Ding</span>, <span class="hlFld-ContribAuthor ">Kaikai  Yu</span>, <span class="hlFld-ContribAuthor ">Huiqiong  He</span>, <span class="hlFld-ContribAuthor ">Jingsong  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Sun</span>, <span class="hlFld-ContribAuthor ">Feng  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>154 </em>, 183-192. <a href="https://doi.org/10.1016/j.bcp.2018.05.004" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DTabersonine%252Battenuates%252Blipopolysaccharide-induced%252Bacute%252Blung%252Binjury%252Bvia%252Bsuppressing%252BTRAF6%252Bubiquitination%26aulast%3DZhang%26aufirst%3DDepeng%26date%3D2018%26volume%3D154%26spage%3D183%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew S.  Eapen</span>, <span class="hlFld-ContribAuthor ">Anudeep  Kota</span>, <span class="hlFld-ContribAuthor ">Howard  Vindin</span>, <span class="hlFld-ContribAuthor ">Kielan D.  McAlinden</span>, <span class="hlFld-ContribAuthor ">Dia  Xenaki</span>, <span class="hlFld-ContribAuthor ">Brian G.  Oliver</span>, <span class="hlFld-ContribAuthor ">Deepak A.  Deshpande</span>, <span class="hlFld-ContribAuthor ">Sukhwinder Singh  Sohal</span>, <span class="hlFld-ContribAuthor ">Pawan  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2018,</strong> <em>132 </em>
                                    (14)
                                     , 1615-1627. <a href="https://doi.org/10.1042/CS20180398" title="DOI URL">https://doi.org/10.1042/CS20180398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20180398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20180398%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DApoptosis%252Bsignal-regulating%252Bkinase%252B1%252Binhibition%252Battenuates%252Bhuman%252Bairway%252Bsmooth%252Bmuscle%252Bgrowth%252Band%252Bmigration%252Bin%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DEapen%26aufirst%3DMathew%25C2%25A0S.%26date%3D2018%26date%3D2018%26volume%3D132%26issue%3D14%26spage%3D1615%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Wenlong  Pei</span>, <span class="hlFld-ContribAuthor ">Mixue  Yang</span>, <span class="hlFld-ContribAuthor ">Yidan  Wu</span>, <span class="hlFld-ContribAuthor ">Danyang  Ma</span>, <span class="hlFld-ContribAuthor ">Furong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianhui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective cleavage of the N-propargyl group from sulfonamides and amides under ruthenium catalysis. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (20)
                                     , 1902-1905. <a href="https://doi.org/10.1016/j.tetlet.2018.03.046" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.03.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.03.046%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Bcleavage%252Bof%252Bthe%252BN-propargyl%252Bgroup%252Bfrom%252Bsulfonamides%252Band%252Bamides%252Bunder%252Bruthenium%252Bcatalysis%26aulast%3DWang%26aufirst%3DJingjing%26date%3D2018%26volume%3D59%26issue%3D20%26spage%3D1902%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fleur M.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors: the road ahead. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (5)
                                     , 353-377. <a href="https://doi.org/10.1038/nrd.2018.21" title="DOI URL">https://doi.org/10.1038/nrd.2018.21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2018.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2018.21%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DKinase%252Binhibitors%25253A%252Bthe%252Broad%252Bahead%26aulast%3DFerguson%26aufirst%3DFleur%2BM.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D5%26spage%3D353%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RK  Singh</span>, <span class="hlFld-ContribAuthor ">M  Diwan</span>, <span class="hlFld-ContribAuthor ">SG  Dastidar</span>, <span class="hlFld-ContribAuthor ">AK  Najmi</span>. </span><span class="cited-content_cbyCitation_article-title">Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro. </span><span class="cited-content_cbyCitation_journal-name">Human & Experimental Toxicology</span><span> <strong>2018,</strong> <em>37 </em>
                                    (5)
                                     , 521-531. <a href="https://doi.org/10.1177/0960327117715901" title="DOI URL">https://doi.org/10.1177/0960327117715901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0960327117715901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0960327117715901%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520%2526%2520Experimental%2520Toxicology%26atitle%3DDifferential%252Beffect%252Bof%252Bp38%252Band%252BMK2%252Bkinase%252Binhibitors%252Bon%252Bthe%252Binflammatory%252Band%252Btoxicity%252Bbiomarkers%252Bin%252Bvitro%26aulast%3DSingh%26aufirst%3DRK%26date%3D2018%26date%3D2017%26volume%3D37%26issue%3D5%26spage%3D521%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojing  Nie</span>, <span class="hlFld-ContribAuthor ">Melinda A.  Chanley</span>, <span class="hlFld-ContribAuthor ">Ruma  Pengal</span>, <span class="hlFld-ContribAuthor ">David B.  Thomas</span>, <span class="hlFld-ContribAuthor ">Shipra  Agrawal</span>, <span class="hlFld-ContribAuthor ">William E.  Smoyer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Renal Physiology</span><span> <strong>2018,</strong> <em>314 </em>
                                    (4)
                                     , F602-F613. <a href="https://doi.org/10.1152/ajprenal.00207.2017" title="DOI URL">https://doi.org/10.1152/ajprenal.00207.2017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajprenal.00207.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajprenal.00207.2017%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Renal%2520Physiology%26atitle%3DPharmacological%252Band%252Bgenetic%252Binhibition%252Bof%252Bdownstream%252Btargets%252Bof%252Bp38%252BMAPK%252Bin%252Bexperimental%252Bnephrotic%252Bsyndrome%26aulast%3DNie%26aufirst%3DXiaojing%26date%3D2018%26volume%3D314%26issue%3D4%26spage%3DF602%26epage%3DF613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Xue</span>, <span class="hlFld-ContribAuthor ">Zhijun  Wu</span>, <span class="hlFld-ContribAuthor ">Jinyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">FPHPB inhibits gastric tumor cell proliferation by inducing G2-M cell cycle arrest. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>98 </em>, 694-700. <a href="https://doi.org/10.1016/j.biopha.2017.12.106" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.12.106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.12.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.12.106%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DFPHPB%252Binhibits%252Bgastric%252Btumor%252Bcell%252Bproliferation%252Bby%252Binducing%252BG2-M%252Bcell%252Bcycle%252Barrest%26aulast%3DXue%26aufirst%3DLei%26date%3D2018%26volume%3D98%26spage%3D694%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yulia B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XVI, 2016. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 173-254. <a href="https://doi.org/10.1016/bs.aihch.2018.02.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.02.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXVI%25252C%252B2016%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2018%26spage%3D173%26epage%3D254%26pub%3DElsevier%26date%3D2018%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-xian  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-qiong  He</span>, <span class="hlFld-ContribAuthor ">Yun-juan  Nie</span>, <span class="hlFld-ContribAuthor ">Yun-he  Ding</span>, <span class="hlFld-ContribAuthor ">Lei  Sun</span>, <span class="hlFld-ContribAuthor ">Feng  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (1)
                                     , 85-96. <a href="https://doi.org/10.1038/aps.2017.131" title="DOI URL">https://doi.org/10.1038/aps.2017.131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.131%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DProtostemonine%252Beffectively%252Battenuates%252Blipopolysaccharide-induced%252Bacute%252Blung%252Binjury%252Bin%252Bmice%26aulast%3DWu%26aufirst%3DYa-xian%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D1%26spage%3D85%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik C.  Dreaden</span>, <span class="hlFld-ContribAuthor ">Yi Wen  Kong</span>, <span class="hlFld-ContribAuthor ">Mohiuddin A.  Quadir</span>, <span class="hlFld-ContribAuthor ">Santiago  Correa</span>, <span class="hlFld-ContribAuthor ">Lucia  Suárez‐López</span>, <span class="hlFld-ContribAuthor ">Antonio E.  Barberio</span>, <span class="hlFld-ContribAuthor ">Mun Kyung  Hwang</span>, <span class="hlFld-ContribAuthor ">Aria C.  Shi</span>, <span class="hlFld-ContribAuthor ">Benjamin  Oberlton</span>, <span class="hlFld-ContribAuthor ">Paige N.  Gallagher</span>, <span class="hlFld-ContribAuthor ">Kevin E.  Shopsowitz</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Elias</span>, <span class="hlFld-ContribAuthor ">Michael B.  Yaffe</span>, <span class="hlFld-ContribAuthor ">Paula T.  Hammond</span>. </span><span class="cited-content_cbyCitation_article-title">RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors. </span><span class="cited-content_cbyCitation_journal-name">Bioengineering & Translational Medicine</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     , 26-36. <a href="https://doi.org/10.1002/btm2.10086" title="DOI URL">https://doi.org/10.1002/btm2.10086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/btm2.10086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbtm2.10086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioengineering%2520%2526%2520Translational%2520Medicine%26atitle%3DRNA%2525E2%252580%252590Peptide%252Bnanoplexes%252Bdrug%252BDNA%252Bdamage%252Bpathways%252Bin%252Bhigh%2525E2%252580%252590grade%252Bserous%252Bovarian%252Btumors%26aulast%3DDreaden%26aufirst%3DErik%2BC.%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D1%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghang  Meng</span>, <span class="hlFld-ContribAuthor ">Bidur  Bhandary</span>, <span class="hlFld-ContribAuthor ">Hanna  Osinska</span>, <span class="hlFld-ContribAuthor ">Jeanne  James</span>, <span class="hlFld-ContribAuthor ">Na  Xu</span>, <span class="hlFld-ContribAuthor ">Kritton  Shay‐Winkler</span>, <span class="hlFld-ContribAuthor ">James  Gulick</span>, <span class="hlFld-ContribAuthor ">Monte S.  Willis</span>, <span class="hlFld-ContribAuthor ">Cynthia  Lander</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Robbins</span>. </span><span class="cited-content_cbyCitation_article-title">MMI‐0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein C. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Heart Association</span><span> <strong>2017,</strong> <em>6 </em>
                                    (9)
                                     <a href="https://doi.org/10.1161/JAHA.117.006590" title="DOI URL">https://doi.org/10.1161/JAHA.117.006590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/JAHA.117.006590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FJAHA.117.006590%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Heart%2520Association%26atitle%3DMMI%2525E2%252580%2525900100%252BInhibits%252BCardiac%252BFibrosis%252Bin%252Ba%252BMouse%252BModel%252BOverexpressing%252BCardiac%252BMyosin%252BBinding%252BProtein%252BC%26aulast%3DMeng%26aufirst%3DQinghang%26date%3D2017%26volume%3D6%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rakesh Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Abul Kalam  Najmi</span>, <span class="hlFld-ContribAuthor ">Sunanda Ghosh  Dastidar</span>. </span><span class="cited-content_cbyCitation_article-title">Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2017,</strong> <em>69 </em>
                                    (4)
                                     , 746-756. <a href="https://doi.org/10.1016/j.pharep.2017.03.023" title="DOI URL">https://doi.org/10.1016/j.pharep.2017.03.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharep.2017.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharep.2017.03.023%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DBiological%252Bfunctions%252Band%252Brole%252Bof%252Bmitogen-activated%252Bprotein%252Bkinase%252Bactivated%252Bprotein%252Bkinase%252B2%252B%252528MK2%252529%252Bin%252Binflammatory%252Bdiseases%26aulast%3DSingh%26aufirst%3DRakesh%2BKumar%26date%3D2017%26volume%3D69%26issue%3D4%26spage%3D746%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Tridente</span>. </span><span class="cited-content_cbyCitation_article-title">Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 9-56. <a href="https://doi.org/10.1016/B978-0-12-809400-6.00002-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-809400-6.00002-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809400-6.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809400-6.00002-0%26sid%3Dliteratum%253Aachs%26atitle%3DKinases%26aulast%3DTridente%26aufirst%3DGiuseppe%26date%3D2017%26spage%3D9%26epage%3D56%26pub%3DElsevier%26atitle%3DAdverse%252BEvents%252Band%252BOncotargeted%252BKinase%252BInhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongxiang  Wu</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Cui</span>, <span class="hlFld-ContribAuthor ">Junsheng  Jian</span>, <span class="hlFld-ContribAuthor ">Zhuo  Zeng</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki Coupling of Amides
              via
              Palladium-Catalyzed C-N Cleavage of
              N
              -Acylsaccharins. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (23)
                                     , 3876-3880. <a href="https://doi.org/10.1002/adsc.201600555" title="DOI URL">https://doi.org/10.1002/adsc.201600555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600555%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSuzuki%252BCoupling%252Bof%252BAmides%252Bvia%252BPalladium-Catalyzed%252BC-N%252BCleavage%252Bof%252BN%252B-Acylsaccharins%26aulast%3DWu%26aufirst%3DHongxiang%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D23%26spage%3D3876%26epage%3D3880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doan Duy Hai  Tran</span>, <span class="hlFld-ContribAuthor ">Alexandra  Koch</span>, <span class="hlFld-ContribAuthor ">Aldrige  Allister</span>, <span class="hlFld-ContribAuthor ">Shashank  Saran</span>, <span class="hlFld-ContribAuthor ">Florian  Ewald</span>, <span class="hlFld-ContribAuthor ">Martina  Koch</span>, <span class="hlFld-ContribAuthor ">Björn  Nashan</span>, <span class="hlFld-ContribAuthor ">Teruko  Tamura</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2016,</strong> <em>28 </em>
                                    (12)
                                     , 1872-1880. <a href="https://doi.org/10.1016/j.cellsig.2016.09.002" title="DOI URL">https://doi.org/10.1016/j.cellsig.2016.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2016.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2016.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DTreatment%252Bwith%252BMAPKAP2%252B%252528MK2%252529%252Binhibitor%252Band%252BDNA%252Bmethylation%252Binhibitor%25252C%252B5-aza%252BdC%25252C%252Bsynergistically%252Btriggers%252Bapoptosis%252Bin%252Bhepatocellular%252Bcarcinoma%252B%252528HCC%252529%252Bvia%252Btristetraprolin%252B%252528TTP%252529%26aulast%3DTran%26aufirst%3DDoan%2BDuy%2BHai%26date%3D2016%26volume%3D28%26issue%3D12%26spage%3D1872%26epage%3D1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Barnes</span>, . </span><span class="cited-content_cbyCitation_article-title">Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2016,</strong> <em>68 </em>
                                    (3)
                                     , 788-815. <a href="https://doi.org/10.1124/pr.116.012518" title="DOI URL">https://doi.org/10.1124/pr.116.012518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.116.012518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.116.012518%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DKinases%252Bas%252BNovel%252BTherapeutic%252BTargets%252Bin%252BAsthma%252Band%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DBarnes%26aufirst%3DPeter%2BJ.%26date%3D2016%26date%3D2016%26volume%3D68%26issue%3D3%26spage%3D788%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MK2 structure. A Pro-rich <i>N</i>-terminal region is connected to the kinase catalytic domain that contains two major phosphorylation sites (Thr222 and Ser272). A third phosphorylation site (Thr334) precedes the nuclear export signal (NES, responsible for MK2 translocation from the nucleus to the cytoplasm) and a bipartite nuclear localization signal (NLS, responsible for accumulation of the p38/MK2 complex within the nucleus of resting cells). A <i>C</i>-terminal domain (p38 binding site) guarantees for direct interactions between MK2 and p38.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereographical representation of the major interactions between ADP and the ATP binding site of MK2, as taken from the PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ny3">1ny3</a>. The adenine ring is involved in two hydrogen bonds (represented as black dotted lines) with Glu139 and Leu141. An additional hydrogen bond is found between the pyrophosphate moiety and the charged terminal group of Lys93. Amino acids of the phosphate binding region, the sugar pocket, and the hinge region are shown as well as the gatekeeper Met138.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Benzopyranopyridine derivatives from Pfizer Global Research and Development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hybridization approach to design pyrazolo-pyperazines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aminopyrazinylthiourea from Merck Research Laboratories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/medium/jm-2015-01457h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MK2 inhibitors extracted from marine sponges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01457/20160422/images/large/jm-2015-01457h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01457&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 101 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Moens, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveinbjørnsson, B.</span><span> </span><span class="NLM_article-title">The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation</span> <span class="citation_source-journal">Genes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.3390/genes4020101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.3390%2Fgenes4020101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24705157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=101-133&author=U.+Moensauthor=S.+Kostenkoauthor=B.+Sveinbj%C3%B8rnsson&title=The+role+of+mitogen-activated+protein+kinase-activated+protein+kinases+%28MAPKAPKs%29+in+inflammation&doi=10.3390%2Fgenes4020101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation</span></div><div class="casAuthors">Moens, Ugo; Kostenko, Sergiy; Sveinbjoernsson, Baldur</div><div class="citationInfo"><span class="NLM_cas:title">Genes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-133, 33 pp.</span>CODEN:
                <span class="NLM_cas:coden">GENEG9</span>;
        ISSN:<span class="NLM_cas:issn">2073-4425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase (MAPK) pathways are implicated in several cellular processes including proliferation, differentiation, apoptosis, cell survival, cell motility, metab., stress response and inflammation.  MAPK pathways transmit and convert a plethora of extracellular signals by three consecutive phosphorylation events involving a MAPK kinase kinase, a MAPK kinase and a MAPK.  In turn MAPKs phosphorylate substrates, including other protein kinases referred to as MAPK-activated protein kinases (MAPKAPKs).  Eleven mammalian MAPKAPKs have been identified: ribosomal-S6-kinases (RSK1-4), mitogen- and stress-activated kinases (MSK1-2), MAPK-interacting kinases (MNK1-2), MAPKAPK-2 (MK2), MAPKAPK-3 (MK3) and MAPKAPK-5 (MK5).  The role of these MAPKAPKs in inflammation will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDcxWGp62ckbVg90H21EOLACvtfcHk0ljSaBmF4OBGgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlGrt7s%253D&md5=3166c5885677dcb50f40bcfa4c37fd3b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fgenes4020101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fgenes4020101%26sid%3Dliteratum%253Aachs%26aulast%3DMoens%26aufirst%3DU.%26aulast%3DKostenko%26aufirst%3DS.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinases%2520%2528MAPKAPKs%2529%2520in%2520inflammation%26jtitle%3DGenes%26date%3D2013%26volume%3D4%26spage%3D101%26epage%3D133%26doi%3D10.3390%2Fgenes4020101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span><span class="refDoi"> DOI: 10.1515/hsz-2013-0197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1515%2Fhsz-2013-0197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23832958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2013&pages=1301-1315&author=M.+Gaestel&title=What+goes+up+must+come+down%3A+molecular+basis+of+MAPKAP+kinase+2%2F3-dependent+regulation+of+the+inflammatory+response+and+its+inhibition&doi=10.1515%2Fhsz-2013-0197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition</span></div><div class="casAuthors">Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1301-1315</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Inflammation is normally a fast and transient response to microbial invaders or sterile damage and has to be stringently controlled.  The closely-related mitogen-activated protein kinase-activated protein kinases MK2 and MK3 are involved in both up- and down-regulation of inflammation in mammals and govern the inflammatory response at different regulatory levels of gene expression and with different kinetics.  In conjunction with their activator MAP kinase p38, MK2 and MK3 stimulate the transcription of immediate-early genes including that of the mRNA-binding protein tristetraprolin (TTP).  TTP competes with the constitutively expressed protein human antigen R in binding to the mRNA destabilizing adenylate-uridylate -rich element.  MK2 and MK3 also regulate the activity of TTP by direct phosphorylation, det. stability and stimulate the translation of cytokine mRNAs.  In addn., TTP controls its own re-synthesis via stability and translation of its mRNA in a phosphorylation-dependent manner.  This results in a complex scenario of gene expression and guarantees fast up-regulation and intrinsic feedback control of the inflammatory response of macrophages.  Inhibition of MK2/3 by small-mol. pharmaceutical inhibitors is an emerging strategy to manipulate the inflammatory response as a therapeutic option.  This strategy could display advantages over the direct inhibition of MAP kinase p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkhC-3wPlU7Vg90H21EOLACvtfcHk0ljSaBmF4OBGgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFent7s%253D&md5=76b71ea718a39f3d007aba58e38ce106</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0197%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DWhat%2520goes%2520up%2520must%2520come%2520down%253A%2520molecular%2520basis%2520of%2520MAPKAP%2520kinase%25202%252F3-dependent%2520regulation%2520of%2520the%2520inflammatory%2520response%2520and%2520its%2520inhibition%26jtitle%3DBiol.%2520Chem.%26date%3D2013%26volume%3D394%26spage%3D1301%26epage%3D1315%26doi%3D10.1515%2Fhsz-2013-0197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gurgis, F. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziaziaris, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1124/mol.113.090365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.113.090365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=345-356&author=F.+M.+S.+Gurgisauthor=W.+Ziaziarisauthor=L.+Munoz&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+in+neuroinflammation%2C+heat+shock+protein+27+phosphorylation%2C+and+cell+cycle%3A+role+and+targeting&doi=10.1124%2Fmol.113.090365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.090365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.090365%26sid%3Dliteratum%253Aachs%26aulast%3DGurgis%26aufirst%3DF.%2BM.%2BS.%26aulast%3DZiaziaris%26aufirst%3DW.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520neuroinflammation%252C%2520heat%2520shock%2520protein%252027%2520phosphorylation%252C%2520and%2520cell%2520cycle%253A%2520role%2520and%2520targeting%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D345%26epage%3D356%26doi%3D10.1124%2Fmol.113.090365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Edmunds, J. J.; Talanian, R. V.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 as a target for anti-inflammatory drug discovery</span>. In  <span class="citation_source-book">Anti-Inflammatory Drug Discovery</span>; <span class="NLM_series">RSC Drug Discovery Series No. 26</span>; <span class="NLM_contrib-group">Levi, J. I.; Laufer, S.</span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Chapter 6, pp  <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1039%2F9781849735346-00158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=158-180&author=J.+J.+Edmunds&author=R.+V.+Talanianauthor=J.+I.+Levi&author=S.+Laufer&title=Anti-Inflammatory+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2F9781849735346-00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849735346-00158%26sid%3Dliteratum%253Aachs%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DMAPKAP%2520kinase%25202%2520as%2520a%2520target%2520for%2520anti-inflammatory%2520drug%2520discovery%26btitle%3DAnti-Inflammatory%2520Drug%2520Discovery%26aulast%3DLevi%26aufirst%3DJ.%2BI.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2012%26spage%3D158%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1006358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1517%2F13543784.2015.1006358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=25599809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVKrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=383-392&author=P.+Norman&title=Investigational+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1517%2F13543784.2015.1006358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-392</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: The p38 protein kinases, in particular p38α and p38β, regulate the prodn. of multiple inflammatory mediators.  Consequentially, considerable effort has been focused on trying to develop p38 inhibitors for the treatment of inflammatory diseases.  Some 20 p38 inhibitors have progressed to clin. development, mostly for the treatment of rheumatoid arthritis, but with little success.  Increasingly, interest has turned to their use in other indications and notably chronic obstructive pulmonary disease (COPD).  Areas covered: In this review, the author discusses the eight p38 inhibitors that have been clin. evaluated.  Acumapimod is the only one of four orally delivered inhibitors that remains in active development while Phase II results of PH-797804 and losmapimod are compared.  The activity of two inhibitors designed for inhaled delivery, RV-568 and PF-03715455, is compared but little is known about AZD-7624 or the discontinued GSK-610677.  Expert opinion: Results from animal models provide a clear rationale for developing p38 inhibitors for COPD, and appear to be (partially) validated by the efficacy seen with PH-797804 and losmapimod.  Inhaled delivery provides the opportunity to enhance p38 inhibition in the lung while reducing unwanted systemic effects of p38 inhibition.  Validation of this hypothesis should come from the results of the recently completed Phase II study with RV-568.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKUbGhXQAMzrVg90H21EOLACvtfcHk0ljD9QOZkOhtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVKrtLk%253D&md5=97485678de1e2d15bf1ace5139cba51e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1006358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1006358%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DInvestigational%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D383%26epage%3D392%26doi%3D10.1517%2F13543784.2015.1006358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Trempolec, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave-Coll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">SnapShot: p38 MAPK substrates</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.cell.2013.01.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=924&author=N.+Trempolecauthor=N.+Dave-Collauthor=A.+R.+Nebreda&title=SnapShot%3A+p38+MAPK+substrates&doi=10.1016%2Fj.cell.2013.01.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DTrempolec%26aufirst%3DN.%26aulast%3DDave-Coll%26aufirst%3DN.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DSnapShot%253A%2520p38%2520MAPK%2520substrates%26jtitle%3DCell%26date%3D2013%26volume%3D152%26spage%3D924%26doi%3D10.1016%2Fj.cell.2013.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Biava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porretta, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battilocchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautebin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzellotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span> </span><span class="NLM_article-title">Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1540</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span><span class="refDoi"> DOI: 10.2174/092986711795328364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F092986711795328364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=21428878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1540-1554&author=M.+Biavaauthor=G.+C.+Porrettaauthor=G.+Poceauthor=C.+Battilocchioauthor=M.+Bottaauthor=F.+Manettiauthor=M.+Roviniauthor=A.+Cappelliauthor=L.+Sautebinauthor=A.+Rossiauthor=C.+Pergolaauthor=C.+Ghelardiniauthor=N.+Galeottiauthor=F.+Makovecauthor=A.+Giordaniauthor=P.+Anzellottiauthor=S.+Tacconelliauthor=P.+Patrignaniauthor=M.+Anzini&title=Enlarging+the+NSAIDs+family%3A+ether%2C+ester+and+acid+derivatives+of+the+1%2C5-diarylpyrrole+scaffold+as+novel+anti-inflammatory+and+analgesic+agents&doi=10.2174%2F092986711795328364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Enlarging the NSAIDs family: ether, esther and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents</span></div><div class="casAuthors">Biava, M.; Porretta, G. C.; Poce, G.; Battilocchio, C.; Botta, M.; Manetti, F.; Rovini, M.; Cappelli, A.; Sautebin, L.; Rossi, A.; Pergola, C.; Ghelardini, C.; Galeotti, N.; Makovec, F.; Giordani, A.; Anzellotti, P.; Tacconelli, S.; Patrignani, P.; Anzini, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1540-1554</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of the coxib family has represented a stimulating approach in the treatment of inflammatory disorders, such as arthritis, and for the management of acute pains, in relation to the well-known traditional Non-Steroidal Anti-inflammatory Drugs (t- NSAIDs).  Prompted by the pursuit for new cyclooxygenase-2 (COX-2) inhibitors, endowed with fine tuned selectivity and high potency, in the past years we have identified novel classes of ether, ester and acid mols. characterized by the 1,5-diarylpyrrole scaffold as potentially powerful anti-inflammatory mols. (12-66).  All compds. proved to exert an in vitro inhibition profile as good as that shown by ref. compds.  Compds. bearing a p-methylsulfonylphenyl substituent at C5 displayed the best issues.  In particular, ester derivs. proved to perform the best in vitro profile in terms of selectivity and activity toward COX-2.  The cell-based assay data showed that an increase of hindrance at the C3 side chain of compds. could translate to activity enhancement.  The human whole blood (HWB) test let to highlight that submitted compds. displayed 5-10 fold higher selectivity for COX-2 vs COX-1 which should translate clin. to an acceptable gastrointestinal safety and mitigate the cardiovascular effects highlighted by highly selective COX-2 inhibitors.  Finally, to assess in vivo anti-inflammatory and analgesic activity three different tests (rat paw pressure, rat paw edema and abdominal constriction) were performed.  Results showed good in vivo anti-inflammatory and analgesic activities.  The issues gained with these classes of compds. represent, nowadays, a potent stimulus for a further enlargement of the NSAIDs family.  In this review we describe the results obtained by our research group on this topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JrB-zrA5MrVg90H21EOLACvtfcHk0li-O36c-wPqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOitLs%253D&md5=6ecdeecc428187ed473c8ce520b19d36</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986711795328364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795328364%26sid%3Dliteratum%253Aachs%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DPorretta%26aufirst%3DG.%2BC.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DBattilocchio%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DRovini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGaleotti%26aufirst%3DN.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DGiordani%26aufirst%3DA.%26aulast%3DAnzellotti%26aufirst%3DP.%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DPatrignani%26aufirst%3DP.%26aulast%3DAnzini%26aufirst%3DM.%26atitle%3DEnlarging%2520the%2520NSAIDs%2520family%253A%2520ether%252C%2520ester%2520and%2520acid%2520derivatives%2520of%2520the%25201%252C5-diarylpyrrole%2520scaffold%2520as%2520novel%2520anti-inflammatory%2520and%2520analgesic%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1540%26epage%3D1554%26doi%3D10.2174%2F092986711795328364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Manetti, F.</span><span> </span><span class="NLM_article-title">LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span><span class="refDoi"> DOI: 10.1002/med.20230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fmed.20230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22886629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKls7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=968-998&author=F.+Manetti&title=LIM+kinases+are+attractive+targets+with+many+macromolecular+partners+and+only+a+few+small+molecule+regulators&doi=10.1002%2Fmed.20230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators</span></div><div class="casAuthors">Manetti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-998</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The LIM kinases 1 and 2 (LIMK1 and LIMK2) are dual specificity (serine/threonine and tyrosine) kinases.  Although they show significant structural similarity, LIMK1 and LIMK2 show different expression, subcellular localization, and functions.  They are involved in many cellular functions, such as migration, cycle, and neuronal differentiation and also have a role in pathol. processes, such as cancer cell invasion and metastatis, as well as in neurodevelopmental disorders (namely, the William's syndrome).  LIM kinases have a relevant no. of known partners that are able to induce or limit the ability of LIMK1 and LIMK2 to phosphorylate and inactivate their major substrate, cofilin.  On the contrary, only a limited no. of small mols. that interact with the two proteins to modulate their kinase activity have been identified.  In this review, the most important partners of LIM kinases and their modulating activity toward LIMKs are described.  The small compds. identified as LIMK1 and LIMK2 modulators are also reported, as well as their role as possible therapeutic agents for LIMK-induced diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zsLWz4v2uLVg90H21EOLACvtfcHk0li-O36c-wPqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKls7vK&md5=1be7588c75c7ec4cc77e35d9d7b08817</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.20230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20230%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26atitle%3DLIM%2520kinases%2520are%2520attractive%2520targets%2520with%2520many%2520macromolecular%2520partners%2520and%2520only%2520a%2520few%2520small%2520molecule%2520regulators%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D968%26epage%3D998%26doi%3D10.1002%2Fmed.20230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevilacqua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, M.</span><span> </span><span class="NLM_article-title">MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2014.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.yjmcc.2014.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=25257914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KlsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=86-101&author=L.+Xuauthor=C.+C.+Yatesauthor=P.+Lockyerauthor=L.+Xieauthor=A.+Bevilacquaauthor=J.+Heauthor=C.+Landerauthor=C.+Pattersonauthor=M.+Willis&title=MMI-0100+inhibits+cardiac+fibrosis+in+myocardial+infarction+by+direct+actions+on+cardiomyocytes+and+fibroblasts+via+MK2+inhibition&doi=10.1016%2Fj.yjmcc.2014.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition</span></div><div class="casAuthors">Xu, Lei; Yates, Cecelia C.; Lockyer, Pamela; Xie, Liang; Bevilacqua, Ariana; He, Jun; Lander, Cynthia; Patterson, Cam; Willis, Monte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86-101</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cell-permeant peptide inhibitor of MAPKAP kinase 2 (MK2), MMI-0100, inhibits MK2 and downstream fibrosis and inflammation.  Recent studies have demonstrated that MMI-0100 reduces intimal hyperplasia in a mouse vein graft model, pulmonary fibrosis in a murine bleomycin-induced model and development of adhesions in conjunction with abdominal surgery.  MK2 is crit. to the pathogenesis of ischemic heart injury as MK2-/- mice are resistant to ischemic remodeling.  Therefore, we tested the hypothesis that inhibiting MK2 with MMI-0100 would protect the heart after acute myocardial infarction (AMI) in vivo.  AMI was induced by placing a permanent LAD coronary ligation.  When MMI-0100 peptide was given 30 min after permanent LAD coronary artery ligation, the resulting fibrosis was reduced/prevented ∼ 50% at a 2 wk time point, with a corresponding improvement in cardiac function and decrease in left ventricular dilation.  In cultured cardiomyocytes and fibroblasts, MMI-0100 inhibited MK2 to reduce cardiomyocyte caspase 3/7 activity, while enhancing primary cardiac fibroblast caspase 3/7 activity, which may explain MMI-0100's salvage of cardiac function and anti-fibrotic effects in vivo.  These findings suggest that therapeutic inhibition of MK2 after acute MI, using rationally-designed cell-permeant peptides, inhibits cardiac fibrosis and maintains cardiac function by mechanisms that involve inhibiting cardiomyocyte apoptosis, while enhancing primary cardiac fibroblast cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplIBsAA5QPoLVg90H21EOLACvtfcHk0li-O36c-wPqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KlsLjE&md5=a8d93f4d3cc4382fc5d3a62c757dde96</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2014.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2014.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYates%26aufirst%3DC.%2BC.%26aulast%3DLockyer%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBevilacqua%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DLander%26aufirst%3DC.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DWillis%26aufirst%3DM.%26atitle%3DMMI-0100%2520inhibits%2520cardiac%2520fibrosis%2520in%2520myocardial%2520infarction%2520by%2520direct%2520actions%2520on%2520cardiomyocytes%2520and%2520fibroblasts%2520via%2520MK2%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2014%26volume%3D77%26spage%3D86%26epage%3D101%26doi%3D10.1016%2Fj.yjmcc.2014.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Streicher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1443</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.109.213199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1161%2FCIRCRESAHA.109.213199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2010&pages=1434-1443&author=J.+M.+Streicherauthor=S.+Renauthor=H.+Herschmanauthor=Y.+Wang&title=MAPK-activated+protein+kinase-2+in+cardiac+hypertrophy+and+cyclooxygenase-2+regulation+in+heart&doi=10.1161%2FCIRCRESAHA.109.213199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.109.213199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.109.213199%26sid%3Dliteratum%253Aachs%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DHerschman%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMAPK-activated%2520protein%2520kinase-2%2520in%2520cardiac%2520hypertrophy%2520and%2520cyclooxygenase-2%2520regulation%2520in%2520heart%26jtitle%3DCirc.%2520Res.%26date%3D2010%26volume%3D106%26spage%3D1434%26epage%3D1443%26doi%3D10.1161%2FCIRCRESAHA.109.213199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warburton, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanburg, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayyali, U. S.</span><span> </span><span class="NLM_article-title">Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1165/rcmb.2007-0077OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1165%2Frcmb.2007-0077OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=17600313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=507-517&author=T.+Liuauthor=R.+R.+Warburtonauthor=O.+E.+Guevaraauthor=N.+S.+Hillauthor=B.+L.+Fanburgauthor=M.+Gaestelauthor=U.+S.+Kayyali&title=Lack+of+MK2+inhibits+myofibroblast+formation+and+exacerbates+pulmonary+fibrosis&doi=10.1165%2Frcmb.2007-0077OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis</span></div><div class="casAuthors">Liu, Tiegang; Warburton, Rod R.; Guevara, Oscar E.; Hill, Nicholas S.; Fenburg, Barry L.; Gaestel, Matthias; Kayyali, Usamah S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-517</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Fibroblasts play a major role in tissue repair and remodeling.  Their differentiation into myofibroblasts, marked by increased expression of smooth muscle-specific α-actin (α-SMA), is believed to be important in wound healing and fibrosis.  The authors have recently described a role for MK2 in this phenotypic differentiation in culture.  In this article, the authors demonstrate that MK2 also regulates myofibroblasts in vivo.  Disruption of MK2 in mice prevented myofibroblast formation in a model of pulmonary fibrosis.  However, MK2 disruption and consequent lack of myofibroblast formation exacerbated fibrosis rather than ameliorated it as previously postulated.  When mice lacking MK2 (MK2-/-) were exposed to bleomycin, more collagen accumulated and more fibroblasts populated fibrotic regions in their lungs than in similarly treated wild-type mice.  While there were many vimentin-pos. cells in the bleomycin-treated MK2-/- mouse lungs, few α-SMA-pos. cells were obsd. in these lungs compared with wild-type mouse lungs.  SiRNA against MK2 reduced α-SMA expression in wild-type mouse embryonic fibroblasts (MEF), consistent with its suppression in MK2-/- MEF.  On the other hand expressing constitutively active MK2 in MK2-/- MEF significantly increased α-SMA expression.  MK2-/- MEF proliferated at a faster rate and produced more collagen; however, they migrated at a slower rate than wild-type MEF.  Overexpressing phosphomimicking HSP27, a target of MK2, did not reverse the effect of MK2 disruption on fibroblast migration.  MK2 disruption did not affect Smad2 activation by transforming growth factor-β.  Thus, MK2 appears to mediate myofibroblast differentiation, and inhibiting that differentiation might contribute to fibrosis rather than protect against it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQYAgJQiTEU7Vg90H21EOLACvtfcHk0liT3SeQllASPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWhsrzN&md5=54a77f1e77e39afdda766e51d771d641</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0077OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0077OC%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWarburton%26aufirst%3DR.%2BR.%26aulast%3DGuevara%26aufirst%3DO.%2BE.%26aulast%3DHill%26aufirst%3DN.%2BS.%26aulast%3DFanburg%26aufirst%3DB.%2BL.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKayyali%26aufirst%3DU.%2BS.%26atitle%3DLack%2520of%2520MK2%2520inhibits%2520myofibroblast%2520formation%2520and%2520exacerbates%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2007%26volume%3D37%26spage%3D507%26epage%3D517%26doi%3D10.1165%2Frcmb.2007-0077OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Vittal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandusky, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, D. S.</span><span> </span><span class="NLM_article-title">Peptide-mediated inhibition of MK2 ameliorates bleomycin-induced pulmonary fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1165/rcmb.2012-0389OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1165%2Frcmb.2012-0389OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23470623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFajs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=47-57&author=R.+Vittalauthor=A.+Fisherauthor=H.+Guauthor=E.+A.+Micklerauthor=A.+Panitchauthor=C.+Landerauthor=O.+W.+Cummingsauthor=G.+E.+Sanduskyauthor=D.+S.+Wilkes&title=Peptide-mediated+inhibition+of+MK2+ameliorates+bleomycin-induced+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0389OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis</span></div><div class="casAuthors">Vittal, Ragini; Fisher, Amanda; Gu, Hongmei; Mickler, Elizabeth A.; Panitch, Alyssa; Lander, Cynthia; Cummings, Oscar W.; Sandusky, George E.; Wilkes, David S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-57</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase-2 (MAPKAPK2, or MK2), a serine/threonine kinase downstream of p38 mitogen-activated protein kinase, has been implicated in inflammation and fibrosis.  Compared with pathol. normal lung tissue, significantly higher concns. of activated MK2 are evident in lung biopsies of patients with idiopathic pulmonary fibrosis (IPF).  Expression is localized to fibroblasts and epithelial cells.  In the murine bleomycin model of pulmonary fibrosis, we obsd. robust, activated MK2 expression on Day 7 (prefibrotic stage) and Day 14 (postfibrotic stage).  To det. the effects of MK2 inhibition during the postinflammatory/prefibrotic and postfibrotic stages, C57BL/6 mice received intratracheal bleomycin instillation (0.025 U; Day 0), followed by PBS or the MK2 inhibitor (MK2i; 37.5 μg/kg), administered via either local (nebulized) or systemic (i.p.) routes.  MK2i or PBS was dosed daily for 14 days subsequent to bleomycin injury, beginning on either Day 7 or Day 14.  Regardless of mode of administration or stage of intervention, MK2i significantly abrogated collagen deposition, myofibroblast differentiation and activated MK2 expression.  MK2i also decreased circulating TNF-α and IL-6 concns., and modulated the local mRNA expression of profibrotic cytokine il-1β, matrix-related genes col1a2, col3a1, and lox, and transforming growth factor-β family members, including smad3, serpine1 (pai1), and smad6/7.  In vitro, MK2i dose-dependently attenuated total MK2, myofibroblast differentiation, the secretion of collagen Type I, fibronectin, and the activation of focal adhesion kinase, whereas activated MK2 was attenuated at optimal doses.  The peptide-mediated inhibition of MK2 affects both inflammatory and fibrotic responses, and thus may offer a promising therapeutic target for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLiS_pENkO7Vg90H21EOLACvtfcHk0liT3SeQllASPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFajs73N&md5=3f6b84ceb5c9bca1216f6160060c196d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0389OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0389OC%26sid%3Dliteratum%253Aachs%26aulast%3DVittal%26aufirst%3DR.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DMickler%26aufirst%3DE.%2BA.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DLander%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DO.%2BW.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DWilkes%26aufirst%3DD.%2BS.%26atitle%3DPeptide-mediated%2520inhibition%2520of%2520MK2%2520ameliorates%2520bleomycin-induced%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2013%26volume%3D49%26spage%3D47%26epage%3D57%26doi%3D10.1165%2Frcmb.2012-0389OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span><span class="refDoi"> DOI: 10.4155/fmc.09.98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.4155%2Ffmc.09.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=21426101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1243-1257&author=A.+Schlapbachauthor=C.+Huppertz&title=Low-molecular-weight+MK2+inhibitors%3A+a+tough+nut+to+crack%21&doi=10.4155%2Ffmc.09.98"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span></div><div class="casAuthors">Schlapbach, Achim; Huppertz, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1243-1257</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 pathway was at the center of interest for anti-inflammatory drug discovery for many years as it is crucial for the biosynthesis of TNF-α, IL-1β, and other mediators.  Most of the anti-inflammatory effects of p38 inhibition are mediated through MAPK-activated protein kinase-2 (MK2), a direct downstream target of p38, which makes MK2 a very interesting drug target.  Within the last 5 years, several classes of low-mol.-wt. MK2 inhibitors were disclosed in the patent and primary literature.  Advanced compds. could be optimized to nanomolar potencies and inhibit TNF-α release, as well as the phosphorylation of the MK2 substrate heat-shock protein 27 in cellular assays.  This article will review the recent progress in this field and will highlight and discuss the most promising compd. series disclosed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4u3apT9vA-rVg90H21EOLACvtfcHk0ljQSgDyAupWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K&md5=0b950af46215982d171a6c8b6de98fd0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.98%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DLow-molecular-weight%2520MK2%2520inhibitors%253A%2520a%2520tough%2520nut%2520to%2520crack%2521%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1243%26epage%3D1257%26doi%3D10.4155%2Ffmc.09.98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of drug action: what does it take for success?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1038/nrd1500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1038%2Fnrd1500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=15340390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=801-808&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+drug+action%3A+what+does+it+take+for+success%3F&doi=10.1038%2Fnrd1500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Biochemical mechanisms of drug action: what does it take for success?</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">801-808</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Drug discovery is extremely difficult.  There are many unanticipated scientific, medical and business challenges to every drug discovery program.  It is important to increase our understanding of the fundamental properties of effective drugs so that we can anticipate potential problems in developing new agents.  This article addresses potential drug discovery and development risks assocd. with the biochem. mechanism of drug action, and proposes simple rules to minimize these risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhyDgozFUdrVg90H21EOLACvtfcHk0ljQSgDyAupWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCnsL4%253D&md5=b06bdc6ace3168dcb011679b43b72aed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1500%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520drug%2520action%253A%2520what%2520does%2520it%2520take%2520for%2520success%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D801%26epage%3D808%26doi%3D10.1038%2Fnrd1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustkern, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span> </span><span class="NLM_article-title">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1124/jpet.110.166173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fjpet.110.166173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=20237073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=797-807&author=R.+J.+Moureyauthor=B.+L.+Burnetteauthor=S.+J.+Brustkernauthor=J.+S.+Danielsauthor=J.+L.+Hirschauthor=W.+F.+Hoodauthor=M.+J.+Meyersauthor=S.+J.+Mnichauthor=B.+S.+Pierceauthor=M.+J.+Saabyeauthor=J.+F.+Schindlerauthor=S.+A.+Southauthor=E.+G.+Webbauthor=J.+Zhangauthor=D.+R.+Anderson&title=A+benzothiophene+inhibitor+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+inhibits+tumor+necrosis+factor+%CE%B1+production+and+has+oral+anti-inflammatory+efficacy+in+acute+and+chronic+models+of+inflammation&doi=10.1124%2Fjpet.110.166173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span></div><div class="casAuthors">Mourey, Robert J.; Burnette, Barry L.; Brustkern, Sarah J.; Daniels, J. Scott; Hirsch, Jeffrey L.; Hood, William F.; Meyers, Marvin J.; Mnich, Stephen J.; Pierce, Betsy S.; Saabye, Matthew J.; Schindler, John F.; South, Sarah A.; Webb, Elizabeth G.; Zhang, Jian; Anderson, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Activation of the p38 kinase pathway in immune cells leads to the transcriptional and translational regulation of proinflammatory cytokines.  Mitogen-activated protein kinase-activated protein kinase 2 (MK2), a direct downstream substrate of p38 kinase, regulates lipopolysaccharide (LPS)-stimulated tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) prodn. through modulating the stability and translation of these mRNAs.  Developing small-mol. inhibitors of MK2 may yield anti-inflammatory efficacy with a different safety profile relative to p38 kinase inhibitors.  This article describes the pharmacol. properties of a benzothiophene MK2 inhibitor, PF-3644022 [(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one].  PF-3644022 is a potent freely reversible ATP-competitive compd. that inhibits MK2 activity (Ki = 3 nM) with good selectivity when profiled against 200 human kinases.  In the human U937 monocytic cell line or peripheral blood mononuclear cells, PF-3644022 potently inhibits TNFα prodn. with similar activity (IC50 = 160 nM).  PF-3644022 blocks TNFα and IL-6 prodn. in LPS-stimulated human whole blood with IC50 values of 1.6 and 10.3 μM, resp.  Inhibition of TNFα in U937 cells and blood correlates closely with inhibition of phospho-heat shock protein 27, a target biomarker of MK2 activity.  PF-3644022 displays good pharmacokinetic parameters in rats and is orally efficacious in both the rat acute LPS-induced TNFα model and the chronic streptococcal cell wall-induced arthritis model.  Dose-dependent inhibition of TNFα prodn. in the acute model and inhibition of paw swelling in the chronic model is obsd. with ED50 values of 6.9 and 20 mg/kg, resp.  PF-3644022 efficacy in the chronic inflammation model is strongly correlated with maintaining a Cmin higher than the EC50 measured in the rat LPS-induced TNFα model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrKp-1XQ0NyLVg90H21EOLACvtfcHk0ljQSgDyAupWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D&md5=312670776fbb3fd39fc2247eba48eb6e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166173%26sid%3Dliteratum%253Aachs%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBurnette%26aufirst%3DB.%2BL.%26aulast%3DBrustkern%26aufirst%3DS.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DHood%26aufirst%3DW.%2BF.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSaabye%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26atitle%3DA%2520benzothiophene%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520inhibits%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520production%2520and%2520has%2520oral%2520anti-inflammatory%2520efficacy%2520in%2520acute%2520and%2520chronic%2520models%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D797%26epage%3D807%26doi%3D10.1124%2Fjpet.110.166173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit26"><span>The Universal Protein Resource (UniProt); <a href="http://www.uniprot.org/uniprot/P49137" class="extLink">http://www.uniprot.org/uniprot/P49137</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Universal+Protein+Resource+%28UniProt%29%3B+http%3A%2F%2Fwww.uniprot.org%2Funiprot%2FP49137+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielemann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">FRET-based detection of different conformations of MK2</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1093/embo-reports/kve157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Fembo-reports%2Fkve157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=703-708&author=A.+Neiningerauthor=H.+Thielemannauthor=M.+Gaestel&title=FRET-based+detection+of+different+conformations+of+MK2&doi=10.1093%2Fembo-reports%2Fkve157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkve157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkve157%26sid%3Dliteratum%253Aachs%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DThielemann%26aufirst%3DH.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DFRET-based%2520detection%2520of%2520different%2520conformations%2520of%2520MK2%26jtitle%3DEMBO%2520Rep.%26date%3D2001%26volume%3D2%26spage%3D703%26epage%3D708%26doi%3D10.1093%2Fembo-reports%2Fkve157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zu, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-K.</span><span> </span><span class="NLM_article-title">Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1074/jbc.270.1.202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.270.1.202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=202-206&author=Y.-L.+Zuauthor=T.+Aiauthor=C.-K.+Huang&title=Characterization+of+an+autoinhibitory+domain+in+human+mitogen-activated+protein+kinase-activated+protein+kinase+2&doi=10.1074%2Fjbc.270.1.202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.1.202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.1.202%26sid%3Dliteratum%253Aachs%26aulast%3DZu%26aufirst%3DY.-L.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.-K.%26atitle%3DCharacterization%2520of%2520an%2520autoinhibitory%2520domain%2520in%2520human%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D202%26epage%3D206%26doi%3D10.1074%2Fjbc.270.1.202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lukas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildeson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frego, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingraham, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B. G.</span><span> </span><span class="NLM_article-title">Catalysis and function of the p38α•MK2a signaling complex</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">9950</span><span class="NLM_x">–</span> <span class="NLM_lpage">9960</span><span class="refDoi"> DOI: 10.1021/bi049508v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049508v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9950-9960&author=S.+M.+Lukasauthor=R.+R.+Kroeauthor=J.+Wildesonauthor=G.+W.+Peetauthor=L.+Fregoauthor=W.+Davidsonauthor=R.+H.+Ingrahamauthor=C.+A.+Pargellisauthor=M.+E.+Labadiaauthor=B.+G.+Werneburg&title=Catalysis+and+function+of+the+p38%CE%B1%E2%80%A2MK2a+signaling+complex&doi=10.1021%2Fbi049508v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi049508v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049508v%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DS.%2BM.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DWildeson%26aufirst%3DJ.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DFrego%26aufirst%3DL.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DIngraham%26aufirst%3DR.%2BH.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DWerneburg%26aufirst%3DB.%2BG.%26atitle%3DCatalysis%2520and%2520function%2520of%2520the%2520p38%25CE%25B1%25E2%2580%25A2MK2a%2520signaling%2520complex%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9950%26epage%3D9960%26doi%3D10.1021%2Fbi049508v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B. T.,  II.</span><span> </span><span class="NLM_article-title">Molecular basis of MAPK-activated protein kinase 2:p38 assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6353</span><span class="NLM_x">–</span> <span class="NLM_lpage">6358</span><span class="refDoi"> DOI: 10.1073/pnas.0701679104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1073%2Fpnas.0701679104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=17395714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1aqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6353-6358&author=A.+Whiteauthor=C.+A.+Pargellisauthor=J.+M.+Studtsauthor=B.+G.+Werneburgauthor=B.+T.+Farmer&title=Molecular+basis+of+MAPK-activated+protein+kinase+2%3Ap38+assembly&doi=10.1073%2Fpnas.0701679104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of MAPK-activated protein kinase 2:p38 assembly</span></div><div class="casAuthors">White, Andre; Pargellis, Christopher A.; Studts, Joey M.; Werneburg, Brian G.; Farmer, Bennett T., II</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6353-6358</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">P38 MAPK and MAPK-activated protein kinase 2 (MK2) are key components of signaling pathways leading to many cellular responses, notably the proinflammatory cytokine prodn.  The phys. assocn. of p38a isoform and MK2 is believed to be physiol. important for this signaling.  We report the 2.7-Å resoln. crystal structure of the unphosphorylated complex between p38a and MK2.  These protein kinases bind "head-to-head," present their resp. active sites on approx. the same side of the heterodimer, and form extensive intermol. interactions.  Among these interactions, the MK2 Ile-366-Ala-390, which includes the bipartite nuclear localization signal, binds to the p38a-docking region.  This binding supports the involvement of noncatalytic regions to the tight binding of the MK2:p38a binary assembly.  The MK2 residues 345-365, contg. the nuclear export signal, block access to the p38a active site.  Some regulatory phosphorylation regions of both protein kinases engage in multiple interactions with one another in this complex.  This structure gives new insights into the regulation of the protein kinases p38a and MK2, aids in the better understanding of their known cellular and biochem. studies, and provides a basis for understanding other regulatory protein-protein interactions involving signal transduction proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouWpJet7sBdrVg90H21EOLACvtfcHk0lhawP9t3j1Uew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1aqsrs%253D&md5=0ccf756d535e7f10b73173f98205ba6f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701679104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701679104%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DStudts%26aufirst%3DJ.%2BM.%26aulast%3DWerneburg%26aufirst%3DB.%2BG.%26aulast%3DFarmer%26aufirst%3DB.%2BT.%26atitle%3DMolecular%2520basis%2520of%2520MAPK-activated%2520protein%2520kinase%25202%253Ap38%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D6353%26epage%3D6358%26doi%3D10.1073%2Fpnas.0701679104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabakhar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepre, C.</span><span> </span><span class="NLM_article-title">Crystal structure of the p38α-MAPKAP kinase 2 heterodimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9733</span><span class="NLM_x">–</span> <span class="NLM_lpage">9739</span><span class="refDoi"> DOI: 10.1074/jbc.M611165200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.M611165200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9733-9739&author=E.+ter+Haarauthor=P.+Prabakharauthor=X.+Liuauthor=C.+Lepre&title=Crystal+structure+of+the+p38%CE%B1-MAPKAP+kinase+2+heterodimer&doi=10.1074%2Fjbc.M611165200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611165200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611165200%26sid%3Dliteratum%253Aachs%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DPrabakhar%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLepre%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520p38%25CE%25B1-MAPKAP%2520kinase%25202%2520heterodimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9733%26epage%3D9739%26doi%3D10.1074%2Fjbc.M611165200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>UniProtKB - P49137 (MAPK2_HUMAN); <a href="http://www.uniprot.org/uniprot/P49137#showFeatures" class="extLink">http://www.uniprot.org/uniprot/P49137#showFeatures</a> (accessed August 4, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UniProtKB+-+P49137+%28MAPK2_HUMAN%29%3B+http%3A%2F%2Fwww.uniprot.org%2Funiprot%2FP49137%23showFeatures+%28accessed+August+4%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DUniProtKB%2520-%2520P49137%2520%2528MAPK2_HUMAN%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankovich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhukhan, R.</span><span> </span><span class="NLM_article-title">Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study</span> <span class="citation_source-journal">BMC Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/1472-6807-9-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1186%2F1472-6807-9-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19296855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BD1MzisV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=16&author=M.+A.+Argiriadiauthor=S.+Sousaauthor=D.+Banachauthor=D.+Marcotteauthor=T.+Xiangauthor=M.+J.+Tomlinsonauthor=M.+Demersauthor=C.+Harrisauthor=S.+Kwakauthor=J.+Hardmanauthor=M.+Pietrasauthor=L.+Quinnauthor=J.+DiMauroauthor=B.+Niauthor=J.+Mankovichauthor=D.+W.+Borhaniauthor=R.+V.+Talanianauthor=R.+Sadhukhan&title=Rational+mutagenesis+to+support+structure-based+drug+design%3A+MAPKAP+kinase+2+as+a+case+study&doi=10.1186%2F1472-6807-9-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study</span></div><div class="casAuthors">Argiriadi Maria A; Sousa Silvino; Banach David; Marcotte Douglas; Xiang Tao; Tomlinson Medha J; Demers Megan; Harris Christopher; Kwak Silvia; Hardman Jennifer; Pietras Margaret; Quinn Lisa; DiMauro Jennifer; Ni Baofu; Mankovich John; Borhani David W; Talanian Robert V; Sadhukhan Ramkrishna</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Structure-based drug design (SBDD) can provide valuable guidance to drug discovery programs.  Robust construct design and expression, protein purification and characterization, protein crystallization, and high-resolution diffraction are all needed for rapid, iterative inhibitor design.  We describe here robust methods to support SBDD on an oral anti-cytokine drug target, human MAPKAP kinase 2 (MK2).  Our goal was to obtain useful diffraction data with a large number of chemically diverse lead compounds.  Although MK2 structures and structural methods have been reported previously, reproducibility was low and improved methods were needed.  RESULTS:  Our construct design strategy had four tactics: N- and C-terminal variations; entropy-reducing surface mutations; activation loop deletions; and pseudoactivation mutations.  Generic, high-throughput methods for cloning and expression were coupled with automated liquid dispensing for the rapid testing of crystallization conditions with minimal sample requirements.  Initial results led to development of a novel, customized robotic crystallization screen that yielded MK2/inhibitor complex crystals under many conditions in seven crystal forms.  In all, 44 MK2 constructs were generated, ~500 crystals were tested for diffraction, and ~30 structures were determined, delivering high-impact structural data to support our MK2 drug design effort.  CONCLUSION:  Key lessons included setting reasonable criteria for construct performance and prioritization, a willingness to design and use customized crystallization screens, and, crucially, initiation of high-throughput construct exploration very early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMsKCHiWtGuYNpW7w2tapOfW6udTcc2eZ-Kmbljv3OyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzisV2lsg%253D%253D&md5=dc6b50caa25458e3f23d349ddaf8a08c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-9-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-9-16%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DSousa%26aufirst%3DS.%26aulast%3DBanach%26aufirst%3DD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DDemers%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DPietras%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DL.%26aulast%3DDiMauro%26aufirst%3DJ.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DMankovich%26aufirst%3DJ.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26aulast%3DSadhukhan%26aufirst%3DR.%26atitle%3DRational%2520mutagenesis%2520to%2520support%2520structure-based%2520drug%2520design%253A%2520MAPKAP%2520kinase%25202%2520as%2520a%2520case%2520study%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2009%26volume%3D9%26spage%3D16%26doi%3D10.1186%2F1472-6807-9-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0ljE7NnrKmGi8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosyak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malakian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L-</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span> </span><span class="NLM_article-title">Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1016/S0969-2126(03)00092-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2FS0969-2126%2803%2900092-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=627-636&author=K.+W.+Underwoodauthor=K.+D.+Parrisauthor=E.+Federicoauthor=L.+Mosyakauthor=R.+M.+Czerwinskiauthor=T.+Shaneauthor=M.+Taylorauthor=K.+Svensonauthor=Y.+Liuauthor=C.-L.+Hsiaoauthor=S.+Wolfromauthor=M.+Maguireauthor=K.+Malakianauthor=J.-B.+Telliezauthor=L.-L-+Linauthor=R.+W.+Krizauthor=J.+Seehraauthor=W.+S.+Somersauthor=M.+L.+Stahl&title=Catalytically+active+MAP+KAP+kinase+2+structures+in+complex+with+staurosporine+and+ADP+reveal+differences+with+the+autoinhibited+enzyme&doi=10.1016%2FS0969-2126%2803%2900092-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2803%2900092-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252803%252900092-3%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DParris%26aufirst%3DK.%2BD.%26aulast%3DFederico%26aufirst%3DE.%26aulast%3DMosyak%26aufirst%3DL.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DShane%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHsiao%26aufirst%3DC.-L.%26aulast%3DWolfrom%26aufirst%3DS.%26aulast%3DMaguire%26aufirst%3DM.%26aulast%3DMalakian%26aufirst%3DK.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DLin%26aufirst%3DL.-L-%26aulast%3DKriz%26aufirst%3DR.%2BW.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DW.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26atitle%3DCatalytically%2520active%2520MAP%2520KAP%2520kinase%25202%2520structures%2520in%2520complex%2520with%2520staurosporine%2520and%2520ADP%2520reveal%2520differences%2520with%2520the%2520autoinhibited%2520enzyme%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D627%26epage%3D636%26doi%3D10.1016%2FS0969-2126%2803%2900092-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgibbon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulghum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span> </span><span class="NLM_article-title">Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">37401</span><span class="NLM_x">–</span> <span class="NLM_lpage">37405</span><span class="refDoi"> DOI: 10.1074/jbc.C200418200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.C200418200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=12171911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVejsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=37401-37405&author=W.+Mengauthor=L.+L.+Swensonauthor=M.+J.+Fitzgibbonauthor=K.+Hayakawaauthor=E.+ter+Haarauthor=A.+E.+Behrensauthor=J.+R.+Fulghumauthor=J.+A.+Lippke&title=Structure+of+mitogen-activated+protein+kinase-activated+protein+%28MAPKAP%29+kinase+2+suggests+a+bifunctional+switch+that+couples+kinase+activation+with+nuclear+export&doi=10.1074%2Fjbc.C200418200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export</span></div><div class="casAuthors">Meng, Wuyi; Swenson, Lora L.; Fitzgibbon, Matthew J.; Hayakawa, Koto; ter Haar, Ernst; Behrens, Anne E.; Fulghum, John R.; Lippke, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">37401-37405</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MAPK-activated protein kinase 2 (MAPKAPK2), one of several kinases directly phosphorylated and activated by p38 MAPK, plays a central role in the inflammatory response.  The activated MAPKAPK2 phosphorylates its nuclear targets CREB/ATF1, serum response factor, and E2A protein E47 and its cytoplasmic targets HSP25/27, LSP-1, 5-lipoxygenase, glycogen synthase, and tyrosine hydroxylase.  The crystal structure of unphosphorylated MAPKAPK2, detd. at 2.8 Å resoln., includes the kinase domain and the C-terminal regulatory domain.  Although the protein is inactive, the kinase domain adopts an active conformation with aspartate 366 mimicking the missing phosphorylated threonine 222 in the activation loop.  The C-terminal regulatory domain forms a helix-turn-helix plus a long strand.  Phosphorylation of threonine 334, which is located between the kinase domain and the C-terminal regulatory domain, may serve as a switch for MAPKAPK2 nuclear import and export.  Phosphorylated MAPKAPK2 masks the nuclear localization signal at its C terminus by binding to p38.  It unmasks the nuclear export signal, which is part of the second C-terminal helix packed along the surface of kinase domain C-lobe, and thereby carries p38 to the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHV1tx4qFo4bVg90H21EOLACvtfcHk0lhA-sSczilLRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVejsr0%253D&md5=d83a709efe4b2a4172161fc8bec73294</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200418200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200418200%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBehrens%26aufirst%3DA.%2BE.%26aulast%3DFulghum%26aufirst%3DJ.%2BR.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520%2528MAPKAP%2529%2520kinase%25202%2520suggests%2520a%2520bifunctional%2520switch%2520that%2520couples%2520kinase%2520activation%2520with%2520nuclear%2520export%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D37401%26epage%3D37405%26doi%3D10.1074%2Fjbc.C200418200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kurumbail, R. G.; Pawlitz, J. L.; Stegeman, R. A.; Stallings, W. C.; Shieh, H.-S.; Mourey, R. J.; Bolten, S. L.; Broadus, R. M.</span><span> </span><span class="NLM_article-title">Crystalline structure of human MPAKAP kinase-2</span>. WO2003/076333, A2, <span class="NLM_month">September</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+G.+Kurumbail&author=J.+L.+Pawlitz&author=R.+A.+Stegeman&author=W.+C.+Stallings&author=H.-S.+Shieh&author=R.+J.+Mourey&author=S.+L.+Bolten&author=R.+M.+Broadus&title=Crystalline+structure+of+human+MPAKAP+kinase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DCrystalline%2520structure%2520of%2520human%2520MPAKAP%2520kinase-2%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1107/S0907444909046411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS0907444909046411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=80-87&author=A.+Fujinoauthor=K.+Fukushimaauthor=N.+Namikiauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Structural+analysis+of+an+MK2-inhibitor+complex%3A+insight+into+the+regulation+of+the+secondary+structure+of+the+Gly-rich+loop+by+TEI-I01800&doi=10.1107%2FS0907444909046411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909046411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909046411%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DNamiki%26aufirst%3DN.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520an%2520MK2-inhibitor%2520complex%253A%2520insight%2520into%2520the%2520regulation%2520of%2520the%2520secondary%2520structure%2520of%2520the%2520Gly-rich%2520loop%2520by%2520TEI-I01800%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D80%26epage%3D87%26doi%3D10.1107%2FS0907444909046411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Fujino-Nakajima, A.</span><span> </span><span class="NLM_article-title">Structural studies of ligand–protein complex: the importance of structural change for drug design</span>. Doctoral Thesis. <span class="NLM_publisher-name">Hokkaido University</span>, <span class="NLM_month">March</span><span class="NLM_day">25</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://eprints.lib.hokudai.ac.jp/dspace/handle/2115/56257" class="extLink">http://eprints.lib.hokudai.ac.jp/dspace/handle/2115/56257</a> (accessed July 31, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Fujino-Nakajima&title=Structural+studies+of+ligand%E2%80%93protein+complex%3A+the+importance+of+structural+change+for+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino-Nakajima%26aufirst%3DA.%26atitle%3DStructural%2520studies%2520of%2520ligand%25E2%2580%2593protein%2520complex%253A%2520the%2520importance%2520of%2520structural%2520change%2520for%2520drug%2520design%26pub%3DHokkaido%2520University%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1348</span><span class="refDoi"> DOI: 10.1107/S1744309113030534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS1744309113030534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24316826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1344-1348&author=A.+Fujinoauthor=K.+Fukushimaauthor=T.+Kubotaauthor=Y.+Matsumotoauthor=M.+Takimoto-Kamimura&title=Structure+of+the+%CE%B2-form+of+human+MK2+in+complex+with+the+non-selective+kinase+inhibitor+TEI-L03090&doi=10.1107%2FS1744309113030534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090</span></div><div class="casAuthors">Fujino, Aiko; Fukushima, Kei; Kubota, Takaharu; Matsumoto, Yoshiyuki; Takimoto-Kamimura, Midori</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2), a serine/threonine kinase from the p38 mitogen-activated protein kinase signalling pathway, plays an important role in the prodn. of TNF-α and other cytokines.  In a previous report, it was shown that MK2 in complex with the selective inhibitor TEI-L01800 adopts an α-helical glycine-rich loop that is induced by the stable nonplanar conformer of TEI-L01800.  To understand the mechanism of the structural change, the structure of MK2 bound to TEI-L03090, which lacks the key substituent found in TEI-L01800, was detd.  MK2-TEI-L03090 has a β-sheet glycine-rich loop in common with other kinases, as predicted.  This result suggests that a small compd. can induce a drastic conformational change in the target protein structure and can be used to design potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6JmH2azAt7Vg90H21EOLACvtfcHk0liy8kLDJE0TxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsrbM&md5=73ddbd723d3257362baf0874956de03f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS1744309113030534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309113030534%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520%25CE%25B2-form%2520of%2520human%2520MK2%2520in%2520complex%2520with%2520the%2520non-selective%2520kinase%2520inhibitor%2520TEI-L03090%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D1344%26epage%3D1348%26doi%3D10.1107%2FS1744309113030534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TI-I01800: insight into the selectivity</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span><span class="refDoi"> DOI: 10.1107/S0909049513020736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1107%2FS0909049513020736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24121337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=905-909&author=A.+Fujinoauthor=K.+Fukushimaauthor=T.+Kubotaauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Crystal+structure+of+human+cyclin-dependent+kinase-2+complex+with+MK2+inhibitor+TI-I01800%3A+insight+into+the+selectivity&doi=10.1107%2FS0909049513020736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity</span></div><div class="casAuthors">Fujino, Aiko; Fukushima, Kei; Kubota, Takaharu; Kosugi, Tomomi; Takimoto-Kamimura, Midori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases.  The crystal structure of the MK2-TEI-I01800 complex has been reported; its Gly-rich loop was found to form an α-helix, not a β-sheet as has been obsd. for other Ser/Thr kinases.  TEI-I01800 is 177-fold selective against MK2 compared with CDK2; in order to understand the inhibitory mechanism of TEI-I01800, the cyclin-dependent kinase 2 (CDK2) complex structure with TEI-I01800 was detd. at 2.0 Å resoln.  Interestingly, the Gly-rich loop of CDK2 formed a β-sheet that was different from that of MK2.  In MK2, TEI-I01800 changed the secondary structure of the Gly-rich loop from a β-sheet to an α-helix by collision between Leu70 and a p-ethoxyphenyl group at the 7-position and bound to MK2.  However, for CDK2, TEI-I01800 bound to CDK2 without this structural change and lost the interaction with the substituent at the 7-position.  In summary, the results of this study suggest that the reason for the selectivity of TEI-I01800 is the favorable conformation of TEI-I01800 itself, making it suitable for binding to the α-form MK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFXyYybtRo3bVg90H21EOLACvtfcHk0liy8kLDJE0TxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsbrN&md5=681e5085a210ae5db2e8c685183016c8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0909049513020736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049513020736%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cyclin-dependent%2520kinase-2%2520complex%2520with%2520MK2%2520inhibitor%2520TI-I01800%253A%2520insight%2520into%2520the%2520selectivity%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2013%26volume%3D20%26spage%3D905%26epage%3D909%26doi%3D10.1107%2FS0909049513020736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericsson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banach, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankovich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhukhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine MK2 inhibitors. Part I: observation of an unexpected inhibitor binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=330-333&author=M.+A.+Argiriadiauthor=A.+M.+Ericssonauthor=C.+M.+Harrisauthor=D.+L.+Banachauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=M.+D.+Demersauthor=J.+DiMauroauthor=R.+W.+Dixonauthor=J.+Hardmanauthor=S.+Kwakauthor=B.+Liauthor=J.+A.+Mankovichauthor=D.+Marcotteauthor=K.+D.+Mullenauthor=B.+Niauthor=M.+Pietrasauthor=R.+Sadhukhanauthor=S.+Sousaauthor=M.+J.+Tomlinsonauthor=L.+Wangauthor=T.+Xiangauthor=R.+V.+Talanian&title=2%2C4-Diaminopyrimidine+MK2+inhibitors.+Part+I%3A+observation+of+an+unexpected+inhibitor+binding+mode&doi=10.1016%2Fj.bmcl.2009.10.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DEricsson%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDemers%26aufirst%3DM.%2BD.%26aulast%3DDiMauro%26aufirst%3DJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMankovich%26aufirst%3DJ.%2BA.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMullen%26aufirst%3DK.%2BD.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DPietras%26aufirst%3DM.%26aulast%3DSadhukhan%26aufirst%3DR.%26aulast%3DSousa%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26atitle%3D2%252C4-Diaminopyrimidine%2520MK2%2520inhibitors.%2520Part%2520I%253A%2520observation%2520of%2520an%2520unexpected%2520inhibitor%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D330%26epage%3D333%26doi%3D10.1016%2Fj.bmcl.2009.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masih, L.</span><span> </span><span class="NLM_article-title">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2005.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=15745802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1587-1590&author=D.+R.+Andersonauthor=S.+Hegdeauthor=E.+Reinhardauthor=L.+Gomezauthor=W.+F.+Vernierauthor=L.+Leeauthor=S.+Liuauthor=A.+Sambandamauthor=P.+A.+Sniderauthor=L.+Masih&title=Aminocyanopyridine+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2005.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span></div><div class="casAuthors">Anderson, David R.; Hegde, Shridhar; Reinhard, Emily; Gomez, Leslie; Vernier, William F.; Lee, Len; Liu, Shuang; Sambandam, Aruna; Snider, Patricia A.; Masih, Liaqat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1587-1590</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered.  These compds. have demonstrated activity against the enzyme with IC50 values as low as 130 nM and suppress the expression of TNFα in U937 cells.  These represent the first small mol. inhibitors of MK-2 to be reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LFlRxNk6lbVg90H21EOLACvtfcHk0lilDsJ7P-OOpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntbw%253D&md5=a6742a967cd1dfa3d03f283a5bb76b8a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSambandam%26aufirst%3DA.%26aulast%3DSnider%26aufirst%3DP.%2BA.%26aulast%3DMasih%26aufirst%3DL.%26atitle%3DAminocyanopyridine%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1587%26epage%3D1590%26doi%3D10.1016%2Fj.bmcl.2005.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dix, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murziani, P. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokicki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zayed, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipling, D.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38α<sup>MAPK</sup> inhibitors in Werner syndrome cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6832</span><span class="NLM_x">–</span> <span class="NLM_lpage">6835</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.10.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6832-6835&author=T.+Davisauthor=M.+C.+Bagleyauthor=M.+C.+Dixauthor=P.+G.+S.+Murzianiauthor=M.+J.+Rokickiauthor=C.+S.+Widdowsonauthor=J.+M.+Zayedauthor=M.+A.+Bachlerauthor=D.+Kipling&title=Synthesis+and+in+vivo+activity+of+MK2+and+MK2+substrate-selective+p38%CE%B1MAPK+inhibitors+in+Werner+syndrome+cells&doi=10.1016%2Fj.bmcl.2007.10.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26aulast%3DDix%26aufirst%3DM.%2BC.%26aulast%3DMurziani%26aufirst%3DP.%2BG.%2BS.%26aulast%3DRokicki%26aufirst%3DM.%2BJ.%26aulast%3DWiddowson%26aufirst%3DC.%2BS.%26aulast%3DZayed%26aufirst%3DJ.%2BM.%26aulast%3DBachler%26aufirst%3DM.%2BA.%26aulast%3DKipling%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520activity%2520of%2520MK2%2520and%2520MK2%2520substrate-selective%2520p38%25CE%25B1MAPK%2520inhibitors%2520in%2520Werner%2520syndrome%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6832%26epage%3D6835%26doi%3D10.1016%2Fj.bmcl.2007.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span><span class="refDoi"> DOI: 10.1021/jm0611004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1021%2Fjm0611004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span></div><div class="casAuthors">Anderson, David R.; Meyers, Marvin J.; Vernier, William F.; Mahoney, Matthew W.; Kurumbail, Ravi G.; Caspers, Nicole; Poda, Gennadiy I.; Schindler, John F.; Reitz, David B.; Mourey, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2647-2654</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent kinase inhibitors selective for mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) for the treatment of rheumatoid arthritis has been prepd. and evaluated.  These inhibitors have IC50 values as low as 10 nM against the target and have good selectivity profiles against a no. of kinases including CDK2, ERK, JNK, and p38.  These MK-2 inhibitors have been shown to suppress TNFα prodn. in U937 cells and to be efficacious in an acute inflammation model.  The structure-activity relationships of this series, the selectivity for MK-2 and their activity in both in vitro and in vivo models are discussed.  The obsd. selectivity is discussed with the aid of an MK-2/inhibitor crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr54CPyUUnyw7Vg90H21EOLACvtfcHk0lilDsJ7P-OOpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVWqsbY%253D&md5=f10df7433917d2833c99e966141a39da</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654%26doi%3D10.1021%2Fjm0611004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Chiang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wene, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbo, J. G.</span><span> </span><span class="NLM_article-title">Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1002/jps.21425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fjps.21425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=18449936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1WjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=248-256&author=P.-C.+Chiangauthor=S.+A.+Southauthor=J.+S.+Danielsauthor=D.+R.+Andersonauthor=S.+P.+Weneauthor=L.+A.+Albinauthor=R.+J.+Moureyauthor=J.+G.+Selbo&title=Aqueous+versus+non-aqueous+salt+delivery+strategies+to+enhance+oral+bioavailability+of+a+mitogen-activated+protein+kinase-activated+protein+kinase+%28MK-2%29+inhibitor+in+rats&doi=10.1002%2Fjps.21425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats</span></div><div class="casAuthors">Chiang, Po-Chang; South, Sarah A.; Daniels, J. Scott; Anderson, David R.; Wene, Steve P.; Albin, Lesley A.; Mourey, Robert J.; Selbo, Jon G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-256</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A potent pyridine-contg. MK2 inhibitor has recently been internally discovered.  In pre-clin. dosing, the low soly. of the neutral form limited oral bioavailability and dose escalation in toxicity studies.  A mesylate salt was developed as part of a formulation strategy to enhance both oral bioavailability and dose escalation orally in pre-clin. rat studies.  Several non-aq. systems were used to deliver the mesylate salt, which resulted in varied oral bioavailability.  It was found that administration of an aq. chaser immediately after dosing drastically increased the oral bioavailability of the salt.  This finding implies that the quantity of water present in vivo is an important consideration when evaluating salts of free bases with low aq. soly. in pre-clin. in vivo rat models where limited aq. vehicle may be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopAOIZBHEqdrVg90H21EOLACvtfcHk0litK2WGrkJv3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1WjtA%253D%253D&md5=8e681ea0d66edf27d98fdf66036fafc7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.21425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21425%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DWene%26aufirst%3DS.%2BP.%26aulast%3DAlbin%26aufirst%3DL.%2BA.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DSelbo%26aufirst%3DJ.%2BG.%26atitle%3DAqueous%2520versus%2520non-aqueous%2520salt%2520delivery%2520strategies%2520to%2520enhance%2520oral%2520bioavailability%2520of%2520a%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%2520%2528MK-2%2529%2520inhibitor%2520in%2520rats%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D248%26epage%3D256%26doi%3D10.1002%2Fjps.21425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Pengal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guess, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benndorf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smoyer, W. E.</span><span> </span><span class="NLM_article-title">Inhibition of the protein kinase MK-2 promotes podocytes from nephrotic syndrome-related injury</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">F509</span><span class="NLM_x">–</span> <span class="NLM_lpage">F519</span><span class="refDoi"> DOI: 10.1152/ajprenal.00661.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1152%2Fajprenal.00661.2010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=F509-F519&author=R.+Pengalauthor=A.+J.+Guessauthor=S.+Agrawalauthor=J.+Manleyauthor=R.+F.+Ransomauthor=R.+J.+Moureyauthor=R.+Benndorfauthor=W.+E.+Smoyer&title=Inhibition+of+the+protein+kinase+MK-2+promotes+podocytes+from+nephrotic+syndrome-related+injury&doi=10.1152%2Fajprenal.00661.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00661.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00661.2010%26sid%3Dliteratum%253Aachs%26aulast%3DPengal%26aufirst%3DR.%26aulast%3DGuess%26aufirst%3DA.%2BJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DManley%26aufirst%3DJ.%26aulast%3DRansom%26aufirst%3DR.%2BF.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBenndorf%26aufirst%3DR.%26aulast%3DSmoyer%26aufirst%3DW.%2BE.%26atitle%3DInhibition%2520of%2520the%2520protein%2520kinase%2520MK-2%2520promotes%2520podocytes%2520from%2520nephrotic%2520syndrome-related%2520injury%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DF509%26epage%3DF519%26doi%3D10.1152%2Fajprenal.00661.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokicki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipling, D.</span><span> </span><span class="NLM_article-title">The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome</span> <span class="citation_source-journal">Chem. Cent. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="refDoi"> DOI: 10.1186/1752-153X-7-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1186%2F1752-153X-7-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=23360642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=18&author=T.+Davisauthor=M.+J.+Rokickiauthor=M.+C.+Bagleyauthor=D.+Kipling&title=The+effect+of+small-molecule+inhibition+of+MAPKAPK2+on+cell+ageing+phenotypes+of+fibroblasts+from+human+Werner+syndrome&doi=10.1186%2F1752-153X-7-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome</span></div><div class="casAuthors">Davis, Terence; Rokicki, Michal J.; Bagley, Mark C.; Kipling, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Central Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18</span>CODEN:
                <span class="NLM_cas:coden">CCJHA2</span>;
        ISSN:<span class="NLM_cas:issn">1752-153X</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Fibroblasts derived from the progeroid Werner syndrome (WS) show reduced replicative lifespan and a "stressed" morphol., both phenotypes being alleviated by using the p38 MAP kinase inhibitor SB203580.  Because p38 is a major hub for the control of stress-signalling pathways we were interested in examg. the possible role for downstream kinases in order to refine our understanding of the role of p38 signalling in regulation of WS cell growth.  To this end we treated WS and normal fibroblasts with MK2 inhibitors to det. whether MK2 inhibition would affect either the growth or morphol. of WS cells.  The first inhibitor, 7,8-dihydroxy-2,4-diamino-3-cyanobenzopyranopyridine (inhibitor 2), resulted in inhibition of WS cell growth and had no effect on morphol., effects that occurred below the level needed to inhibit MK2 and thus suggestive of inhibitor toxicity.  The second inhibitor, 2-(2-quinolin-3-ylpyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo-[3,2-c]pyridin-4-one (CMPD16), resulted in a significant extension of WS fibroblast replicative capacity compared to normal cells.  In addn., CMPD16 reverted the WS cellular morphol. to that seen in normal dermal fibroblasts.  These data suggest that MK2 activity plays a substantial role in proliferation control in WS cells.  CMPD16 was not as effective in cellular lifespan extension as SB203580, however, suggesting that, although MK2 is a downstream kinase involved in cell cycle arrest, other p38 targets may play a role.  Alternatively, as CMPD16 is toxic to cell growth at levels just above those that extend lifespan, it is possible that the therapeutic window is too small.  However, as CMPD16 does show significant effects in WS fibroblasts, this acts as proof-of-principle for the efforts to design and synthesize improved MK2 inhibitors.  As MK2 is involved in inflammatory processes and inflammation plays a major role in WS phenotypes, these data suggest MK2 as a potential therapeutic target for the treatment of Werner syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplRBsO_pQJR7Vg90H21EOLACvtfcHk0litK2WGrkJv3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVensrs%253D&md5=c16ff6dc7073ddaf226bfd2eb5c1d383</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1186%2F1752-153X-7-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1752-153X-7-18%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DRokicki%26aufirst%3DM.%2BJ.%26aulast%3DBagley%26aufirst%3DM.%2BC.%26aulast%3DKipling%26aufirst%3DD.%26atitle%3DThe%2520effect%2520of%2520small-molecule%2520inhibition%2520of%2520MAPKAPK2%2520on%2520cell%2520ageing%2520phenotypes%2520of%2520fibroblasts%2520from%2520human%2520Werner%2520syndrome%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2013%26volume%3D7%26spage%3D18%26doi%3D10.1186%2F1752-153X-7-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchler, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.05.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4657-4663&author=J.+I.+Trujilloauthor=M.+J.+Meyersauthor=D.+R.+Andersonauthor=S.+Hegdeauthor=M.+W.+Mahoneyauthor=W.+F.+Vernierauthor=I.+P.+Buchlerauthor=K.+K.+Wuauthor=S.+Yangauthor=S.+J.+Hartmannauthor=D.+B.+Reitz&title=Novel+tetrahydro-%CE%B2-carboline-1-carboxylic+acids+as+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2007.05.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DBuchler%26aufirst%3DI.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DS.%2BJ.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520tetrahydro-%25CE%25B2-carboline-1-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4657%26epage%3D4663%26doi%3D10.1016%2Fj.bmcl.2007.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessment of selectivity and cellular potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.02.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4878-4881&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Mourey&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+structure-activity+relationships%2C+assessment+of+selectivity+and+cellular+potency&doi=10.1016%2Fj.bmcl.2009.02.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520structure-activity%2520relationships%252C%2520assessment%2520of%2520selectivity%2520and%2520cellular%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4878%26epage%3D4881%26doi%3D10.1016%2Fj.bmcl.2009.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M. D.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: improvements in kinase selectivity and cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.02.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4882-4884&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Moureyauthor=M.+D.+Parikh&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+improvements+in+kinase+selectivity+and+cell+potency&doi=10.1016%2Fj.bmcl.2009.02.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520improvements%2520in%2520kinase%2520selectivity%2520and%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4882%26epage%3D4884%26doi%3D10.1016%2Fj.bmcl.2009.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckenzie, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. W.,  II.</span><span> </span><span class="NLM_article-title">Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.2174/18723128112066660018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F18723128112066660018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=24138031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFajt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=15-22&author=J.+S.+Danielsauthor=Y.+Laiauthor=S.+A.+Southauthor=P.-C.+Chiangauthor=D.+Walkerauthor=B.+Fengauthor=R.+Mirelesauthor=L.+O.+Whiteleyauthor=J.+W.+Mckenzieauthor=J.+Stevensauthor=R.+Moureyauthor=D.+Andersonauthor=J.+W.+Davis&title=Inhibition+of+hepatobiliary+transporters+by+a+novel+kinase+inhibitor+contributes+to+hepatotoxicity+in+beagle+dogs&doi=10.2174%2F18723128112066660018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs</span></div><div class="casAuthors">Daniels, John Scott; Lai, Yurong; South, Sarah; Chiang, Po-Chang; Walker, Daniel; Feng, Bo; Mireles, Rouchelle; Whiteley, Laurence O.; McKenzie, Jeremy W.; Stevens, Jeffrey; Mourey, Robert; Anderson, David; Davis, John W., II</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">PF-022 (1) is a novel polycyclic benzothiophene kinase inhibitor selective for mitogen-activated protein kinase-activated protein kinase 2 (MK2).  Compd. 1 emerged as an inhibitor bearing submicromolar potency against MK2 (IC50 5 nM) and demonstrated projected human pharmacokinetics sufficient for oral dosing.  However, following a single, oral administration of 1 to beagle dogs, animals experienced an acute liver injury characterized by increases in biomarkers assocd. with hepatotoxicity; particularly noteworthy was the reversible elevation in bile salts and total bilirubin.  Accompanying this observation was an ADME appraisal which included hepatic bioactivation of 1 in multiple species and the in vitro inhibition of P-glycoprotein (P-gp; IC50 21 μM).  Simply attenuating the bioactivation via structural modification proved ineffective in improving the in vivo tolerability of this polycyclic scaffold.  Hence, disruption of hepatobiliary transporters by the compd. series was hypothesized as the likely mechanism contributing to the acute hepatotoxicity.  Indeed, closer in vitro examn. employing transporter gene overexpressing MDCK cell lines and membrane vesicles revealed potent compd.-dependent inhibition of human multi-drug resistance-assocd. protein 2 (MRP2/ABCC2; IC50 38 μM) and bile salt export pump (BSEP/ABCB11; IC50 10 μM), two crucial hepatobiliary transport proteins accountable for bilirubin and bile salt homeostasis, resp.  Subsequent introduction of pKa-altering modifications to a second generation compd. PF029 proved successful in reducing its affinity for these key efflux transporters (MRP2 IC50 >>80 μM; BSEP IC50 > 70 μM; P-gp > 90 μM), consequently mitigating this overt organ toxicity in dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUobVwgG0UbVg90H21EOLACvtfcHk0ljv7ntUTPyydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFajt7Y%253D&md5=fc0902d34c34968575639a38bbd62172</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F18723128112066660018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18723128112066660018%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DChiang%26aufirst%3DP.-C.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMireles%26aufirst%3DR.%26aulast%3DWhiteley%26aufirst%3DL.%2BO.%26aulast%3DMckenzie%26aufirst%3DJ.%2BW.%26aulast%3DStevens%26aufirst%3DJ.%26aulast%3DMourey%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DJ.%2BW.%26atitle%3DInhibition%2520of%2520hepatobiliary%2520transporters%2520by%2520a%2520novel%2520kinase%2520inhibitor%2520contributes%2520to%2520hepatotoxicity%2520in%2520beagle%2520dogs%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2013%26volume%3D7%26spage%3D15%26epage%3D22%26doi%3D10.2174%2F18723128112066660018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">South, S. A.; Stevens, J.; Walker, G.; Parikh, M.; Walker, D.; Rock, D.; Thompson, D.; Mourey, R.; Anderson, D.; Daniels, J. S.</span><span> </span><span class="NLM_article-title">Hepatic metabolism of a novel kinase inhibitor reveals a dual mechanism of bioactivation</span>. <span class="NLM_conf-name">15th North American Regional ISSX Meeting</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">October 12–16, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=South%2C+S.+A.%3B+Stevens%2C+J.%3B+Walker%2C+G.%3B+Parikh%2C+M.%3B+Walker%2C+D.%3B+Rock%2C+D.%3B+Thompson%2C+D.%3B+Mourey%2C+R.%3B+Anderson%2C+D.%3B+Daniels%2C+J.+S.+Hepatic+metabolism+of+a+novel+kinase+inhibitor+reveals+a+dual+mechanism+of+bioactivation.+15th+North+American+Regional+ISSX+Meeting%2C+San+Diego%2C+CA%2C+October+12%E2%80%9316%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSouth%26aufirst%3DS.%2BA.%26atitle%3DHepatic%2520metabolism%2520of%2520a%2520novel%2520kinase%2520inhibitor%2520reveals%2520a%2520dual%2520mechanism%2520of%2520bioactivation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span> </span><span class="NLM_article-title">Sonic Hedgehog stimulates glycolysis and proliferation of breast cancer cells: modulation of PFKFB3 activation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bbrc.2015.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2015&pages=862-868&author=X.+Geauthor=P.+Lyuauthor=Y.+Guauthor=L.+Liauthor=J.+Liauthor=Y.+Wangauthor=L.+Zhangauthor=C.+Fuauthor=Z.+Cao&title=Sonic+Hedgehog+stimulates+glycolysis+and+proliferation+of+breast+cancer+cells%3A+modulation+of+PFKFB3+activation&doi=10.1016%2Fj.bbrc.2015.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DZ.%26atitle%3DSonic%2520Hedgehog%2520stimulates%2520glycolysis%2520and%2520proliferation%2520of%2520breast%2520cancer%2520cells%253A%2520modulation%2520of%2520PFKFB3%2520activation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D464%26spage%3D862%26epage%3D868%26doi%3D10.1016%2Fj.bbrc.2015.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petricci, E.</span><span> </span><span class="NLM_article-title">Structure-activity relationships and mechanism of action of small molecule Smoothened modulators discovered by high-throughput screening and rational design</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1007/7355_2014_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2F7355_2014_61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=43-108&author=F.+Manettiauthor=M.+Taddeiauthor=E.+Petricci&title=Structure-activity+relationships+and+mechanism+of+action+of+small+molecule+Smoothened+modulators+discovered+by+high-throughput+screening+and+rational+design&doi=10.1007%2F7355_2014_61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2F7355_2014_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2014_61%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DPetricci%26aufirst%3DE.%26atitle%3DStructure-activity%2520relationships%2520and%2520mechanism%2520of%2520action%2520of%2520small%2520molecule%2520Smoothened%2520modulators%2520discovered%2520by%2520high-throughput%2520screening%2520and%2520rational%2520design%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2015%26volume%3D16%26spage%3D43%26epage%3D108%26doi%3D10.1007%2F7355_2014_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span><span class="refDoi"> DOI: 10.1021/jm2013369</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013369" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVylsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1559-1571&author=A.+Solinasauthor=H.+Faureauthor=H.+Roudautauthor=E.+Traiffortauthor=A.+Schoenfelderauthor=A.+Mannauthor=F.+Manettiauthor=M.+Taddeiauthor=M.+Ruat&title=Acylthiourea%2C+acylurea%2C+and+acylguanidine+derivatives+with+potent+hedgehog+inhibiting+activity&doi=10.1021%2Fjm2013369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity</span></div><div class="casAuthors">Solinas, Antonio; Faure, Helene; Roudaut, Hermine; Traiffort, Elisabeth; Schoenfelder, Angele; Mann, Andre; Manetti, Fabrizio; Taddei, Maurizio; Ruat, Martial</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1559-1571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Smoothened (Smo) receptor is the major transducer of the Hedgehog (Hh) signaling pathway.  On the basis of the structure of the acylthiourea Smo antagonist (MRT-10), a no. of different series of analogous compds. were prepd. by ligand-based structural optimization.  The acylthioureas, originally identified as actives, were converted into the corresponding acylureas or acylguanidines.  In each series, similar structural trends delivered potent compds. with IC50 values in the nanomolar range with respect to the inhibition of the Hh signaling pathway in various cell-based assays and of BODIPY-cyclopamine binding to human Smo.  The similarity of their biol. activities, in spite of discrete structural differences, may reveal the existence of hydrogen-bonding interactions between the ligands and the receptor pocket.  Biol. potency of compds. I(X = S, O) and II (MRT-83) were comparable to those of the clin. candidate GDC-0449.  These findings suggest that these original mols. will help delineate Smo and Hh functions and can be developed as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOqY0lv-AC7Vg90H21EOLACvtfcHk0lhCbtPYovCHUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVylsrw%253D&md5=65039a713bea1d973353182fbba3e528</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm2013369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013369%26sid%3Dliteratum%253Aachs%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DAcylthiourea%252C%2520acylurea%252C%2520and%2520acylguanidine%2520derivatives%2520with%2520potent%2520hedgehog%2520inhibiting%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1559%26epage%3D1571%26doi%3D10.1021%2Fjm2013369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorojankina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1124/mol.110.069708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.110.069708" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=453-460&author=H.+Roudautauthor=E.+Traiffortauthor=T.+Gorojankinaauthor=L.+Vincentauthor=H.+Faureauthor=A.+Schoenfelderauthor=A.+Mannauthor=F.+Manettiauthor=A.+Solinasauthor=M.+Taddeiauthor=M.+Ruat&title=Identification+and+mechanism+of+action+of+the+acylguanidine+MRT-83%2C+a+novel+potent+Smoothened+antagonist&doi=10.1124%2Fmol.110.069708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.069708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.069708%26sid%3Dliteratum%253Aachs%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DGorojankina%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520mechanism%2520of%2520action%2520of%2520the%2520acylguanidine%2520MRT-83%252C%2520a%2520novel%2520potent%2520Smoothened%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D453%26epage%3D460%26doi%3D10.1124%2Fmol.110.069708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roudaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorojankina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfelder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as Smoothened antagonists</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span><span class="refDoi"> DOI: 10.1124/mol.110.065102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1124%2Fmol.110.065102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=658-665&author=F.+Manettiauthor=H.+Faureauthor=H.+Roudautauthor=T.+Gorojankinaauthor=E.+Traiffortauthor=A.+Schoenfelderauthor=A.+Mannauthor=A.+Solinasauthor=M.+Taddeiauthor=M.+Ruat&title=Virtual+screening-based+discovery+and+mechanistic+characterization+of+the+acylthiourea+MRT-10+family+as+Smoothened+antagonists&doi=10.1124%2Fmol.110.065102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.065102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.065102%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DGorojankina%26aufirst%3DT.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DSolinas%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DVirtual%2520screening-based%2520discovery%2520and%2520mechanistic%2520characterization%2520of%2520the%2520acylthiourea%2520MRT-10%2520family%2520as%2520Smoothened%2520antagonists%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D658%26epage%3D665%26doi%3D10.1124%2Fmol.110.065102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaz, S.</span><span> </span><span class="NLM_article-title">Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.1021/jm201217q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201217q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ogsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2035-2047&author=S.+Natesanauthor=R.+Subramaniamauthor=C.+Bergeronauthor=S.+Balaz&title=Binding+affinity+prediction+for+ligands+and+receptors+forming+tautomers+and+ionization+species%3A+inhibition+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK2%29&doi=10.1021%2Fjm201217q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Affinity Prediction for Ligands and Receptors Forming Tautomers and Ionization Species: Inhibition of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2)</span></div><div class="casAuthors">Natesan, Senthil; Subramaniam, Rajesh; Bergeron, Charles; Balaz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2035-2047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of ionization and tautomerism of ligands and receptors is one of the unresolved issues in structure-based prediction of binding affinities.  Our soln. utilizes the thermodn. master equation, expressing the exptl. obsd. assocn. const. as the sum of products, each valid for a specific ligand-receptor species pair, consisting of the assocn. microconstant and the fractions of the involved ligand and receptor species.  The microconstants are characterized by structure-based simulations, which are run for individual species pairs.  Here we incorporated the multispecies approach into the QM/MM linear response method and used it for structural correlation of published inhibition data on mitogen-activated protein kinase (MAPK)-activated protein kinase (MK2) by 66 benzothiophene and pyrrolopyridine analogs, forming up to five tautomers and seven ionization species under exptl. conditions.  Extensive cross-validation showed that the resulting models were stable and predictive.  Inclusion of all tautomers and ionization ligand species was essential: the explained variance increased to 90% from 66% for the single-species model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph5PM-NCtdi7Vg90H21EOLACvtfcHk0lhCbtPYovCHUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ogsbg%253D&md5=346653d98cea8a45bf643cc7f985435f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm201217q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201217q%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSubramaniam%26aufirst%3DR.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DBalaz%26aufirst%3DS.%26atitle%3DBinding%2520affinity%2520prediction%2520for%2520ligands%2520and%2520receptors%2520forming%2520tautomers%2520and%2520ionization%2520species%253A%2520inhibition%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2035%26epage%3D2047%26doi%3D10.1021%2Fjm201217q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">The discovery of carboline analogs as potent MAPKAP-K2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4664</span><span class="NLM_x">–</span> <span class="NLM_lpage">4669</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.05.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4664-4669&author=J.-P.+Wuauthor=J.+Wangauthor=A.+Abeywardaneauthor=D.+Andersenauthor=M.+Emmanuelauthor=E.+Gautschiauthor=D.+R.+Goldbergauthor=M.+A.+Kashemauthor=S.+Lukasauthor=W.+Maoauthor=L.+Martinauthor=T.+Morwickauthor=N.+Mossauthor=C.+Pargellisauthor=U.+R.+Patelauthor=L.+Patnaudeauthor=G.+W.+Peetauthor=D.+Skowauthor=R.+J.+Snowauthor=Y.+Wardauthor=B.+Werneburgauthor=A.+White&title=The+discovery+of+carboline+analogs+as+potent+MAPKAP-K2+inhibitors&doi=10.1016%2Fj.bmcl.2007.05.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.101%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DD.%26aulast%3DEmmanuel%26aufirst%3DM.%26aulast%3DGautschi%26aufirst%3DE.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DU.%2BR.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520carboline%2520analogs%2520as%2520potent%2520MAPKAP-K2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4664%26epage%3D4669%26doi%3D10.1016%2Fj.bmcl.2007.05.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netherton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+DeLeonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torcelliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Wastiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2&doi=10.1016%2Fj.bmcl.2007.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0lgaPBHIqWACgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeLeon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWasti%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941%26doi%3D10.1016%2Fj.bmcl.2007.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieselmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of indole-based MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2008.01.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1994-1999&author=Z.+Xiongauthor=D.+A.+Gaoauthor=D.+A.+Coganauthor=D.+R.+Goldbergauthor=M.-H.+Haoauthor=N.+Mossauthor=E.+Packauthor=C.+Pargellisauthor=D.+Skowauthor=T.+Trieselmannauthor=B.+Werneburgauthor=A.+White&title=Synthesis+and+SAR+studies+of+indole-based+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2008.01.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.119%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DHao%26aufirst%3DM.-H.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTrieselmann%26aufirst%3DT.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520indole-based%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1994%26epage%3D1999%26doi%3D10.1016%2Fj.bmcl.2008.01.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Hillig, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberspaecher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteclaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Tiemann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, U.</span><span> </span><span class="NLM_article-title">Structural basis for a high affinity inhibitor bound to protein kinase MK2</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span><span class="refDoi"> DOI: 10.1016/j.jmb.2007.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jmb.2007.03.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=735-745&author=R.+C.+Hilligauthor=U.+Eberspaecherauthor=F.+Monteclaroauthor=M.+Huberauthor=D.+Nguyenauthor=A.+Mengelauthor=B.+Muller-Tiemannauthor=U.+Egner&title=Structural+basis+for+a+high+affinity+inhibitor+bound+to+protein+kinase+MK2&doi=10.1016%2Fj.jmb.2007.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DMonteclaro%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DMengel%26aufirst%3DA.%26aulast%3DMuller-Tiemann%26aufirst%3DB.%26aulast%3DEgner%26aufirst%3DU.%26atitle%3DStructural%2520basis%2520for%2520a%2520high%2520affinity%2520inhibitor%2520bound%2520to%2520protein%2520kinase%2520MK2%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D369%26spage%3D735%26epage%3D745%26doi%3D10.1016%2Fj.jmb.2007.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wilde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Someren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteegh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seegers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klop, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeets, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oubrie, A.</span><span> </span><span class="NLM_article-title">Structure-based lead identification of ATP-competitive MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3818</span><span class="NLM_x">–</span> <span class="NLM_lpage">3822</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.04.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3818-3822&author=T.+Barfauthor=A.+Kapteinauthor=S.+de+Wildeauthor=R.+van+der+Heijdenauthor=R.+van+Somerenauthor=D.+Demontauthor=C.+Schultz-Fademrechtauthor=J.+Versteeghauthor=M.+van+Zeelandauthor=N.+Seegersauthor=B.+Kazemierauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=J.+de+Roosauthor=H.+Klopauthor=R.+Smeetsauthor=C.+Hofstraauthor=J.+Hornbergauthor=A.+Oubrie&title=Structure-based+lead+identification+of+ATP-competitive+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2011.04.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3Dde%2BWilde%26aufirst%3DS.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DR.%26aulast%3Dvan%2BSomeren%26aufirst%3DR.%26aulast%3DDemont%26aufirst%3DD.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DVersteegh%26aufirst%3DJ.%26aulast%3Dvan%2BZeeland%26aufirst%3DM.%26aulast%3DSeegers%26aufirst%3DN.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DKlop%26aufirst%3DH.%26aulast%3DSmeets%26aufirst%3DR.%26aulast%3DHofstra%26aufirst%3DC.%26aulast%3DHornberg%26aufirst%3DJ.%26aulast%3DOubrie%26aufirst%3DA.%26atitle%3DStructure-based%2520lead%2520identification%2520of%2520ATP-competitive%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3818%26epage%3D3822%26doi%3D10.1016%2Fj.bmcl.2011.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Hanau, C. E.; Mershon, S. M.; Graneto, M. J.; Meyers, M. J.; Hegde, S. G.; Buchler, I. P.; Wu, K. K.; Liu, S.; Nacro, K.</span><span> </span><span class="NLM_article-title">Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2</span>. WO2004/058176 A2, <span class="NLM_month">July</span><span class="NLM_day">15</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+E.+Hanau&author=S.+M.+Mershon&author=M.+J.+Graneto&author=M.+J.+Meyers&author=S.+G.+Hegde&author=I.+P.+Buchler&author=K.+K.+Wu&author=S.+Liu&author=K.+Nacro&title=Acyclic+pyrazole+compounds+for+the+inhibition+of+mitogen+activated+protein+kinase-activated+protein+kinase-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanau%26aufirst%3DC.%2BE.%26atitle%3DAcyclic%2520pyrazole%2520compounds%2520for%2520the%2520inhibition%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase-2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oubrie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zwart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenboom, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kimpe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteegh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leandro-Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span> </span><span class="NLM_article-title">Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3827</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.04.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3823-3827&author=A.+Kapteinauthor=A.+Oubrieauthor=E.+de+Zwartauthor=N.+Hoogenboomauthor=J.+de+Witauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=G.+Vogelauthor=V.+de+Kimpeauthor=C.+Schultz-Fademrechtauthor=J.+Borsboomauthor=M.+van+Zeelandauthor=J.+Versteeghauthor=B.+Kazemierauthor=J.+de+Roosauthor=F.+Wijnandsauthor=J.+Dulosauthor=M.+Jaegerauthor=P.+Leandro-Garciaauthor=T.+Barf&title=Discovery+of+selective+and+orally+available+spiro-3-piperidyl+ATP-competitive+MK2+inhibitors&doi=10.1016%2Fj.bmcl.2011.04.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3Dde%2BZwart%26aufirst%3DE.%26aulast%3DHoogenboom%26aufirst%3DN.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3DVogel%26aufirst%3DG.%26aulast%3Dde%2BKimpe%26aufirst%3DV.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DBorsboom%26aufirst%3DJ.%26aulast%3Dvan%2BZeeland%26aufirst%3DM.%26aulast%3DVersteegh%26aufirst%3DJ.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DWijnands%26aufirst%3DF.%26aulast%3DDulos%26aufirst%3DJ.%26aulast%3DJaeger%26aufirst%3DM.%26aulast%3DLeandro-Garcia%26aufirst%3DP.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520selective%2520and%2520orally%2520available%2520spiro-3-piperidyl%2520ATP-competitive%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3823%26epage%3D3827%26doi%3D10.1016%2Fj.bmcl.2011.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Oubrie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zwart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenboom, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goorden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kimpe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazemier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span> </span><span class="NLM_article-title">Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.10.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=613-618&author=A.+Oubrieauthor=A.+Kapteinauthor=E.+de+Zwartauthor=N.+Hoogenboomauthor=R.+Goordenauthor=B.+van+de+Karauthor=M.+van+Hoekauthor=V.+de+Kimpeauthor=R.+van+der+Heijdenauthor=J.+Borsboomauthor=B.+Kazemierauthor=J.+de+Roosauthor=M.+Scheffersauthor=J.+Lommerseauthor=C.+Schultz-Fademrechtauthor=T.+Barf&title=Novel+ATP+competitive+MK2+inhibitors+with+potent+biochemical+and+cell-based+activity+throughout+the+series&doi=10.1016%2Fj.bmcl.2011.10.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3Dde%2BZwart%26aufirst%3DE.%26aulast%3DHoogenboom%26aufirst%3DN.%26aulast%3DGoorden%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DB.%26aulast%3Dvan%2BHoek%26aufirst%3DM.%26aulast%3Dde%2BKimpe%26aufirst%3DV.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DR.%26aulast%3DBorsboom%26aufirst%3DJ.%26aulast%3DKazemier%26aufirst%3DB.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%26aulast%3DScheffers%26aufirst%3DM.%26aulast%3DLommerse%26aufirst%3DJ.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DNovel%2520ATP%2520competitive%2520MK2%2520inhibitors%2520with%2520potent%2520biochemical%2520and%2520cell-based%2520activity%2520throughout%2520the%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D613%26epage%3D618%26doi%3D10.1016%2Fj.bmcl.2011.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span> </span><span class="NLM_article-title">Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3238</span><span class="NLM_x">–</span> <span class="NLM_lpage">3242</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.04.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3238-3242&author=S.+Linauthor=M.+Lombardoauthor=S.+Malkaniauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=S.+Luellauthor=E.+Carballo-Janeauthor=L.+Yang&title=Novel+1-%282-aminopyrazin-3-yl%29methyl-2-thioureas+as+potent+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2009.04.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.088%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DNovel%25201-%25282-aminopyrazin-3-yl%2529methyl-2-thioureas%2520as%2520potent%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3238%26epage%3D3242%26doi%3D10.1016%2Fj.bmcl.2009.04.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Meng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarri, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span> </span><span class="NLM_article-title">Potency switch between CHK1 and MK2: discovery of imidazo[1,2-<i>a</i>]pyrazine- and imidazo[1,2-<i>c</i>]pyrimidine-based kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2013.03.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2863-2867&author=Z.+Mengauthor=J.+P.+Ciavarriauthor=A.+McRinerauthor=Y.+Zhaoauthor=L.+Zhaoauthor=P.+A.+Reddyauthor=X.+Zhangauthor=T.+O.+Fischmannauthor=C.+Whitehurstauthor=M.+A.+Siddiqui&title=Potency+switch+between+CHK1+and+MK2%3A+discovery+of+imidazo%5B1%2C2-a%5Dpyrazine-+and+imidazo%5B1%2C2-c%5Dpyrimidine-based+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2013.03.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.100%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DCiavarri%26aufirst%3DJ.%2BP.%26aulast%3DMcRiner%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DReddy%26aufirst%3DP.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DWhitehurst%26aufirst%3DC.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26atitle%3DPotency%2520switch%2520between%2520CHK1%2520and%2520MK2%253A%2520discovery%2520of%2520imidazo%255B1%252C2-a%255Dpyrazine-%2520and%2520imidazo%255B1%252C2-c%255Dpyrimidine-based%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2863%26epage%3D2867%26doi%3D10.1016%2Fj.bmcl.2013.03.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelchli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6146</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2008.10.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6142-6146&author=A.+Schlapbachauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=G.+Kochauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=J.+Velcickyauthor=R.+Waelchliauthor=C.+Huppertz&title=Pyrrolo-pyrimidones%3A+a+novel+class+of+MK2+inhibitors+with+potent+cellular+activity&doi=10.1016%2Fj.bmcl.2008.10.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DWaelchli%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DPyrrolo-pyrimidones%253A%2520a%2520novel%2520class%2520of%2520MK2%2520inhibitors%2520with%2520potent%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6142%26epage%3D6146%26doi%3D10.1016%2Fj.bmcl.2008.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span> </span><span class="NLM_article-title">Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.138" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1293-1297&author=J.+Velcickyauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=C.+Huppertzauthor=G.+Kochauthor=M.+Kroemerauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=A.+Schlapbach&title=Novel+3-aminopyrazole+inhibitors+of+MK-2+discovered+by+scaffold+hopping+strategy&doi=10.1016%2Fj.bmcl.2009.10.138"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.138%26sid%3Dliteratum%253Aachs%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DNovel%25203-aminopyrazole%2520inhibitors%2520of%2520MK-2%2520discovered%2520by%2520scaffold%2520hopping%2520strategy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1293%26epage%3D1297%26doi%3D10.1016%2Fj.bmcl.2009.10.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4715</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.04.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4715-4718&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=P.+Hiestandauthor=W.+Jahnkeauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+I&doi=10.1016%2Fj.bmcl.2010.04.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4715%26epage%3D4718%26doi%3D10.1016%2Fj.bmcl.2010.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood-Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4719</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.04.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4719-4723&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=J.+Dawsonauthor=R.+Feifelauthor=S.+Hawtinauthor=A.+Littlewood-Evansauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+II&doi=10.1016%2Fj.bmcl.2010.04.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4719%26epage%3D4723%26doi%3D10.1016%2Fj.bmcl.2010.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericsson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiriadi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perron, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmetra, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talanian, R. V.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine MK2 inhibitors. Part I: structure-based inhibitor optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.10.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2009.10.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=334-337&author=C.+M.+Harrisauthor=A.+M.+Ericssonauthor=M.+A.+Argiriadiauthor=C.+Barberisauthor=D.+W.+Borhaniauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=G.+A.+Cunhaauthor=R.+W.+Dixonauthor=K.+E.+Frankauthor=E.+F.+Johnsonauthor=J.+Kamensauthor=S.+Kwakauthor=B.+Liauthor=K.+D.+Mullenauthor=D.+C.+Perronauthor=L.+Wangauthor=N.+Wishartauthor=X.+Wuauthor=X.+Zhangauthor=T.+R.+Zmetraauthor=R.+V.+Talanian&title=2%2C4-Diaminopyrimidine+MK2+inhibitors.+Part+I%3A+structure-based+inhibitor+optimization&doi=10.1016%2Fj.bmcl.2009.10.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.10.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.10.103%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DEricsson%26aufirst%3DA.%2BM.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DKamens%26aufirst%3DJ.%26aulast%3DKwak%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMullen%26aufirst%3DK.%2BD.%26aulast%3DPerron%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZmetra%26aufirst%3DT.%2BR.%26aulast%3DTalanian%26aufirst%3DR.%2BV.%26atitle%3D2%252C4-Diaminopyrimidine%2520MK2%2520inhibitors.%2520Part%2520I%253A%2520structure-based%2520inhibitor%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D334%26epage%3D337%26doi%3D10.1016%2Fj.bmcl.2009.10.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenouchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unoki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunliffe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalloo-Hosein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-<i>a</i>]pyrimidine inhibitors using a focused library and structure-based optimization approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1021/jm300411k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300411k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6700-6715&author=T.+Kosugiauthor=D.+R.+Mitchellauthor=A.+Fujinoauthor=M.+Imaiauthor=M.+Kambeauthor=S.+Kobayashiauthor=H.+Makinoauthor=Y.+Matsuedaauthor=Y.+Oueauthor=K.+Komatsuauthor=K.+Imaizumiauthor=Y.+Sakaiauthor=S.+Sugiuraauthor=O.+Takenouchiauthor=G.+Unokiauthor=Y.+Yamakoshiauthor=V.+Cunliffeauthor=J.+Frearsonauthor=R.+Gordonauthor=C.+J.+Harrisauthor=H.+Kalloo-Hoseinauthor=J.+Leauthor=G.+Patelauthor=D.+J.+Simpsonauthor=B.+Sherborneauthor=P.+S.+Thomasauthor=N.+Suzukiauthor=M.+Takimoto-Kamimuraauthor=K.+Kataoka&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MAPKAP-K2%29+as+an+antiinflammatory+target%3A+discovery+and+in+vivo+activity+of+selective+pyrazolo%5B1%2C5-a%5Dpyrimidine+inhibitors+using+a+focused+library+and+structure-based+optimization+approach&doi=10.1021%2Fjm300411k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach</span></div><div class="casAuthors">Kosugi, Tomomi; Mitchell, Dale R.; Fujino, Aiko; Imai, Minoru; Kambe, Mika; Kobayashi, Shinji; Makino, Hiroaki; Matsueda, Yohei; Oue, Yasuhiro; Komatsu, Kanji; Imaizumi, Keiichiro; Sakai, Yuri; Sugiura, Satoshi; Takenouchi, Osami; Unoki, Gen; Yamakoshi, Yuko; Cunliffe, Vicky; Frearson, Julie; Gordon, Richard; Harris, C. John; Kalloo-Hosein, Heidi; Le, Joelle; Patel, Gita; Simpson, Donald J.; Sherborne, Brad; Thomas, Peter S.; Suzuki, Naotaka; Takimoto-Kamimura, Midori; Kataoka, Ken-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6700-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library.  A homol. model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the obsd. selectivity over CDK2.  An x-ray crystal structure of a compd. from the active series bound to cryst. MAPKAP-K2 confirmed the predicted binding mode.  This has enabled the discovery of a series of pyrazolo[1,5-a]pyrimidine derivs. showing good in vitro cellular 000 0 potency as anti-TNF-α agents and in vivo efficacy in a mouse model of endotoxin shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyvBMzPdy8KbVg90H21EOLACvtfcHk0lgacmPgZ1331g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gs7k%253D&md5=78a9e895c0f7a058407de9e344a75458</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300411k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300411k%26sid%3Dliteratum%253Aachs%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMitchell%26aufirst%3DD.%2BR.%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DMakino%26aufirst%3DH.%26aulast%3DMatsueda%26aufirst%3DY.%26aulast%3DOue%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DImaizumi%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DY.%26aulast%3DSugiura%26aufirst%3DS.%26aulast%3DTakenouchi%26aufirst%3DO.%26aulast%3DUnoki%26aufirst%3DG.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DCunliffe%26aufirst%3DV.%26aulast%3DFrearson%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DKalloo-Hosein%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DSimpson%26aufirst%3DD.%2BJ.%26aulast%3DSherborne%26aufirst%3DB.%26aulast%3DThomas%26aufirst%3DP.%2BS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DK.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MAPKAP-K2%2529%2520as%2520an%2520antiinflammatory%2520target%253A%2520discovery%2520and%2520in%2520vivo%2520activity%2520of%2520selective%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520inhibitors%2520using%2520a%2520focused%2520library%2520and%2520structure-based%2520optimization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6700%26epage%3D6715%26doi%3D10.1021%2Fjm300411k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Miglani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voleti, S. R.</span><span> </span><span class="NLM_article-title">Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2009.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ejmech.2009.09.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=98-105&author=R.+Miglaniauthor=I.+A.+Cliffeauthor=S.+R.+Voleti&title=Assessment+of+the+putative+binding+conformation+of+a+pyrazolopyridine+class+of+inhibitors+of+MAPKAPK2+using+computational+studies&doi=10.1016%2Fj.ejmech.2009.09.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMiglani%26aufirst%3DR.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DVoleti%26aufirst%3DS.%2BR.%26atitle%3DAssessment%2520of%2520the%2520putative%2520binding%2520conformation%2520of%2520a%2520pyrazolopyridine%2520class%2520of%2520inhibitors%2520of%2520MAPKAPK2%2520using%2520computational%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.ejmech.2009.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirincich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J. B.</span><span> </span><span class="NLM_article-title">Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3342</span><span class="NLM_x">–</span> <span class="NLM_lpage">3351</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmc.2009.03.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3342-3351&author=F.+Loveringauthor=S.+Kirincichauthor=W.+Wangauthor=K.+Combsauthor=L.+Resnickauthor=J.+E.+Sabalskiauthor=J.+Buteraauthor=J.+Liuauthor=K.+Parrisauthor=J.+B.+Telliez&title=Identification+and+SAR+of+squarate+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmc.2009.03.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DKirincich%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DCombs%26aufirst%3DK.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DButera%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DTelliez%26aufirst%3DJ.%2BB.%26atitle%3DIdentification%2520and%2520SAR%2520of%2520squarate%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3342%26epage%3D3351%26doi%3D10.1016%2Fj.bmc.2009.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Williams, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Soest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R. J.</span><span> </span><span class="NLM_article-title">Meroterpenoid MAPKAP (MK2) inhibitors isolated from the Indonesian marine sponge <i>Acanthodendrilla</i> sp</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2127</span><span class="NLM_x">–</span> <span class="NLM_lpage">2129</span><span class="refDoi"> DOI: 10.1021/np049808d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np049808d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2127-2129&author=D.+E.+Williamsauthor=J.-B.+Telliezauthor=J.+Liuauthor=A.+Tahirauthor=R.+van+Soestauthor=R.+J.+Andersen&title=Meroterpenoid+MAPKAP+%28MK2%29+inhibitors+isolated+from+the+Indonesian+marine+sponge+Acanthodendrilla+sp&doi=10.1021%2Fnp049808d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fnp049808d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049808d%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DA.%26aulast%3Dvan%2BSoest%26aufirst%3DR.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DMeroterpenoid%2520MAPKAP%2520%2528MK2%2529%2520inhibitors%2520isolated%2520from%2520the%2520Indonesian%2520marine%2520sponge%2520Acanthodendrilla%2520sp%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D2127%26epage%3D2129%26doi%3D10.1021%2Fnp049808d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Basabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodero, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urones, J. G.</span><span> </span><span class="NLM_article-title">Synthesis of (+)-makassaric acid, a protein kinase MK2 inhibitor</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6008</span><span class="NLM_x">–</span> <span class="NLM_lpage">6012</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.tet.2010.06.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=6008-6012&author=P.+Basabeauthor=M.+Martinauthor=O.+Boderoauthor=A.+Blancoauthor=I.+S.+Marcosauthor=D.+Diezauthor=J.+G.+Urones&title=Synthesis+of+%28%2B%29-makassaric+acid%2C+a+protein+kinase+MK2+inhibitor&doi=10.1016%2Fj.tet.2010.06.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBasabe%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DBodero%26aufirst%3DO.%26aulast%3DBlanco%26aufirst%3DA.%26aulast%3DMarcos%26aufirst%3DI.%2BS.%26aulast%3DDiez%26aufirst%3DD.%26aulast%3DUrones%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520of%2520%2528%252B%2529-makassaric%2520acid%252C%2520a%2520protein%2520kinase%2520MK2%2520inhibitor%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D6008%26epage%3D6012%26doi%3D10.1016%2Fj.tet.2010.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Yang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span> </span><span class="NLM_article-title">3D QSAR analysis on pyrrolopyridine analogs as mitogen-activated protein kinase-activated protein kinase 2 (MK-2) inhibitors</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.2174/157018007782794509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.2174%2F157018007782794509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=557-561&author=Z.+Q.+Yangauthor=P.+H.+Sunauthor=W.+M.+Chen&title=3D+QSAR+analysis+on+pyrrolopyridine+analogs+as+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29+inhibitors&doi=10.2174%2F157018007782794509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2174%2F157018007782794509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157018007782794509%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BQ.%26aulast%3DSun%26aufirst%3DP.%2BH.%26aulast%3DChen%26aufirst%3DW.%2BM.%26atitle%3D3D%2520QSAR%2520analysis%2520on%2520pyrrolopyridine%2520analogs%2520as%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%2520inhibitors%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2007%26volume%3D4%26spage%3D557%26epage%3D561%26doi%3D10.2174%2F157018007782794509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Nayana, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommisetty, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairy, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muttineni, R.</span><span> </span><span class="NLM_article-title">Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1021/ci800294y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800294y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=53-67&author=R.+S.+Nayanaauthor=S.+K.+Bommisettyauthor=K.+Singhauthor=S.+K.+Bairyauthor=S.+Nunnaauthor=A.+Pramodauthor=R.+Muttineni&title=Structural+analysis+of+carboline+derivatives+as+inhibitors+of+MAPKAP+K2+using+3D+QSAR+and+docking+studies&doi=10.1021%2Fci800294y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Carboline Derivatives As Inhibitors of MAPKAP K2 Using 3D QSAR and Docking Studies</span></div><div class="casAuthors">Nayana, Ravi Shashi; Bommisetty, Suneel Kumar; Singh, Kriti; Bairy, Santhosh Kumar; Nunna, Sivakumari; Pramod, Akula; Muttineni, Ravikumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-67</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MAPKAPK2 (MK2), a substrate of p38 MAPKs, plays central role in p38-mediated signal transduction, and its inhibitors are promisingly useful in the treatment of inflammatory diseases.  The computational approaches comprising both ligand-based drug design and structure-based drug design were used as virtual screening strategies for the discovery of novel MK2 inhibitors.  Two quant. pharmacophore models were generated with a training set of 27 MK2 inhibitors using HypoGen module of CATALYST.  The two models suggested that two hydrogen bond acceptors, one hydrogen bond donor, and one hydrophobic feature are essential for ligand binding.  Further, 3D QSAR model with comparative mol. field anal. (CoMFA) and comparative mol. similarity index anal. (CoMSIA) was constructed using a training set of 42 inhibitors.  The predictive CoMFA and CoMSIA models have cross-validated coeffs. (q2) of 0.804 and 0.765 and regression coeffs. (r2) of 0.984 and 0.986, resp.  The structure-based studies were carried out by docking 77 known MAPKAPK2 inhibitors into the active site of receptor using Glide and analyzing the hotspots of the active site.  Docking studies revealed that Met138, Leu141, Asp207, Lys93, Cys140, Leu70, Thr206, and Gly143 are showing interactions with highly active compds.  The structure activity relationships elucidated here for carboline derivs. combined with their binding information will provide an integrated approach to explore the chem. space further for improving the potency of MAPKAPK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSC-1xZKSw5rVg90H21EOLACvtfcHk0liwsQtGDNNcEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlartw%253D%253D&md5=d347971b0bb0632728cd4f057f2992b1</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fci800294y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800294y%26sid%3Dliteratum%253Aachs%26aulast%3DNayana%26aufirst%3DR.%2BS.%26aulast%3DBommisetty%26aufirst%3DS.%2BK.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DBairy%26aufirst%3DS.%2BK.%26aulast%3DNunna%26aufirst%3DS.%26aulast%3DPramod%26aufirst%3DA.%26aulast%3DMuttineni%26aufirst%3DR.%26atitle%3DStructural%2520analysis%2520of%2520carboline%2520derivatives%2520as%2520inhibitors%2520of%2520MAPKAP%2520K2%2520using%25203D%2520QSAR%2520and%2520docking%2520studies%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D53%26epage%3D67%26doi%3D10.1021%2Fci800294y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Hao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span> </span><span class="NLM_article-title">A computational study on thiourea analogs as potent MK-2 inhibitors</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7057</span><span class="NLM_x">–</span> <span class="NLM_lpage">7079</span><span class="refDoi"> DOI: 10.3390/ijms13067057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.3390%2Fijms13067057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22837679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=7057-7079&author=M.+Haoauthor=H.+Renauthor=F.+Luoauthor=S.+Zhangauthor=J.+Qiuauthor=M.+Jiauthor=H.+Siauthor=G.+Li&title=A+computational+study+on+thiourea+analogs+as+potent+MK-2+inhibitors&doi=10.3390%2Fijms13067057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A computational study on thiourea analogs as potent MK-2 inhibitors</span></div><div class="casAuthors">Hao, Ming; Ren, Hong; Luo, Fang; Zhang, Shuwei; Qiu, Jieshan; Ji, Mingjuan; Si, Hongzong; Li, Guohui</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7057-7079</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-activated protein kinase 2 (MK-2) has been identified as a drug target for the treatment of inflammatory diseases.  Currently, a series of thiourea analogs as potent MK-2 inhibitors were studied using comprehensive computational methods by 3D-QSAR, mol. docking and mol. dynamics simulations for a further improvement in activities.  The optimal 3D models exhibit high statistical significance of the results, esp. for the CoMFA results with r2ncv, q2 values of 0.974, 0.536 for the internal validation, and r2pred, r2m values of 0.910, 0.723 for the external validation and Roy's index, resp.  In addn., more rigorous validation criteria suggested by Tropsha were also employed to check the built models.  Graphic representation of the results, as contoured 3D coeff. plots, also provides a clue to the reasonable modification of mols.: (i) The substituent with a bulky size and electron-rich group at the C5 position of the pyrazine ring is required to enhance the potency; (ii) The H-bond acceptor group in the C3 position of the pyrazine ring is likely to be helpful to increase MK-2 inhibition; (iii) The small and electropos. substituent as a hydrogen bond donor of the C2 position in the oxazolone ring is favored; in addn., several important amino acid residues were also identified as playing an important role in MK-2 inhibition.  The agreement between 3D-QSAR, mol. docking and mol. dynamics simulations also proves the rationality of the developed models.  These results, we hope, may be helpful in designing novel and potential MK-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotV6IEuaqULVg90H21EOLACvtfcHk0lgx-HWMqVvyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWhsLk%253D&md5=089420d060e77ef69a5fb7c94b107cfd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3390%2Fijms13067057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms13067057%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DA%2520computational%2520study%2520on%2520thiourea%2520analogs%2520as%2520potent%2520MK-2%2520inhibitors%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D7057%26epage%3D7079%26doi%3D10.3390%2Fijms13067057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Kaushik, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span> </span><span class="NLM_article-title">Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span><span class="refDoi"> DOI: 10.1007/s00044-011-9910-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2Fs00044-011-9910-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3777-3784&author=U.+Kaushikauthor=V.+Sharmaauthor=V.+Kumar&title=Computation+of+pharmacophore+models+for+the+prediction+of+mitogen-activated+protein+kinase+activated+protein+kinase-2+inhibitory+activity+of+pyrrolopyridines&doi=10.1007%2Fs00044-011-9910-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines</span></div><div class="casAuthors">Kaushik, Upasna; Sharma, Vikas; Kumar, Vipin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3777-3784</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">This article is an attempt to formulate the three-dimensional pharmacophore modeling of pyrrolopyridine derivs. inhibiting mitogen-activated protein kinase activated protein kinase-2 (MK2).  To understand the essential structural features for MK2 inhibitors, pharmacophore hypothesis were built on the basis of a set of known MK2 inhibitors selected from literature using PHASE program.  Three pharmacophore models with one hydrogen-bond acceptor (A), two hydrogen-bond donors (D), one hydrophobic group (H) and one arom. ring (R) as pharmacophoric features were developed.  Amongst them the pharmacophore hypothesis ADDHR1 yielded a statistically significant 3D-QSAR model with 0.926 as R2 value and was considered to be the best pharmacophore hypothesis.  The developed pharmacophore model was externally validated by predicting the activity of test set mols.  The squared predictive correlation coeff. of 0.882 was obsd. between exptl. and predicted activity values of test set mols.  The geometry and features of pharmacophore was expected to be useful for the design of selective MK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyUkSvcSf72rVg90H21EOLACvtfcHk0lgx-HWMqVvyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOitL%252FF&md5=6da180db8ee951a3a07cbb478922d91b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs00044-011-9910-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-011-9910-z%26sid%3Dliteratum%253Aachs%26aulast%3DKaushik%26aufirst%3DU.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DComputation%2520of%2520pharmacophore%2520models%2520for%2520the%2520prediction%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase-2%2520inhibitory%2520activity%2520of%2520pyrrolopyridines%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2012%26volume%3D21%26spage%3D3777%26epage%3D3784%26doi%3D10.1007%2Fs00044-011-9910-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Wang, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">Applications of 3D-QSAR and structure-based pharmacophore modeling, virtual screening, ADMET, and molecular docking of putative MAPKAP-K2 (MK2) inhibitors</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4418</span><span class="NLM_x">–</span> <span class="NLM_lpage">4429</span><span class="refDoi"> DOI: 10.1007/s00044-013-0492-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1007%2Fs00044-013-0492-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=4418-4429&author=T.-J.+Wangauthor=L.+Zhouauthor=J.+Feiauthor=Z.-C.+Liauthor=L.+He&title=Applications+of+3D-QSAR+and+structure-based+pharmacophore+modeling%2C+virtual+screening%2C+ADMET%2C+and+molecular+docking+of+putative+MAPKAP-K2+%28MK2%29+inhibitors&doi=10.1007%2Fs00044-013-0492-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00044-013-0492-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-013-0492-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-J.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DFei%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.-C.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DApplications%2520of%25203D-QSAR%2520and%2520structure-based%2520pharmacophore%2520modeling%252C%2520virtual%2520screening%252C%2520ADMET%252C%2520and%2520molecular%2520docking%2520of%2520putative%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D4418%26epage%3D4429%26doi%3D10.1007%2Fs00044-013-0492-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Lopes, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span> </span><span class="NLM_article-title">Inhibition of Hsp27 phosphorylation by a cell-permeant MAPKAP kinase 2 inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bbrc.2009.03.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2009&pages=535-539&author=L.+B.+Lopesauthor=C.+Flynnauthor=P.+Komalavilasauthor=A.+Panitchauthor=C.+M.+Brophyauthor=B.+L.+Seal&title=Inhibition+of+Hsp27+phosphorylation+by+a+cell-permeant+MAPKAP+kinase+2+inhibitor&doi=10.1016%2Fj.bbrc.2009.03.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%26aufirst%3DL.%2BB.%26aulast%3DFlynn%26aufirst%3DC.%26aulast%3DKomalavilas%26aufirst%3DP.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26atitle%3DInhibition%2520of%2520Hsp27%2520phosphorylation%2520by%2520a%2520cell-permeant%2520MAPKAP%2520kinase%25202%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D382%26spage%3D535%26epage%3D539%26doi%3D10.1016%2Fj.bbrc.2009.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Ward, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1002/psc.1168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fpsc.1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19691016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSnsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=668-674&author=B.+Wardauthor=B.+L.+Sealauthor=C.+M.+Brophyauthor=A.+Panitch&title=Design+of+a+bioactive+cell-penetrating+peptide%3A+when+a+transduction+domain+does+more+than+transduce&doi=10.1002%2Fpsc.1168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce</span></div><div class="casAuthors">Ward, Brian; Seal, Brandon L.; Brophy, Colleen M.; Panitch, Alyssa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">668-674</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The discovery of cell-penetrating peptides (CPPs) has facilitated delivery of peptides into cells to affect cellular behavior.  Previously, we were successful at developing a phosphopeptide mimetic of the small heat shock-like protein HSP20.  Building on this success we developed a cell-permeant peptide inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MK2).  It is well documented that inhibition of MK2 may be beneficial for a myriad of human diseases including those involving inflammation and fibrosis.  During the optimization of the activity and specificity of the MK2 inhibitor (MK2i) we closely examd. the effect of cell-penetrating peptide identity.  Surprisingly, the identity of the CPP dictated kinase specificity and functional activity to an extent that rivaled that of the therapeutic peptide.  The results reported herein have wide implications for delivering therapeutics with CPPs and indicate that judicious choice of CPP is crucial to the ultimate therapeutic success.  Published in 2009 by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlxXNoAiKkUbVg90H21EOLACvtfcHk0liCGmzA58SZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSnsbbL&md5=3f7bbb4f6c77c45c3ae0e741f6564168</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fpsc.1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.1168%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DDesign%2520of%2520a%2520bioactive%2520cell-penetrating%2520peptide%253A%2520when%2520a%2520transduction%2520domain%2520does%2520more%2520than%2520transduce%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2009%26volume%3D15%26spage%3D668%26epage%3D674%26doi%3D10.1002%2Fpsc.1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Brugnano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2011.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jconrel.2011.05.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2011&pages=128-133&author=J.+L.+Brugnanoauthor=B.+K.+Chanauthor=B.+L.+Sealauthor=A.+Panitch&title=Cell-penetrating+peptides+can+confer+biological+function%3A+regulation+of+inflammatory+cytokines+in+human+monocytes+by+MK2+inhibitor+peptides&doi=10.1016%2Fj.jconrel.2011.05.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2011.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2011.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBrugnano%26aufirst%3DJ.%2BL.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DSeal%26aufirst%3DB.%2BL.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DCell-penetrating%2520peptides%2520can%2520confer%2520biological%2520function%253A%2520regulation%2520of%2520inflammatory%2520cytokines%2520in%2520human%2520monocytes%2520by%2520MK2%2520inhibitor%2520peptides%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2011%26volume%3D155%26spage%3D128%26epage%3D133%26doi%3D10.1016%2Fj.jconrel.2011.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Ward, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavalukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugnano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions</span> <span class="citation_source-journal">J. Surg. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27</span><span class="NLM_x">–</span> <span class="NLM_lpage">e36</span><span class="refDoi"> DOI: 10.1016/j.jss.2011.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jss.2011.01.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2011&pages=e27-e36&author=B.+C.+Wardauthor=S.+Kavalukasauthor=J.+Brugnanoauthor=A.+Barbulauthor=A.+Panitch&title=Peptide+inhibitors+of+MK2+show+promise+for+inhibition+of+abdominal+adhesions&doi=10.1016%2Fj.jss.2011.01.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2011.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2011.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%2BC.%26aulast%3DKavalukas%26aufirst%3DS.%26aulast%3DBrugnano%26aufirst%3DJ.%26aulast%3DBarbul%26aufirst%3DA.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DPeptide%2520inhibitors%2520of%2520MK2%2520show%2520promise%2520for%2520inhibition%2520of%2520abdominal%2520adhesions%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D169%26spage%3De27%26epage%3De36%26doi%3D10.1016%2Fj.jss.2011.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Muto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, A.</span><span> </span><span class="NLM_article-title">Inhibitor of mitogen activated protein kinase activated protein kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/j.vph.2011.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.vph.2011.07.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=47-55&author=A.+Mutoauthor=A.+Panitchauthor=N.+Kimauthor=K.+Parkauthor=P.+Komalavilasauthor=C.+M.+Brophyauthor=A.+Dardik&title=Inhibitor+of+mitogen+activated+protein+kinase+activated+protein+kinase+II+with+MMI-0100+reduces+intimal+hyperplasia+ex+vivo+and+in+vivo&doi=10.1016%2Fj.vph.2011.07.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2011.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2011.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DMuto%26aufirst%3DA.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DKomalavilas%26aufirst%3DP.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DDardik%26aufirst%3DA.%26atitle%3DInhibitor%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%2520II%2520with%2520MMI-0100%2520reduces%2520intimal%2520hyperplasia%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2012%26volume%3D56%26spage%3D47%26epage%3D55%26doi%3D10.1016%2Fj.vph.2011.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Lopes, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smoke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komalavilas, P.</span><span> </span><span class="NLM_article-title">A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model</span> <span class="citation_source-journal">J. Vasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span><span class="refDoi"> DOI: 10.1016/j.jvs.2010.06.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.jvs.2010.06.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=20864298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FjtValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=1596-1607&author=L.+B.+Lopesauthor=C.+M.+Brophyauthor=C.+R.+Flynnauthor=z.+Yiauthor=B.+P.+Bowenauthor=C.+Smokeauthor=B.+Sealauthor=A.+Panitchauthor=P.+Komalavilas&title=A+novel+cell+permeant+peptide+inhibitor+of+MAPKAP+kinase+II+inhibits+intimal+hyperplasia+in+a+human+saphenous+vein+organ+culture+model&doi=10.1016%2Fj.jvs.2010.06.168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model</span></div><div class="casAuthors">Lopes Luciana B; Brophy Colleen M; Flynn Charles R; Yi Zhengping; Bowen Benjamin P; Smoke Christopher; Seal Brandon; Panitch Alyssa; Komalavilas Padmini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1596-607</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The present study was aimed at developing a new cell-permeant peptide inhibitor (MK2i) of the kinase that phosphorylates and activates heat-shock protein (HSP)27 (MAPKAP kinase II), and evaluating the ability of this peptide to inhibit HSP27 phosphorylation and intimal thickening.  METHODS:  The ability of MK2i to reduce HSP27 phosphorylation and cell migration was evaluated in A7R5 cells stimulated with arsenite or lysophosphatidic acid.  Stable isotopic labeling using amino acids in cell culture, in combination with liquid chromatography mass spectrometry, was used to characterize the effect of MK2i on global protein expression in fibroblasts.  The effect of MK2i on intimal thickening and connective tissue growth factor expression was evaluated in human saphenous vein (HSV) rings maintained with 30% fetal bovine serum for 14 days by light microscopy and immunoblotting.  RESULTS:  Pretreatment of cells with MK2i (10 μM) prior to arsenite or lysophosphatidic acid stimulation decreased phosphorylation of HSP27 (36% ± 9% and 33% ± 10%, respectively) compared with control (not pretreated) cells.  MK2i also inhibited A7R5 migration, and downregulated the transforming growth factor-induced expression of collagen and fibronectin in keloid cells, two major matrix proteins involved in the development of intimal hyperplasia.  Treatment of HSV segments with MK2i enhanced relaxation, reduced HSP27 phosphorylation (40% ± 17%), connective tissue growth factor expression (17% ± 5%), and intimal thickness (48.2% ± 10.5%) compared with untreated segments.  On the other hand, treatment with a recombinant fusion protein containing a cell-permeant peptide attached to the HSP27 sequence increased intimal thickness of HSV segments by 48% ± 14%.  CONCLUSION:  Our results suggest that HSP27 may play a role in the development of processes leading to intimal hyperplasia in HSV, and reduction of HSP27 phosphorylation by MK2i may be a potential strategy to inhibit the development of intimal hyperplasia in HSV to prevent the autologous vascular graft failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyHbQQNoHXoyXXDYhVZBdlfW6udTcc2ebVbjtjTG3Yqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FjtValtw%253D%253D&md5=bb924717dab0bc485cddccccf42ce19c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2010.06.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2010.06.168%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%26aufirst%3DL.%2BB.%26aulast%3DBrophy%26aufirst%3DC.%2BM.%26aulast%3DFlynn%26aufirst%3DC.%2BR.%26aulast%3DYi%26aufirst%3Dz.%26aulast%3DBowen%26aufirst%3DB.%2BP.%26aulast%3DSmoke%26aufirst%3DC.%26aulast%3DSeal%26aufirst%3DB.%26aulast%3DPanitch%26aufirst%3DA.%26aulast%3DKomalavilas%26aufirst%3DP.%26atitle%3DA%2520novel%2520cell%2520permeant%2520peptide%2520inhibitor%2520of%2520MAPKAP%2520kinase%2520II%2520inhibits%2520intimal%2520hyperplasia%2520in%2520a%2520human%2520saphenous%2520vein%2520organ%2520culture%2520model%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2010%26volume%3D52%26spage%3D1596%26epage%3D1607%26doi%3D10.1016%2Fj.jvs.2010.06.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Brugnano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitch, A.</span><span> </span><span class="NLM_article-title">Matrix stiffness affects endocytic uptake of MK2-inhibitor peptides</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84821</span><span class="refDoi"> DOI: 10.1371/journal.pone.0084821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1371%2Fjournal.pone.0084821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e84821&author=J.+L.+Brugnanoauthor=A.+Panitch&title=Matrix+stiffness+affects+endocytic+uptake+of+MK2-inhibitor+peptides&doi=10.1371%2Fjournal.pone.0084821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0084821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0084821%26sid%3Dliteratum%253Aachs%26aulast%3DBrugnano%26aufirst%3DJ.%2BL.%26aulast%3DPanitch%26aufirst%3DA.%26atitle%3DMatrix%2520stiffness%2520affects%2520endocytic%2520uptake%2520of%2520MK2-inhibitor%2520peptides%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De84821%26doi%3D10.1371%2Fjournal.pone.0084821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasopoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalghatgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orminati, J.-P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, J. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaddupathy, R. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintner, E. A.</span><span> </span><span class="NLM_article-title">An affinity selection-mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries. Discovery of a novel antagonist of <i>E. coli</i> dihydrofolate reductase</span> <span class="citation_source-journal">Int. J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/j.ijms.2003.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ijms.2003.11.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=238&publication_year=2004&pages=77-83&author=D.+A.+Annisauthor=J.+Athanasopoulosauthor=P.+J.+Curranauthor=J.+S.+Felschauthor=K.+Kalghatgiauthor=W.+H.+Leeauthor=H.+M.+Nashauthor=J.-P.+A.+Orminatiauthor=K.+E.+Rosnerauthor=J.+W.+Shippsauthor=R.+R.+A.+Thaddupathyauthor=A.+N.+Tylerauthor=L.+Vilenchikauthor=C.+R.+Wagnerauthor=E.+A.+Wintner&title=An+affinity+selection-mass+spectrometry+method+for+the+identification+of+small+molecule+ligands+from+self-encoded+combinatorial+libraries.+Discovery+of+a+novel+antagonist+of+E.+coli+dihydrofolate+reductase&doi=10.1016%2Fj.ijms.2003.11.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ijms.2003.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijms.2003.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DFelsch%26aufirst%3DJ.%2BS.%26aulast%3DKalghatgi%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DOrminati%26aufirst%3DJ.-P.%2BA.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShipps%26aufirst%3DJ.%2BW.%26aulast%3DThaddupathy%26aufirst%3DR.%2BR.%2BA.%26aulast%3DTyler%26aufirst%3DA.%2BN.%26aulast%3DVilenchik%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWintner%26aufirst%3DE.%2BA.%26atitle%3DAn%2520affinity%2520selection-mass%2520spectrometry%2520method%2520for%2520the%2520identification%2520of%2520small%2520molecule%2520ligands%2520from%2520self-encoded%2520combinatorial%2520libraries.%2520Discovery%2520of%2520a%2520novel%2520antagonist%2520of%2520E.%2520coli%2520dihydrofolate%2520reductase%26jtitle%3DInt.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D238%26spage%3D77%26epage%3D83%26doi%3D10.1016%2Fj.ijms.2003.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spacciapoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C. E.</span><span> </span><span class="NLM_article-title">Discovery and hit-to-lead optimization of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1021/ml200113y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200113y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=632-637&author=X.+Huangauthor=G.+W.+Shippsauthor=C.+C.+Chengauthor=P.+Spacciapoliauthor=X.+Zhangauthor=M.+A.+McCoyauthor=D.+F.+Wyssauthor=X.+Yangauthor=A.+Achabauthor=K.+Soucyauthor=D.+K.+Montavonauthor=D.+M.+Murphyauthor=C.+E.+Whitehurst&title=Discovery+and+hit-to-lead+optimization+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1021%2Fml200113y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fml200113y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200113y%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DSpacciapoli%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMcCoy%26aufirst%3DM.%2BA.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAchab%26aufirst%3DA.%26aulast%3DSoucy%26aufirst%3DK.%26aulast%3DMontavon%26aufirst%3DD.%2BK.%26aulast%3DMurphy%26aufirst%3DD.%2BM.%26aulast%3DWhitehurst%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520hit-to-lead%2520optimization%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D632%26epage%3D637%26doi%3D10.1021%2Fml200113y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.11.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=22169260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=65-70&author=X.+Huangauthor=X.+Zhuauthor=X.+Chenauthor=W.+Zhouauthor=D.+Xiaoauthor=S.+Degradoauthor=R.+Aslanianauthor=J.+Fossettaauthor=D.+Lundellauthor=F.+Tianauthor=P.+Trivediauthor=A.+Palani&title=A+three-step+protocol+for+lead+optimization%3A+quick+identification+of+key+conformational+features+and+functional+groups+in+the+SAR+studies+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.11.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span></div><div class="casAuthors">Huang, Xianhai; Zhu, Xiaohong; Chen, Xiao; Zhou, Wei; Xiao, Dong; Degrado, Sylvia; Aslanian, Robert; Fossetta, James; Lundell, Daniel; Tian, Fang; Trivedi, Prashant; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A three-step protocol for SAR development was introduced and applied to the SAR studies of the MK2 inhibitor program.  Following this protocol, key conformational features and functional groups for improving MK2 inhibitor activity were quickly identified.  Through this effort, the initial gap obsd. between in vitro binding activity and cellular activity in the lead identification stage was very much reduced.  Compd. 28 was identified with single digit binding activity (IC50 = 8 nM) and good cellular activity (EC50 = 310 nM).  This provides further evidence that non-ATP-competitive binding MK2 inhibitors are feasible by targeting the outside ATP pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrI2-Vf5BZWbVg90H21EOLACvtfcHk0li9gw_3AbAyeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyquw%253D%253D&md5=da2ff998ada081c76f2e9e251af7e109</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.074%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DDegrado%26aufirst%3DS.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DA%2520three-step%2520protocol%2520for%2520lead%2520optimization%253A%2520quick%2520identification%2520of%2520key%2520conformational%2520features%2520and%2520functional%2520groups%2520in%2520the%2520SAR%2520studies%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D65%26epage%3D70%26doi%3D10.1016%2Fj.bmcl.2011.11.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of a potent dihydrooxadiazole series of non-ATP competitive MK2 (MAPKAPK2) inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1021/ml200238g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200238g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=100-105&author=J.+Qinauthor=P.+Dhondiauthor=X.+Huangauthor=R.+Aslanianauthor=J.+Fossettaauthor=F.+Tianauthor=D.+Lundellauthor=A.+Palani&title=Discovery+of+a+potent+dihydrooxadiazole+series+of+non-ATP+competitive+MK2+%28MAPKAPK2%29+inhibitors&doi=10.1021%2Fml200238g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fml200238g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200238g%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520dihydrooxadiazole%2520series%2520of%2520non-ATP%2520competitive%2520MK2%2520%2528MAPKAPK2%2529%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D100%26epage%3D105%26doi%3D10.1021%2Fml200238g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofolarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of potent MK2 non-ATP competitive inhibitors usign 1,2-substituted azoles as cis-amide isosteres</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3613</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2014.05.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3609-3613&author=D.+Xiaoauthor=X.+Zhuauthor=M.+Sofolaridesauthor=S.+Degradoauthor=N.+Shaoauthor=A.+Raoauthor=X.+Chenauthor=R.+Aslanianauthor=J.+Fossettaauthor=F.+Tianauthor=P.+Trivediauthor=D.+Lundellauthor=A.+Palani&title=Discovery+of+a+novel+series+of+potent+MK2+non-ATP+competitive+inhibitors+usign+1%2C2-substituted+azoles+as+cis-amide+isosteres&doi=10.1016%2Fj.bmcl.2014.05.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSofolarides%26aufirst%3DM.%26aulast%3DDegrado%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DN.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520MK2%2520non-ATP%2520competitive%2520inhibitors%2520usign%25201%252C2-substituted%2520azoles%2520as%2520cis-amide%2520isosteres%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3609%26epage%3D3613%26doi%3D10.1016%2Fj.bmcl.2014.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofolarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spacciapoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehurst, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span> </span><span class="NLM_article-title">Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3262</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2013.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3262-3266&author=D.+Xiaoauthor=A.+Palaniauthor=X.+Huangauthor=M.+Sofolaridesauthor=W.+Zhouauthor=X.+Chenauthor=R.+Aslanianauthor=Z.+Guoauthor=J.+Fossettaauthor=F.+Tianauthor=P.+Trivediauthor=P.+Spacciapoliauthor=C.+E.+Whitehurstauthor=D.+Lundell&title=Conformation+constraint+of+anilides+enabling+the+discovery+of+tricyclic+lactams+as+potent+MK2+non-ATP+competitive+inhibitors&doi=10.1016%2Fj.bmcl.2013.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DSofolarides%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DSpacciapoli%26aufirst%3DP.%26aulast%3DWhitehurst%26aufirst%3DC.%2BE.%26aulast%3DLundell%26aufirst%3DD.%26atitle%3DConformation%2520constraint%2520of%2520anilides%2520enabling%2520the%2520discovery%2520of%2520tricyclic%2520lactams%2520as%2520potent%2520MK2%2520non-ATP%2520competitive%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3262%26epage%3D3266%26doi%3D10.1016%2Fj.bmcl.2013.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Rao, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span> </span><span class="NLM_article-title">Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2011.11.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1068-1072&author=A.+U.+Raoauthor=D.+Xiaoauthor=X.+Huangauthor=W.+Zhouauthor=J.+Fossettaauthor=D.+Lundellauthor=F.+Tianauthor=P.+Trivediauthor=R.+Aslanianauthor=A.+Palani&title=Facile+synthesis+of+tetracyclic+azepine+and+oxazocine+derivatives+and+their+potential+as+MAPKAP-K2+%28MK2%29+kinase&doi=10.1016%2Fj.bmcl.2011.11.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.113%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DA.%2BU.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DFossetta%26aufirst%3DJ.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DP.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DFacile%2520synthesis%2520of%2520tetracyclic%2520azepine%2520and%2520oxazocine%2520derivatives%2520and%2520their%2520potential%2520as%2520MAPKAP-K2%2520%2528MK2%2529%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1068%26epage%3D1072%26doi%3D10.1016%2Fj.bmcl.2011.11.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersoy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristoffersson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span> </span><span class="NLM_article-title">4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4740</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2010.06.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4738-4740&author=H.+Olssonauthor=P.+Sjoauthor=O.+Ersoyauthor=A.+Kristofferssonauthor=J.+Larssonauthor=B.+Norden&title=4-Anilino-6-phenyl-quinoline+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK2%29&doi=10.1016%2Fj.bmcl.2010.06.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.107%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DSjo%26aufirst%3DP.%26aulast%3DErsoy%26aufirst%3DO.%26aulast%3DKristoffersson%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DNorden%26aufirst%3DB.%26atitle%3D4-Anilino-6-phenyl-quinoline%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4738%26epage%3D4740%26doi%3D10.1016%2Fj.bmcl.2010.06.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of p38: has the fat lady sung?</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.1002/art.24264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1002%2Fart.24264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19180514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=317-320&author=M.+C.+Genovese&title=Inhibition+of+p38%3A+has+the+fat+lady+sung%3F&doi=10.1002%2Fart.24264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38: has the fat lady sung?</span></div><div class="casAuthors">Genovese Mark C</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-20</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnT0jWinaMx0PI-fCgwosgfW6udTcc2eYQXpcWvwuzcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D&md5=b8aaf19800021f9f8fb00f4220c8194a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fart.24264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24264%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520p38%253A%2520has%2520the%2520fat%2520lady%2520sung%253F%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D317%26epage%3D320%26doi%3D10.1002%2Fart.24264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cheung, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Feedback control of the protein kinase TAK1 by SAPK2a/p38α</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5793</span><span class="NLM_x">–</span> <span class="NLM_lpage">5805</span><span class="refDoi"> DOI: 10.1093/emboj/cdg552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1093%2Femboj%2Fcdg552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5793-5805&author=P.+C.+Cheungauthor=D.+G.+Campbellauthor=A.+R.+Nebredaauthor=P.+Cohen&title=Feedback+control+of+the+protein+kinase+TAK1+by+SAPK2a%2Fp38%CE%B1&doi=10.1093%2Femboj%2Fcdg552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg552%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DP.%2BC.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DFeedback%2520control%2520of%2520the%2520protein%2520kinase%2520TAK1%2520by%2520SAPK2a%252Fp38%25CE%25B1%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5793%26epage%3D5805%26doi%3D10.1093%2Femboj%2Fcdg552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of anti-inflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+anti-inflammatory+drugs&doi=10.1016%2Fj.ceb.2009.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0li711nSdNdzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520anti-inflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D317%26epage%3D324%26doi%3D10.1016%2Fj.ceb.2009.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span> </span><span class="NLM_article-title">Targeting innate immunity protein kinase signalling in inflammation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1038/nrd2829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1038%2Fnrd2829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=480-499&author=M.+Gaestelauthor=A.+Kotlyarovauthor=M.+Kracht&title=Targeting+innate+immunity+protein+kinase+signalling+in+inflammation&doi=10.1038%2Fnrd2829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd2829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2829%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DKracht%26aufirst%3DM.%26atitle%3DTargeting%2520innate%2520immunity%2520protein%2520kinase%2520signalling%2520in%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D480%26epage%3D499%26doi%3D10.1038%2Fnrd2829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6629</span><span class="NLM_x">–</span> <span class="NLM_lpage">6639</span><span class="refDoi"> DOI: 10.1021/jm100540x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100540x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6629-6639&author=C.+Liuauthor=J.+Linauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+Hynesauthor=H.+Wuauthor=A.+J.+Dyckmanauthor=T.+Liauthor=J.+Wityakauthor=K.+M.+Gilloolyauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+F.+Zhangauthor=K.+W.+McIntyreauthor=L.+Salter-Cidauthor=D.+J.+Shusterauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=S.+E.+Kieferauthor=K.+F.+Kishauthor=J.+A.+Newittauthor=M.+McKinnonauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+4-%285-%28cyclopropylcarbamoyl%29-2-methylphenylamino%29-5-methyl-N-propylpyrrolo%5B1%2C2-f%5D%5B1%2C2%2C4%5Dtriazine-6-carboxamide+%28BMS-582949%29%2C+a+clinical+p38%CE%B1+MAP+kinase+inhibitor+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm100540x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm100540x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100540x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25204-%25285-%2528cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methyl-N-propylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carboxamide%2520%2528BMS-582949%2529%252C%2520a%2520clinical%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6629%26epage%3D6639%26doi%3D10.1021%2Fjm100540x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrudhula, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everlof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesenberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carbonyl) (propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a clinical prodrug of p38α MAP kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7775</span><span class="NLM_x">–</span> <span class="NLM_lpage">7784</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00839</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00839" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7775-7784&author=C.+Liuauthor=J.+Linauthor=J.+Hynesauthor=H.+Wuauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=T.+G.+Dharauthor=V.+M.+Vrudhulaauthor=J.+H.+Sunauthor=S.+Chaoauthor=R.+Zhaoauthor=B.+Wangauthor=B.+C.+Chenauthor=G.+Everlofauthor=C.+Gesenbergauthor=H.+Zhangauthor=P.+H.+Maratheauthor=K.+W.+McIntyreauthor=T.+L.+Taylorauthor=K.+Gilloolyauthor=D.+J.+Shusterauthor=M.+McKinnonauthor=J.+H.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+%28%284-%285-%28Cyclopropylcarbamoyl%29-2-methylphenylamino%29-5-methylpyrrolo%5B1%2C2-f%5D%5B1%2C2%2C4%5Dtriazine-6-carbonyl%29+%28propyl%29carbamoyloxy%29methyl-2-%284-%28phosphonooxy%29phenyl%29acetate+%28BMS-751324%29%2C+a+clinical+prodrug+of+p38%CE%B1+MAP+kinase+inhibitor&doi=10.1021%2Facs.jmedchem.5b00839"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00839%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DVrudhula%26aufirst%3DV.%2BM.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DEverlof%26aufirst%3DG.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520%2528%25284-%25285-%2528Cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carbonyl%2529%2520%2528propyl%2529carbamoyloxy%2529methyl-2-%25284-%2528phosphonooxy%2529phenyl%2529acetate%2520%2528BMS-751324%2529%252C%2520a%2520clinical%2520prodrug%2520of%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7775%26epage%3D7784%26doi%3D10.1021%2Facs.jmedchem.5b00839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iakovleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deppenmeier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radzioch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackshear, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2399</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1128/MCB.26.6.2399-2407.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1128%2FMCB.26.6.2399-2407.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=16508014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2399-2407&author=E.+Hittiauthor=T.+Iakovlevaauthor=M.+Brookauthor=S.+Deppenmeierauthor=A.+D.+Gruberauthor=D.+Radziochauthor=A.+R.+Clarkauthor=P.+J.+Blackshearauthor=A.+Kotlyarovauthor=M.+Gaestel&title=Mitogen-activated+protein+kinase-activated+protein+kinase+2+regulates+tumor+necrosis+factor+mRNA+stability+and+translation+mainly+by+altering+tristetraprolin+expression%2C+stability%2C+and+binding+to+adenine%2Furidine-rich+element&doi=10.1128%2FMCB.26.6.2399-2407.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element</span></div><div class="casAuthors">Hitti, Edward; Iakovleva, Tatiana; Brook, Matthew; Deppenmeier, Stefanie; Gruber, Achim D.; Radzioch, Danuta; Clark, Andrew R.; Blackshear, Perry J.; Kotlyarov, Alexey; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2399-2407</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) p38/MAPK-activated protein kinase 2 (MK2) signaling pathway plays an important role in the posttranscriptional regulation of tumor necrosis factor (TNF), which is dependent on the adenine/uridine-rich element (ARE) in the 3' untranslated region of TNF mRNA.  After lipopolysaccharide (LPS) stimulation, MK2-deficient macrophages show a 90% redn. in TNF prodn. compared to the wild type.  Tristetraprolin (TTP), a protein induced by LPS, binds ARE and destabilizes TNF mRNA.  Accordingly, macrophages lacking TTP produce large amts. of TNF.  Here, we generated MK2/TTP double knockout mice and show that, after LPS stimulation, bone marrow-derived macrophages produce TNF mRNA and protein levels comparable to those of TTP knockout cells, indicating that in the regulation of TNF biosynthesis TTP is genetically downstream of MK2.  In addn., we show that MK2 is essential for the stabilization of TTP mRNA, and phosphorylation by MK2 leads to increased TTP protein stability but reduced ARE affinity.  These data suggest that MK2 inhibits the mRNA destabilizing activity of TTP and, in parallel, codegrdn. of TTP together, with the target mRNA resulting in increased cellular levels of TTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4feIpdvtDbVg90H21EOLACvtfcHk0ljcoRN7wJQREw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygurs%253D&md5=a932366c73c9851e331b017ed2cf73ee</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.6.2399-2407.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.6.2399-2407.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DIakovleva%26aufirst%3DT.%26aulast%3DBrook%26aufirst%3DM.%26aulast%3DDeppenmeier%26aufirst%3DS.%26aulast%3DGruber%26aufirst%3DA.%2BD.%26aulast%3DRadzioch%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DBlackshear%26aufirst%3DP.%2BJ.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520regulates%2520tumor%2520necrosis%2520factor%2520mRNA%2520stability%2520and%2520translation%2520mainly%2520by%2520altering%2520tristetraprolin%2520expression%252C%2520stability%252C%2520and%2520binding%2520to%2520adenine%252Furidine-rich%2520element%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2399%26epage%3D2407%26doi%3D10.1128%2FMCB.26.6.2399-2407.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ronkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedje, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bcp.2010.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1915-1920&author=N.+Ronkinaauthor=M.+B.+Menonauthor=J.+Schwermannauthor=C.+Tiedjeauthor=E.+Hittiauthor=A.+Kotlyarovauthor=M.+Gaestel&title=MAPKAP+kinases+MK2+and+MK3+in+inflammation%3A+complex+regulation+of+TNF+biosynthesis+via+expression+and+phosphorylation+of+tristetraprolin&doi=10.1016%2Fj.bcp.2010.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DRonkina%26aufirst%3DN.%26aulast%3DMenon%26aufirst%3DM.%2BB.%26aulast%3DSchwermann%26aufirst%3DJ.%26aulast%3DTiedje%26aufirst%3DC.%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinases%2520MK2%2520and%2520MK3%2520in%2520inflammation%253A%2520complex%2520regulation%2520of%2520TNF%2520biosynthesis%2520via%2520expression%2520and%2520phosphorylation%2520of%2520tristetraprolin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1915%26epage%3D1920%26doi%3D10.1016%2Fj.bcp.2010.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1016%2Fj.bmcl.2015.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Linauthor=S.+Malkaniauthor=M.+Lombardoauthor=L.+Yangauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=J.+J.+Hale&title=Design%2C+synthesis%2C+and+biological+evaluation+of+aminopyrazine+derivatives+as+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2015.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520aminopyrazine%2520derivatives%2520as%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1016%2Fj.bmcl.2015.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rogalla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnsperger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preville, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducasse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieske, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor α by phosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">18947</span><span class="refDoi"> DOI: 10.1074/jbc.274.27.18947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10.1074%2Fjbc.274.27.18947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=10383393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;key=1%3ACAS%3A528%3ADyaK1MXksVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18947&author=T.+Rogallaauthor=M.+Ehrnspergerauthor=X.+Previlleauthor=A.+Kotlyarovauthor=G.+Lutschauthor=C.+Ducasseauthor=C.+Paulauthor=M.+Wieskeauthor=A.-P.+Arrigoauthor=J.+Buchnerauthor=M.+Gaestel&title=Regulation+of+Hsp27+oligomerization%2C+chaperone+function%2C+and+protective+activity+against+oxidative+stress%2Ftumor+necrosis+factor+%CE%B1+by+phosphorylation&doi=10.1074%2Fjbc.274.27.18947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor α by phosphorylation</span></div><div class="casAuthors">Rogalla, Thorsten; Ehrnsperger, Monika; Preville, Xavier; Kotlyarov, Alexey; Lutsch, Gudrun; Ducasse, Cecile; Paul, Catherine; Wieske, Martin; Arrigo, Andre-Patrick; Buchner, Johannes; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18947-18956</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The small heat shock proteins (sHsps) from human (Hsp27) and mouse (Hsp25) form large oligomers which can act as mol. chaperones in vitro and protect cells from heat shock and oxidative stress when overexpressed.  In addn., mammalian sHsps are rapidly phosphorylated by MAPKAP kinase 2/3 at two or three serine residues in response to various extracellular stresses.  Here we analyze the effect of sHsp phosphorylation on its quaternary structure, chaperone function, and protection against oxidative stress.  We show that in vitro phosphorylation of recombinant sHsp as well as mol. mimicry of Hsp27 phosphorylation lead to a significant decrease of the oligomeric size.  We demonstrate that both phosphorylated sHsps and the triple mutant Hsp27-S15D,S78D,S82D show significantly decreased abilities to act as mol. chaperones suppressing thermal denaturation and facilitating refolding of citrate synthase in vitro.  In parallel, Hsp27 and its mutants were analyzed for their ability to confer resistance against oxidative stress when overexpressed in L929 and 13.S.1.24 cells.  While wild type Hsp27 confers resistance, the triple mutant S15D,S78D,S82D cannot protect against oxidative stress effectively.  These data indicate that large oligomers of sHsps are necessary for chaperone action and resistance against oxidative stress whereas phosphorylation down-regulates these activities by dissocn. of sHsp complexes to tetramers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqu7XpGFfUrVg90H21EOLACvtfcHk0lgOCbOlpta_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVWlsrY%253D&md5=482a8e582b95984ba46724882cbffc13</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.27.18947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.27.18947%26sid%3Dliteratum%253Aachs%26aulast%3DRogalla%26aufirst%3DT.%26aulast%3DEhrnsperger%26aufirst%3DM.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DLutsch%26aufirst%3DG.%26aulast%3DDucasse%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DWieske%26aufirst%3DM.%26aulast%3DArrigo%26aufirst%3DA.-P.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520Hsp27%2520oligomerization%252C%2520chaperone%2520function%252C%2520and%2520protective%2520activity%2520against%2520oxidative%2520stress%252Ftumor%2520necrosis%2520factor%2520%25CE%25B1%2520by%2520phosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18947%26doi%3D10.1074%2Fjbc.274.27.18947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span> </span><span class="NLM_article-title">An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease</span>. ClinicalTrials.go; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT01867762" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01867762</a> (accessed October 19, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Effectiveness+and+Safety+Study+of+Inhaled+JNJ+49095397+%28RV568%29+in+Patients+With+Moderate+to+Severe+Chronic+Obstructive+Pulmonary+Disease.+ClinicalTrials.go%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2013%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01867762+%28accessed+October+19%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Effectiveness%2520and%2520Safety%2520Study%2520of%2520Inhaled%2520JNJ%252049095397%2520%2528RV568%2529%2520in%2520Patients%2520With%2520Moderate%2520to%2520Severe%2520Chronic%2520Obstructive%2520Pulmonary%2520Disease%26jtitle%3DClinicalTrials.go%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Cumming, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edfeldt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evertsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, S. L.</span><span> </span><span class="NLM_article-title">Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1021/jm501038s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501038s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=278-293&author=J.+G.+Cummingauthor=J.+E.+Debreczeniauthor=F.+Edfeldtauthor=F.+Evertssonauthor=M.+Harrisonauthor=G.+A.+Holdgateauthor=M.+J.+Jamesauthor=S.+G.+Lamontauthor=K.+Oldhamauthor=J.+E.+Sullivanauthor=S.+L.+Wells&title=Discovery+and+characterization+of+MAPK-activated+protein+kinase-2+prevention+of+activation+inhibitors&doi=10.1021%2Fjm501038s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm501038s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501038s%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DEdfeldt%26aufirst%3DF.%26aulast%3DEvertsson%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DM.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DOldham%26aufirst%3DK.%26aulast%3DSullivan%26aufirst%3DJ.%2BE.%26aulast%3DWells%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520MAPK-activated%2520protein%2520kinase-2%2520prevention%2520of%2520activation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D278%26epage%3D293%26doi%3D10.1021%2Fjm501038s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2oza" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2oza','PDB','2oza'); return false;">PDB: 2oza</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4tyh" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4tyh','PDB','4tyh'); return false;">PDB: 4tyh</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2onl" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2onl','PDB','2onl'); return false;">PDB: 2onl</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ka0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ka0','PDB','3ka0'); return false;">PDB: 3ka0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ny3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ny3','PDB','1ny3'); return false;">PDB: 1ny3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1nxk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1nxk','PDB','1nxk'); return false;">PDB: 1nxk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kwp" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kwp','PDB','1kwp'); return false;">PDB: 1kwp</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3a2c" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3a2c','PDB','3a2c'); return false;">PDB: 3a2c</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3wi6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3wi6','PDB','3wi6'); return false;">PDB: 3wi6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kc3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kc3','PDB','3kc3'); return false;">PDB: 3kc3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2p3g" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2p3g','PDB','2p3g'); return false;">PDB: 2p3g</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyk','PDB','3fyk'); return false;">PDB: 3fyk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyj" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fyj','PDB','3fyj'); return false;">PDB: 3fyj</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pzy" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pzy','PDB','2pzy'); return false;">PDB: 2pzy</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jbo" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jbo','PDB','2jbo'); return false;">PDB: 2jbo</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r2y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r2y','PDB','3r2y'); return false;">PDB: 3r2y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r30" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3r30','PDB','3r30'); return false;">PDB: 3r30</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kga" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kga','PDB','3kga'); return false;">PDB: 3kga</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3m2w" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3m2w','PDB','3m2w'); return false;">PDB: 3m2w</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fpm" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3fpm','PDB','3fpm'); return false;">PDB: 3fpm</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01457&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-8%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01457" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01457" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2d97df5c3c16","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
